0001144204-15-054993.txt : 20150924 0001144204-15-054993.hdr.sgml : 20150924 20150915144042 ACCESSION NUMBER: 0001144204-15-054993 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20150531 FILED AS OF DATE: 20150915 DATE AS OF CHANGE: 20150915 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DYNACQ HEALTHCARE INC CENTRAL INDEX KEY: 0000890908 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 760375477 STATE OF INCORPORATION: NV FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-21574 FILM NUMBER: 151107543 BUSINESS ADDRESS: STREET 1: 4301 VISTA ROAD CITY: PASADENA STATE: TX ZIP: 77504 BUSINESS PHONE: 713-378-2000 MAIL ADDRESS: STREET 1: 4301 VISTA ROAD CITY: PASADENA STATE: TX ZIP: 77504 FORMER COMPANY: FORMER CONFORMED NAME: DYNACQ INTERNATIONAL INC DATE OF NAME CHANGE: 19960126 10-Q 1 v419848_10q.htm 10-Q

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended May 31, 2015

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _______________ to _________________________

 

Commission File Number: 000-21574

 

DYNACQ HEALTHCARE, INC.

(Exact name of registrant as specified in its charter)

 

Nevada 76-0375477
(State or other jurisdiction of (I.R.S. Employer Identification No.)
incorporation or organization)  
   
4301 Vista Road  
Pasadena, Texas 77504
(Address of principal executive offices) (Zip Code)

 

(713) 378-2000

(Registrant’s telephone number, including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes x No ¨

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. (Check One):

 

Large accelerated filer ¨ Accelerated filer ¨ Non-accelerated filer ¨ Smaller reporting company x

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

 

As of August 31, 2015, the number of shares outstanding of the registrant's common stock, par value $.001 per share, was 13,460,124.

 

 

 

 

Table of Contents

 

    Page
     
PART I—FINANCIAL INFORMATION 3
   
Item 1. Financial Statements. 3
     
  Consolidated Balance Sheets as of May 31, 2015 and August 31, 2014. 3
     
  Consolidated Statements of Operations for the three and nine months ended May 31, 2015 and 2014. 5
     
  Consolidated Statements of Comprehensive Income (Loss) for the three and nine months ended May 31, 2015 and 2014. 6
     
  Consolidated Statements of Cash Flows for the nine months ended May 31, 2015 and 2014. 7
     
  Notes to Consolidated Financial Statements. 8
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations. 17
     
Item 3. Quantitative and Qualitative Disclosures About Market Risk. 23
     
Item 4. Controls and Procedures. 23
     
PART II–OTHER INFORMATION 23
   
Item 1. Legal Proceedings. 23
     
Item 1A. Risk Factors. 24
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds. 24
     
Item 3. Defaults Upon Senior Securities. 24
     
Item 4. Mine Safety Disclosures. 24
     
Item 5. Other Information. 24
     
Item 6. Exhibits. 25
     
Signatures 26
     
Index of Exhibits 27

 

 2 
 

 

PART I - FINANCIAL INFORMATION

 

ITEM 1 - FINANCIAL STATEMENTS

 

Dynacq Healthcare, Inc.

Consolidated Balance Sheets

 

   May 31, 2015   August 31, 2014 
   (Unaudited)     
Assets          
Current assets:          
Cash and cash equivalents  $17,554,608   $16,819,504 
Accounts receivable, net of allowances of approximately $122,597,000 and $154,132,000   1,037,864    1,986,633 
Accounts receivable, other   355,531    380,456 
Inventories   248,638    298,662 
Interest receivable   99,311    122,041 
Prepaid expenses   60,258    262,944 
Total current assets   19,356,211    19,870,240 
Investments available-for-sale   12,049,876    20,678,130 
Property and equipment, net   6,315,953    6,224,136 
Income tax receivable   800,920    800,920 
Other assets   187,101    187,101 
Total assets  $38,710,060   $47,760,527 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 3 
 

 

Dynacq Healthcare, Inc.

Consolidated Balance Sheets (continued)

 

   May 31, 2015   August 31, 2014 
   (Unaudited)     
Liabilities and equity          
Current liabilities:          
Accounts payable  $1,348,121   $1,015,856 
Accrued liabilities   16,246,301    18,512,986 
Current portion of notes payable       6,734 
Current portion of capital lease obligations   30,259    26,513 
Total current liabilities   17,624,681    19,562,089 
Non-current liabilities:          
Long-term portion of capital lease obligations   15,789    41,123 
Total liabilities   17,640,470    19,603,212 
           
Commitments and contingencies          
           
Equity:          
Dynacq stockholders’ equity:          
Preferred stock, $.01 par value; 5,000,000 shares authorized, none issued or outstanding        
Common stock, $.001 par value; 100,000,000 shares authorized, 14,418,626 shares issued and 13,460,124 shares outstanding at May 31, 2015; 14,418,626 shares issued and 13,888,010 shares outstanding at August 31, 2014   14,419    14,419 
Treasury stock, 958,502 shares at May 31, 2015 and 530,616 shares at August 31, 2014, at cost   (172,115)   (27,061)
Additional paid-in capital   10,627,768    10,479,745 
Accumulated other comprehensive income   8,229,315    12,616,346 
Retained earnings   2,306,344    5,010,061 
Total Dynacq stockholders’ equity   21,005,731    28,093,510 
Non-controlling interest   63,859    63,805 
Total equity   21,069,590    28,157,315 
Total liabilities and equity  $38,710,060   $47,760,527 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 4 
 

 

Dynacq Healthcare, Inc.

Consolidated Statements of Operations

(Unaudited)

 

   Three months ended May 31,   Nine months ended May 31, 
   2015   2014   2015   2014 
Net patient service revenue  $1,047,426   $2,748,772   $5,120,992   $7,239,406 
Costs and expenses:                    
Compensation and benefits   1,584,218    1,588,618    4,865,531    4,632,833 
Medical services and supplies   252,614    532,021    1,107,839    1,453,584 
Other operating expenses   1,296,099    1,158,181    3,834,285    3,316,921 
Depreciation and amortization   87,143    85,788    260,223    280,632 
Total costs and expenses   3,220,074    3,364,608    10,067,878    9,683,970 
Operating loss   (2,172,648)   (615,836)   (4,946,886)   (2,444,564)
Other income (expense):                    
Rent and other income   2,118,542    194,775    1,950,393    611,884 
Interest income   178,921    226,705    607,980    653,320 
Interest expense   (108,186)   (105,113)   (315,151)   (346,535)
Total other income, net   2,189,277    316,367    2,243,222    918,669 
Income (loss) before income taxes   16,629    (299,469)   (2,703,664)   (1,525,895)
Provision (benefit) for income taxes                
Net income (loss)   16,629    (299,469)   (2,703,664)   (1,525,895)
Less:  Net (income) loss attributable to noncontrolling interest   32    29    (53)   (4)
Net income (loss) attributable to Dynacq Healthcare, Inc.  $16,661   $(299,440)  $(2,703,717)  $(1,525,899)
Basic and diluted income (loss) per common share  $0.00   $(0.02)  $(0.20)  $(0.11)
Basic and diluted average common shares outstanding   13,674,067    14,418,626    13,802,433    14,431,126 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 5 
 

 

Dynacq Healthcare, Inc.

Consolidated Statements of Comprehensive Income (Loss)

(Unaudited)

 

   Three months ended May 31,   Nine months ended May 31, 
   2015   2014   2015   2014 
Net income (loss)  $16,629   $(299,469)  $(2,703,664)  $(1,525,895)
Other comprehensive income (loss):                    
Net change in fair value of available-for-sale securities, net of taxes of $-0-   (1,895,533)   1,194,983    (4,387,031)   3,766,295 
Other comprehensive income (loss)   (1,895,533)   1,194,983    (4,387,031)   3,766,295 
Comprehensive income (loss)   (1,878,904)   895,514    (7,090,695)   2,240,400 
Less comprehensive (income) loss attributable to noncontrolling interest   32    29    (53)   (4)
Comprehensive income (loss) attributable to Dynacq Healthcare, Inc.  $(1,878,872)  $895,543   $(7,090,748)  $2,240,396 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 6 
 

 

Dynacq Healthcare, Inc.

Consolidated Statements of Cash Flows

(Unaudited)

 

   Nine months ended May 31, 
   2015   2014 
Cash flows from operating activities          
Net loss  $(2,703,664)  $(1,525,895)
Adjustments to reconcile net loss to net cash from operating activities:          
Depreciation and amortization   260,223    280,632 
Gain on sale of investments available-for-sale and trading securities   (2,094,000)   (161,864)
Stock based compensation   148,023    148,023 
Gain on sale of assets   (2,750)    
Foreign currency exchange (gains) losses   335,223    (60,485)
Changes in operating assets and liabilities:          
Accounts receivable   948,769    (752,967)
Accounts receivable, other   24,925     
Interest receivable   22,730    (50,513)
Inventories   50,024    (11,677)
Prepaid expenses   202,686    34,464 
Income tax receivable       569,430 
Accounts payable   332,265    (29,916)
Accrued liabilities   (2,239,623)   4,240,480 
Net cash from operating activities   (4,715,169)   2,679,712 
           
Cash flows from investing activities          
Sales proceeds of investments available-for-sale and trading securities   6,000,000    1,233,286 
Purchase of equipment   (352,040)   (231,280)
Sales proceeds of equipment   2,750     
Net cash from investing activities   5,650,710    1,002,006 
          
Cash flows from financing activities          
Principal payments on notes payable   (6,734)   (30,028)
Purchase of treasury stock   (172,115)    
Payments on capital lease   (21,588)   (108,776)
Net cash from financing activities   (200,437)   (138,804)
           
Net change in cash and cash equivalents   735,104    3,542,914 
Cash at beginning of period   16,819,504    13,585,447 
Cash at end of period  $17,554,608   $17,128,361 
Supplemental cash flow disclosures          
Cash paid during the period for:          
Interest  $2,527   $21,564 
Income taxes  $0   $0 
Non cash investing and financing activities:          
Unrealized change in fair value of available-for-sale securities  $(4,387,031)  $3,766,295 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 7 
 

 

Dynacq Healthcare, Inc.

 

Notes to Consolidated Financial Statements

 

May 31, 2015

(Unaudited)

 

General

 

Dynacq Healthcare, Inc., a Nevada corporation (the “Company”), is a holding company that through its subsidiaries in the United States develops and manages general acute care hospitals that principally provide specialized surgeries. The Company through its United States subsidiaries owns and operates one general acute care hospital in Pasadena, Texas. The Company through its subsidiary in Hong Kong invests in debt and equity securities, including short-term investments in initial public offerings and pre-initial public offerings.

 

Basis of Presentation

 

The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete consolidated financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. All such adjustments are of a normal and recurring nature. The majority of the Company's expenses are "cost of revenue" items. Costs that could be classified as general and administrative by the Company would include the corporate office costs, including advertising and marketing expenses, which were approximately $1.1 million and $1.0 million for the three months ended May 31, 2015 and 2014, respectively, and approximately $3.0 million and $2.8 million for the nine months ended May 31, 2015 and 2014, respectively. These financial statements should be read in conjunction with the audited financial statements as of August 31, 2014. Operating results for the three and nine months ended May 31, 2015 are not necessarily indicative of the results that may be expected for the year ending August 31, 2015.

 

Reclassification

 

Certain previously reported financial information has been reclassified to conform to the current period’s presentation. The impact of such reclassification was not significant to the prior period’s overall presentation.

 

Cash and Cash Equivalents

 

The Company considers all highly liquid instruments with maturities of three months or less on the date of purchase to be cash equivalents. Cash equivalents are carried at cost, which approximates fair value.

 

Investments in Available-for-Sale and Trading Securities

 

The Company’s investments in debt instruments (corporate and municipal bonds) are recorded at fair value based on quoted market prices that are traded in less active markets or priced using a quoted market price for similar investments or are priced using non-binding market consensus prices that can be corroborated by observable market data (Level 2). These investments are classified as available-for-sale securities. These investments are subject to default risk. Unrealized gains in the fair value are reported in accumulated other comprehensive income, net of related income tax effect. The Company regularly monitors its investment portfolio for any decline in fair value that is other than temporary and records any such impairment as an impairment loss. The determination of the gain or loss on the sale of any security is made using the specific identification method. During the three months ended May 31, 2015, one particular security was called with sales proceeds of $6 million, on which the Company had a gain of approximately $2.1 million.

 

The Company also invested in initial public offerings of equity securities on the Hong Kong Stock Exchange. These investments are classified as trading securities, and were carried at fair value. These investments were subject to fluctuations in the market price. During the nine months ended May 31, 2014, the Company had a net gain of $161,864 in these securities. During the first quarter of fiscal year 2014, the Company sold all of its trading securities and has not held any such securities since November 30, 2013.

 

 8 
 

 

Notes Payable

 

In November 2011, the Company borrowed $116,339 as notes payable from a financial institution at an interest rate of 4.5%, which was to be repaid in 36 monthly installments, and was secured by specific equipment purchased at our Pasadena facility. The Company paid down the balance of $6,734 of notes payable during the three months ended November 30, 2014.

 

Inventories

 

Inventories, consisting primarily of medical supplies, are stated at the lower of cost or market, with cost determined by use of the average cost method.

 

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The most significant of the Company’s estimates is the determination of revenue to recognize for the services the Company provides and the determination of allowances, which includes the contractual allowance and the provision for doubtful accounts. See “Revenue Recognition” below for further discussion. Actual results could differ materially from those estimates used in the preparation of these financial statements.

 

Net Income (Loss) per Common Share

 

The following table presents the computation of basic and diluted income (loss) per common share attributable to the Company:

 

   Three months ended May 31,   Nine months ended May 31, 
   2015   2014   2015   2014 
Basic and diluted loss per common share:                    
Numerator:                    
Net income (loss)  $16,629   $(299,469)  $(2,703,664)  $(1,525,895)
Less:  Net (income) loss attributable to noncontrolling interest   32    29    (53)   (4)
Net income (loss) attributable to Dynacq Healthcare, Inc.  $16,661   $(299,440)  $(2,703,717)  $(1,525,899)
Denominator:                    
Basic and diluted average common shares outstanding   13,674,067    14,418,626    13,802,433    14,431,126 
Basic and diluted income (loss) per common share:  $0.00   $(0.02)  $(0.20)  $(0.11)

 

Basic net income (loss) per share is computed by dividing net income (loss) available to common shareholders by the weighted average number of common shares outstanding for the reporting period. Diluted net income (loss) per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. For the calculation of diluted net income (loss) per share, the basic weighted average number of shares is increased by the dilutive effect of stock options determined using the treasury stock method. However, if it is anti-dilutive, the dilutive effect of the stock options is not included in the calculation of diluted net income (loss) per share. Stock options with exercise prices exceeding current market prices that were excluded from the computation of net income (loss) per share amounted to approximately 784,000 shares and 1,013,000 shares for the nine months ended May 31, 2015 and 2014, respectively.

 

Treasury Stock

 

In September 2013, as part of a settlement agreement with a former employee, the Company received 125,000 shares of common stock of the Company previously issued to him. These shares were accounted for as treasury shares with zero cost, and were retired in the second quarter of fiscal year 2014.

 

 9 
 

 

In August 2014 and April 2015, binding settlement agreements were reached with some of the shareholders in a law suit whereby the Company received 530,616, shares and 427,886 shares, respectively, of stock owned by the shareholders. Based on an independent appraisal, the value of these shares repurchased as treasury stock were $27,061 and $145,054, respectively.

 

Stock Based Compensation

 

Year 2011 Stock Incentive Plan

 

The purpose of the Year 2011 Stock Incentive Plan (“2011 Plan”) is to strengthen the Company by providing an incentive to its employees, officers, consultants and directors and to encourage them to devote their abilities and industry to the success of the Company’s business enterprise. It is intended that this purpose be achieved by extending to employees, officers, consultants and directors of the Company and its subsidiaries an added long-term incentive for high levels of performance and unusual efforts through the grant of incentive stock options, non-qualified stock options, stock appreciation rights, dividend equivalent rights, performance awards and restricted stock. The Company has reserved 15,000,000 shares of common stock for issuance under the 2011 Plan. As of May 31, 2015, there remain 250,000 shares to be issued upon exercise of outstanding options, and 14,750,000 shares which can be issued under the 2011 Plan after giving effect to shares issued and canceled.

 

2000 Incentive Plan

 

The Company's 2000 Incentive Plan ("2000 Plan") provides for options and other stock-based awards that may be granted to eligible employees, officers, consultants and non-employee directors of the Company or its subsidiaries. The Company had reserved 5,000,000 shares of common stock for future issuance under the 2000 Plan. The 2000 Plan does not have a fixed termination date, provided that no incentive stock option can be granted subsequent to August 29, 2011. As of May 31, 2015, there remain 534,000 shares to be issued upon exercise of outstanding options, and no new stock options awards will be issued under the 2000 Plan.

 

The following table summarizes the stock option activities for the nine months ended May 31, 2015 (share amounts in thousands):

   Shares   Weighted Average
Option Exercise
Price Per Share
 
Outstanding, August 31, 2014   995   $2.18 
Granted        
Exercised        
Expired or canceled   (211)   4.27 
Outstanding, May 31, 2015   784    1.62 

 

For the nine months ended May 31, 2015 and 2014, there were no stock options exercised. The aggregate intrinsic value of the stock options outstanding as of May 31, 2015 and 2014 is $-0-, since the market price is lower than the exercise price.

 

The following summarizes information related to stock options outstanding as of May 31, 2015, and related weighted average price and life information:  

 

    Options Outstanding   Options Exercisable 
Exercise Prices   Number of
Shares
   Weighted Average
Remaining Contractual
Life (Years)
   Number of Shares 
    (Share Amounts In Thousands) 
$1.10    250    6.6    188 
$1.86    534    6.1    401 
Total    784    6.3    589 

 

 10 
 

 

For the three months ended May 31, 2015 and 2014, stock-based compensation expense associated with the Company’s stock options was $49,341 in each period. For the nine months ended May 31, 2015 and 2014, stock-based compensation expense associated with the Company’s stock options was $148,023 in each period. The total unrecognized compensation expense for outstanding stock options as of May 31, 2015 was $33,000, and will be recognized, in general, over five months.

 

Fair Value of Financial Instruments

 

The fair value of financial instruments is estimated based on market trading information, where available. Absent published market values for an instrument or other assets, management uses observable market data to arrive at its estimates of fair value. Management believes that the carrying amount of cash and cash equivalents, accounts receivable and accrued liabilities approximate fair value. Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. A three-level fair value hierarchy prioritizes the inputs used to measure fair value. The three levels of inputs used to measure fair value are as follows:

 

Level 1  Quoted prices in active markets for identical assets or liabilities.

 

Level 2  Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted price for identical or similar assets and liabilities in markets that are not active; or other input that are observable or can be corroborated by observable market data.

 

Level 3  Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. This includes certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.

 

The following table summarizes our financial assets and liabilities measured and reported in the Company’s statement of financial position at fair value on a recurring basis as of May 31, 2015, segregated among the appropriate levels within the fair value hierarchy:

 

   Quoted prices in active
markets for identical
   Significant other
observable inputs
   Significant
unobservable
 
   (Level 1)   (Level 2)   (Level 3) 
Assets               
Investments available-for-sale  $   $12,049,876   $ 

 

The Company’s investments in Level 2 are in perpetual debt instruments (corporate and municipal bonds) traded on the European markets, at a cost of $4,078,646, are recorded at fair value based on quoted market prices that are traded in less active markets or priced using a quoted market price for similar investments or are priced using non-binding market consensus prices that can be corroborated by observable market data (Level 2), and there has been no change in valuation techniques for these investments (Level 2).

 

Foreign Currency Translation

 

The functional currency of the Company as a whole is the U.S. Dollar. The Company has designated the U.S. Dollar as the functional currency for Sino Bond Inc. Limited, a Hong Kong corporation and wholly owned subsidiary of the Company (“Sino Bond”). The effects of foreign currency exchange adjustments are included as a component of Rent and Other Income in the Consolidated Statements of Operations.

 

Revenue Recognition

 

Background

 

The Company's revenue recognition policy is significant because net patient service revenue is a primary component of its results of operations. Revenue is recognized as services are delivered. The determination of the amount of revenue to be recognized in connection with the Company's services is subject to significant judgments and estimates, which are discussed below.

 

 11 
 

 

Revenue Recognition Policy

 

The Company has established billing rates for its medical services which it bills as services are delivered. Gross billings are then reduced by the Company’s estimate of allowances, which includes the contractual allowance and the provision for doubtful accounts, to arrive at net patient service revenues. Net patient service revenues may not represent amounts ultimately collected. The Company adjusts current period revenue for differences in estimated revenue recorded in prior periods and actual cash collections.

 

The following table shows gross revenues and allowances for the three and nine months ended May 31, 2015 and 2014:

 

   Three months ended May 31,   Nine months ended May 31, 
   2015   2014   2015   2014 
                 
Gross billed charges  $5,798,725   $8,148,181   $22,116,554   $21,806,599 
Allowances   4,751,299    5,399,409    16,995,562    14,567,193 
Net revenue  $1,047,426   $2,748,772   $5,120,992   $7,239,406 
Allowance percentage   82%   66%   77%   67%

 

Contractual Allowance

 

The Company computes its contractual allowance based on the estimated collections on its gross billed charges. The Company computes its estimate by taking into account collections received, up to 30 days after the end of the period, for the services performed and also estimating amounts collectible for the services performed within the last six months. A significant amount of our net revenue results from Texas workers' compensation claims, which are governed by the rules and regulations of the Texas Department of Workers’ Compensation (“TDWC”) and the workers’ compensation healthcare networks. If our hospital chooses to participate in a network, the amount of revenue that will be generated from workers’ compensation claims will be governed by the network contract.

 

For claims arising prior to the implementation of workers’ compensation networks and out of network claims, inpatient and outpatient surgical services are either reimbursed pursuant to the Acute Care In-Patient Hospital Fee Guideline or at a "fair and reasonable" rate for services in which the fee guideline is not applicable. Starting March 1, 2008, the Texas Workers’ Compensation 2008 Acute Care Hospital Outpatient and Inpatient Facility Fee Guidelines (the “Guidelines”) became effective. Under these Guidelines, the reimbursement amounts are determined by applying the most recently adopted and effective Medicare reimbursement formula and factors; however, if the maximum allowable reimbursement for the procedure performed cannot be calculated using these Guidelines, then reimbursement is determined on a fair and reasonable basis.

 

Should we disagree with the amount of reimbursement provided by a third-party payer, we are required to pursue the medical dispute resolution (“MDR”) process at the TDWC to request proper reimbursement for services. From January 2007 to November 2008, the Company had been successful in its pursuit of collections regarding the stop-loss cases pending before the State Office of Administrative Hearings (“SOAH”), receiving positive rulings in over 90% of its claims presented for administrative determination. A 2007 district court decision upholding our interpretation of the statute as applied to the stop-loss claims was appealed by certain insurance carriers, and on November 13, 2008 the Third Court of Appeals determined that in order for a hospital to be reimbursed at 75% of its usual and customary audited charges for an inpatient admission, the hospital must not only bill at least $40,000, but also show that the admission involved unusually costly and unusually extensive services. Procedurally, the decision means that each case where a carrier raised an issue regarding whether the services provided were unusually costly or unusually extensive would be remanded to either SOAH or MDR for a case-by-case determination of whether the services provided meet these standards. As a result of the Third Court of Appeals opinion, any stop-loss cases pending at SOAH have been remanded to the TDWC since these cases have not been reviewed or decided by the two-prong standard decided by the Third Court of Appeals. The SOAH Administrative Law judges determined that the most appropriate location for these cases is the TDWC.

 

A petition asking the Texas Supreme Court to review the Third Court of Appeals decision has been denied. Therefore, the Company is bound by the Third Court of Appeals decision. The Texas Supreme Court’s decision delayed final adjudication in these pending stop-loss cases. The uncertain outcome in these cases will depend on a very lengthy process. We anticipate further, lengthy litigation at the Travis County District Courts and the Texas Courts of Appeals. Because of this lengthy process and the uncertainty of recovery in these cases, collection of a material amount of funds in these pending stop-loss cases cannot be anticipated.

 

 12 
 

 

Through May 2015, insurance carriers have voluntarily paid the awards in the decisions and orders issued by SOAH, plus interest, in approximately 180 cases, involving approximately $11 million in claims. In most of these cases, when the payments were made, the carriers requested refunds of the payments made in the event that the SOAH decisions and orders were reversed on appeal (which they were). Our request that the TDWC Commissioner enforce the awards which were not voluntarily paid by the carriers was refused in approximately 130 cases. As a result of the reversal of the SOAH decisions and orders, Texas Mutual Insurance Company and other carriers filed petitions in Travis County district court seeking a refund in cases in which the awards were voluntarily paid. The district court found in favor of Texas Mutual and the Company was ordered to refund approximately $4.2 million, including prejudgment interest, pending remand for a case-by-case determination of whether the services provided were unusually costly and unusually extensive. The Company did not object to the reversal and remand of the SOAH decisions and orders, but did object to the judgments ordering refunds and those judgments were appealed to the Third Court of Appeals. As part of the appeals, the Company deposited the amounts that were ordered to be refunded as cash deposits into the registry of the court in order to stay execution of the judgments ordering refunds. On June 6, 2013, the judgments ordering refunds were reversed by the Court of Appeals. The Court of Appeals held that if Texas Mutual wants a refund, it must pursue the refund demand administratively through the TDWC rather than through the district courts. Texas Mutual filed a motion for rehearing with the Court of Appeals which ultimately was denied. The Company filed motions in all 47 cases with the district court asking that the district clerk be ordered to release the deposited funds to the Company, and in January 2014, the Company received the deposits and accrued interest totaling $4.2 million. In addition, Texas Mutual filed three additional petitions in district court for cases that were left out of the original 47. The court granted Texas Mutual’s petitions and ordered the Company to refund approximately $300,000, including prejudgment interest to Texas Mutual. These judgments were granted before the Court of Appeals reversed the district court’s original judgments. These three cases were appealed to the Court of Appeals and the funds ordered refunded were deposited with the district clerk. As with the other 47 cases, the Court of Appeals reversed the district court’s final judgments in these three cases and the Company filed motions with the district court asking that the district clerk be ordered to release the deposited funds to the Company, and in February 2014, the Company received the deposits and accrued interest totaling approximately $300,000. The total refund received by the Company in fiscal year 2014 for the 50 stop-loss cases discussed above was $4,476,097.

 

During the time that the carriers’ petitions seeking refunds were pending, because of the uncertainty of the results at that time, as of May 31, 2015, the Company has accrued the total potential refund amount of $11.3 million, and an additional amount of $3.8 million in interest payable, as accrued liabilities. This includes the deposit amounts refunded back to the Company in January and February 2014. We do not anticipate that any other carriers will pursue refund demands through district court but instead will pursue them administratively through TDWC. The cases in which the SOAH decisions and orders were reversed have been or are being remanded to TDWC for determinations of whether the services provided were unusually costly and unusually extensive. The carriers contend that the voluntary payments made pursuant to the Decisions and Orders were premature payments by the carriers and may be ordered to be refunded. The Company disagrees with this contention. After the reversal of the judgments it obtained from the district court ordering refunds, on December 4, 2013, Texas Mutual made a formal request to the Commissioner of Workers’ Compensation that he administratively order the Company to make refunds to Texas Mutual (in the same amount that was sought in the district court). The Company responded to this request on December 11, 2013, asking that it be denied. The matter is pending at this time. As to the matters remanded to TDWC and SOAH, once the Company is given the opportunity to present its evidence regarding whether the services provided were unusually costly and unusually extensive, the Company anticipates that it will prevail in many of the underlying stop-loss fee disputes and that payments refunded to the carriers will be recaptured. In March 2014, a settlement conference with one self-insured entity successfully resolved the stop-loss cases in which that entity was involved. Although the Company is willing to participate in settlement negotiations, we anticipate that few, if any, other carriers are interested in doing so at this time. It is anticipated that hearings at SOAH on the pending stop-loss cases will begin in November 2015.

 

Due to the uncertainties associated with these stop-loss fee dispute cases, the Company recognized increases in the contractual allowance at our Pasadena facility of $10,254,990 during fiscal year 2011 and $149,875 during the fiscal quarter ended August 31, 2013, (and an additional contractual allowance amount of $779,583 during fiscal year 2011 and $136,542 during the fiscal quarter ended August 31, 2013, at our Garland facility, which was classified as discontinued operations). The Company has also recognized interest expense related to these refunds starting from fiscal year 2011.

 

 13 
 

 

Some claims regarding payment for ambulatory surgical center and hospital outpatient services remain pending at the TDWC and/or SOAH. It is expected that these remaining claims will be adjudicated at SOAH and possibly in the Texas district and appellate courts. The basis for reimbursement for these services made the subject of these pending cases is the same as it was for the other ASC and outpatient cases that have been either tried or settled: the determination of “fair and reasonable” charges. In 2007, the Company received unfavorable rulings from SOAH in all of its appeals of unfavorable decisions related to services provided in 2001 and 2002. The 179 cases, which were appealed to the Travis County district courts, challenged the constitutionality of the relevant statutory language. The Company received an unfavorable ruling in its lead case in March 2009, which ruling was appealed to and was upheld by the Third Court of Appeals on August 26, 2010. The Texas Supreme Court denied a petition asking for review of the Third Court of Appeals decision. The unfavorable interpretation by the Texas Courts of Appeal in the Company’s lead case negatively affects the recovery of additional reimbursement, not only in the lead case, but in the remaining 178 pending cases. Consequently, the Company is bound by the Third Court of Appeals’ ruling that interprets the applicable statute and fee guideline to require that the amount that will be paid to a provider must not only be at a “fair and reasonable rate” but also must “ensure the quality of medical care” and “achieve effective cost control” and be the same or less than that charged to others with an equivalent standard of living. This ruling has impacted cases in which a fee guideline was not applicable, specifically all pending cases involving ambulatory surgical services provided from 2001 through 2004 as well as all pending cases involving hospital outpatient services provided prior to March 1, 2008, when the Guidelines took effect. Since the Third Court of Appeals’ unfavorable ruling, collection, if any, in these cases depends on the Company’s ability to establish the criteria in this ruling. The Company was given the opportunity to establish the criteria in approximately 80 cases, which were set for hearing on the merits from March through May 2012 and was unsuccessful. In 2014, hearings were held in 23 of the Company’s hospital outpatient cases at SOAH. Decisions and Orders were handed down by SOAH adopting the methodology for determining “fair and reasonable” reimbursement that was put forth by the Company and ordered additional reimbursement in each of the 23 cases plus interest be paid to the Company. The carrier has appealed these decisions to Travis County district court and the cases have been consolidated. In April 2015 a large group of outpatient cases with various carriers were tried at SOAH. The Company and the carriers have presented their evidence and the parties’ closing arguments were filed in June 2015.

 

Due to the uncertainties regarding the accounts receivable in the MDR process, the 2008 and 2010 Third Court of Appeals’ opinions and our legal counsel’s advice that settlements with insurance carriers in stop-loss cases have virtually stopped, the Company had fully reserved all accounts receivable related to the MDR process as of August 31, 2008. The Company has had settlement negotiations with insurance carriers for ambulatory surgical center and hospital outpatient cases. Some of these negotiations have been successful. Any monies collected for these MDR accounts receivable is recorded as current period’s net patient service revenues.

 

Provision for Doubtful Accounts

 

Although outcomes vary, our policy is to attempt to collect amounts due from patients, including co-payments and deductibles due from patients with insurance, at the time of service while complying with all federal and state laws and regulations. In non-emergency circumstances or for elective procedures and services, it is our policy to verify insurance prior to a patient being treated; however, there are various exceptions that can occur.

 

The Company computes its allowances based on the estimated collections on its gross billed charges. The Company computes its estimate of allowance, which is a combination of contractual allowance and provision for doubtful accounts, by taking into account collections received, up to 30 days after the end of the period, for the services performed and also estimating amounts collectible for the services performed within the last six months.

 

Accounts receivable represent net receivables for services provided by the Company. At each balance sheet date management reviews the accounts receivable for collectibility and provides full allowance reserves for any accounts receivable deemed uncollectible.

 

The allowances stated as a percentage of gross receivables at the balance sheet dates is larger than the allowance percentage used to reduce gross billed charges due to the application of partial cash collections to the outstanding gross receivable balances, without any adjustment being made to the allowances. The allowance amounts netted against gross receivables are not adjusted until such time as the final collections on an individual receivable are recognized.

 

The focal point of our business is providing patient care services, including complex orthopedic and bariatric procedures. The Company pursues optimal reimbursement from third-party payers for these services. In some instances, we do not have contractual arrangements with third-party payers which provide for “prompt payment” which may result in additional time to collect the expected reimbursement.

 

 14 
 

 

The collection process may also be extended due to our efforts to obtain all optimal reimbursement available to the Company. Specifically, for medical services provided to injured workers, the Company may initially receive reimbursement that may not be within the fee guidelines or regulatory guidelines mandating reimbursement. The Company reviews and pursues those particular claims that are determined to warrant additional reimbursement pursuant to the fee or regulatory guidelines. The Company's pursuit of additional reimbursement amounts that it believes are due under fee or regulatory guidelines may be accomplished through established dispute resolution procedures with applicable regulatory authorities.

 

Noncontrolling Interest

 

The equity of minority investors (minority investors are generally physician groups and other healthcare providers that perform surgeries at the Company’s facilities) in certain subsidiaries of the Company is reported on the consolidated balance sheets as noncontrolling interest. Noncontrolling interest reported in the consolidated income statements reflect the respective interests in the income or loss of the limited partnerships or limited liability companies attributable to the minority investors (equity interest was 1% at May 31, 2015).

 

Accumulated Other Comprehensive Income (Loss)

 

The following table summarizes the changes in accumulated other comprehensive income (loss) by component:

 

   Three months ended May 31,   Nine months ended May 31, 
   2015   2014   2015   2014 
Available-for-sale securities                    
Accumulated other comprehensive income balance, beginning of period  $10,124,848   $11,953,646   $12,616,346   $9,382,334 
Other comprehensive income (loss):                    
Unrealized gains (losses), net of taxes of $-0-   198,467    1,194,983    (2,293,031)   3,766,295 
Reclassification adjustments for gains included in rent and other income   (2,094,000)       (2,094,000)    
Tax provision                
Amount reclassified from accumulated other comprehensive income   (2,094,000)       (2,094,000)    
Other comprehensive income (loss)   (1,895,533)   1,194,983    (4,387,031)   3,766,295 
Accumulated other comprehensive income balance, end of period  $8,229,315   $13,148,629   $8,229,315   $13,148,629 

 

Contingencies

 

Due to the uncertainties associated with the stop-loss fee dispute cases, the Company has accrued an amount of $11.3 million, and an additional amount of $3.8 million in interest payable, as accrued liabilities. For a detailed discussion of this, see Revenue Recognition Policy under Notes to Consolidated Financial Statements.

 

The Company maintains various insurance policies that cover its Pasadena facility including occurrence medical malpractice coverage. In addition, all physicians granted privileges at the Pasadena facility are required to maintain medical malpractice insurance coverage. The Company also maintains general liability and property insurance coverage, including flood coverage. The Company does not currently maintain workers’ compensation coverage in Texas. In regard to the Employee Health Insurance Plan, until April 2014, the Company was self-insured with specific and aggregate re-insurance with stop-loss levels appropriate for the Company’s group size. Effective May 1, 2014, the Company has taken coverage for its employees under a fully insured health plan.

 

We do not carry director and officer liability insurance. As permitted under Nevada law and pursuant to our governing documents and indemnification agreements with certain of our officers and directors, we indemnify our directors and officers against monetary damages, including advancing expenses, to the fullest extent permitted by Nevada law.

 

 15 
 

 

Ping S. Chu, James G. Gerace (both former members of our Board of Directors), and Eric G. Carter (former legal counsel) along with eleven other claimants instigated a series of lawsuits making claims against Ella Y.T.C. Chan (in her individual capacity and in her capacity as Independent Executrix of the Estate of Chiu M. Chan, Deceased, our former Chief Executive Officer and director), Eric K. Chan (our current Chief Executive Officer and director), and Dynacq Healthcare, Inc. All claims were settled in mediations and as part of the settlements Dynacq repurchased 530,616 shares of Dynacq common stock in August 2014, and 427,886 shares of Dynacq stock subsequently in April 2015. These buybacks represent all stock held by each of the claimants. Additionally, as part of this settlement, Dynacq settled claims made by Eric G. Carter for payment of attorney fees, and claims by a company controlled by Mr. Carter, for breach of contract. The Company recognized $2,047,652 of expense associated with these settlements during the fiscal year ended August 31, 2014. This amount is reported as other operating expenses in the consolidated statements of operations. A portion of the settlements were attributed to the repurchase of the Company’s common stock.

 

The Company is routinely involved in litigation and administrative proceedings that are incidental to its business. Specifically, all judicial review of unsatisfactory determinations of reimbursement amounts due us for our Texas facilities’ fees must be made in the district courts of Travis County, Texas in what can often be a lengthy procedure.

 

Recent Accounting Pronouncements

 

No recent accounting pronouncements or other authoritative guidance has been issued that management considers likely to have a material impact on our consolidated financial statements.

 

Industry Segments and Geographic Information

 

The Industry Segment “U.S. Division” comprises of the Company’s Pasadena facility. The Company at the present time has the U.S. Division and the Corporate Division.

 

Certain previously reported financial information has been reclassified to conform to the current period’s presentation.

 

Corporate Division

 

The Company formed Sino Bond to hold and manage investments in Hong Kong. Sino Bond invests in debt instruments (corporate and municipal) and equity securities in Europe and Asia, including initial public offerings and pre-initial public offerings. The Company invests in various marketable securities. During the three months ended May 31, 2015, one particular security was called on which the Company had a gain of approximately $2.1 million. As of May 31, 2015, the balance of these securities is valued at approximately $12.0 million. During the nine months ended May 31, 2014, the Company also traded in initial public offerings of equity securities on the Hong Kong Stock Exchange and had a net gain of $161,864 in these securities. During the first quarter of fiscal year 2014, the Company sold all of its trading securities and has not held any such securities since November 30, 2013.

 

The Corporate Division includes interest and other income related to its investments in securities, corporate personnel compensation expenses, and general and administrative expenses. Such expenses and income are not allocated to our operating division, as they relate to our general corporate activities.

 

We generally evaluate performance based on profit or loss from operations before income taxes and non-recurring charges and other criteria. The accounting policies of the reportable segments are the same as those described in the summary of significant accounting policies. There are no transfers between segments.

 

Summarized financial information concerning the business segments from continuing operations is as follows:

 

   Three months ended May 31,   Nine months ended May 31, 
   2015   2014   2015   2014 
Revenues from external customers                    
Net patient service revenues                    
U.S. Division  $1,047,426   $2,748,772   $5,120,992   $7,239,406 
Corporate                
Consolidated  $1,047,426   $2,748,772   $5,120,992   $7,239,406 
                     
Income (loss) before taxes                    
U.S. Division  $(1,284,694)  $186,954   $(2,600,470)  $(165,472)
Corporate   1,301,323    (486,423)   (103,194)   (1,360,423)
Consolidated  $16,629   $(299,469)  $(2,703,664)  $(1,525,895)

 

 16 
 

 

   May 31, 2015   August 31, 2014 
Total Assets          
U.S. Division  $16,488,296   $15,967,472 
Corporate   22,221,764    31,793,055 
Consolidated  $38,710,060   $47,760,527 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

This quarterly report on Form 10-Q contains forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expects,” “intends,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” or the negative of these terms or other comparable terminology. These statements are only predictions. Actual events or results may differ materially. Such forward-looking statements relate to future events or future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our Company’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by the forward-looking statements, including the risks and uncertainties described in “Risk Factors” in our annual report on Form 10-K for the fiscal year ended August 31, 2014. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. You must read the following discussion of the results of our business and our operations and financial condition in conjunction with our consolidated financial statements, including the notes, included in this quarterly report on Form 10-Q and our audited consolidated financial statements, including the notes, included in our Annual Report on Form 10-K for the fiscal year ended August 31, 2014.

 

Update on Critical Accounting Policies and Estimates

 

There have been no changes to the critical accounting policies used in our reporting of results of operations and financial position for the three and nine months ended May 31, 2015. For a discussion of our critical accounting policies see Management's Discussion and Analysis of Financial Condition and Results of Operations in our Form 10-K for the fiscal year ended August 31, 2014.

 

 17 
 

 

Results of Operations

 

   Three Months Ended May 31, 2015   Three Months Ended May 31, 2014 
   U.S.
Division
   Corporate   Total   U.S.
Division
   Corporate   Total 
Net patient service revenue  $1,047,426   $   $1,047,426   $2,748,772   $   $2,748,772 
Costs and expenses:                              
Compensation and benefits   1,008,226    575,992    1,584,218    1,037,457    551,161    1,588,618 
Medical services and supplies   252,614        252,614    532,021        532,021 
Other operating expenses   889,407    406,692    1,296,099    855,476    302,705    1,158,181 
Depreciation and amortization   86,468    675    87,143    84,785    1,003    85,788 
Total costs and expenses   2,236,715    983,359    3,220,074    2,509,739    854,869    3,364,608 
Operating income (loss)   (1,189,289)   (983,359)   (2,172,648)   239,033    (854,869)   (615,836)
Other income (expense):                              
Rent and other income   4,106    2,114,436    2,118,542    44,644    150,131    194,775 
Interest income       178,921    178,921        226,705    226,705 
Interest expense   (99,511)   (8,675)   (108,186)   (96,723)   (8,390)   (105,113)
Total other income (expense), net   (95,405)   2,284,682    2,189,277    (52,079)   368,446    316,367 
Income (loss) before income taxes  $(1,284,694)  $1,301,323    16,629   $186,954   $(486,423)   (299,469)
Provision (benefit) for income taxes                            
Net income (loss)             16,629              (299,469)
Less:  Net loss attributable to noncontrolling interest             32              29 
Net income (loss) attributable to Dynacq Healthcare, Inc.            $16,661             $(299,440)
                               
Operational statistics (Number of medical procedures) for Pasadena facility:                              
Inpatient:                              
Bariatric   9              15           
Orthopedic   14              14           
Other   2              6           
Total inpatient procedures   25              35           
Outpatient:                              
Orthopedic   57              56           
Other   101              130           
Total outpatient procedures   158              186           
Total procedures   183              221           

 

 18 
 

 

   Nine Months Ended May 31, 2015   Nine Months Ended May 31, 2014 
   U.S.
Division
   Corporate   Total   U.S.
Division
   Corporate   Total 
Net patient service revenue  $5,120,992   $   $5,120,992   $7,239,406   $   $7,239,406 
Costs and expenses:                              
Compensation and benefits   3,199,280    1,666,251    4,865,531    2,928,711    1,704,122    4,632,833 
Medical services and supplies   1,107,839        1,107,839    1,453,584        1,453,584 
Other operating expenses   2,875,441    958,844    3,834,285    2,502,108    814,813    3,316,921 
Depreciation and amortization   258,146    2,077    260,223    277,624    3,008    280,632 
Total costs and expenses   7,440,706    2,627,172    10,067,878    7,162,027    2,521,943    9,683,970 
Operating income (loss)   (2,319,714)   (2,627,172)   (4,946,886)   77,379    (2,521,943)   (2,444,564)
Other income (expense):                              
Rent and other income   9,096    1,941,297    1,950,393    76,202    535,682    611,884 
Interest income       607,980    607,980        653,320    653,320 
Interest expense   (289,852)   (25,299)   (315,151)   (319,053)   (27,482)   (346,535)
Total other income (expense), net   (280,756)   2,523,978    2,243,222    (242,851)   1,161,520    918,669 
Loss before income taxes  $(2,600,470)  $(103,194)   (2,703,664)  $(165,472)  $(1,360,423)   (1,525,895)
Benefit for income taxes                            
Net loss             (2,703,664)             (1,525,895)
Less:  Net income attributable to noncontrolling interest             (53)             (4)
Net loss attributable to Dynacq Healthcare, Inc.            $(2,703,717)            $(1,525,899)
                               
Operational statistics (Number of medical procedures) for Pasadena facility:                              
Inpatient:                              
Bariatric   15              50           
Orthopedic   46              32           
Other   6              19           
Total inpatient procedures   67              101           
Outpatient:                              
Orthopedic   223              197           
Other   375              371           
Total outpatient procedures   598              568           
Total procedures   665              669           

 

 19 
 

 

Three Months Ended May 31, 2015 Compared to the Three Months Ended May 31, 2014

 

U.S. Division

 

Due to the uncertainties associated with the stop-loss fee dispute cases, the Company has accrued an amount of $11.3 million, and an additional amount of $3.8 million in interest payable as accrued liabilities. For a detailed discussion of this, see Revenue Recognition discussed in Item 1 - Notes to Consolidated Financial Statements.

 

Net patient service revenue decreased by $1,701,346, or 62%, from $2,748,772 to $1,047,426, and total surgical cases decreased by 17% from 221 cases for the three months ended May 31, 2014 to 183 cases for the three months ended May 31, 2015.  While the number of cases decreased by 17%, net patient service revenue decreased by 62%, primarily due to a change in the surgical mix of cases. The gross billed charges decreased by 28% from $8,148,181 for the three months ended May 31, 2014 to $5,798,725 for the three months ended May 31, 2015. However, due to an increase in allowances from 66% to 82%, net patient service revenue decreased by 62%. The increase in allowances is due to an increased pressure by insurance carriers towards lower reimbursements, and also due to lower collections in the current period compared to the prior period on old accounts receivable that was fully reserved for.

 

Total costs and expenses decreased by $273,024, or 11%, from $2,509,739 for the three months ended May 31, 2014 to $2,236,715 for the three months ended May 31, 2015. The following discusses the various changes in costs and expenses:

 

·Compensation and benefits decreased by $29,231, or 3%, primarily associated with decrease in workforce due to lower gross billed charges.

 

·Medical services and supplies expenses decreased by $279,407 or 53%, primarily due to a 17% decrease in the total number of cases and also due a change in the surgical mix of cases. Inpatient cases decreased by 29%, which generally require more medical services and supplies.

 

·Other operating expenses increased by $33,931, or 4%, primarily due to higher professional fees incurred for implementation of electronic medical records.

 

Other expense for the three months ended May 31, 2015 and 2014 of $95,405 and $52,079, respectively, includes interest expense associated with the stop-loss cases discussed above.

 

Corporate Division

 

Compensation and benefits for the Corporate Division includes all corporate personnel compensation and benefits. It also includes $49,341 of non-cash compensation expense for each of the three months ended May 31, 2015 and 2014, related to employees’ incentive stock options granted in fiscal years 2007, 2011 and 2012. Apart from the stock option expense discussed above, compensation and benefits increased by 5% in 2015, compared to 2014, due to general increases in pay rates.

 

Other operating expenses include all corporate general and administrative expenses, including other professional fees such as legal expenses and audit expenses. It increased by $103,987, from $302,705 for the three months ended May 31, 2014 to $406,692 for the three months ended May 31, 2015. The increase in other operating expenses is due to an increase in legal and other professional fees primarily relating to the law suits that were ongoing in the current period. For a detailed discussion of this, see Contingencies discussed in Item 1 - Notes to Consolidated Financial Statements.

 

Rent and other income increased by $1,964,305, from $150,131 for the three months ended May 31, 2014 to $2,114,436 for the three months ended May 31, 2015. Rent and other income for the three months ended May 31, 2015 includes (a) a gain of $2,094,000 on a bond called during the current period, (b) collections of $22,492 on accounts receivable of the Company’s hospitals that were sold in prior years, and were fully reserved for, and (c) miscellaneous other income of $42,554. These gains were offset by an amount of $44,610 in foreign currency losses. Rent and other income for the three months ended May 31, 2014 includes (a) an amount of $9,791 in foreign currency losses, and (b) miscellaneous other income of $159,922.

 

 20 
 

 

Interest income of $178,921 and $226,705 for the three months ended May 31, 2015 and 2014, respectively, are primarily related to the Company’s investments in bonds.

 

Investments in securities

 

The Company’s investments in debt instruments (corporate and municipal bonds) are recorded at fair value based on quoted market prices that are traded in less active markets or priced using a quoted market price for similar investments or are priced using non-binding market consensus prices that can be corroborated by observable market data (Level 2). These investments are classified as available-for-sale securities. As of May 31, 2015, these securities are valued at approximately $12.0 million. Unrealized gains in these investments of $8.2 million are included in accumulated other comprehensive income in the Consolidated Balance Sheet as at May 31, 2015. During the three months ended May 31, 2015, one particular security was called with sales proceeds of $6 million, on which the Company had a gain of approximately $2.1 million.

 

Income Taxes

 

The Company did not recognize a benefit or provision for income taxes for the three months ended May 31, 2015 and 2014, due to the uncertainty of the Company’s ability to recognize the benefit from the carry forward of net operating losses. The Company has recorded a full valuation allowance against its deferred tax assets.

 

Nine Months Ended May 31, 2015 Compared to the Nine Months Ended May 31, 2014

 

U.S. Division

 

Due to the uncertainties associated with the stop-loss fee dispute cases, the Company has accrued an amount of $11.3 million, and an additional amount of $3.8 million in interest payable as accrued liabilities. For a detailed discussion of this, see Revenue Recognition discussed in Item 1 - Notes to Consolidated Financial Statements.

 

Net patient service revenue decreased by $2,118,414, or 29%, from $7,239,406 to $5,120,992, and total surgical cases decreased by 1% from 669 cases for the nine months ended May 31, 2014 to 665 cases for the nine months ended May 31, 2015.  While the number of cases decreased by 1%, net patient service revenue decreased by 29%, primarily due to a change in the surgical mix of cases. The gross billed charges increased by 1% from $21,806,599 for the nine months ended May 31, 2014 to $22,116,554 for the nine months ended May 31, 2015. However, due to an increase in allowances from 67% to 77%, net patient service revenue decreased by 29%. The increase in allowances is due to an increased pressure by insurance carriers towards lower reimbursements, and also due to lower collections in the current period compared to the prior period on old accounts receivable that was fully reserved for.

 

 Total costs and expenses increased by $278,679, or 4%, from $7,162,027 for the nine months ended May 31, 2014 to $7,440,706 for the nine months ended May 31, 2015. The following discusses the various changes in costs and expenses:

 

·Compensation and benefits increased by $270,569, or 9%, primarily associated with increase in workforce due to higher gross billed charges and general increases in pay rates.

 

·Medical services and supplies expenses decreased by $345,745, or 24%, primarily due to a change in the surgical mix of cases. Inpatient cases decreased by 34%, which generally require more medical services and supplies.

 

·Other operating expenses increased by $373,333, or 15%, primarily associated with higher gross billed charges, and also due to higher professional fees incurred for implementation of electronic medical records.

 

Other expense for the nine months ended May 31, 2015 and 2014 of $280,756 and $242,851, respectively, includes interest expense associated with the stop-loss cases discussed above.

 

Corporate Division

 

Compensation and benefits for the Corporate Division includes all corporate personnel compensation and benefits. It also includes $148,023 of non-cash compensation expense for each of the nine months ended May 31, 2015 and 2014, related to employees’ incentive stock options granted in fiscal years 2007, 2011 and 2012. Apart from the stock option expense discussed above, compensation and benefits decreased by 2% in 2015, compared to 2014, due to a reduction in corporate staff, partially offset by general increases in pay rates.

 

 21 
 

 

Other operating expenses include all corporate general and administrative expenses, including other professional fees such as legal expenses and audit expenses. It increased by $144,031, from $814,813 for the nine months ended May 31, 2014 to $958,844 for the nine months ended May 31, 2015. The increase in other operating expenses is due to an increase in legal and other professional fees primarily relating to the law suits that were ongoing in the current period. For a detailed discussion of this, see Contingencies discussed in Item 1 - Notes to Consolidated Financial Statements.

 

Rent and other income increased by $1,405,615, from $535,682 for the nine months ended May 31, 2014 to $1,941,297 for the nine months ended May 31, 2015. Rent and other income for the nine months ended May 31, 2015 includes (a) a gain of $2,094,000 on a bond called during the current period, (b) collections of $185,945 on accounts receivable of the Company’s hospitals that were sold in prior years, and were fully reserved for, and (c) miscellaneous other income of $105,759. These gains were offset by an amount of $444,407 in foreign currency losses. Rent and other income for the nine months ended May 31, 2014 includes (a) an amount of $74,839 in foreign currency gains, (b) a gain of $161,864 in trading securities, and (b) miscellaneous other income of $298,979.

 

Interest income of $607,980 and $653,320 for the nine months ended May 31, 2015 and 2014, respectively, are primarily related to the Company’s investments in bonds.

 

Investments in securities

 

The Company’s investments in debt instruments (corporate and municipal bonds) are recorded at fair value based on quoted market prices that are traded in less active markets or priced using a quoted market price for similar investments or are priced using non-binding market consensus prices that can be corroborated by observable market data (Level 2). These investments are classified as available-for-sale securities. As of May 31, 2015, these securities are valued at approximately $12.0 million. Unrealized gains in these investments of $8.2 million are included in accumulated other comprehensive income in the Consolidated Balance Sheet as at May 31, 2015. During the nine months ended May 31, 2015, one particular security was called with sales proceeds of $6 million, on which the Company had a gain of approximately $2.1 million.

 

During the nine months ended May 31, 2014, the Company also traded in initial public offerings of equity securities on the Hong Kong Stock Exchange and had gains of $161,864 in these securities. During the first quarter of fiscal year 2014, the Company sold all of its trading securities and has not held any such securities since November 30, 2013.

 

Income Taxes

 

The Company did not recognize a benefit or provision for income taxes for the nine months ended May 31, 2015 and 2014, due to the uncertainty of the Company’s ability to recognize the benefit from the carry forward of net operating losses. The Company has recorded a full valuation allowance against its deferred tax assets.

 

Liquidity and Capital Resources

 

Our fiscal year 2014 Annual Report on Form 10-K includes a detailed discussion of our liquidity, contractual obligations and commitments. The information presented below updates and should be read in conjunction with the information disclosed in that Form 10-K.

 

Cash flow from operating activities

 

Cash flow used in operating activities was $4,715,169 during the nine months ended May 31, 2015, primarily due to (a) a net loss of $2,703,664, (b) a decrease in accounts payable and accrued liabilities of $1,907,358, and (c) a gain of $2,094,000 on sale of an available for sale security. Partially offsetting these cash outflows were (a) a decrease in accounts receivable of $948,769, (b) foreign currency losses of $335,223, (c) a decrease in prepaid expenses of $202,686, and (d) depreciation and amortization of $260,223.

 

Cash flows from investing activities

 

Cash flow provided by investing activities was $5,650,710, primarily due to sales proceeds of $6,000,000 of available for sale securities, which was partially offset by purchase of equipment of $352,040.

 

 22 
 

 

Cash flows from financing activities

 

Cash flow used in financing activities was $200,437 for purchase of treasury stock of $172,115 and payments on capital leases and notes payable of $28,322.

 

We believe we will be able to meet our ongoing liquidity and cash needs for at least the next twelve months based on the amount of available cash and cash equivalents.

 

Recent Accounting Pronouncements

 

See notes to the Consolidated Financial Statements - Recent Accounting Pronouncements, which is incorporated herein by reference.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

 

Not required.

 

Item 4. Controls and Procedures.

 

Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures

 

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation to assess the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report, pursuant to Exchange Act Rule 13a-15(e). Based on that evaluation, our principal executive officer and principal financial officer concluded that, as of May 31, 2015, our disclosure controls and procedures were effective.

 

Changes in Internal Control over Financial Reporting.

 

There have been no significant changes in our internal control over financial reporting during the most recently completed fiscal quarter or in other factors that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.

 

Our management, including our principal executive officer and principal financial officer, does not expect that our disclosure controls or internal controls will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. In addition, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of error of fraud, if any, within a company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by management’s override of the control. The design of any systems of controls is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, control may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of these inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

 

PART II - OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

Ping S. Chu, James G. Gerace (both former members of our Board of Directors), and Eric G. Carter (former legal counsel) along with eleven other claimants instigated a series of lawsuits making claims against Ella Y.T.C. Chan (in her individual capacity and in her capacity as Independent Executrix of the Estate of Chiu M. Chan, Deceased, our former Chief Executive Officer and director), Eric K. Chan (our current Chief Executive Officer and director), and Dynacq Healthcare, Inc. All claims were settled in mediations and as part of the settlements Dynacq repurchased 530,616 shares of Dynacq common stock in August 2014, and 427,886 shares of Dynacq stock subsequently in April 2015. These buybacks represent all stock held by each of the claimants. Additionally, as part of this settlement, Dynacq settled claims made by Eric G. Carter for payment of attorney fees, and claims by a company controlled by Mr. Carter, for breach of contract. The Company recognized $2,047,652 of expense associated with these settlements during the fiscal year ended August 31, 2014. This amount is reported as other operating expenses in the consolidated statements of operations. A portion of the settlements were attributed to the repurchase of the Company’s common stock.

 

 23 
 

 

The Company is routinely involved in litigation and administrative proceedings that are incidental to its business. Specifically, all judicial review of unsatisfactory determinations of reimbursement amounts due us for our Texas facilities’ fees must be made in the district courts of Travis County, Texas in what can often be a lengthy procedure. Please refer to Revenue Recognition, as well as Business – Government Regulation – Texas Workers’ Compensation Systems in our Form 10-K for the fiscal year ended August 31, 2014, for a detailed description of the MDR process and our accounts receivable. The Company cannot predict whether any litigation or administrative proceeding to which it may become a party will have a material adverse effect on the Company's results of operations, cash flows or financial condition.

 

Item 1A. Risk Factors.

 

The Company’s Risk Factors as disclosed in its Form 10-K for the year ended August 31, 2014 have not materially changed.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

Purchases of Equity Securities by the Company

 

On February 29, 2008 the Company’s Board of Directors authorized a program of repurchasing up to 2 million of its outstanding securities from time to time in open market transactions at prevailing prices on NASDAQ. In April 2015, binding settlement agreements were reached with some of the shareholders in a law suit discussed in Part II, Item 1 – Legal Proceedings, whereby Dynacq received 427,886 shares of the Company’s stock owned by said plaintiffs. Based on an independent appraisal, the value of these shares repurchased as treasury stock was $145,054.

 

Shares repurchased during the quarter ended May 31, 2015 include the following:

 

Period  Total Number of
Shares Purchased
   Average
Price per
Share
   Total Number of
Shares
Purchased as
Part of Publicly
Announced
Plans or
Programs
   Maximum Number of
Shares that May Yet
be Purchased Under
the Publicly
Announced Plans or
Programs
 
                 
March 1 – 31, 2015      $        1,252,172 
April 1 - 30, 2015   427,886    0.34        1,252,172 
May 1 - 31, 2015               1,252,172 
Total   427,886   $0.34        1,252,172 

 

Item 3. Defaults Upon Senior Securities.

 

None.

 

Item 4. Mine Safety Disclosures.

 

None.

 

Item 5. Other Information.

 

None.

 

 24 
 

 

Item 6. Exhibits.

 

EXHIBIT NO.   IDENTIFICATION OF EXHIBIT
Exhibit 31.1   Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
Exhibit 31.2   Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
Exhibit 32.1   Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
Exhibit 32.2   Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS   XBRL Instance Document.
101.SCH   XBRL Taxonomy Extension Schema Document.
101.CAL   XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF   XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB   XBRL Taxonomy Extension Label Linkbase Document.
101.PRE   XBRL Taxonomy Extension Presentation Linkbase Document

 

 25 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

    DYNACQ HEALTHCARE, INC.
       
Date: September 15, 2015   By: /s/ Eric K. Chan
      Eric K. Chan
      Chief Executive Officer
      (duly authorized officer)
       
Date: September 15, 2015   By: /s/ Hemant Khemka
      Hemant Khemka
      Chief Financial Officer
      (principal financial and accounting officer)

 

 26 
 

 

INDEX OF EXHIBITS

 

EXHIBIT NO.   IDENTIFICATION OF EXHIBIT
Exhibit 31.1   Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
Exhibit 31.2   Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
Exhibit 32.1   Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
Exhibit 32.2   Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS   XBRL Instance Document.
101.SCH   XBRL Taxonomy Extension Schema Document.
101.CAL   XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF   XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB   XBRL Taxonomy Extension Label Linkbase Document.
101.PRE   XBRL Taxonomy Extension Presentation Linkbase Document

 

 27 

 

EX-31.1 2 v419848_ex31-1.htm EXHIBIT 31.1

 

EXHIBIT 31.1

 

CERTIFICATION

 

I, Eric K. Chan, Chief Executive Officer of Dynacq Healthcare, Inc., certify that:

 

1.I have reviewed this quarterly report on Form 10-Q of Dynacq Healthcare, Inc.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;

 

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

/s/ Eric K. Chan  
Eric K. Chan  
Chief Executive Officer  
(principal executive officer)  
   
Date: September 15, 2015  

 

 

 

EX-31.2 3 v419848_ex31-2.htm EXHIBIT 31.2

 

EXHIBIT 31.2

 

CERTIFICATION

 

I, Hemant Khemka, Chief Financial Officer of Dynacq Healthcare, Inc., certify that:

 

1.I have reviewed this quarterly report on Form 10-Q of Dynacq Healthcare, Inc.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;

 

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

/s/ Hemant Khemka  
Hemant Khemka  
Chief Financial Officer  
(principal financial and accounting officer)  
   
Date: September 15, 2015  

 

 

 

EX-32.1 4 v419848_ex32-1.htm EXHIBIT 32.1

 

EXHIBIT 32.1

 

CERTIFICATION OF PERIODIC REPORT

 

In connection with the Quarterly Report of Dynacq Healthcare, Inc. (the “Company”) on Form 10-Q for the quarterly period ended May 31, 2015 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Eric K. Chan, Chief Executive Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

 

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

/s/ Eric K. Chan  
Eric K. Chan  
Chief Executive Officer  
   
September 15, 2015  

 

 

 

EX-32.2 5 v419848_ex32-2.htm EXHIBIT 32.2

 

EXHIBIT 32.2

 

CERTIFICATION OF PERIODIC REPORT

 

In connection with the Quarterly Report of Dynacq Healthcare, Inc. (the “Company”) on Form 10-Q for the quarterly period ended May 31, 2015 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Hemant Khemka, Chief Financial Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

 

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

/s/ Hemant Khemka  
Hemant Khemka  
Chief Financial Officer  
   
September 15, 2015  

 

 

 

EX-101.INS 6 dyii-20150531.xml XBRL INSTANCE DOCUMENT 0000890908 2014-01-01 2014-01-31 0000890908 2014-02-01 2014-02-28 0000890908 2014-03-01 2014-05-31 0000890908 2015-03-01 2015-05-31 0000890908 2015-05-31 0000890908 2014-08-01 2014-08-31 0000890908 2014-08-31 0000890908 2015-08-31 0000890908 2013-09-01 2014-05-31 0000890908 2013-09-01 2014-08-31 0000890908 2013-09-01 2013-09-30 0000890908 2014-09-01 2015-05-31 0000890908 2014-09-01 2014-11-30 0000890908 2008-11-01 2008-11-13 0000890908 2011-11-01 2011-11-30 0000890908 2008-11-13 0000890908 2011-11-30 0000890908 2013-08-31 0000890908 2014-05-31 0000890908 2015-02-28 0000890908 2014-02-28 0000890908 dyii:Year2011StockIncentivePlanMember 2015-05-31 0000890908 dyii:Year2000StockIncentivePlanMember 2015-05-31 0000890908 country:HK 2013-09-01 2014-05-31 0000890908 dyii:UsDivisionSegmentMember 2014-09-01 2015-05-31 0000890908 us-gaap:IntersegmentEliminationMember 2014-09-01 2015-05-31 0000890908 dyii:UsDivisionSegmentMember 2013-09-01 2014-05-31 0000890908 us-gaap:IntersegmentEliminationMember 2013-09-01 2014-05-31 0000890908 dyii:UsDivisionSegmentMember 2015-03-01 2015-05-31 0000890908 us-gaap:IntersegmentEliminationMember 2015-03-01 2015-05-31 0000890908 dyii:UsDivisionSegmentMember 2014-03-01 2014-05-31 0000890908 us-gaap:IntersegmentEliminationMember 2014-03-01 2014-05-31 0000890908 dyii:UsDivisionSegmentMember 2015-05-31 0000890908 us-gaap:IntersegmentEliminationMember 2015-05-31 0000890908 dyii:UsDivisionSegmentMember 2014-08-31 0000890908 us-gaap:IntersegmentEliminationMember 2014-08-31 0000890908 dyii:RangeOneMember 2014-09-01 2015-05-31 0000890908 dyii:RangeTwoMember 2014-09-01 2015-05-31 0000890908 dyii:RangeOneMember 2015-05-31 0000890908 dyii:RangeTwoMember 2015-05-31 0000890908 us-gaap:FairValueInputsLevel2Member 2015-05-31 0000890908 dyii:PasadenaFacilityMember 2010-09-01 2011-08-31 0000890908 dyii:PasadenaFacilityMember 2013-06-01 2013-08-31 0000890908 dyii:GarlandFacilityMember 2010-09-01 2011-08-31 0000890908 dyii:GarlandFacilityMember 2013-06-01 2013-08-31 0000890908 us-gaap:SubsequentEventMember 2015-04-01 2015-04-30 0000890908 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2015-05-31 0000890908 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2015-05-31 0000890908 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2015-05-31 0000890908 country:HK 2014-09-01 2015-05-31 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure 17554608 16819504 1037864 1986633 248638 298662 99311 122041 60258 262944 19356211 19870240 12049876 20678130 6315953 6224136 187101 187101 38710060 47760527 355531 380456 1348121 1015856 16246301 18512986 0 6734 30259 26513 17624681 19562089 15789 41123 17640470 19603212 0 0 14419 14419 10627768 10479745 8229315 12616346 2306344 5010061 21005731 28093510 63859 63805 21069590 28157315 38710060 47760527 172115 27061 5120992 7239406 4865531 4632833 1107839 1453584 3834285 3316921 260223 280632 10067878 9683970 -4946886 -2444564 1950393 611884 607980 653320 315151 346535 2243222 918669 -2703664 -1525895 0 0 -2703664 -1525895 53 4 -2703717 -1525899 13802433 14431126 1047426 2748772 1584218 1588618 252614 532021 1296099 1158181 87143 85788 3220074 3364608 -2172648 -615836 2118542 194775 178921 226705 108186 105113 2189277 316367 16629 -299469 0 0 16629 -299469 -32 -29 16661 -299440 13674067 14418626 -4387031 3766295 -7090695 2240400 -7090748 2240396 -1895533 1194983 -1878904 895514 -1878872 895543 2094000 161864 148023 148023 -335223 60485 2750 0 -948769 752967 -50024 11677 -202686 -34464 -22730 50513 0 -569430 332265 -29916 -2239623 4240480 -4715169 2679712 2750 0 352040 231280 5650710 1002006 -24925 0 6734 30028 21588 108776 -200437 -138804 735104 3542914 13585447 17128361 2527 21564 0 0 -4387031 3766295 -172115 0 784000 1013000 -2703664 -1525895 53 4 16629 -299469 -32 -29 -0.02 15000000 250000 14750000 5000000 534000 995000 0 0 211000 784000 2.18 0 0 4.27 1.62 784000 P6Y3M18D 589000 49341 148023 33000 5798725 8148181 4751299 5399409 0.82 0.66 22116554 21806599 16995562 14567193 0.77 0.67 12616346 9382334 -2094000 0 0 0 -2094000 0 -4387031 3766295 8229315 13148629 10124848 11953646 -2094000 0 0 0 -2094000 0 -1895533 1194983 3800000 11300000 530616 2047652 2100000 161864 5120992 0 7239406 0 -2600470 -103194 -165472 -1360423 1047426 0 2748772 0 -1284694 1301323 186954 -486423 16488296 22221764 15967472 31793055 10-Q false 2015-05-31 2015 Q3 DYNACQ HEALTHCARE INC 0000890908 --08-31 Smaller Reporting Company DYII 13460124 122597000 154132000 0.01 0.01 0.001 0.001 5000000 5000000 100000000 100000000 14418626 13460124 14418626 13888010 958502 530616 0.00 -0.20 -0.11 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="center"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>General</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><b>&#160;</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Dynacq Healthcare, Inc., a Nevada corporation (the &#8220;Company&#8221;), is a holding company that through its subsidiaries in the United States develops and manages general acute care hospitals that principally provide specialized surgeries. The Company through its United States subsidiaries owns and operates one general acute care hospital in Pasadena, Texas. The Company through its subsidiary in Hong Kong invests in debt and equity securities, including short-term investments in initial public offerings and pre-initial public offerings.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>Basis of Presentation</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete consolidated financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. All such adjustments are of a normal and recurring nature. The majority of the Company's expenses are "cost of revenue" items. Costs that could be classified as general and administrative by the Company would include the corporate office costs, including advertising and marketing expenses, which were approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1.1</font> million and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1.0</font> million for the three months ended May 31, 2015 and 2014, respectively, and approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3.0</font> million and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2.8</font> million for the nine months ended May 31, 2015 and 2014, respectively. These financial statements should be read in conjunction with the audited financial statements as of August 31, 2014. Operating results for the three and nine months ended May 31, 2015 are not necessarily indicative of the results that may be expected for the year ending August 31, 2015.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 1100000 1000000 3000000 2800000 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>Reclassification</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Certain previously reported financial information has been reclassified to conform to the current period&#8217;s presentation. The impact of such reclassification was not significant to the prior period&#8217;s overall presentation.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif"> Cash and Cash Equivalents</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company considers all highly liquid instruments with maturities of three months or less on the date of purchase to be cash equivalents. Cash equivalents are carried at cost, which approximates fair value.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> -6000000 -1233286 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Investments in Available-for-Sale and Trading Securities</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company&#8217;s investments in debt instruments (corporate and municipal bonds) are recorded at fair value based on quoted market prices that are traded in less active markets or priced using a quoted market price for similar investments or are priced using non-binding market consensus prices that can be corroborated by observable market data (Level 2). These investments are classified as available-for-sale securities. These investments are subject to default risk. Unrealized gains in the fair value are reported in accumulated other comprehensive income, net of related income tax effect. The Company regularly monitors its investment portfolio for any decline in fair value that is other than temporary and records any such impairment as an impairment loss. The determination of the gain or loss on the sale of any security is made using the specific identification method. During the three months ended May 31, 2015, one particular security was called with sales proceeds of $6 million, on which the Company had a gain of approximately $2.1 million.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company also invested in initial public offerings of equity securities on the Hong Kong Stock Exchange. These investments are classified as trading securities, and were carried at fair value. These investments were subject to fluctuations in the market price. During the nine months ended May 31, 2014, the Company had a net gain of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">161,864</font> in these securities. During the first quarter of fiscal year 2014, the Company sold all of its trading securities and has not held any such securities since November 30, 2013.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif" align="justify">Industry Segments and Geographic Information</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Industry Segment &#8220;U.S. Division&#8221; comprises of the Company&#8217;s Pasadena facility. The Company at the present time has the U.S. Division and the Corporate Division.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Certain previously reported financial information has been reclassified to conform to the current period&#8217;s presentation.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><u>Corporate Division</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company formed Sino Bond to hold and manage investments in Hong Kong. Sino Bond invests in debt instruments (corporate and municipal) and equity securities in Europe and Asia, including initial public offerings and pre-initial public offerings. The Company invests in various marketable securities. During the three months ended May 31, 2015, one particular security was called on which the Company had a gain of approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2.1</font> million. As of May 31, 2015, the balance of these securities is valued at approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">12.0</font> million. During the nine months ended May 31, 2014, the Company also traded in initial public offerings of equity securities on the Hong Kong Stock Exchange and had a net gain of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">161,864</font> in these securities. During the first quarter of fiscal year 2014, the Company sold all of its trading securities and has not held any such securities since November 30, 2013.</div> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Corporate Division includes interest and other income related to its investments in securities, corporate personnel compensation expenses, and general and administrative expenses. Such expenses and income are not allocated to our operating division, as they relate to our general corporate activities.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">We generally evaluate performance based on profit or loss from operations before income taxes and non-recurring charges and other criteria. The accounting policies of the reportable segments are the same as those described in the summary of significant accounting policies. There are no transfers between segments.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Summarized financial information concerning the business segments from continuing operations is as follows:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="51%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="23%" colspan="5"> <div>Three&#160;months&#160;ended&#160;May&#160;31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="23%" colspan="5"> <div>Nine&#160;months&#160;ended&#160;May&#160;31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="51%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700; TEXT-DECORATION: underline" width="51%"> <div>Revenues from external customers</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="51%"> <div>Net patient service revenues</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>U.S. Division</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,047,426</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2,748,772</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>5,120,992</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>7,239,406</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Corporate</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 26px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Consolidated</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>1,047,426</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>2,748,772</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>5,120,992</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>7,239,406</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700; TEXT-DECORATION: underline" width="51%"> <div>Income (loss) before taxes</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>U.S. Division</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(1,284,694)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>186,954</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(2,600,470)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(165,472)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Corporate</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,301,323</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(486,423)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(103,194)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(1,360,423)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 26px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Consolidated</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>16,629</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(299,469)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(2,703,664)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(1,525,895)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160; <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></div> </td> </tr> </table> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0in; WIDTH: 90%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="65%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>May&#160;31,&#160;2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>August&#160;31,&#160;2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700; TEXT-DECORATION: underline" width="65%"> <div>Total Assets</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>U.S. Division</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>16,488,296</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>15,967,472</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>Corporate</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>22,221,764</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>31,793,055</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 26px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>Consolidated</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>38,710,060</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>47,760,527</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Summarized financial information concerning the business segments from continuing operations is as follows:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="51%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="23%" colspan="5"> <div>Three&#160;months&#160;ended&#160;May&#160;31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="23%" colspan="5"> <div>Nine&#160;months&#160;ended&#160;May&#160;31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="51%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700; TEXT-DECORATION: underline" width="51%"> <div>Revenues from external customers</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="51%"> <div>Net patient service revenues</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>U.S. Division</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,047,426</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2,748,772</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>5,120,992</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>7,239,406</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Corporate</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 26px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Consolidated</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>1,047,426</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>2,748,772</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>5,120,992</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>7,239,406</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700; TEXT-DECORATION: underline" width="51%"> <div>Income (loss) before taxes</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>U.S. Division</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(1,284,694)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>186,954</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(2,600,470)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(165,472)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Corporate</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,301,323</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(486,423)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(103,194)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(1,360,423)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 26px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Consolidated</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>16,629</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(299,469)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(2,703,664)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(1,525,895)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160; <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0in; WIDTH: 90%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="65%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>May&#160;31,&#160;2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>August&#160;31,&#160;2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700; TEXT-DECORATION: underline" width="65%"> <div>Total Assets</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>U.S. Division</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>16,488,296</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>15,967,472</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>Corporate</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>22,221,764</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>31,793,055</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 26px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>Consolidated</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>38,710,060</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>47,760,527</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif"> Notes Payable</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">In November 2011, the Company borrowed $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">116,339</font> as notes payable from a financial institution at an interest rate of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 4.5</font>%, which was to be repaid in <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">36</font> monthly installments, and was secured by specific equipment purchased at our Pasadena facility. The Company paid down the balance of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">6,734</font> of notes payable during the three months ended November 30, 2014.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><b>Recent Accounting Pronouncements</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">No recent accounting pronouncements or other authoritative guidance has been issued that management considers likely to have a material impact on our consolidated financial statements.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><b>Contingencies</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Due to the uncertainties associated with the stop-loss fee dispute cases, the Company has accrued an amount of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">11.3</font> million, and an additional amount of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3.8</font> million in interest payable, as accrued liabilities. For a detailed discussion of this, see Revenue Recognition Policy under Notes to Consolidated Financial Statements.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company maintains various insurance policies that cover its Pasadena facility including occurrence medical malpractice coverage. In addition, all physicians granted privileges at the Pasadena facility are required to maintain medical malpractice insurance coverage. The Company also maintains general liability and property insurance coverage, including flood coverage. The Company does not currently maintain workers&#8217; compensation coverage in Texas. In regard to the Employee Health Insurance Plan, until April 2014, the Company was self-insured with specific and aggregate re-insurance with stop-loss levels appropriate for the Company&#8217;s group size. Effective May 1, 2014, the Company has taken coverage for its employees under a fully insured health plan.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">We do not carry director and officer liability insurance. As permitted under Nevada law and pursuant to our governing documents and indemnification agreements with certain of our officers and directors, we indemnify our directors and officers against monetary damages, including advancing expenses, to the fullest extent permitted by Nevada law.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Ping S. Chu, James G. Gerace (both former members of our Board of Directors), and Eric G. Carter (former legal counsel) along with eleven other claimants instigated a series of lawsuits making claims against Ella Y.T.C. Chan (in her individual capacity and in her capacity as Independent Executrix of the Estate of Chiu M. Chan, Deceased, our former Chief Executive Officer and director), Eric K. Chan (our current Chief Executive Officer and director), and Dynacq Healthcare, Inc. All claims were settled in mediations and as part of the settlements Dynacq repurchased <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 530,616</font> shares of Dynacq common stock in August 2014, and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 427,886</font> shares of Dynacq stock subsequently in April 2015. These buybacks represent all stock held by each of the claimants. Additionally, as part of this settlement, Dynacq settled claims made by Eric G. Carter for payment of attorney fees, and claims by a company controlled by Mr. Carter, for breach of contract. The Company recognized $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2,047,652</font> of expense associated with these settlements during the fiscal year ended August 31, 2014. This amount is reported as other operating expenses in the consolidated statements of operations. A portion of the settlements were attributed to the repurchase of the Company&#8217;s common stock.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company is routinely involved in litigation and administrative proceedings that are incidental to its business. Specifically, all judicial review of unsatisfactory determinations of reimbursement amounts due us for our Texas facilities&#8217; fees must be made in the district courts of Travis County, Texas in what can often be a lengthy procedure.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 116339 0.045 P36M 6734 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><strong>Accumulated Other Comprehensive Income (Loss)</strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The following table summarizes the changes in accumulated other comprehensive income (loss) by component:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="51%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="23%" colspan="5"> <div>Three&#160;months&#160;ended&#160;May&#160;31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="23%" colspan="5"> <div>Nine&#160;months&#160;ended&#160;May&#160;31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="51%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; TEXT-DECORATION: underline" width="51%"> <div>Available-for-sale securities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Accumulated other comprehensive income balance, beginning of period</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>10,124,848</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>11,953,646</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>12,616,346</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>9,382,334</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Other comprehensive income (loss):</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Unrealized gains (losses), net of taxes of $-0-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>198,467</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,194,983</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(2,293,031)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>3,766,295</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Reclassification adjustments for gains included in rent and other income</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(2,094,000)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(2,094,000)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Tax provision</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 26px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Amount reclassified from accumulated other comprehensive income</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(2,094,000)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(2,094,000)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 39px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Other comprehensive income (loss)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(1,895,533)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>1,194,983</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(4,387,031)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>3,766,295</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Accumulated other comprehensive income balance, end of period</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>8,229,315</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>13,148,629</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>8,229,315</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>13,148,629</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160; <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The following table summarizes the changes in accumulated other comprehensive income (loss) by component:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="51%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="23%" colspan="5"> <div>Three&#160;months&#160;ended&#160;May&#160;31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="23%" colspan="5"> <div>Nine&#160;months&#160;ended&#160;May&#160;31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="51%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; TEXT-DECORATION: underline" width="51%"> <div>Available-for-sale securities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Accumulated other comprehensive income balance, beginning of period</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>10,124,848</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>11,953,646</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>12,616,346</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>9,382,334</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Other comprehensive income (loss):</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Unrealized gains (losses), net of taxes of $-0-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>198,467</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,194,983</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(2,293,031)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>3,766,295</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Reclassification adjustments for gains included in rent and other income</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(2,094,000)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(2,094,000)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Tax provision</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 26px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Amount reclassified from accumulated other comprehensive income</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(2,094,000)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(2,094,000)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 39px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Other comprehensive income (loss)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(1,895,533)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>1,194,983</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(4,387,031)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>3,766,295</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Accumulated other comprehensive income balance, end of period</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>8,229,315</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>13,148,629</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>8,229,315</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>13,148,629</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160; <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif"> Noncontrolling Interest</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The equity of minority investors (minority investors are generally physician groups and other healthcare providers that perform surgeries at the Company&#8217;s facilities) in certain subsidiaries of the Company is reported on the consolidated balance sheets as noncontrolling interest. Noncontrolling interest reported in the consolidated income statements reflect the respective interests in the income or loss of the limited partnerships or limited liability companies attributable to the minority investors (equity interest was <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 1</font>% at May 31, 2015).</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif" align="justify">Revenue Recognition</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: italic 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: italic 10pt Times New Roman, Times, Serif" align="justify">Background</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: italic 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company's revenue recognition policy is significant because net patient service revenue is a primary component of its results of operations. Revenue is recognized as services are delivered. The determination of the amount of revenue to be recognized in connection with the Company's services is subject to significant judgments and estimates, which are discussed below.&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: italic 10pt Times New Roman, Times, Serif" align="justify">Revenue Recognition Policy</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company has established billing rates for its medical services which it bills as services are delivered. Gross billings are then reduced by the Company&#8217;s estimate of allowances, which includes the contractual allowance and the provision for doubtful accounts, to arrive at net patient service revenues. Net patient service revenues may not represent amounts ultimately collected. The Company adjusts current period revenue for differences in estimated revenue recorded in prior periods and actual cash collections.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The following table shows gross revenues and allowances for the three and nine months ended May 31, 2015 and 2014:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="24%" colspan="6"> <div>Three&#160;months&#160;ended&#160;May&#160;31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="24%" colspan="6"> <div>Nine&#160;months&#160;ended&#160;May&#160;31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>Gross billed charges</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>5,798,725</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8,148,181</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>22,116,554</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>21,806,599</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>Allowances</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>4,751,299</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>5,399,409</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>16,995,562</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>14,567,193</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>Net revenue</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>1,047,426</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>2,748,772</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>5,120,992</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>7,239,406</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>Allowance percentage</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>82</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>66</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>77</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>67</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>% <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></div> </td> </tr> </table> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: italic 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: italic 10pt Times New Roman, Times, Serif"> Contractual Allowance</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company computes its contractual allowance based on the estimated collections on its gross billed charges. The Company computes its estimate by taking into account collections received, up to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">30</font> days after the end of the period, for the services performed and also estimating amounts collectible for the services performed within the last six months. A significant amount of our net revenue results from Texas workers' compensation claims, which are governed by the rules and regulations of the Texas Department of Workers&#8217; Compensation (&#8220;TDWC&#8221;) and the workers&#8217; compensation healthcare networks. If our hospital chooses to participate in a network, the amount of revenue that will be generated from workers&#8217; compensation claims will be governed by the network contract.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">For claims arising prior to the implementation of workers&#8217; compensation networks and out of network claims, inpatient and outpatient surgical services are either reimbursed pursuant to the Acute Care In-Patient Hospital Fee Guideline or at a "fair and reasonable" rate for services in which the fee guideline is not applicable. Starting March 1, 2008, the Texas Workers&#8217; Compensation 2008 Acute Care Hospital Outpatient and Inpatient Facility Fee Guidelines (the &#8220;Guidelines&#8221;) became effective. Under these Guidelines, the reimbursement amounts are determined by applying the most recently adopted and effective Medicare reimbursement formula and factors; however, if the maximum allowable reimbursement for the procedure performed cannot be calculated using these Guidelines, then reimbursement is determined on a fair and reasonable basis.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Should we disagree with the amount of reimbursement provided by a third-party payer, we are required to pursue the medical dispute resolution (&#8220;MDR&#8221;) process at the TDWC to request proper reimbursement for services. From January 2007 to November 2008, the Company had been successful in its pursuit of collections regarding the stop-loss cases pending before the State Office of Administrative Hearings (&#8220;SOAH&#8221;), receiving positive rulings in over <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 90</font>% of its claims presented for administrative determination. A 2007 district court decision upholding our interpretation of the statute as applied to the stop-loss claims was appealed by certain insurance carriers, and on November 13, 2008 the Third Court of Appeals determined that in order for a hospital to be reimbursed at <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 75</font>% of its usual and customary audited charges for an inpatient admission, the hospital must not only bill at least $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">40,000</font>, but also show that the admission involved unusually costly and unusually extensive services. Procedurally, the decision means that each case where a carrier raised an issue regarding whether the services provided were unusually costly or unusually extensive would be remanded to either SOAH or MDR for a case-by-case determination of whether the services provided meet these standards. As a result of the Third Court of Appeals opinion, any stop-loss cases pending at SOAH have been remanded to the TDWC since these cases have not been reviewed or decided by the two-prong standard decided by the Third Court of Appeals. The SOAH Administrative Law judges determined that the most appropriate location for these cases is the TDWC.</div> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">A petition asking the Texas Supreme Court to review the Third Court of Appeals decision has been denied. Therefore, the Company is bound by the Third Court of Appeals decision. The Texas Supreme Court&#8217;s decision delayed final adjudication in these pending stop-loss cases. The uncertain outcome in these cases will depend on a very lengthy process. We anticipate further, lengthy litigation at the Travis County District Courts and the Texas Courts of Appeals. Because of this lengthy process and the uncertainty of recovery in these cases, collection of a material amount of funds in these pending stop-loss cases cannot be anticipated.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Through May 2015, insurance carriers have voluntarily paid the awards in the decisions and orders issued by SOAH, plus interest, in approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 180</font> cases, involving approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">11</font> million in claims. In most of these cases, when the payments were made, the carriers requested refunds of the payments made in the event that the SOAH decisions and orders were reversed on appeal (which they were). Our request that the TDWC Commissioner enforce the awards which were not voluntarily paid by the carriers was refused in approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 130</font> cases. As a result of the reversal of the SOAH decisions and orders, Texas Mutual Insurance Company and other carriers filed petitions in Travis County district court seeking a refund in cases in which the awards were voluntarily paid. The district court found in favor of Texas Mutual and the Company was ordered to refund approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">4.2</font> million, including prejudgment interest, pending remand for a case-by-case determination of whether the services provided were unusually costly and unusually extensive. The Company did not object to the reversal and remand of the SOAH decisions and orders, but did object to the judgments ordering refunds and those judgments were appealed to the Third Court of Appeals. As part of the appeals, the Company deposited the amounts that were ordered to be refunded as cash deposits into the registry of the court in order to stay execution of the judgments ordering refunds.&#160;On June 6, 2013, the judgments ordering refunds were reversed by the Court of Appeals. The Court of Appeals held that if Texas Mutual wants a refund, it must pursue the refund demand administratively through the TDWC rather than through the district courts. Texas Mutual filed a motion for rehearing with the Court of Appeals which ultimately was denied. The Company filed motions in all 47 cases with the district court asking that the district clerk be ordered to release the deposited funds to the Company, and in January 2014, the Company received the deposits and accrued interest totaling $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">4.2</font> million. In addition, Texas Mutual filed three additional petitions in district court for cases that were left out of the original 47. The court granted Texas Mutual&#8217;s petitions and ordered the Company to refund approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">300,000</font>, including prejudgment interest to Texas Mutual. These judgments were granted before the Court of Appeals reversed the district court&#8217;s original judgments. These three cases were appealed to the Court of Appeals and the funds ordered refunded were deposited with the district clerk. As with the other <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">47</font> cases, the Court of Appeals reversed the district court&#8217;s final judgments in these three cases and the Company filed motions with the district court asking that the district clerk be ordered to release the deposited funds to the Company, and in February 2014, the Company received the deposits and accrued interest totaling approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">300,000</font>. The total refund received by the Company in fiscal year 2014 for the 50 stop-loss cases discussed above was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">4,476,097</font>.</div> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">During the time that the carriers&#8217; petitions seeking refunds were pending, because of the uncertainty of the results at that time, as of May 31, 2015, the Company has accrued the total potential refund amount of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">11.3</font> million, and an additional amount of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3.8</font> million in interest payable, as accrued liabilities. This includes the deposit amounts refunded back to the Company in January and February 2014. We do not anticipate that any other carriers will pursue refund demands through district court but instead will pursue them administratively through TDWC. The cases in which the SOAH decisions and orders were reversed have been or are being remanded to TDWC for determinations of whether the services provided were unusually costly and unusually extensive. The carriers contend that the voluntary payments made pursuant to the Decisions and Orders were premature payments by the carriers and may be ordered to be refunded. The Company disagrees with this contention. After the reversal of the judgments it obtained from the district court ordering refunds, on December 4, 2013, Texas Mutual made a formal request to the Commissioner of Workers&#8217; Compensation that he administratively order the Company to make refunds to Texas Mutual (in the same amount that was sought in the district court). The Company responded to this request on December 11, 2013, asking that it be denied. The matter is pending at this time. As to the matters remanded to TDWC and SOAH, once the Company is given the opportunity to present its evidence regarding whether the services provided were unusually costly and unusually extensive, the Company anticipates that it will prevail in many of the underlying stop-loss fee disputes and that payments refunded to the carriers will be recaptured. In March 2014, a settlement conference with one self-insured entity successfully resolved the stop-loss cases in which that entity was involved. Although the Company is willing to participate in settlement negotiations, we anticipate that few, if any, other carriers are interested in doing so at this time. It is anticipated that hearings at SOAH on the pending stop-loss cases will begin in November 2015.</div> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Due to the uncertainties associated with these stop-loss fee dispute cases, the Company recognized increases in the contractual allowance at our Pasadena facility of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">10,254,990</font> during fiscal year 2011 and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">149,875</font> during the fiscal quarter ended August 31, 2013, (and an additional contractual allowance amount of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">779,583</font> during fiscal year 2011 and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">136,542</font> during the fiscal quarter ended August 31, 2013, at our Garland facility, which was classified as discontinued operations). The Company has also recognized interest expense related to these refunds starting from fiscal year 2011.</div> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Some claims regarding payment for ambulatory surgical center and hospital outpatient services remain pending at the TDWC and/or SOAH. It is expected that these remaining claims will be adjudicated at SOAH and possibly in the Texas district and appellate courts. The basis for reimbursement for these services made the subject of these pending cases is the same as it was for the other ASC and outpatient cases that have been either tried or settled: the determination of &#8220;fair and reasonable&#8221; charges. In 2007, the Company received unfavorable rulings from SOAH in all of its appeals of unfavorable decisions related to services provided in 2001 and 2002. The <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 179</font> cases, which were appealed to the Travis County district courts, challenged the constitutionality of the relevant statutory language. The Company received an unfavorable ruling in its lead case in March 2009, which ruling was appealed to and was upheld by the Third Court of Appeals on August 26, 2010. The Texas Supreme Court denied a petition asking for review of the Third Court of Appeals decision. The unfavorable interpretation by the Texas Courts of Appeal in the Company&#8217;s lead case negatively affects the recovery of additional reimbursement, not only in the lead case, but in the remaining <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 178</font> pending cases. Consequently, the Company is bound by the Third Court of Appeals&#8217; ruling that interprets the applicable statute and fee guideline to require that the amount that will be paid to a provider must not only be at a &#8220;fair and reasonable rate&#8221; but also must &#8220;ensure the quality of medical care&#8221; and &#8220;achieve effective cost control&#8221; and be the same or less than that charged to others with an equivalent standard of living. This ruling has impacted cases in which a fee guideline was not applicable, specifically all pending cases involving ambulatory surgical services provided from 2001 through 2004 as well as all pending cases involving hospital outpatient services provided prior to March 1, 2008, when the Guidelines took effect. Since the Third Court of Appeals&#8217; unfavorable ruling, collection, if any, in these cases depends on the Company&#8217;s ability to establish the criteria in this ruling. The Company was given the opportunity to establish the criteria in approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">80</font> cases, which were set for hearing on the merits from March through May 2012 and was unsuccessful. In 2014, hearings were held in 23 of the Company&#8217;s hospital outpatient cases at SOAH. Decisions and Orders were handed down by SOAH adopting the methodology for determining &#8220;fair and reasonable&#8221; reimbursement that was put forth by the Company and ordered additional reimbursement in each of the 23 cases plus interest be paid to the Company. The carrier has appealed these decisions to Travis County district court and the cases have been consolidated. In April 2015 a large group of outpatient cases with various carriers were tried at SOAH. The Company and the carriers have presented their evidence and the parties&#8217; closing arguments were filed in June 2015.</div> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Due to the uncertainties regarding the accounts receivable in the MDR process, the 2008 and 2010 Third Court of Appeals&#8217; opinions and our legal counsel&#8217;s advice that settlements with insurance carriers in stop-loss cases have virtually stopped, the Company had fully reserved all accounts receivable related to the MDR process as of August 31, 2008. The Company has had settlement negotiations with insurance carriers for ambulatory surgical center and hospital outpatient cases. Some of these negotiations have been successful. Any monies collected for these MDR accounts receivable is recorded as current period&#8217;s net patient service revenues.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <i>Provision for Doubtful Accounts</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Although outcomes vary, our policy is to attempt to collect amounts due from patients, including co-payments and deductibles due from patients with insurance, at the time of service while complying with all federal and state laws and regulations. In non-emergency circumstances or for elective procedures and services, it is our policy to verify insurance prior to a patient being treated; however, there are various exceptions that can occur.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company computes its allowance<i>s</i> based on the estimated collections on its gross billed charges. The Company computes its estimate of allowance, which is a combination of contractual allowance and provision for doubtful accounts, by taking into account collections received, up to 30 days after the end of the period, for the services performed and also estimating amounts collectible for the services performed within the last six months.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Accounts receivable represent net receivables for services provided by the Company. At each balance sheet date management reviews the accounts receivable for collectibility and provides full allowance reserves for any accounts receivable deemed uncollectible.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The allowances stated as a percentage of gross receivables at the balance sheet dates is larger than the allowance percentage used to reduce gross billed charges due to the application of partial cash collections to the outstanding gross receivable balances, without any adjustment being made to the allowances. The allowance amounts netted against gross receivables are not adjusted until such time as the final collections on an individual receivable are recognized.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The focal point of our business is providing patient care services, including complex orthopedic and bariatric procedures. The Company pursues optimal reimbursement from third-party payers for these services. In some instances, we do not have contractual arrangements with third-party payers which provide for &#8220;prompt payment&#8221; which may result in additional time to collect the expected reimbursement.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The collection process may also be extended due to our efforts to obtain all optimal reimbursement available to the Company. Specifically, for medical services provided to injured workers, the Company may initially receive reimbursement that may not be within the fee guidelines or regulatory guidelines mandating reimbursement. The Company reviews and pursues those particular claims that are determined to warrant additional reimbursement pursuant to the fee or regulatory guidelines. The Company's pursuit of additional reimbursement amounts that it believes are due under fee or regulatory guidelines may be accomplished through established dispute resolution procedures with applicable regulatory authorities.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><b>Inventories</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Inventories, consisting primarily of medical supplies, are stated at the lower of cost or market, with cost determined by use of the average cost method.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The following table shows gross revenues and allowances for the three and nine months ended May 31, 2015 and 2014:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="24%" colspan="6"> <div>Three&#160;months&#160;ended&#160;May&#160;31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="24%" colspan="6"> <div>Nine&#160;months&#160;ended&#160;May&#160;31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>Gross billed charges</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>5,798,725</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8,148,181</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>22,116,554</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>21,806,599</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>Allowances</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>4,751,299</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>5,399,409</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>16,995,562</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>14,567,193</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>Net revenue</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>1,047,426</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>2,748,772</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>5,120,992</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>7,239,406</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>Allowance percentage</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>82</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>66</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>77</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>67</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>% <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong>Net Income (Loss) per Common Share</strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The following table presents the computation of basic and diluted income (loss) per common share attributable to the Company:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="51%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="23%" colspan="5"> <div>Three&#160;months&#160;ended&#160;May&#160;31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="23%" colspan="5"> <div>Nine&#160;months&#160;ended&#160;May&#160;31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="51%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Basic and diluted loss per common share:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Numerator:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 26px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Net income (loss)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>16,629</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(299,469)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(2,703,664)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(1,525,895)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 26px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Less: Net (income) loss attributable to noncontrolling interest</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>32</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>29</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(53)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(4)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 26px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Net income (loss) attributable to Dynacq Healthcare, Inc.</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>16,661</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(299,440)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(2,703,717)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(1,525,899)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Denominator:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 26px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Basic and diluted average common shares outstanding</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>13,674,067</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>14,418,626</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>13,802,433</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>14,431,126</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 26px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Basic and diluted income (loss) per common share:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>0.00</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>(0.02)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>(0.20)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>(0.11)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Basic net income (loss) per share is computed by dividing net income (loss) available to common shareholders by the weighted average number of common shares outstanding for the reporting period. Diluted net income (loss) per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. For the calculation of diluted net income (loss) per share, the basic weighted average number of shares is increased by the dilutive effect of stock options determined using the treasury stock method. However, if it is anti-dilutive, the dilutive effect of the stock options is not included in the calculation of diluted net income (loss) per share. Stock options with exercise prices exceeding current market prices that were excluded from the computation of net income (loss) per share amounted to approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 784,000</font> shares and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 1,013,000</font> shares for the nine months ended May 31, 2015 and 2014, respectively.</div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The following table presents the computation of basic and diluted income (loss) per common share attributable to the Company:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="51%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="23%" colspan="5"> <div>Three&#160;months&#160;ended&#160;May&#160;31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="23%" colspan="5"> <div>Nine&#160;months&#160;ended&#160;May&#160;31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="51%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Basic and diluted loss per common share:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Numerator:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 26px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Net income (loss)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>16,629</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(299,469)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(2,703,664)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(1,525,895)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 26px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Less: Net (income) loss attributable to noncontrolling interest</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>32</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>29</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(53)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(4)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 26px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Net income (loss) attributable to Dynacq Healthcare, Inc.</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>16,661</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(299,440)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(2,703,717)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(1,525,899)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Denominator:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 26px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Basic and diluted average common shares outstanding</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>13,674,067</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>14,418,626</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>13,802,433</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>14,431,126</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 26px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Basic and diluted income (loss) per common share:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>0.00</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>(0.02)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>(0.20)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>(0.11)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif" align="justify">Treasury Stock</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">In September 2013, as part of a settlement agreement with a former employee, the Company received <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 125,000</font> shares of common stock of the Company previously issued to him. These shares were accounted for as treasury shares with zero cost, and were retired in the second quarter of fiscal year 2014.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">In August 2014 and April 2015, binding settlement agreements were reached with some of the shareholders in a law suit whereby the Company received <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 530,616</font>, shares and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 427,886</font> shares, respectively, of stock owned by the shareholders. Based on an independent appraisal, the value of these shares repurchased as treasury stock were $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">27,061</font> and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">145,054</font>, respectively.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif" align="justify">Stock Based Compensation&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><u>Year 2011 Stock Incentive Plan</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The purpose of the Year 2011 Stock Incentive Plan (&#8220;2011 Plan&#8221;) is to strengthen the Company by providing an incentive to its employees, officers, consultants and directors and to encourage them to devote their abilities and industry to the success of the Company&#8217;s business enterprise. It is intended that this purpose be achieved by extending to employees, officers, consultants and directors of the Company and its subsidiaries an added long-term incentive for high levels of performance and unusual efforts through the grant of incentive stock options, non-qualified stock options, stock appreciation rights, dividend equivalent rights, performance awards and restricted stock. The Company has reserved <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 15,000,000</font> shares of common stock for issuance under the 2011 Plan. As of May 31, 2015, there remain <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 250,000</font> shares to be issued upon exercise of outstanding options, and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 14,750,000</font> shares which can be issued under the 2011 Plan after giving effect to shares issued and canceled.</div> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <u>2000 Incentive Plan</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company's 2000 Incentive Plan ("2000 Plan") provides for options and other stock-based awards that may be granted to eligible employees, officers, consultants and non-employee directors of the Company or its subsidiaries. The Company had reserved <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 5,000,000</font> shares of common stock for future issuance under the 2000 Plan. The 2000 Plan does not have a fixed termination date, provided that no incentive stock option can be granted subsequent to August 29, 2011. As of May 31, 2015, there remain <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 534,000</font> shares to be issued upon exercise of outstanding options, and no new stock options awards will be issued under the 2000 Plan.</div> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The following table summarizes the stock option activities for the nine months ended May 31, 2015 (share amounts in thousands):</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0in; WIDTH: 90%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Shares</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Weighted&#160;Average<br/> Option&#160;Exercise<br/> Price&#160;Per&#160;Share</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>Outstanding, August 31, 2014</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>995</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>2.18</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>Granted</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>Exercised</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>Expired or canceled</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(211)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>4.27</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>Outstanding, May 31, 2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>784</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1.62</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">For the nine months ended May 31, 2015 and 2014, there were no stock options exercised. The aggregate intrinsic value of the stock options outstanding as of May 31, 2015 and 2014 is $-<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0</font></font>-, since the market price is lower than the exercise price.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The following summarizes information related to stock options outstanding as of May 31, 2015, and related weighted average price and life information: <font style="FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="5%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="22%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="47%" colspan="5"> <div>Options&#160;Outstanding</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="23%" colspan="2"> <div>Options&#160;Exercisable</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="27%" colspan="2"> <div>Exercise&#160;Prices</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="23%" colspan="2"> <div>Number&#160;of&#160;<br/> Shares</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="23%" colspan="2"> <div>Weighted&#160;Average<br/> Remaining&#160;Contractual<br/> Life&#160;(Years)</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="23%" colspan="2"> <div>Number&#160;of&#160;Shares</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="5%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="22%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="71%" colspan="8"> <div>(Share&#160;Amounts&#160;In&#160;Thousands)</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="5%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="22%"> <div>1.10</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="22%"> <div>250</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="22%"> <div>6.6</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="22%"> <div>188</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="5%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="22%"> <div>1.86</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="22%"> <div>534</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="22%"> <div>6.1</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="22%"> <div>401</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="5%"> <div>Total</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="22%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="22%"> <div>784</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="22%"> <div>6.3</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="22%"> <div>589</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"><font style="FONT-WEIGHT: normal">For the three months ended May 31, 2015 and 2014, stock-based compensation expense associated with the Company&#8217;s stock options was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">49,341</font></font> in each period. For the nine months ended May 31, 2015 and 2014, stock-based compensation expense associated with the Company&#8217;s stock options was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">148,023</font></font> in each period. The total unrecognized compensation expense for outstanding stock options as of May 31, 2015 was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">33,000</font>, and will be recognized, in general, over five months.</font></font></div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The following table summarizes the stock option activities for the nine months ended May 31, 2015 (share amounts in thousands):</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0in; WIDTH: 90%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Shares</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Weighted&#160;Average<br/> Option&#160;Exercise<br/> Price&#160;Per&#160;Share</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>Outstanding, August 31, 2014</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>995</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>2.18</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>Granted</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>Exercised</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>Expired or canceled</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(211)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>4.27</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>Outstanding, May 31, 2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>784</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1.62</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The following summarizes information related to stock options outstanding as of May 31, 2015, and related weighted average price and life information: <font style="FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="5%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="22%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="47%" colspan="5"> <div>Options&#160;Outstanding</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="23%" colspan="2"> <div>Options&#160;Exercisable</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="27%" colspan="2"> <div>Exercise&#160;Prices</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="23%" colspan="2"> <div>Number&#160;of&#160;<br/> Shares</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="23%" colspan="2"> <div>Weighted&#160;Average<br/> Remaining&#160;Contractual<br/> Life&#160;(Years)</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="23%" colspan="2"> <div>Number&#160;of&#160;Shares</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="5%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="22%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="71%" colspan="8"> <div>(Share&#160;Amounts&#160;In&#160;Thousands)</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="5%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="22%"> <div>1.10</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="22%"> <div>250</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="22%"> <div>6.6</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="22%"> <div>188</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="5%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="22%"> <div>1.86</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="22%"> <div>534</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="22%"> <div>6.1</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="22%"> <div>401</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="5%"> <div>Total</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="22%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="22%"> <div>784</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="22%"> <div>6.3</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="22%"> <div>589</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 49341 148023 0 P5M 1.10 1.86 250000 534000 188000 401000 P6Y7M6D P6Y1M6D 4078646 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The following table summarizes our financial assets and liabilities measured and reported in the Company&#8217;s statement of financial position at fair value on a recurring basis as of May 31, 2015, segregated among the appropriate levels within the fair value hierarchy:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Quoted&#160;prices&#160;in&#160;active</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Significant&#160;other</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Significant</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>markets&#160;for&#160;identical</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>observable&#160;inputs</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>unobservable</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="63%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(Level 1)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>(Level&#160;2)</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>(Level&#160;3)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="63%"> <div>Assets</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Investments available-for-sale</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>12,049,876</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><b>Foreign Currency Translation</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The functional currency of the Company as a whole is the U.S. Dollar. The Company has designated the U.S. Dollar as the functional currency for Sino Bond Inc. Limited, a Hong Kong corporation and wholly owned subsidiary of the Company (&#8220;Sino Bond&#8221;). The effects of foreign currency exchange adjustments are included as a component of Rent and Other Income in the Consolidated Statements of Operations.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 0.9 0.75 40000 P30D 180 11000000 130 4200000 4200000 300000 47 300000 4476097 11300000 3800000 10254990 149875 779583 136542 179 178 80 P6M <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif" align="justify">Use of Estimates</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The most significant of the Company&#8217;s estimates is the determination of revenue to recognize for the services the Company provides and the determination of allowances, which includes the contractual allowance and the provision for doubtful accounts. See &#8220;Revenue Recognition&#8221; below for further discussion. Actual results could differ materially from those estimates used in the preparation of these financial statements.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 800920 800920 0 0 0 0 0 0 0 0 0 0 125000 530616 27061 427886 145054 0 12049876 0 198467 1194983 -2293031 3766295 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif" align="justify">Fair Value of Financial Instruments</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The fair value of financial instruments is estimated based on market trading information, where available. Absent published market values for an instrument or other assets, management uses observable market data to arrive at its estimates of fair value. Management believes that the carrying amount of cash and cash equivalents, accounts receivable and accrued liabilities approximate fair value. Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. A three-level fair value hierarchy prioritizes the inputs used to measure fair value. The three levels of inputs used to measure fair value are as follows:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Level 1 &#160;Quoted prices in active markets for identical assets or liabilities.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -0.5in; MARGIN: 0pt 0px 0pt 0.5in; FONT: 10pt Times New Roman, Times, Serif" align="justify">Level 2 &#160;Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted price for identical or similar assets and liabilities in markets that are not active; or other input that are observable or can be corroborated by observable market data.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -0.5in; MARGIN: 0pt 0px 0pt 0.5in; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -0.5in; MARGIN: 0pt 0px 0pt 0.5in; FONT: 10pt Times New Roman, Times, Serif" align="justify">Level 3 &#160;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. This includes certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The following table summarizes our financial assets and liabilities measured and reported in the Company&#8217;s statement of financial position at fair value on a recurring basis as of May 31, 2015, segregated among the appropriate levels within the fair value hierarchy:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Quoted&#160;prices&#160;in&#160;active</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Significant&#160;other</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Significant</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>markets&#160;for&#160;identical</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>observable&#160;inputs</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>unobservable</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="63%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(Level 1)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>(Level&#160;2)</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>(Level&#160;3)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="63%"> <div>Assets</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Investments available-for-sale</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>12,049,876</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company&#8217;s investments in Level 2 are in perpetual debt instruments (corporate and municipal bonds) traded on the European markets, at a cost of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">4,078,646</font>, are recorded at fair value based on quoted market prices that are traded in less active markets or priced using a quoted market price for similar investments or are priced using non-binding market consensus prices that can be corroborated by observable market data (Level 2), and there has been no change in valuation techniques for these investments (Level 2).</div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>Basis of Presentation</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete consolidated financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. All such adjustments are of a normal and recurring nature. The majority of the Company's expenses are "cost of revenue" items. Costs that could be classified as general and administrative by the Company would include the corporate office costs, including advertising and marketing expenses, which were approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1.1</font> million and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1.0</font> million for the three months ended May 31, 2015 and 2014, respectively, and approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3.0</font> million and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2.8</font> million for the nine months ended May 31, 2015 and 2014, respectively. These financial statements should be read in conjunction with the audited financial statements as of August 31, 2014. Operating results for the three and nine months ended May 31, 2015 are not necessarily indicative of the results that may be expected for the year ending August 31, 2015.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>Reclassification</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Certain previously reported financial information has been reclassified to conform to the current period&#8217;s presentation. The impact of such reclassification was not significant to the prior period&#8217;s overall presentation.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif"> Cash and Cash Equivalents</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company considers all highly liquid instruments with maturities of three months or less on the date of purchase to be cash equivalents. Cash equivalents are carried at cost, which approximates fair value.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif"> Investments in Available-for-Sale and Trading Securities</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company&#8217;s investments in debt instruments (corporate and municipal bonds) are recorded at fair value based on quoted market prices that are traded in less active markets or priced using a quoted market price for similar investments or are priced using non-binding market consensus prices that can be corroborated by observable market data (Level 2). These investments are classified as available-for-sale securities. These investments are subject to default risk. Unrealized gains in the fair value are reported in accumulated other comprehensive income, net of related income tax effect. The Company regularly monitors its investment portfolio for any decline in fair value that is other than temporary and records any such impairment as an impairment loss. The determination of the gain or loss on the sale of any security is made using the specific identification method. During the three months ended May 31, 2015, one particular security was called with sales proceeds of $6 million, on which the Company had a gain of approximately $2.1 million.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company also invested in initial public offerings of equity securities on the Hong Kong Stock Exchange. These investments are classified as trading securities, and were carried at fair value. These investments were subject to fluctuations in the market price. During the nine months ended May 31, 2014, the Company had a net gain of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">161,864</font> in these securities. During the first quarter of fiscal year 2014, the Company sold all of its trading securities and has not held any such securities since November 30, 2013.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 0.01 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif"> Notes Payable</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">In November 2011, the Company borrowed $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">116,339</font> as notes payable from a financial institution at an interest rate of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 4.5</font>%, which was to be repaid in <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">36</font> monthly installments, and was secured by specific equipment purchased at our Pasadena facility. The Company paid down the balance of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">6,734</font> of notes payable during the three months ended November 30, 2014.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><b>Inventories</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Inventories, consisting primarily of medical supplies, are stated at the lower of cost or market, with cost determined by use of the average cost method.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif" align="justify">Use of Estimates</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The most significant of the Company&#8217;s estimates is the determination of revenue to recognize for the services the Company provides and the determination of allowances, which includes the contractual allowance and the provision for doubtful accounts. See &#8220;Revenue Recognition&#8221; below for further discussion. Actual results could differ materially from those estimates used in the preparation of these financial statements.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif" align="justify">Stock Based Compensation&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><u>Year 2011 Stock Incentive Plan</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The purpose of the Year 2011 Stock Incentive Plan (&#8220;2011 Plan&#8221;) is to strengthen the Company by providing an incentive to its employees, officers, consultants and directors and to encourage them to devote their abilities and industry to the success of the Company&#8217;s business enterprise. It is intended that this purpose be achieved by extending to employees, officers, consultants and directors of the Company and its subsidiaries an added long-term incentive for high levels of performance and unusual efforts through the grant of incentive stock options, non-qualified stock options, stock appreciation rights, dividend equivalent rights, performance awards and restricted stock. The Company has reserved <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 15,000,000</font> shares of common stock for issuance under the 2011 Plan. As of May 31, 2015, there remain <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 250,000</font> shares to be issued upon exercise of outstanding options, and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 14,750,000</font> shares which can be issued under the 2011 Plan after giving effect to shares issued and canceled.</div> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <u>2000 Incentive Plan</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company's 2000 Incentive Plan ("2000 Plan") provides for options and other stock-based awards that may be granted to eligible employees, officers, consultants and non-employee directors of the Company or its subsidiaries. The Company had reserved <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 5,000,000</font> shares of common stock for future issuance under the 2000 Plan. The 2000 Plan does not have a fixed termination date, provided that no incentive stock option can be granted subsequent to August 29, 2011. As of May 31, 2015, there remain <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 534,000</font> shares to be issued upon exercise of outstanding options, and no new stock options awards will be issued under the 2000 Plan.</div> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The following table summarizes the stock option activities for the nine months ended May 31, 2015 (share amounts in thousands):</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0in; WIDTH: 90%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Shares</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Weighted&#160;Average<br/> Option&#160;Exercise<br/> Price&#160;Per&#160;Share</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>Outstanding, August 31, 2014</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>995</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>2.18</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>Granted</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>Exercised</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>Expired or canceled</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(211)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>4.27</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>Outstanding, May 31, 2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>784</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1.62</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">For the nine months ended May 31, 2015 and 2014, there were no stock options exercised. The aggregate intrinsic value of the stock options outstanding as of May 31, 2015 and 2014 is $-<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0</font></font>-, since the market price is lower than the exercise price.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The following summarizes information related to stock options outstanding as of May 31, 2015, and related weighted average price and life information: <font style="FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="5%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="22%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="47%" colspan="5"> <div>Options&#160;Outstanding</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="23%" colspan="2"> <div>Options&#160;Exercisable</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="27%" colspan="2"> <div>Exercise&#160;Prices</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="23%" colspan="2"> <div>Number&#160;of&#160;<br/> Shares</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="23%" colspan="2"> <div>Weighted&#160;Average<br/> Remaining&#160;Contractual<br/> Life&#160;(Years)</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="23%" colspan="2"> <div>Number&#160;of&#160;Shares</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="5%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="22%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="71%" colspan="8"> <div>(Share&#160;Amounts&#160;In&#160;Thousands)</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="5%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="22%"> <div>1.10</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="22%"> <div>250</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="22%"> <div>6.6</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="22%"> <div>188</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="5%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="22%"> <div>1.86</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="22%"> <div>534</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="22%"> <div>6.1</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="22%"> <div>401</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="5%"> <div>Total</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="22%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="22%"> <div>784</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="22%"> <div>6.3</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="22%"> <div>589</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"><font style="FONT-WEIGHT: normal">For the three months ended May 31, 2015 and 2014, stock-based compensation expense associated with the Company&#8217;s stock options was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">49,341</font></font> in each period. For the nine months ended May 31, 2015 and 2014, stock-based compensation expense associated with the Company&#8217;s stock options was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">148,023</font></font> in each period. The total unrecognized compensation expense for outstanding stock options as of May 31, 2015 was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">33,000</font>, and will be recognized, in general, over five months.</font></font></div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif" align="justify">Fair Value of Financial Instruments</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The fair value of financial instruments is estimated based on market trading information, where available. Absent published market values for an instrument or other assets, management uses observable market data to arrive at its estimates of fair value. Management believes that the carrying amount of cash and cash equivalents, accounts receivable and accrued liabilities approximate fair value. Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. A three-level fair value hierarchy prioritizes the inputs used to measure fair value. The three levels of inputs used to measure fair value are as follows:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Level 1 &#160;Quoted prices in active markets for identical assets or liabilities.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -0.5in; MARGIN: 0pt 0px 0pt 0.5in; FONT: 10pt Times New Roman, Times, Serif" align="justify">Level 2 &#160;Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted price for identical or similar assets and liabilities in markets that are not active; or other input that are observable or can be corroborated by observable market data.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -0.5in; MARGIN: 0pt 0px 0pt 0.5in; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -0.5in; MARGIN: 0pt 0px 0pt 0.5in; FONT: 10pt Times New Roman, Times, Serif" align="justify">Level 3 &#160;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. This includes certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The following table summarizes our financial assets and liabilities measured and reported in the Company&#8217;s statement of financial position at fair value on a recurring basis as of May 31, 2015, segregated among the appropriate levels within the fair value hierarchy:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Quoted&#160;prices&#160;in&#160;active</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Significant&#160;other</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Significant</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>markets&#160;for&#160;identical</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>observable&#160;inputs</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>unobservable</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="63%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(Level 1)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>(Level&#160;2)</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>(Level&#160;3)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="63%"> <div>Assets</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Investments available-for-sale</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>12,049,876</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company&#8217;s investments in Level 2 are in perpetual debt instruments (corporate and municipal bonds) traded on the European markets, at a cost of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">4,078,646</font>, are recorded at fair value based on quoted market prices that are traded in less active markets or priced using a quoted market price for similar investments or are priced using non-binding market consensus prices that can be corroborated by observable market data (Level 2), and there has been no change in valuation techniques for these investments (Level 2).</div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><b>Foreign Currency Translation</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The functional currency of the Company as a whole is the U.S. Dollar. The Company has designated the U.S. Dollar as the functional currency for Sino Bond Inc. Limited, a Hong Kong corporation and wholly owned subsidiary of the Company (&#8220;Sino Bond&#8221;). The effects of foreign currency exchange adjustments are included as a component of Rent and Other Income in the Consolidated Statements of Operations.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif" align="justify">Revenue Recognition</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: italic 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: italic 10pt Times New Roman, Times, Serif" align="justify">Background</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: italic 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company's revenue recognition policy is significant because net patient service revenue is a primary component of its results of operations. Revenue is recognized as services are delivered. The determination of the amount of revenue to be recognized in connection with the Company's services is subject to significant judgments and estimates, which are discussed below.&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: italic 10pt Times New Roman, Times, Serif" align="justify">Revenue Recognition Policy</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company has established billing rates for its medical services which it bills as services are delivered. Gross billings are then reduced by the Company&#8217;s estimate of allowances, which includes the contractual allowance and the provision for doubtful accounts, to arrive at net patient service revenues. Net patient service revenues may not represent amounts ultimately collected. The Company adjusts current period revenue for differences in estimated revenue recorded in prior periods and actual cash collections.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The following table shows gross revenues and allowances for the three and nine months ended May 31, 2015 and 2014:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="24%" colspan="6"> <div>Three&#160;months&#160;ended&#160;May&#160;31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="24%" colspan="6"> <div>Nine&#160;months&#160;ended&#160;May&#160;31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>Gross billed charges</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>5,798,725</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8,148,181</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>22,116,554</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>21,806,599</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>Allowances</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>4,751,299</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>5,399,409</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>16,995,562</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>14,567,193</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>Net revenue</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>1,047,426</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>2,748,772</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>5,120,992</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>7,239,406</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>Allowance percentage</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>82</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>66</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>77</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>67</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>% <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></div> </td> </tr> </table> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: italic 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: italic 10pt Times New Roman, Times, Serif"> Contractual Allowance</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company computes its contractual allowance based on the estimated collections on its gross billed charges. The Company computes its estimate by taking into account collections received, up to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">30</font> days after the end of the period, for the services performed and also estimating amounts collectible for the services performed within the last six months. A significant amount of our net revenue results from Texas workers' compensation claims, which are governed by the rules and regulations of the Texas Department of Workers&#8217; Compensation (&#8220;TDWC&#8221;) and the workers&#8217; compensation healthcare networks. If our hospital chooses to participate in a network, the amount of revenue that will be generated from workers&#8217; compensation claims will be governed by the network contract.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">For claims arising prior to the implementation of workers&#8217; compensation networks and out of network claims, inpatient and outpatient surgical services are either reimbursed pursuant to the Acute Care In-Patient Hospital Fee Guideline or at a "fair and reasonable" rate for services in which the fee guideline is not applicable. Starting March 1, 2008, the Texas Workers&#8217; Compensation 2008 Acute Care Hospital Outpatient and Inpatient Facility Fee Guidelines (the &#8220;Guidelines&#8221;) became effective. Under these Guidelines, the reimbursement amounts are determined by applying the most recently adopted and effective Medicare reimbursement formula and factors; however, if the maximum allowable reimbursement for the procedure performed cannot be calculated using these Guidelines, then reimbursement is determined on a fair and reasonable basis.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Should we disagree with the amount of reimbursement provided by a third-party payer, we are required to pursue the medical dispute resolution (&#8220;MDR&#8221;) process at the TDWC to request proper reimbursement for services. From January 2007 to November 2008, the Company had been successful in its pursuit of collections regarding the stop-loss cases pending before the State Office of Administrative Hearings (&#8220;SOAH&#8221;), receiving positive rulings in over <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 90</font>% of its claims presented for administrative determination. A 2007 district court decision upholding our interpretation of the statute as applied to the stop-loss claims was appealed by certain insurance carriers, and on November 13, 2008 the Third Court of Appeals determined that in order for a hospital to be reimbursed at <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 75</font>% of its usual and customary audited charges for an inpatient admission, the hospital must not only bill at least $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">40,000</font>, but also show that the admission involved unusually costly and unusually extensive services. Procedurally, the decision means that each case where a carrier raised an issue regarding whether the services provided were unusually costly or unusually extensive would be remanded to either SOAH or MDR for a case-by-case determination of whether the services provided meet these standards. As a result of the Third Court of Appeals opinion, any stop-loss cases pending at SOAH have been remanded to the TDWC since these cases have not been reviewed or decided by the two-prong standard decided by the Third Court of Appeals. The SOAH Administrative Law judges determined that the most appropriate location for these cases is the TDWC.</div> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">A petition asking the Texas Supreme Court to review the Third Court of Appeals decision has been denied. Therefore, the Company is bound by the Third Court of Appeals decision. The Texas Supreme Court&#8217;s decision delayed final adjudication in these pending stop-loss cases. The uncertain outcome in these cases will depend on a very lengthy process. We anticipate further, lengthy litigation at the Travis County District Courts and the Texas Courts of Appeals. Because of this lengthy process and the uncertainty of recovery in these cases, collection of a material amount of funds in these pending stop-loss cases cannot be anticipated.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Through May 2015, insurance carriers have voluntarily paid the awards in the decisions and orders issued by SOAH, plus interest, in approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 180</font> cases, involving approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">11</font> million in claims. In most of these cases, when the payments were made, the carriers requested refunds of the payments made in the event that the SOAH decisions and orders were reversed on appeal (which they were). Our request that the TDWC Commissioner enforce the awards which were not voluntarily paid by the carriers was refused in approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 130</font> cases. As a result of the reversal of the SOAH decisions and orders, Texas Mutual Insurance Company and other carriers filed petitions in Travis County district court seeking a refund in cases in which the awards were voluntarily paid. The district court found in favor of Texas Mutual and the Company was ordered to refund approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">4.2</font> million, including prejudgment interest, pending remand for a case-by-case determination of whether the services provided were unusually costly and unusually extensive. The Company did not object to the reversal and remand of the SOAH decisions and orders, but did object to the judgments ordering refunds and those judgments were appealed to the Third Court of Appeals. As part of the appeals, the Company deposited the amounts that were ordered to be refunded as cash deposits into the registry of the court in order to stay execution of the judgments ordering refunds.&#160;On June 6, 2013, the judgments ordering refunds were reversed by the Court of Appeals. The Court of Appeals held that if Texas Mutual wants a refund, it must pursue the refund demand administratively through the TDWC rather than through the district courts. Texas Mutual filed a motion for rehearing with the Court of Appeals which ultimately was denied. The Company filed motions in all 47 cases with the district court asking that the district clerk be ordered to release the deposited funds to the Company, and in January 2014, the Company received the deposits and accrued interest totaling $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">4.2</font> million. In addition, Texas Mutual filed three additional petitions in district court for cases that were left out of the original 47. The court granted Texas Mutual&#8217;s petitions and ordered the Company to refund approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">300,000</font>, including prejudgment interest to Texas Mutual. These judgments were granted before the Court of Appeals reversed the district court&#8217;s original judgments. These three cases were appealed to the Court of Appeals and the funds ordered refunded were deposited with the district clerk. As with the other <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">47</font> cases, the Court of Appeals reversed the district court&#8217;s final judgments in these three cases and the Company filed motions with the district court asking that the district clerk be ordered to release the deposited funds to the Company, and in February 2014, the Company received the deposits and accrued interest totaling approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">300,000</font>. The total refund received by the Company in fiscal year 2014 for the 50 stop-loss cases discussed above was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">4,476,097</font>.</div> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">During the time that the carriers&#8217; petitions seeking refunds were pending, because of the uncertainty of the results at that time, as of May 31, 2015, the Company has accrued the total potential refund amount of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">11.3</font> million, and an additional amount of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3.8</font> million in interest payable, as accrued liabilities. This includes the deposit amounts refunded back to the Company in January and February 2014. We do not anticipate that any other carriers will pursue refund demands through district court but instead will pursue them administratively through TDWC. The cases in which the SOAH decisions and orders were reversed have been or are being remanded to TDWC for determinations of whether the services provided were unusually costly and unusually extensive. The carriers contend that the voluntary payments made pursuant to the Decisions and Orders were premature payments by the carriers and may be ordered to be refunded. The Company disagrees with this contention. After the reversal of the judgments it obtained from the district court ordering refunds, on December 4, 2013, Texas Mutual made a formal request to the Commissioner of Workers&#8217; Compensation that he administratively order the Company to make refunds to Texas Mutual (in the same amount that was sought in the district court). The Company responded to this request on December 11, 2013, asking that it be denied. The matter is pending at this time. As to the matters remanded to TDWC and SOAH, once the Company is given the opportunity to present its evidence regarding whether the services provided were unusually costly and unusually extensive, the Company anticipates that it will prevail in many of the underlying stop-loss fee disputes and that payments refunded to the carriers will be recaptured. In March 2014, a settlement conference with one self-insured entity successfully resolved the stop-loss cases in which that entity was involved. Although the Company is willing to participate in settlement negotiations, we anticipate that few, if any, other carriers are interested in doing so at this time. It is anticipated that hearings at SOAH on the pending stop-loss cases will begin in November 2015.</div> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Due to the uncertainties associated with these stop-loss fee dispute cases, the Company recognized increases in the contractual allowance at our Pasadena facility of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">10,254,990</font> during fiscal year 2011 and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">149,875</font> during the fiscal quarter ended August 31, 2013, (and an additional contractual allowance amount of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">779,583</font> during fiscal year 2011 and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">136,542</font> during the fiscal quarter ended August 31, 2013, at our Garland facility, which was classified as discontinued operations). The Company has also recognized interest expense related to these refunds starting from fiscal year 2011.</div> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Some claims regarding payment for ambulatory surgical center and hospital outpatient services remain pending at the TDWC and/or SOAH. It is expected that these remaining claims will be adjudicated at SOAH and possibly in the Texas district and appellate courts. The basis for reimbursement for these services made the subject of these pending cases is the same as it was for the other ASC and outpatient cases that have been either tried or settled: the determination of &#8220;fair and reasonable&#8221; charges. In 2007, the Company received unfavorable rulings from SOAH in all of its appeals of unfavorable decisions related to services provided in 2001 and 2002. The <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 179</font> cases, which were appealed to the Travis County district courts, challenged the constitutionality of the relevant statutory language. The Company received an unfavorable ruling in its lead case in March 2009, which ruling was appealed to and was upheld by the Third Court of Appeals on August 26, 2010. The Texas Supreme Court denied a petition asking for review of the Third Court of Appeals decision. The unfavorable interpretation by the Texas Courts of Appeal in the Company&#8217;s lead case negatively affects the recovery of additional reimbursement, not only in the lead case, but in the remaining <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 178</font> pending cases. Consequently, the Company is bound by the Third Court of Appeals&#8217; ruling that interprets the applicable statute and fee guideline to require that the amount that will be paid to a provider must not only be at a &#8220;fair and reasonable rate&#8221; but also must &#8220;ensure the quality of medical care&#8221; and &#8220;achieve effective cost control&#8221; and be the same or less than that charged to others with an equivalent standard of living. This ruling has impacted cases in which a fee guideline was not applicable, specifically all pending cases involving ambulatory surgical services provided from 2001 through 2004 as well as all pending cases involving hospital outpatient services provided prior to March 1, 2008, when the Guidelines took effect. Since the Third Court of Appeals&#8217; unfavorable ruling, collection, if any, in these cases depends on the Company&#8217;s ability to establish the criteria in this ruling. The Company was given the opportunity to establish the criteria in approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">80</font> cases, which were set for hearing on the merits from March through May 2012 and was unsuccessful. In 2014, hearings were held in 23 of the Company&#8217;s hospital outpatient cases at SOAH. Decisions and Orders were handed down by SOAH adopting the methodology for determining &#8220;fair and reasonable&#8221; reimbursement that was put forth by the Company and ordered additional reimbursement in each of the 23 cases plus interest be paid to the Company. The carrier has appealed these decisions to Travis County district court and the cases have been consolidated. In April 2015 a large group of outpatient cases with various carriers were tried at SOAH. The Company and the carriers have presented their evidence and the parties&#8217; closing arguments were filed in June 2015.</div> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Due to the uncertainties regarding the accounts receivable in the MDR process, the 2008 and 2010 Third Court of Appeals&#8217; opinions and our legal counsel&#8217;s advice that settlements with insurance carriers in stop-loss cases have virtually stopped, the Company had fully reserved all accounts receivable related to the MDR process as of August 31, 2008. The Company has had settlement negotiations with insurance carriers for ambulatory surgical center and hospital outpatient cases. Some of these negotiations have been successful. Any monies collected for these MDR accounts receivable is recorded as current period&#8217;s net patient service revenues.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <i>Provision for Doubtful Accounts</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Although outcomes vary, our policy is to attempt to collect amounts due from patients, including co-payments and deductibles due from patients with insurance, at the time of service while complying with all federal and state laws and regulations. In non-emergency circumstances or for elective procedures and services, it is our policy to verify insurance prior to a patient being treated; however, there are various exceptions that can occur.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company computes its allowance<i>s</i> based on the estimated collections on its gross billed charges. The Company computes its estimate of allowance, which is a combination of contractual allowance and provision for doubtful accounts, by taking into account collections received, up to 30 days after the end of the period, for the services performed and also estimating amounts collectible for the services performed within the last six months.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Accounts receivable represent net receivables for services provided by the Company. At each balance sheet date management reviews the accounts receivable for collectibility and provides full allowance reserves for any accounts receivable deemed uncollectible.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The allowances stated as a percentage of gross receivables at the balance sheet dates is larger than the allowance percentage used to reduce gross billed charges due to the application of partial cash collections to the outstanding gross receivable balances, without any adjustment being made to the allowances. The allowance amounts netted against gross receivables are not adjusted until such time as the final collections on an individual receivable are recognized.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The focal point of our business is providing patient care services, including complex orthopedic and bariatric procedures. The Company pursues optimal reimbursement from third-party payers for these services. In some instances, we do not have contractual arrangements with third-party payers which provide for &#8220;prompt payment&#8221; which may result in additional time to collect the expected reimbursement.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The collection process may also be extended due to our efforts to obtain all optimal reimbursement available to the Company. Specifically, for medical services provided to injured workers, the Company may initially receive reimbursement that may not be within the fee guidelines or regulatory guidelines mandating reimbursement. The Company reviews and pursues those particular claims that are determined to warrant additional reimbursement pursuant to the fee or regulatory guidelines. The Company's pursuit of additional reimbursement amounts that it believes are due under fee or regulatory guidelines may be accomplished through established dispute resolution procedures with applicable regulatory authorities.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif"> Noncontrolling Interest</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The equity of minority investors (minority investors are generally physician groups and other healthcare providers that perform surgeries at the Company&#8217;s facilities) in certain subsidiaries of the Company is reported on the consolidated balance sheets as noncontrolling interest. Noncontrolling interest reported in the consolidated income statements reflect the respective interests in the income or loss of the limited partnerships or limited liability companies attributable to the minority investors (equity interest was <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 1</font>% at May 31, 2015).</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><b>Recent Accounting Pronouncements</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">No recent accounting pronouncements or other authoritative guidance has been issued that management considers likely to have a material impact on our consolidated financial statements.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 161864 6000000 2100000 EX-101.SCH 7 dyii-20150531.xsd XBRL TAXONOMY EXTENSION SCHEMA 101 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink 102 - Statement - Consolidated Balance Sheets link:presentationLink link:definitionLink link:calculationLink 103 - Statement - Consolidated Balance Sheets [Parenthetical] link:presentationLink link:definitionLink link:calculationLink 104 - Statement - Consolidated Statements of Operations link:presentationLink link:definitionLink link:calculationLink 105 - Statement - Consolidated Statements of Comprehensive Income (Loss) link:presentationLink link:definitionLink link:calculationLink 106 - Statement - Consolidated Statements of Comprehensive Income (Loss) [Parenthetical] link:presentationLink link:definitionLink link:calculationLink 107 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:definitionLink link:calculationLink 108 - Disclosure - General link:presentationLink link:definitionLink link:calculationLink 109 - Disclosure - Basis of Presentation link:presentationLink link:definitionLink link:calculationLink 110 - Disclosure - Reclassification link:presentationLink link:definitionLink link:calculationLink 111 - Disclosure - Cash and Cash Equivalents link:presentationLink link:definitionLink link:calculationLink 112 - Disclosure - Investments in Available-for-Sale and Trading Securities link:presentationLink link:definitionLink link:calculationLink 113 - Disclosure - Notes payable link:presentationLink link:definitionLink link:calculationLink 114 - Disclosure - Inventories link:presentationLink link:definitionLink link:calculationLink 115 - Disclosure - Use of Estimates link:presentationLink link:definitionLink link:calculationLink 116 - Disclosure - Net Income (Loss) per Common Share link:presentationLink link:definitionLink link:calculationLink 117 - Disclosure - Treasury Stock link:presentationLink link:definitionLink link:calculationLink 118 - Disclosure - Stock Based Compensation link:presentationLink link:definitionLink link:calculationLink 119 - Disclosure - Fair Value of Financial Instruments link:presentationLink link:definitionLink link:calculationLink 120 - Disclosure - Foreign Currency Translation link:presentationLink link:definitionLink link:calculationLink 121 - Disclosure - Revenue Recognition link:presentationLink link:definitionLink link:calculationLink 122 - Disclosure - Noncontrolling Interest link:presentationLink link:definitionLink link:calculationLink 123 - Disclosure - Accumulated Other Comprehensive Income (Loss) link:presentationLink link:definitionLink link:calculationLink 124 - Disclosure - Contingencies link:presentationLink link:definitionLink link:calculationLink 125 - Disclosure - Recent Accounting Pronouncements link:presentationLink link:definitionLink link:calculationLink 126 - Disclosure - Industry Segments and Geographic Information link:presentationLink link:definitionLink link:calculationLink 127 - Disclosure - Significant Accounting Policies (Policies) link:presentationLink link:definitionLink link:calculationLink 128 - Disclosure - Net Income (Loss) per Common Share (Tables) link:presentationLink link:definitionLink link:calculationLink 129 - Disclosure - Stock Based Compensation (Tables) link:presentationLink link:definitionLink link:calculationLink 130 - Disclosure - Fair Value of Financial Instruments (Tables) link:presentationLink link:definitionLink link:calculationLink 131 - Disclosure - Revenue Recognition (Tables) link:presentationLink link:definitionLink link:calculationLink 132 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Tables) link:presentationLink link:definitionLink link:calculationLink 133 - Disclosure - Industry Segments and Geographic Information (Tables) link:presentationLink link:definitionLink link:calculationLink 134 - Disclosure - Basis of Presentation (Details Textual) link:presentationLink link:definitionLink link:calculationLink 135 - Disclosure - Investments in Available-for-Sale and Trading Securities (Details Textual) link:presentationLink link:definitionLink link:calculationLink 136 - Disclosure - Notes Payable (Details Textual) link:presentationLink link:definitionLink link:calculationLink 137 - Disclosure - Net Income (Loss) per Common Share (Details) link:presentationLink link:definitionLink link:calculationLink 138 - Disclosure - Net Income (Loss) per Common Share (Details Textual) link:presentationLink link:definitionLink link:calculationLink 139 - Disclosure - Treasury Stock (Details Textual) link:presentationLink link:definitionLink link:calculationLink 140 - Disclosure - Stock Based Compensation (Details) link:presentationLink link:definitionLink link:calculationLink 141 - Disclosure - Stock Based Compensation (Details 1) link:presentationLink link:definitionLink link:calculationLink 142 - Disclosure - Stock Based Compensation (Details Textual) link:presentationLink link:definitionLink link:calculationLink 143 - Disclosure - Fair Value of Financial Instruments (Details) link:presentationLink link:definitionLink link:calculationLink 144 - Disclosure - Fair Value of Financial Instruments (Details Textual) link:presentationLink link:definitionLink link:calculationLink 145 - Disclosure - Revenue Recognition (Details) link:presentationLink link:definitionLink link:calculationLink 146 - Disclosure - Revenue Recognition (Details Textual) link:presentationLink link:definitionLink link:calculationLink 147 - Disclosure - Noncontrolling Interest (Details Textual) link:presentationLink link:definitionLink link:calculationLink 148 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Details) link:presentationLink link:definitionLink link:calculationLink 149 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Details Textual) link:presentationLink link:definitionLink link:calculationLink 150 - Disclosure - Contingencies (Details Textuals) link:presentationLink link:definitionLink link:calculationLink 151 - Disclosure - Industry Segments and Geographic Information (Details) link:presentationLink link:definitionLink link:calculationLink 152 - Disclosure - Industry Segments and Geographic Information (Details 1) link:presentationLink link:definitionLink link:calculationLink 153 - Disclosure - Industry Segments and Geographic Information (Details Textual) link:presentationLink link:definitionLink link:calculationLink 154 - Disclosure - Significant Accounting Policies (Details Textual) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 8 dyii-20150531_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 dyii-20150531_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 dyii-20150531_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 11 dyii-20150531_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 12 R39.htm IDEA: XBRL DOCUMENT v3.2.0.727
Treasury Stock (Details Textual) - USD ($)
1 Months Ended 9 Months Ended
Apr. 30, 2015
Aug. 31, 2014
Sep. 30, 2013
May. 31, 2015
Treasury Stock [Line Items]        
Treasury Stock, Shares, Acquired   530,616 125,000 530,616
Treasury Stock, Value, Acquired, Cost Method   $ 27,061    
Subsequent Event [Member]        
Treasury Stock [Line Items]        
Treasury Stock, Shares, Acquired 427,886      
Treasury Stock, Value, Acquired, Cost Method $ 145,054      
XML 13 R48.htm IDEA: XBRL DOCUMENT v3.2.0.727
Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)
3 Months Ended 9 Months Ended
May. 31, 2015
May. 31, 2014
May. 31, 2015
May. 31, 2014
Available-for-sale securities        
Accumulated other comprehensive income balance, beginning of period $ 10,124,848 $ 11,953,646 $ 12,616,346 $ 9,382,334
Other comprehensive income (loss):        
Unrealized gains (losses), net of taxes of $-0- 198,467 1,194,983 (2,293,031) 3,766,295
Reclassification adjustments for gains included in rent and other income (2,094,000) 0 (2,094,000) 0
Tax provision 0 0 0 0
Amount reclassified from accumulated other comprehensive income (2,094,000) 0 (2,094,000) 0
Other comprehensive income (loss) (1,895,533) 1,194,983 (4,387,031) 3,766,295
Accumulated other comprehensive income balance, end of period $ 8,229,315 $ 13,148,629 $ 8,229,315 $ 13,148,629
EXCEL 14 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0````(`,ME.$<71Q9N\@$``+8@```3````6T-O;G1E;G1?5'EP97-= M+GAM;,W:S4[C,!`'\%>IG[_Y"G.=G88X[+J4_+?&(MM3U;'VGD:SRWV@Y%Y6VOO!M#H9-[+M MV!UDG;O5RK34N?;!YBUURJ7I4XY7LSL=THVV.07;#6P*[#]Y7>+L8PI&'TAW ML2=*=JAC>AHH'JN_C[Q4OJ*5?AC2NPH_W[LZT#"MB;WQSZ6N=SE+S+\MJQR- M;ZIPN/%OG1E;AN;']6\[ROD_7LO!3=S:X2KH1W-08'NR,95C;;49CXWJT87- M#^5):%^A-!8Z??_3T*=@9-/AA$B\JP\!TH<$Z4.!]-&`]'$&TL=G MD#Z^@/3Q%:0/OD!I!$54CD(J1S&5HZ#*453E**QR%%QW8OG*\M"_V/Z'D4X$G1H>)%]2-F`Q+M*;V" M^GH`A3&^.R6:E((C-Z."N[_8_`)02P,$%`````@`RV4X1UWP<_ON`0``;"`` M`!H```!X;"]?K M'^G8E$/?Y?8PY,6?T['+J^G^NFI+&58AY$V;3DV^Z8?434]W_7AJRG0Y[L/0 M;%Z;?0I:U\LP7LZI'A\^SEX\;]?5^+R5:O&S&?>IK*O?_?B:VY1*#N>3W$P+ M3(_?AO2=Y?O=[K!)3_WFUREUY8N*\&^!*LP'Z7R04H)L/L@H03X?Y)2@.!\4 M*4'+^:`E)>AV/NB6$G0W'W1'";J?#[JG!$D-9*PY20AKCM8"N!:.UP+`%H[8 M`L@6CMD"T!:.V@+8%H[;`N`6CMP"Z!:.W0+P%H[>"O16CMX*]%;2MS;ZV.;H MK4!OY>BM0&_EZ*U`;^7HK4!OY>BM0&_EZ*U`;^7HK4!OY>AM0&_CZ&U`;^/H M;4!O(^V5H,T2CMX&]#:.W@;T-H[>!O0VCMX&]#:.W@;T-H[>!O0VCMX.]':. MW@[T=H[>#O1VCMX.]';27C?:[.;H[4!OY^CM0&_GZ.U`;^?H[4!OY^CM0&_G MZ!V!WI&C=P1Z1X[>$>@=.7I'H'?DZ!TO],YM,Z;M2QD/W3Y?N^:_X;#H`N]< MWH[I^BGGJ;#A0NLRK93"^7CU%_D\]6](^/1CP>,[4$L#!!0````(`,ME.$=% M>#1\7@,``&P-```0````9&]C4')O<',O87!P+GAM;+U737/:,!#]*QI.Z2$Q MX2-M,]0S"?EH9]J$*30]=A1YP9H(R=7*3.BO[UH&`D%V8P[E@BR]MUKM>UK, M0&/[?&1-!M9)0/8\5QK/:?)3*W4N.X\B%"G,.9X01-/JU-@Y=_1H9Y&93J6` M*R/R.6@7==KMLPB>'>@$DN-L$[05#XI=+K),2<&=-#K^)H4U:*:.73\+4(/H M-<`S*/(81&ZE6\;M$K,]Y3%CP14,::]XRA5"B7J9])BAF6=<+Z/RZ:O43_@C MFY@K[F";M;M01D^YA80VW8F^F?28STLZIRJXPY3K&23;V/W%=2T>P&)QTM/. M29L^FQ*LY\O8P!.I9R,N+<:#A3M?@'#&KF1:N$-52HPH1,>'">6'+?;($8KA MI]:"6\FU:S&4?^BQTRJW+6?]6&7H;/S3V"=,`1P.HLVD'VYCM\>R%_>['D&C M762T.5F\*MO.N8N9B70*\'XZXM;]IU+X,ZT+T>^VMDZ_#L$N=,*NM2,[LB^Z MW(K$VR[)9C0T&HV2"9DK89=<<2V`C?=*^!8\^S7B_^:,'7T562(S4W9/1FS* M*2[.`9RSQAR.:9!S"QHL5\&U2X[2LT<6D")55_X[",41Y7357<+I40Z,DYQ^ MC*`TC-+A9<*OZHX)@\<#P.BW-G''78C"\+8&543::F MIAE<_X%0'/@:G22C58#NP)$7A9D#._IJ$-\Q4KZ096XT^2?(F5C@F-LEZ6+$ M4Q#B5\B'2.H5O@"-U<6\H8O+'KC*?;XW4I-Y)5>4%ZWF\S#'6)`SS8:YM:#% MDDTLUZCJ9*5JT0XDKYEI68F[,U0-[:Q1U(AGE(,#Q<>8_>N[0L M7&8AI>/*15@U,K:CP)1SE6Z4H6\60IC<8\FS1M-8^#M0X84DIV^2!&:ESPIS MWH*969ZE,JP1U<^[_-5F=.TJ'5%OBNN7S= M3O-"=[MO[SWLZ`H<]0%DS5M&MU_3,D9ERWB)/Z&WK)RK<`UJ!>V^/X`3-L%N MS]A+KJ%Q/+LYIW=Z`"?L@UJ#]L(^J.?TWF[J5?'"BM8QJ-Q-FMZ:U_SV],(N MJ.=\_'?#W#-.U0]NS2WMAUU0SSF@&_1W7+#WUOKJ'37:_6\5_P502P,$%``` M``@`RV4X1VR+8BD_`0``:0,``!$```!D;V-0;!$M)<3S+2CF1Z%"A^3:.,4PA&Y#+.,[ MM@%29-F4*$`F&#)R!*:V)R95*3CE#A@:U^$%[_%V[^H($YQ`#0HT>I*/%$7(M0=RU0]GO5.B,X)0_R4'T[>/?/SW$#$FZRH.7 M?573-*-F'.O"P#EY7SR]Q+-)I?;(-(>@\I)B:V&>G#N_C>\?EH])563Y;9K- MTF*RS`LZF=)\]G&<[,+?8%AU0_Q;QV>#<;LHL88K=QLU(BXW?D:0`,^=M"B- MO@H7,=_$$>;WJT_@>#VH$\;+MH.V,4[X*MZO(3J^G+"RC7'M*?4CNGA5U1=0 M2P,$%`````@`RV4X1YE&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M3A^%$5B-;'EDD81_ MOTV23;J;/`0LZ?O.14?GZ#AY\^XN8NB&B)3R> +]O6N[!3+UES@6QHO(];JM-O= M5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,!$U=!)KF(M/+Y;,7\ MVMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9KQ]'22(""R7V4!;I) M]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2BW`A(5M>5`TR``6'!VULS2`Y9>*?IU ME!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D`4.`#?$T4Q0?*]!MHK@PI+2 M7)#6SRFU4!H(FLB!]4>"(<7K;YH]5Z%82=J$^!!&&N*< M<^9ST6S[!Z5&T?95O-RCEU@5`9<8WS2J-2S%UGB5P/&MG#P=$Q+-E`L&08:7 M)"82J3E^34@3_BNEVOZKR2.FJW"$2M"/F(9-AIRM1:!MG&IA&!: M$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+D!&_'H8X2IKMHG%8 M!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T!Z.:60F]A%9JGZJ' M-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+`.7\N?<^E[[GT/:'2 MMSAD6R4)RU3393>*$IY"&V[I4_5*E=?E MK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.WF)&Y"M-2D&_#^>G%>!KB M.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#0X=Y>U^89Y7&4#04 M;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O&`RN0HGQ,C$7H<.>77%_C MT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55ORL+YJ/;053L_^6:W( MGPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SCYL=Q3E.X$G:V#P(R MN;LYJ7IE,6>F\M\M#`DL6XA9$N)-7>W5YYNTB42%(JP#`4A%W+C[^^3:G>,U_HL M@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF8$O#>FZ=+2?_VU[4 M/;07/4;SHYG@'K.'YA,L0Z1^P7V*BH`1 MJV*^NJ]/^26<.[1[\8$@F_S6VZ3VW>`,?-2K6J5D*Q$_2P=\'Y(&8XQ;]#1? MCQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!U4#E/]O4#6CV#30< MD05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_`5!+`P04````"`#+93A'V;#M;ED" M``!N"P``#0```'AL+W-T>6QE9A;T6V94>@#T^6,Z>_?OIP[,20ILG2DKSHZNC>54J,LLH$,>J-?7_B,40X MC$->LRE3%4A%S54$OW800*>F\G'?G;>?7:@'JR)_6KW$/RZ_W(7Z$>$-\88J\]^3C,!>\O M8`P=$(?5"U@@JOT#XYX**B10^H:U`HMPQ+#SN$>4))(8,$>,T*6#QP:P1='Z M,<*%M+E=AF&>D=]GDD420;_]O3U=TK/;P6R/4+JY/0W$88F4PI)/]02T]FQ9 MZLUQP;$3:?UV>!<2+8/QU5J`'73>1,@,RRYS`%=0'%*<*QT@23$WHQ*ED2Z4 M$DP;&4&%X(@:RE5$:VC:%%/Z9#[!W_D&=Y,#YV/NV(?`J%B9^B!:LR\#>ZC> M.IOC7J<='\0+FKQ+H*-16=+E=TH*SK`3ZZ"I:&>[Z(,M]'&(5JQ@+B1YT?ZF M$%(-8`G!`DM%TG7DKT3E##>JK6"OR;;W[RNS7"0&PO=V]R:V)O;VLN>&ULE9=;<]LV M$$;_"H9/SD,J\:;8GB@SOEVQ5/>Q`Y.0A#$(L`#H2WY]EY1=?Y00-GH2 M21$'M[.[Q%=W_&SLXX,QC^RE4MH=VVFT]KX^'HUR$.>F:"JA_2@9CRQ]JK>6%:84&]AB+=U?;W]$K!1+WBB_H,&^]SN-XB1+DLF&T;YV+\6S M0V#[@/'"RR>QX`_3:!PQWGAS*947]IQ[<65-4TN](E;$EM(Z/V^GV[U922TK M^:,=-]VYM7G^W5CYPVC/U;RP1JFN5?M'UXAZ]/SAKMV):309 M$_!).OD@E?2OTZB[5J*=R6AK*MWR?UPQW2W.^Q:S$UVR"^V)PF9ZLWFT-.T8 MZ.59V75LCR5=V%D9;Y8*06"==-Q`$D`DNP%87_?<@"E M`$K_!S3W]--.TC&S9#>UL`#*`)3M!3HS50V@'$#YOJ`)@"8`FNP'XFX-H"\` M^K(+NA):6*Z@P2$T.-QM<,J=[/JYM<)1G]N&'$'SH]WF=Z*@F':2,LN.6V.4 M:QR8-,V,<5*TN[CXIY%/7+731DC/T("B,_U$*62S6E*SDR.%;SU[8]-D0OXX"8[1BTI_`7O:&CA7%`PS^=:!?^PGE)@=EO MB^+%`?.NZ6JF"U,)=O#=./>)402TTE64KNF%:9JA2AT,PDG M34_#H/7HVYF@G4G`3II]5T**PC0=@C*$T71==+D)42AK$I!UILN&=I,,$ZM- MI+91?R7,RO)Z+1&%LB8!6>>TP5VRV1H:)<_M":*]2<#>P1!*#A&%$BIS^FL=O`W*?D(-"IP&A!VU,$T2AV&E`[$$3 MTA11O8^!@-C!PL4.SH6G"N`8HE#U-*#Z8`U)AI0?=#/]`NB4/5T7]535#U%U=.`ZOUJL3-#1*'J:4#UGT=-!\7O M.50]"Z@^B,IB1*'M6<#V813:GJ'M6<#VP5C.T/8,;<\"M@^C,D3U/GZ#B3V0 M%MZV$07-T/4LX/H0B'Q`%+J>A5P/U\QW'*+0]2S@^F"VRM#U#%W/`JX/HXX0 MA:YG`==[97@G:K!NY>AZ'G!],(?FZ'J.KN?!C^H^OYOID]1]=S=#U/ MWXZU'R=9.LQ++?LMV-[_84KJNSVUTP&]4>J, MGMWH[X9W9]L-^?VX_^U?4$L#!!0````(`,ME.$?9QD.$3`(``/,'```8```` M>&PO=V]R:W-H965T&ULC97+CILP%(9?!?$`@VTN248$*4E5 MM8M*HUFT:R=Q`AK`U';"].UK^SA,,O(`&WSA_\]W?,][+MYDR9@*WINZE>NP M5*I[CB)Y*%E#Y1/O6*O_G+AHJ-)-<8YD)Q@]6E-31P2A+&IHU89%;OM>1)'S MBZJKEKV(0%Z:AHI_6U;S?AWB\-;Q6IU+93JB(H\&W[%J6"LKW@:"G=;A!C_O M<&(D5O&[8KV\JPR@3`BJBRO;L;HVD33YKPOZP33& M^_HM^G<[7)W^GDJVX_6?ZJA*G2T*@R,[T4NM7GG_@[DQI";@@=?2?H/#12K> MW"QAT-!W**O6ECW\2;"S^0W$&##`U$60F1W7-ZIHD0O>![*C M9K7QLY8+$T1'#O1@I)XG&U/8F2KR:X'RZ&K"/"B(56Q!@0=%I&-[`23TV8FU MDZ\!.U#$TX#X$0"=F]C:DVE[\FA/P)Y8>^K+#Q1;4&33@-0+2*U],0(`Q7(: MD'D!F;6O1@"@P&B:L/`2%N#'CXC62E)`@(0@G$Y#EE[($B#>G9(!Q$EF;)65 M%[$"?S(R54XR8Q08>1FV6T?(1B;+:98KM$(SEAUC/\F=S+&M==/,H1`_!8XG M'MM?3D-F;#`<^REPB@D>HS@-F4'QGW4,1YG$7Z_-SFEPG&0(D\_72G1WQS9, MG.W;(X,#O[0*KMBA=WC?-L3>T1_R(N_HF?VBXERU,MASI6]Z>R&?.%=,)X&> M=#*E?H&'1LU.RE07)DMXDZ"A>'=[8H=WOO@/4$L#!!0````(`,ME.$=C__TV M800``+@4```8````>&PO=V]R:W-H965T&ULC9A-;]LX$(;_ MBN'[UISAAZC`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`;#-),2G/+&HBF)6* M1=:@5J$KZ70X-Z;&XB1A^G2OG.N) M958J&%D3CHGB$_&W3*4LIS@3-3%1.G=M61.RY'*;2S7#K/0PIC/%5?QLKXFS M\>'/KS_F8_OU(G9^_V&E(G;UYAW3J7RN_BZ[Y\.Q7SRTP]`VTUNEI[8=JM"2 M^A3&N:_*W>6BKIZ&\6K-'%T)[F]X27EY6;_P%02P,$%`````@`RV4X M1^V^%DI<`@``=0@``!@```!X;"]W;W)KOXDS8])[;YM.;/RSE)=U$(C]F;54K/B%=>K.D?^+:MK3_NV4-'S8^]J>!U_ITEGH@ M*(M@CCO4+>M$S3NO9\>-_P6O*VP00_RJV2#NKCTMO^/\37=^'#8^T@ZL87NI M4U#5W%C%FD9G4I7_C$G_U]2!]]=3]F]FNDI_1P6K>/.[/LBSLD6^=V!'>FWD M*Q^^LW$.L4ZXYXTP_][^*B1OIQ#?:^D[M'5GV@'N)-$89@\@8P"9`_!R0#@& MA$\!`9B9>7VEDI9%SP=/7*C>;;Q6>*^3J,R>FHQ0ZV1R]F:ERN)6)J@(;CK/ M`T(,L@6$N(EJ).(9"51]JP1YE(A`@H`$?BS1&20%"4`P(7&>(H3<9#62<81# MG;,$)$!Q%.$N(=2%')0?H-,+( MJF2&E5.^X#0R.(P2A,G"4U[-9)9E"']BG3"V6\'[,UW8D^W(Y'$6(^L[:7(" M+@Y1@I_7*;@[("[TQ'[2_E1WPMMQJ^LO@'F3L..4E^F MNA"&PO=V]R:W-H965T&ULE9C?;Z-(#,?_E2CO+>/YQ5"ED9;` MZ>[AI-4^W#W3AC;1AI`#NMG[[V_`AK3=B<.I4A/(QY[YSAC;S.I<-]_;75EV MBY_5X=@^+G===WJ(HO9Y5U9%>U^?RJ/_Y:5NJJ+SE\UKU)Z:LM@.1M4ADD+8 MJ"KVQ^5Z-=S[VJQ7]5MWV!_+K\VB?:NJHODW+0_U^7$)R_'&M_WKKNMO1.M5 M--EM]U5Y;/?U<=&4+X_++_"02]DC`_'7OCRW[[XO^LD_U?7W_N*/[>-2]',H M#^5SU[LH_,>/#KTG/_(_Y/0R9F_X_OOH_;=!KI_^4]&6F_KP]W[;[?QL MQ7*Q+5^*MT/WK3[_7I(&TSM\K@_M\'_Q_-9V=36:+!=5\1,_]\?A\XR_6$UF M80-)!G(RF,8)&R@R4!<#?@1-!GKN"(8,S*<1(M0^K%Q6=,5ZU=3G17LJ^GB" M!X\WO1/O>>&7J_4[,?ALAKU8KWZL8UA%/WH_'Q`Y("DA\CJ2(7)Q$OGQ@Y.0 MR]`(=Y+\XN3I-]7&:&M=*H;W^.,1Q0&)4@@@('6MIKW,; MY&2L7?QY8=]S&7(&I$@2ALMI:E(E6MC;^O1'?0KU:71B;MN;X/H8M`_J1KL4 M$3!.2W#7N(@$RL#T=&'G%^^\!Q^I!3 M3FGI#*./.`4VD3.2C`OJ*B(M!*T8=429V7&0B):V0DG&6$^:$#\W; MRI*@L@0G)!AEB"CIFX5P_B)MQ"FKK>#4)93GA(T=%S(Y@HGU`1R+VP)!!!4. MM[U$)IA28NXDQ-)J+KF,I/4!JIALE8V@3K3UF8B1.0VNM39VQC,(G\HQI6#` M2NIFQ`+(\%)AE7-,T*7$2`!G=+"LC"N%("0ZCID'-)LX(U3"A3N!UH\\)U-! MN!`#ECO'1')*#,0NX7+LAC@I;2Q8BQ.)CX?,6`V M@;%0UC)/23Z28*1QR9R=##1_!?DNIIPJP!4XKE> M@9B;>^;F[IF;O6?N_^Y9N&T`JLU6>44CQF^<9;"-%)>-T\$EHE>T"?0;%T/P,:>7M)'$C9N14B2$56*3P+T0 MIL0$)^Y((2)WXEX$/3G2-V$,E5\HF',,$.Y=)'8'7`>1$@,^R?M77:X@C*36 M/H.'W\8I.B>?3OBJP(7HQ:<"D)_?M*-W)S!5V;P.9U_MXKE^.W9XJ##=G<[7 MO@S':Y_NI_"P@<#]#!YR/#V[N%^O3L5K^6?1O.Z/[>*I[KJZ&HYW7NJZ*_VD MQ;V?_*XLMM/%H7SI^J]QKPK/T/"BJT_CD>!T+KG^#U!+`P04````"`#+93A' M?(34*L<"``#,"0``&````'AL+W=OO8LM8]+[:.I6C/VME+M1$(CEEC6E>.8[UJI_UKQK2JF6W280NXZ5 M*T-JZ@"%81HT9=7Z16[V7KLBYWM95RU[[3RQ;YJR^SMA-3^._<@_;;Q5FZW4 M&T&1!SUO536L%15OO8ZMQ_Y+-)I3C3"`7Q4[BHMW3\>^X/Q=+WZLQGZH0V`U M6TIMH52/`YNRNM:&E.,_UN;9I29>OI^L?S-J5?2+4K`IKW]7*[E5P8:^MV+K M4'/*O6/(_P3Q9:FIN`+`'UA-Z/ MFQ!;0GPFX$$"M@3\J(?$$I)/'@+0;C(W*V59Y!T_>F)7ZN,4C12\TT:494^E M2ZA*&)N=J461'PJ*\^"@[5Q!D(%,`$+0;<@,(%&/")1_9Q#(=WE`AC[@8`H( M$@_$<-?(_(N1FV'&UV%BR%5L^!F]=M$:"`$E`(G2%`V@IH!Z0I3B=``W.^%( M&*@P)LD-E`591+'MX%3 M`$81Q30;P,VL01QG*DG1;>`<@#'1I7E`8>I4F()",J`P?51A^J#"]%&%Z?\I M)$Z%!!1F`PK)22'):.@\E58AL=]+DD0#L)FU1T(:IA>!?Q4(0(1PB,/POL#, M*3`#@<[/S@H$2(P&I`'$_9%;60!Y2@9J.[<8?%\,=8JA<(8NLO&U)=%SN;+/ M3?RJ*]&^7-@9LVU*]%PN@IWGQ#8EVIA(=<+-3")%(]8T3^W0(5PR:(@E/@M:T;;0,X2_'$*UL& M7+6"(PG5)GB.UOO$(AS@5PN#NI@CZ_T@Q)M=_"@W06@M`(5"6P5BAB/D0*D5 M,HG_C)KGE)9X.3^I?W/5&O<'HB`7]'=;ZL:8#0-40D5ZJE_%\!W&$I96L!!4 MN2\J>J4%.U$"Q,B['UONQL'O?`U'VCPA'@GQ1)CRS!.2D9"<"8N[A,5(6/QO MAN5(6%YEP+YVU[D=T21+I1B0ZH@]3M':P*45,\DR#UBE=SQ\%!D_TGDILWD MH\V%;U8R-NLJ!W>8E2_%8\+;B/PA8O<0L;]&^$+PQ0E@(&MW]Q0J1,^UKVF* M3M?[.;8GZ"J^C=9Y-!/?F>?`W]ZS?)9VI(:?1-8M5^@@M#FW[GA50F@P9L,G MT]/&/%C3@D*E[71EF^WOL%]HT9U>I.E9S/X!4$L#!!0````(`,ME.$?G6'4< MD`0``,H5```8````>&PO=V]R:W-H965T&ULC9A-;^,V$(;_ MBN"[U^0,/Z3`,1"K*-I#@<4>VK-B,[&QDN5*2KS]]Y7$H9/L,F/F$%ORR^$[ M_'@TXOK2=M_[@W-#]J.I3_W]XC`,Y[O5JM\=7%/U7]JS.XV_/+5=4PWC9?>\ MZL^=J_9SHZ9>@1!FU53'TV*SGN]][3;K]F6HCR?WM^'9\/PW1CM5FOKNWVQ\:=^F-[RCKW=+]XD'7"UVPU3B&K\>'6EJ^LITMCSOQ3TK<^IX?OO(?KO<[JC_<>J M=V5;_W/<#X?1K5AD>_=4O=3#M_;RAZ,<]!1PU];]_#_;O?1#VX0FBZRI?OC/ MXVG^O/A?+%*S>`.@!G!M<.TGW@"I`;XU4'.FWMF:0VZ]>-%+A>O4Z!/FA@UFQ)<@,AUM2<-.EY=H4RA,63]QG$H/0<5.5T[0`##L M8LX)=$4A$YY_,DY4Z4&HV!4=D`I8&!YD%`W42+*$88(X7"'`E>EK2Z*ELE)+ M%D2D!&,+*Q,>SA#G*P2^)BQ&B/,5`E^9B=V2R(CYC\N+HL&X5O*$)0!QP`)5 MAI+;(B1:CH\RP2W?,@@!)20M@3AI@:I-R=5")+KQJ"=5BI089C6GF"HS@? M@8I$X'!$HJ6TP&ZDDH0I$Q^'(U"]"=S3#`(=I502@QSU/>#%'&31$:N0)C2R*+^OU+:,23UZ%64*2P%N.L MQ4!'CK5!9')9:-X5*5'G6JF$`@GCM$6B+7"T#2*KM3+-@1`)C_,V##E](M%286\$I2U*B-09^.7U9O3LB:USW/!\=]MFN?3D- M_OCJ>O=Z//D`TQ';3_>W\J[TAXQO83;K<_7L_JJZY^.ISQ[;86B;^9SMJ6T' M-WH37\9A/[AJ?[VHW=,P?;73?/BC1G\QM.=P5-_H:0!``"Q`P``&````'AL+W=O+F!@?HW9\&M>+6I;IE9M#`ZT!2 MDJ5)L$)I MPI=4H[&H%@HEBK_'5?1AG>*?VV2F72>D,R%="?>!P&*C8/.)6UX6&B=B!N[/ M;K-S<.U%G#)QWHP;.VCJ,'A9G,I-EA;LY(4N,)%XF#$K@CGUJRU2>HV>!GKZ M,SV[I&?1838[S'X6R"\%\BB0SP+YM1$CYK!@MM^:L+,]5:#;<'4,J7#L;=S2 MM;K>SHROM+R$U!+`P04````"`#+93A']?*&>J8!``"Q`P``&````'AL M+W=O;`?@R(>2VNYIYUR_ M8\Q6'2AN;[`'[?\T:!1W/C4ML[T!7D>2DBS/LCNFN-"T+&+MQ90%#DX*#2^& MV$$I;OX=0.*XIRLZ%UY%V[E08&7!%EXM%&@K4!,#S9X^KG:'34!$P!\!HSV+ M2?!^1'P+R:]Z3[-@`214+BAPOYS@":0,0K[Q^Z3YV3(0S^-9_4>;$9)#0T?I'O%\2=,(]P&P0JEC5]2#=:AFBF4*/Z15J'C.J8_VX>) M=IV03X1\(=QGT7AJ%&T^<\?+PN!(;,_#V:UV'FZ"B%)@P"X)Y]:LM'V>X'-I<`F"6PF M@?MK(R;,8<8\?&G"SO94@6GCU;&DPD&[M*5+=;F=CWD\DT]X6?2\A=_0(/HP+?/;FXIZ?S[61()C0OAULPQWZ"I0$``+$#```9````>&PO=V]R:W-H965TEN/E]`HGSD>9T+;R(?G"A MP.J*;;Q6*-!6H"8&NB-]S`^G,B`BX(>`V5[%)'@_([Z&Y%M[I%FP`!(:%Q2X M7R[P!%(&(=_XUZ+YWC(0K^-5_4N;$9)"QV?I'O!^2LL M(^R#8(/2QB]I)NM0K11*%']+J]!QG=.??;[0[A.*A5!LA$]9-)X:19N?N>-U M97`F=N3A[/*#AYL@XI6)]V;]V%'3Q,'KZE+G95:Q2Q"ZP23B:<%L".;5[[8H MZ#UZ$>G%O^F[6_HN.=PM#O^C?WDK4":!X74U\AZ^<],+;``=H@/?/GO84S+X][,E M$CH7PH\^-NE*I<3AN#Z0[976?P!02P,$%`````@`RV4X1[AAE3:E`0``L0,` M`!D```!X;"]W;W)K&ULA5/+;MLP$/P5@A\0RK*< M%(8L($X1M(<"00[MF996$A&2JY"4E?Y]^9`4NS"0B[B[FIF=Y:.N6'/F*U[4-S>X0#:_VG1*.Y\:CIF!P.\B20E69YE]TQQH6E5QMJ+ MJ4H4?T3C>F\VHZ2!EH_2O>+T`^81=D&P1FGCE]2C=:@6"B6*?Z15 MZ+A.Z<\NFVFW"?E,R%?"MTA@J5&T^9T[7I4&)V(''LYNL_=P$T2\,O'>K!\[ M:IHX>%6>JTU1E.P?6;+7)ZBYY'>OXU?7M-WR:'V]GA[FN! MXEJ@2`+%+'!_:\2$.2Z8A_^:L(L]56"Z>'4LJ7'4+FWI6EUOYV,>S^037I4# M[^`7-YW0EIS0^9.-!]`B.O#ML[L=);U_/VLBH74A?/"Q25P)$W);4]T-ZY8<^8K7M0W-[A`-K_ M:=$H[GQJ.F8'`[R))"59GF5?F.)"TZJ,M6=3E3@Z*30\&V)'I;CY=P2)TX%N MZ%)X$5WO0H%5)5MYC5"@K4!-#+0'^K#9'XN`B(#?`B9[$9/@_83X&I*?S8%F MP0)(J%U0X'XYPR-(&81\X[^SYGO+0+R,%_7O<5KO_L0M/*+\(QK7>[,9)0VT M?)3N!:*]63]VU#1Q\*H\5YOBOF3G('2%2<3CC%D1 MS*O?;)'36_0\TO//Z=MK^C8YW,X.OWTN4%P+%$F@2`*[[-:("7-<,!^'9!=[ MJL!T\>I84N.H7=K2M;K>SH<\GLD[O"H'WL$O;CJA+3FA\R<;#Z!%=.#;9W<[ M2GK_?M9$0NM"^-7')EVIE#@ROM+J/U!+`P04````"`#+93A'ZO6,[*4! M``"Q`P``&0```'AL+W=OP)$W);4]TMZYX<"8K7M0W#[@`-K_:=$H[GQJ.F8'`[R))"59GF5?F.)" MTZJ,M6=3E3@Z*30\&V)'I;CY=P*)TY%NZ%)X$5WO0H%5)5MYC5"@K4!-#+1' M^K@YG(J`B(#?`B9[%9/@_8SX&I*?S9%FP0)(J%U0X'ZYP!-(&81\X[^SYGO+ M0+R.%_7O<5KO_LPM/*'\(QK7>[,9)0VT?)3N!:W.7BX"2)> MF7AOUH\=-4T?6[+7)ZCYY'>OXY?7M+WR:' MV]GA]G.!XE:@2`+%+%#<&S%A3@MF]Z$)N]I3!::+5\>2&D?MTI:NU?5V/N;Q M3-[A53GP#GYQTPEMR1F=/]EX`"VB`]\^>]A1TOOWLR826A?"O8]-NE(I<3@L M#V1]I=5_4$L#!!0````(`,ME.$=/.S]GI0$``+`#```9````>&PO=V]R:W-H M965T+F M!@?HW9\&M>+6I;IE9M#`ZT!2DJ5)]IXFW`!(JZQ6X6T[P"%)Z(=?X[ZSYU=(3S^-%_2E,Z]P?N8%'E.^BMITS MFU!20\-':5]Q>H9YA*T7K%":\"75:"RJA4*)XI]Q%7U8I_@GRV?:=4(Z$]*5 M<)\$X[%1L/F+6UX6&B=B!N[/;K-S<.U%G#)QWHP;.VCJ,'A9G,HL*=C)ZUQ` M(N\0(9L5P9SXU0XIO49/`SW]F9Y=TK-H,(O=M[<_"^27`GD4R&>!NVLC1LQA MP=Q_:\+.ME2!;L/-,:3"L;=Q1]?J>CD?TG`D7_"R&'@+?[AN16_($:T[V+#_ M#:(%USZYV5+2N>>S)A(:Z\,[%^MXHV)B<5C>Q_I(R_]02P,$%`````@`RV4X M1]Z##X"E`0``L0,``!D```!X;"]W;W)K&ULA5/+ M;MLP$/P5@A\02K*=MH8L($X1M(<"00[MF996$A&2JY"4E?Y]^9`4NS"0B[B[ MFIF=Y:.N6'/F*U[4-S>X0#:_VG1*.Y\:CIF!P.\B20E M69%E]TQQH6E5QMJSJ4H#\AOH;D9W.@6;``$FH7%+A?SO`(4@8A MW_AMUOQH&8B7\:+^%*?U[D_;4=)`RT?I7G#Z`?,(NR!8H[3Q M2^K1.E0+A1+%W],J=%RG]&=3S+3;A&(F%"OA:Q:-IT;1YG?N>%4:G(@=>#B[ M?._A)HAX9>*]63]VU#1Q\*H\5_GN6\G.0>@*DXC'&;,BF%>_V:*@M^A%I!>? MTS?7]$URN$G=[[//!;;7`MLDL)T%\ELC)LQQP?SODEWLJ0+3Q:MC28VC=FE+ MU^IZ.Q_B(;(/>%4.O(-?W'1"6W)"YT\V'D"+Z,"WS^YVE/3^_:R)A-:%\(N/ M3;I2*7$X+`]D?:75/U!+`P04````"`#+93A'G_G[3J0!``"Q`P``&0```'AL M+W=O2FSL<0+D_#6K)K4MUR\R@@=>!)`5+DV3').\5+8M0>]9E@:,5O8)G M3W4M0ID=%-#0'^K#9'W./"("_/4SF M(B;>^PGQU2>_ZP--O`404%FOP-URAD<0P@NYQF^SYF=+3[R,%_6?85KG_L0- M/*+XU]>VUQ[%=8I_LD6 MVFU".A/2E7"?!..Q4;#YQ"TO"XT3,0/W9[?9.[CV(DZ9.&_&C1TT=1B\+,[E M9I<5[.R%KC"1>)PQ*X(Y]9LM4GJ+G@9Z^CT]NZ9GT6$V.\R_%\BO!?(HD,\" MVULC1LQQP>R^-&$7>RI!M^'J&%+AJ&SF`0``L0,``!D```!X;"]W;W)K&ULA5/;3N,P$/T5RQ^`T[30;I5&HJP0/*R$>&"?W6226-B>8#L-^_?XDH9V M58F7>&9RSIDSOA0CFG?;`3CRJ:2V.]HYUV\9LU4'BML;[$'[/PT:Q9U/3Z7 M(SR`E$'(-_Z8-+];!N)Y?%)_C--Z]P=NX0'E7U&[SIO-**FAX8-TKS@^P33" M;1"L4-KX)=5@':H3A1+%/],J=%S']"??3+3KA'PBY#-ADT7CJ5&T^9L[7A8& M1V)['LYNL?5P$T2\,O'>K!\[:IHX>%DY_%,ON%ET?,6_G#3"FW)`9T_V7@`#:(#WSZ[N:6D\^]G M3B0T+H1K'YMTI5+BL#\]D/F5EE]02P,$%`````@`RV4X1[%>QIJE`0``L0,` M`!D```!X;"]W;W)K&ULC5/;;J,P$/T5RQ]0`Z%- M%1&DIJMJ]V&EJ@_MLP,#6+49:IO0_?OZ`C191=I]P3/#.6?.^%),J-]-!V#) MIY*]V=/.VF''F*DZ4-SZ*AV=.'='?( M/2(`7@5,YBPFWOL1\=TGO^H]3;P%D%!9K\#=:$+3"0>9LR*8$[]:HN,7J-G@9[]F[ZYI&^BP\WL\#\$ M\DN!/`KDL\#FVH@1*M!MN#J&5#CV-F[I6EUOYT,6SN0;7A8# M;^$WUZWH#3FB=2<;#J!!M.#:)S>WE'3N_:R)A,;Z<.MB':]43"P.RP-97VGY M!5!+`P04````"`#+93A'$*2"T:4!``"Q`P``&0```'AL+W=OV1=L[U!\9LU8'B]@%[T/Y/ M@T9QYU/3,ML;X'4D*U;_':;W[,[?PC/*/J%WGS6:4U-#P M0;I7''_`-,(V"%8H;?R2:K`.U4RA1/'WM`H=US']6>\FVGU"/A'RA?"81>.I M4;3YC3M>%@9'8GL>SFYU\'`31+PR\=ZL'SMJFCAX65S*U7Y;L$L0NL$DXFG" M+`CFU>^VR.D]>A[I^=?T]2U]G1RN)X>[KP4VMP*;)+"9!/;W1DR8TXQY_-2$ M7>VI`M/&JV-)A8-V:4N7ZG([G_)X)A_PLNAY"[^X:86VY(S.GVP\@`;1@6^? M/6PIZ?S[61()C0OAWL&PO=V]R:W-H965T[#2E4?VF<'!K!J,]0VH?OW]05H4D7J"YX9SCESQI=B M0OUF.@!+/I3LS8YVU@Y;QDS5@>+F"@?HW9\&M>+6I;IE9M#`ZT!2DF5)\HLI M+GI:%J'VI,L"1RM%#T^:F%$IKO_O0>*THRE="L^B[:POL+)@*Z\6"GHCL"<: MFAV]3[?[W","X$7`9$YBXKT?$-]\\K?>T<1;``F5]0K<+4=X`"F]D&O\/FM^ MM?3$TWA1_QVF=>X/W,`#RE=1V\Z932BIH>&CM,\X_8%YA&LO6*$TX4NJT5A4 M"X42Q3_B*OJP3O%/GLZTRX1L)F0KX38)QF.C8/.16UX6&B=B!N[/+MTZN/8B M3IDX;\:-'31U&+PLCF5ZPHQD,.:-W)A@-H$"VX]LG5-26=>S]K(J&Q/KQQL8Y7*B86 MA^6!K*^T_`102P,$%`````@`RV4X1X!1IM^E`0``L0,``!D```!X;"]W;W)K M&ULA5/;;J,P$/T5RQ]0$R#=*B)(35=5^[!2U8?V MV8$!K-H,M4WH_OWZ`C191>H+GAG..7/&EV)"_6$Z`$N^E.S-GG;6#CO&3-6! MXN8&!^C=GP:UXM:ENF5FT,#K0%*2I4ERRQ07/2V+4'O198&CE:*'%TW,J!37 M?P\@<=K3#5T*KZ+MK"^PLF`KKQ8*>B.P)QJ:/;W?[`ZY1P3`FX#)G,7$>S\B M?OCDN=[3Q%L`"97U"MPM)W@`*;V0:_PY:WZW],3S>%%_#-,Z]T=NX`'ENZAM MY\PFE-30\%':5YR>8!YAZP4KE"9\234:BVJA4*+X5UQ%']8I_LFRF7:=D,Z$ M="7<)<%X;!1L_N:6EX7&B9B!^[/;[!Q<>Q&G3)PWX\8.FCH,7A:GSD MA2XPD7B8,2N".?6K+5)ZC9X&>OHS/;ND9]%A-CO,?Q;(+P7R*)#/`MMK(T;, M8<'<_M>$G>VI`MV&JV-(A6-OXY:NU?5VWJ?A3+[A93'P%OYPW8K>D"-:=[+A M`!I$"ZY]2#K*RW_`5!+`P04````"`#+ M93A'L=LO.*#+&C4MQ\[$'BM*,K>BH\BZYWH<"JDBV\ M1BC05J`F!MH=?5AM]T5`1,"+@,F>Q21X/R"^A>1/LZ-9L``2:A<4N%^.\`A2 M!B'?^-^L^=4R$,_CD_JO.*UW?^`6'E&^BL;UWFQ&20,M'Z5[QNDWS"/&D6;/[GC56EP(G;@ MX>Q66P\W0<0K$^_-^K&CIHF#5^6Q6FWN2G8,0A>81-S/F`7!O/K5%CF]1L\C M/?^>OKZDKY/#]>QP\[U`<2E0)(%B%KB_-F+"[&?,??9?$W:VIPI,%Z^.)36. MVJ4M7:K+[7S(XYE\P:MRX!W\Y:83VI(#.G^R\0!:1`>^?79S2TGOW\^22&A= M".]\;-*52HG#X?1`EE=:?0)02P,$%`````@`RV4X1S>^)=&G`0``L@,``!D` M``!X;"]W;W)K&ULA5/;;J,P$/T5RQ]0`Z%I&Q&D MIJO5[L-*51_:9P<&L&HSK&U"]^_K"]!D%:DO>&8XY\P97XH)];OI`"SY4+(W M>]I9.^P8,U4'BIL;'*!W?QK4BEN7ZI:900.O`TE)EB7)EBDN>EH6H?:LRP)' M*T4/SYJ842FN_QU`XK2G*5T*+Z+MK"^PLF`KKQ8*>B.P)QJ:/7U,=X?<(P+@ M54;Z*VG3.;4%)#PT=I7W#Z!?,(MUZP0FG"EU2CL:@6"B6*?\15]&&= MXI]\.].N$[*9D*V$^R08CXV"S1_<\K+0.!$S<']VZ<[!M1=QRL1Y,V[LH*G# MX&5Q*M.'M&`G+W2!B<3#C%D1S*E?;9'1:_0LT.\VW_,WE_Q-M+B)[;?WWPOD MEP)Y%,CG&;-K,T;,8<'\[Y*=;:H"W8:[8TB%8V_CGJ[5]7H^9N%0ON!E,?`6 M_G#=BMZ0(UIWM.$$&D0+KGURLS+3\! M4$L#!!0````(`,ME.$>Z,@_,I@$``+$#```9````>&PO=V]R:W-H965T6CG-"\VA[`D3U#9?=,<:%I5<;:LZE*')T4&IX-L:-2W/P[@L3I0#=T M*;R(KG>AP*J2K;Q&*-!6H"8&V@-]W.R/14!$P&\!D[V(2?!^0GP-R<_F0+-@ M`234+BAPOYSA":0,0K[QWUGSO64@7L:+^O4/X1C>N]V8R2!EH^ M2O>"TP^81]@%P1JEC5]2C]:A6BB4*/Z65J'C.J4_NV*FW2;D,R%?"5^R:#PU MBC:_<<>KTN!$[,##V6WV'FZ"B%ORG.U^5J4[!R$KC")>)PQ M*X)Y]9LMTW?)H?;V>'N&PO=V]R:W-H965T+V"GO0_D^#1G'G4],RVQO@=20IR?(LNV&* M"TW+(M9>3%G@X*30\&*('93BYF,/$L<=7=&Y\"K:SH4"*PNV\&JA0%N!FAAH M=O1^M=UO`B("_@H8[4E,@O<#XEM(GNL=S8(%D%"YH,#]9O[GA9&!R)[7DXN]76PTT0\[-^[*AIXN!E<2Q7=[<%.P:A,TPB[B?,@F!>_6*+G%ZBYY&>_TQ?G]/7R>%Z M'4LJ'+1+6[I4E]MYG\&PO=V]R:W-H M965T6CG-"\V1[`D7U#< MWN$`VO]IT2CN?&HZ9@<#O(DD)5F>9=^8XD+3JHRU%U.5.#HI-+P88D>EN/EW M!(G3@6[H4G@57>]"@54E6WF-4*"M0$T,M`?ZL-D?BX"(@-\")GL1D^#]A/@6 MDJ?F0+-@`234+BAPOYSA$:0,0K[QWUGSLV4@7L:+^L\XK7=_XA8>4?X1C>N] MV8R2!EH^2O>*TR^81]@%P1JEC5]2C]:A6BB4*/Z>5J'C.J4_Q4*[3;H*(5R;>F_5C1TT3!Z_*@* MDXC'A-FL".;5;[;(Z2UZGEI\3=]>T[?)X79VN/U:H+@6*))`,0L4MT9,F.." MV?W7A%WLJ0+3Q:MC28VC=FE+U^IZ.Q_R>":?\*H<>`?/W'1"6W)"YT\V'D"+ MZ,"WS^YVE/3^_:R)A-:%\+N/3;I2*7$X+`]D?:75!U!+`P04````"`#+93A' M'JM6D5,"``"#"```&0```'AL+W=OL&O M2O\6=VPZVHN&]8C3T]9[QIL=3K7$*'XW=!1W8Z23WS/VKB<_CULOT#G0EAZD MMB#JF)7%KY MQL8?%/:0:,,#:X7Y18>+D*R;0CS4D0][;7IS'>V=/(`P=T`(`>&7`-^"3)K? MB"15R=F(Q$#TR\,;)>?:1#DCE9M0VS:>W&R\*J]5&*2E?]5&#QH;N+,:?%/X MRMV)"#U7>&@1R^'18WAD,XPL/8J6#>)'@]@:Q+#%S+5%J]G%`"F6(8D3D@`D MGX%8#8Y7["1U0E*`%#.0%"#9,B1S0C(+P<$,9-*L^$_D3D@.!N$,Q&IPDBQ# M"B>D`$@T`RD`DB]#<."DF&6-B6*XT083S=`7'?0)@.`+P7'6" M"!?!"H[[$,!P"H1S!3J)@J\5ZM\UB8[RL^F%`AW8I9>V1]Q6;_WV.31-YE-> ME0,YTU^$GYM>H#V3JE69CG)B3%+%#YX2#]7JB^`V:>E)ZF&FQMSV2#N1;)A: M_NV[H_H/4$L#!!0````(`,ME.$<#&P%1I0$``+$#```9````>&PO=V]R:W-H M965T)5MYT*!E05;>;74T%N)/3'0'.C39G_,`R("?DF8[%5,0N\GQ+>0 M_*@/-`LM@(+*!07AES,\@U)!R!O_F34OEH%X'2_JW^*TOON3L/",ZK>L7>>; MS2BIH1&C%N>2\TW!SD'H M!I.(QX2Y()A7OVO!Z3TZ3Q8?T[>W]&WJ<)O<=_G'`OFM0)X$\GE$?F_$A#DN MF.U_)NQJ3S68-EX=2RH<>Y>V=*VNM_.)QS.YP,MB$"W\%*:5O24G=/YDXP$T MB`Z\??;P2$GGW\^:*&A<"#_YV*0KE1*'P_)`UE=:_@-02P,$%`````@`RV4X M1PI]*3"P`0``%@0``!D```!X;"]W;W)K&ULC51? M;YLP$/\JEC]`34AHJH@@-9VF[6%2U8?MV8$#K-H0CZE?3`ECRIF1GCK2UMC\P9LH6%#=WV$/G3FK4BEL7ZH:97@.O`DE) MEB;)/5-<=+3(0^Y9%SD.5HH.GC4Q@U)<_SF!Q/%(-W1.O(BFM3[!BIPMO$HH MZ(S`CFBHC_1Q@7NE@L\@91> MR!G_GC3?+3WQ>C^K?PW=NNK/W,`3RE^BLJTK-J&D@IH/TK[@^`VF%D*%)4H3 MOJ0DHFV3D@G0OJ!P*)1*/,+M[S(-8[$]-S/;G-P M<.U%G#)QM1G7=M#4H?$BOQ1INLO9Q0O=8"+Q%#&;!<&<^JI%2M?H:;3XG+Z] MI6]CA=OHOO\/@=VMP"X*[*86L[46(^8T8^X_-\E63;))8/\/DQGS\,&$70U. M@6["_32DQ*&S<6Y+=GD"CVD8_#N\R'O>P`^N&]$9-7LSH@$` M`+$#```9````>&PO=V]R:W-H965T9)!:V)]A.`W^/+TUHJTJ\Q#.3#+MQ\;4'BN*$+.A5>1=NY4&!EP69>+11H*U`3`\V&WB_6 MVU5`1,!_`:,]BDGH?8?X'I*_]89FH0604+F@P/VRAP>0,@AYXX^#YH]E(![' MD_I3G-9WO^,6'E"^B=IUOMF,DAH:/DCWBN,S'$:X#H(52AN_I!JL0S51*%'\ M,ZU"QW5,?_YD!]IE0GX@Y&<$EHQBFX_<\;(P.!+;\W!VB[6'FR#BE8GOS?JQ MHZ:)@Y?%OLSSNX+M@]`))A&W";.8$&ULA5/;;IPP$/T5RQ\0LT"::,4B95-5[4.E*`_MLQ<&L&)[ MJ&V6]._K"Y#=:J6\X)GA7&9\J68T;W8`<.1=26T/='!NW#-FFP$4MW13^X4&!UQ39>*Q1H*U`3`]V!/NWVQS(@(N"7@-E>Q"3T?D)\"\F/]D"S MT`)(:%Q0X'XYPS-(&82\\9]%\\,R$"_C5?U;G-9W?^(6GE'^%JT;?+,9)2UT M?)+N%>?OL(QP'P0;E#9^23-9AVJE4*+X>UJ%CNN<_CSD"^TV(5\(^49XS&+C MR2BV^94[7E<&9V)''LYNM_=P$T2\,O&]63]VU#1Q\+HZUWF15^PGCU;&DP4F[M*5;=;N=3_$0V0>\KD;>PT]N>J$M.:'S)QL/H$-TX.VS MNWM*!O]^MD1"YT+XX&.3KE1*'([K`]E>:?T/4$L#!!0````(`,ME.$=G_63] MI0$``+$#```9````>&PO=V]R:W-H965T]#^3X-&<>=3TS+;&^!U)"G)\BS;,<6% MIF41:R^F+'!P4FAX,<0.2G'S[P02QR-=T;GP*MK.A0(K"[;P:J%`6X&:&&B. M]&EU.&T"(@)^"QCM54Q"[V?$MY#\K(\T"RV`A,H%!>Z7"SR#E$'(&_^=-#\L M`_$ZGM6_QVE]]V=NX1GE'U&[SC>;45)#PP?I7G'\`=,(VR!8H;3Q2ZK!.E0S MA1+%W],J=%S']&>_GVCW"?E$R!?"8Q8;3T:QS6_<\;(P.!+;\W!VJX.'FR#B ME8GOS?JQHZ:)@Y?%IO4 MX3JY[QZ_%MC<"FR2P&8:<7=OQ(0YS9C])Q-VM:<*3!NOCB45#MJE+5VJR^U\ MRN.9?,#+HNS)!(:%\*]CTVZ4BEQ MV,\/9'FEY7]02P,$%`````@`RV4X1V]Y&H*Q`0``%@0``!D```!X;"]W;W)K M&ULA539;J,P%/T5RQ]0LR2=3D20FE95YV&DJ@\S MSPYI!NC>-TH):M]0M,;T&6@>2X"1+DELB*).X+,+>BRX+-5C.)+QH9`8AJ/YW M`*[&/4[QO/'*VL[Z#5(69.'53(`T3$FDH=GC^W1WV'I$`/QA,)JS.?+9CTJ] M^<6O>H\3'P$X5-8K4#>NI[E^X<7'L1IXQ<-N/*#IHZ%%X6IS++[PIR\D(7 MF$@\1$RZ((A37[7(\!H]BQ;7Z?DE/8\)\TA/\NL"FTN!31383"7^7"LQ8@X3 M9I-<-]FNFFPG@?0;DQGS]5.0L\8)T&TXGP95:I`V]FW97:[`?18:_PDOBYZV M\)OJEDF#CLJZXQ.ZW"AEP=DG-UN,.G=)EP6'QOJI.W5(QW,;%U;U\RU"@0YM&=:&BT(*:HD M9:5_7RZRO$1V+52W1ICF=?`B%SP#EK] MI>2"$:6/HL*R$T`*2V(4A[[_A!EI6B]-;.Q%I`GO%6U:>!%(]HP1\6\+E`\; M+_!.@=>FJI4)X#3!$Z]H&+2RX2T24&Z\YV"]CPW"`GXW,,B+/3+>#YR_F,5ED8PYU3:7Y3W4G%VHGB(D7>W-JU=!_?E*1YI\X1P)(03 M8<"\;5`[`3B46!Y;;)U+^*[8CA0 ML`CF0"M7COBFWA\0F4-$#Q+M1S>+;S?7P1>-Q$!4]B\L4<[[5KG23-%I2CR' MIA%OXMM@O0MFXIF>*FX(G.73I",5_"*B:EJ)#ESI]K==6G*N0-OU%[JRM9Y[ MTX%"J&PO=V]R:W-H965TNC4DR/C%$NUY"=?]!QP;4B4^%$0I#[%;>>5A=E[ MX67!!DG:#EXX$@.EF/][!L+&C1=ZEXW7]M1(O>&7A3_QZI9")UK6(0['C;<- MU[M<(PS@=PNCN)DCG7W/V)M>_*PW7J`C`(&#U`I8#6>H@!`MI(S_.LVKI2;> MSB_JW\UI5?H]%E`Q\J>M9:/"!AZJX8@'(E_9^`/<$59:\,"(,/_H,`C)Z(7B M(8K?[=AV9ASMDSQPM'E"Y`C11)A\Y@FQ(\2/$A)'2*Z$Q)3&'L448H&?M=`=)C*89XO)HL\AE86$ M$\)7`6931-Z<0V13?&&PB-A91!8O9XCO,\2V$K&K1+8LD-P+V,UMX@3R^Y"= MP63VH`X3!OJW;+2:-5HYHV]?&%E,&CQHE,X:I=9H]8!`-EO3[/&:YK,)\N6: M5A83IF&>)I_#=K,P&\>_N3D4^,FT(($.;.BD?66GW:G+;2-]\S[L5ZK[V69U ME2F+'I_@%^:GMA-HSZ2ZU^;Z'1F3H)(%3RL/-:H_3PL"1ZFGF9ISV[+L0K+^ MTH"GKT#Y'U!+`P04````"`#+93A'6/3$*>X!``!@!0``&0```'AL+W=OQXCP34FV`;K?>Y05C`[PY&>35')O<# MY^]F\7++`WQ>CZI_[35ZNP/1,*>TS_= M4;4ZV3!`1ZC)B:HW/CZ#+R$U@A6GTGY1=9**LXD2($8^W-CU=AS=3AI[VC(A M]H1X)LP^RX3$$Y)/!.PRLW4]$47*0O`1R8&8GQVM-5P8$:V,=#%2GY/5%/:D MRN)%UC="JR)U\Z#8?939@? M]TVR19/,"SQ^8^(Q67C?)%\TR;U`]/6)[1TFRY///Q9?W6@&HK$O7:**GWKE M+O0_YIS!=H_?$@#U.IV-R\HU,I, M+#U,_FIEK^!U!+`P04````"`#+93A'J0?MMJ8"```@"0``&0`` M`'AL+W=OQ9TQZ'VW3 MB;F_E_(P"P*QWK.6BD=^8)WZ9\O[EDJU['>!./2,;HQ1VP0X#$G0TKKSR\+L M/?=EP8^RJ3OVW'OBV+:T_[M@#3_-?>0/&R_U;B_U1E`6P6BWJ5O6B9IW7L^V M<_\)S5:Y)@SPJV8G7VO#R?5#_9K)5T;]2P2K>_*XW#B>^U]`.>=6>>)_B'Q-;,;8"M`1X-1C]N@\@:1&>#:0^Q-8B_ZB&Q M!LDG#P'D;BJWI)*61<]/GCA0?9S03.&]%E'*GBJ74)TPFKWI15F\EYC@(GC7 M0E<,-LP"F'0"60*"1B)0`3BCP+[+`X8H;CNH@$BCB1CNBJS^$[D99G0=9@3% MBFRQOB`07PO$(!`;@2R_CK$S2`JE``01@B>H"J@'G."6`Y>&$2'Q;7!E M093@),N3^_DESOP2HY*'+D=@MP`DPK>1"A!W_H`L`7E(HMO,RC+Q_62(,QD" MR:")9I&A662"JLBY6;&S-+99Y-RL%*43S2*7SLWYG)*[PU/W82OFCC M[CC'Y_V%VA6(\5R[5U#+#9&ULA53;;N,@ M$/T5Y`\H^-(DBAQ+B:O5[L-*51_:9V*/+RH7%W#<_?OEXCA)E:HO!H9SSIP! MQODDU;ON``SZY$SH7=09,VPQUE4'G.H'.8"P.XU4G!J[5"W6@P):>Q)G."%D MA3GM153D/O:LBER.AO4"GA72(^=4_3L`D],NBJ-SX*5O.^,"N,CQPJM[#D+W M4B`%S2[:Q]LR.UATE=SY+P?I7QWBS_U+B+.`C"HC%.@=CA!"8PY(9OX M8]:\I'3$Z_E9_9>OUKH_4@VE9&]];3IKED2HAH:.S+S(Z3?,)3PZP4HR[;^H M&K61_$R)$*>?8>R%'Z>PLR$S[3XAF0G)0ECRW">D,R&]$/S1X>#,U_5$#2UR M)2>D!^HN.]Y:N'(B5AG98K0])Z^I_$D5^:E(5JL![%8@"P+9++"Y-2D\YC&4$3#K M348(^1Y6!EA,XO0:%_S@JQOBH%K_:'24QKX??\V-E`:L-?)@+7:VK9<%@\:XZ=IY#R\]+(P;NR(K4H6>UQLI_[K^%L/=4(`_A3DE9<]#V=?-OIWFVU,3+?J?^9E:KTF^P($M&_Y8[ M6:BP@>_MR!X?J?QD[3MQ2T!:<,NH,$]O>Q2251W%]RK\8]NR-FUKW\".-DR( M'"'J">%]0NP(\9D`[Q*@(\!G"<@1T$TD8-=N=FZ%)VBZA3L)H7;*HV2:@9,6NL)$!K-P&!2-8]86$_8(H!(,QHC\(8O( M6J3!N,728=`X9-7)A'>2.LSCI/%UTMAN6.PLGA"`UP+0"D`G$%]GK`W&$I<6 M@^(@"9-QV,K"P@@%03`.6P^JC:9&@ZF12PV'?%*;NL,HG\6)#IX,^T\<;NK"8$*(`P1L?&PO=V]R:W-H965TO3X2#3,@-B8=__F_& MD3UY3]D'+PD1WE=3MWSIET)TBR#@NY(TF,]H1UKYSX&R!@NY9,>`=XS@O4YJ MZ@`!D`0-KEJ_R'7LC14Y/8FZ:LD;\_BI:3#[MR8U[9<^]"^!]^I8"A4(BCP8 M\O950UI>T=9CY+#T5W"Q@:&2:,6?BO3\YMU3Q6\I_5"+7_NE#U0-I"8[H2RP M?)S)AM2U+^P_=KBQ_BSG9T/IOM1>EK!;XWIX<\*D6[[3_ M26P/L3+5:M?O;FGPS8-'<"L@EH2!@X[H30)H37 MA$AW:BK3?7W'`A0P`>,V)G9S8%I$XBTA,$=D8(IF*2)V( MU"+@",)HOB$()VUHY@1E%H1&0$:39M$DSMS)F5M.Z.)DAF,U,YB]ID#@Q.BP MXD0C_5C1A%X@=%/LH<_B,0J<3$%NBCWW6>*B0&@Q1A7-T(3#"T,WR9[_+!WY M.E8$9PEZ``4W]V9#V%'/$^[MZ*D5YDX;HL/,6B%U[S[$UVJ6Z?OX:E/D'3Z2 MWY@=JY9[6RKDK:XOWP.E@LC"P$QN>"FG[;"HR4&HUU1]"3-_S$+0[C).AYE> M_`=02P,$%`````@`RV4X1V_CRCTR`@``1P@``!D```!X;"]W;W)K&ULC9;;CILP$(9?!?$`,>:_#5HAQ!P`_M;A'?$-' M/,AO&LIZ).2270`?&49G'=03$$=1#GK4#6%=Z;T75E?T*D@WX!<6\&O?(_;[ M@`F=]B$,YXW7[M(*M0'J"BQQYZ['`^_H$##<[,,O<'>`A9)HQ<\.3_SN/E#) M'RE]4XOOYWT8J1PPP2>A+)"\W/`3)D0Y2?*[-?W+5('W][/[LRY7IG]$'#]1 M\JL[BU9F&X7!&3?H2L0KG;YA6T.F#$^4?9AK-^CK9+XI M(QOF#HAM0+P$Q)H##$BG^14)5%>,3@$?D7IY<"?E3)E(YT#FQF79VI/IPNOJ M5L=E68&;,GK0F,##K-DN&B#]G9#X$9(82&P,MM&Z0?)HD!J#Q!K`QRP'KG2(%<%-F7N`W`,',X\NL:(L M\?CQ@.Z9@[E/F\PBC]&&A9M3^+2)$:71Y]D"=V?$B"[X!V*7;N#!D0IYW.A3 MH:%48&D2;:19*T_U94%P(]1MH2CFG#,+0'$JR=`"``#;"P``&0```'AL+W=O/2?T2+'Z@T6N"P8O7G\@E4!HH6$ M,R4BE3VYOEQNG=9D>O/*XJV,P[`(WI30%TRD,2N#R2,W9&,@J$<$T@#H(O*A M")&F#P18&T0>#W@8%=F.B^RL2#J>2?PUD]BL9VS7<\)2)%\%$B.06(&[/%J- M24VF!A.Z$=M[A--$"II(K8D8"I&;/3.89!XGR(U:3T)M#`HELS`:"+D%8<[4 M,C"US*:6N%=O93'R5(!K;$U#**>9'#236S,I5)$&L^DPV7B0&1AD9@7R@/;T],3#AQ!H`G7WX7R@/"P(I:'^#!Q4 M%])M*X)MF6LI1@/!5JB[N\9,@3BWI1BV9&\Z!)[KSE)L3VP^:LJ!=-N"KT]D M[T\439!(X3)*OU%&\"6#LBEE9$`3J@@&NDW!EPW*IQ21`:5Q,N()Q!E+P:=& MI"'LI'M&[NWIM17F?[.?[?O2QT@U,G?S*[18(V!^@Q9;TW5^R)?%!9_(+\Q. M5&ULC93;CILP%$5_Q>(#QN862$20FJE&[4.ET3RTSTXX!#0V9FPG M3/^^O@!-*E3R@B_LL\[>(+L8A'Q7#8!&GYQU:A\T6O<[C-6I`4[5D^BA,V]J M(3G59BG/6/42:.6*.,,1(1O,:=L%9>'V7F59B(MF;0>O$JD+YU3^/@`3PSX( M@VGCK3TWVF[@LL!S7=5RZ%0K.B2AW@=?PMTA)%;B%#];&-3-'%GS1R'>[>)[ MM0^(]0`,3MHBJ!FN\`R,69+I_#%"__:TA;?SB?[BXAK[1ZK@6;!?;:4;XY8$ MJ(*:7IA^$\,W&#.D%G@23+DG.EV4%GPJ"1"GGWYL.S<._DU.QK+E@F@LB.:" MR!OWC9S-KU33LI!B0*JG]N>%.R.7%F+(R'A3)K9C2A>\+*YE',8%OEK0G<87 M'B9-,FNPX2\VB>Z;)+Y)-`+2=4!\#X@](!X!FW5`LN@@\8#D/F7G))E/Z25D MO4.ZV"$=+6;K@,UBQLWC&;-%!]E_,J8^HY>$$4FV>?9`HWRQ43XZS=CAF31@MM>^:&CYM\_BF^.24_/\(/*<]LI=!3:G#AW,&HA-!@$>3+?K3$7 MV[Q@4&L[S>P']4?=+[3HIYMKOC[+/U!+`P04````"`#+93A'7^MD?9]!^IT6CN/.A.3#;&^!--"G)BBQ;,L6%IG45 MUYY-7>'12:'AV1![5(J;SRU('#8TI]/"BSAT+BRPNF*SKQ$*M!6HB8%V0W_E MZVT9%%'P*F"P9W,2:M\AOH?@L=G0+)0`$O8N$+@?3O``4@:03_QO9'ZG#,;S M^43_$[OUU>^XA0>4;Z)QG2\VHZ2!EA^E>\'A+XPMW`;@'J6-7[(_6H=JLE"B M^$<:A8[CD';NLM%VW5",AF(V%*GPE"B6^9L[7E<&!V)['NXN7WNY"1!/)KXV MZ]N.3!,;KZM3OIN62[_2\3.SK;G!WCBYB"T)3MT_IKB M:;:(#CPGN[FEI/./80XDM"Y,5WYNTO^1`H?]]+?/3Z[^`E!+`P04````"`#+ M93A'APWN9X,"```2"```&0```'AL+W=O)%'QE3PUC:=7(9'I4Z+*)+;(VNI_,9/K-/?[+EHJ=)#<8CD M23"ZLZ*VB6`J>..MDX#'9L M3\^->N*7'\R7@(WAEC?2?@;;LU2\[25AT-(W]ZP[^[RX;U#L9>,"Z`5P$`QQ MQ@6)%R3O`C0K0%Z`OAH!>P&^BQ"YVFWGUE31LA#\$L@3-3\GL-"X,";:.=#M MDGHEK*>P:U$6KV4"81&]&J,;!EIFY1@R@ZP=`@8BT@F,9@'#L0C0RF<"5(X@ MR4P.GYIL/IA,IIGN M373+TL\+)*,%$E\@&=M+CEGU3#;-5#V33S-K MSR3Q-+/IF?OS);HZ\5HF#O:ND<&6GSOE]O`P.UQG#]"IWO.%=/IQM]T;X_Z@AX&#=LK\TI,T]V= MY0:*G_H;>/@;4/X'4$L#!!0````(`,ME.$<"G%:4.P,``,H.```9````>&PO M=V]R:W-H965T/M-H]B-E)-V_M7JDN^*C*NIV' M^ZX[W$91N]ZK*F]O]$'5YLE6-U7>F+V7#O MN5G,]+$KBUH]-T%[K*J\^7.G2GV:AR1T-UZ*W;[K;T2+673F;8I*U6VAZZ!1 MVWGXC=RNJ.PA`^)GH4[MI_.@'_RKUF_]Q??-/(S[,:A2K;L^1&X.[VJIRK*/ M9)1_0]!_FCWQ\[F+_CA,UPS_-6_54I>_BDVW-Z.-PV"CMOFQ[%[T::5@#KP/ MN-9E._P'ZV/;ZB90,DE(@)#X$A@0F"^! M`X'[$@00A"]!`D'Z$E(@I%\(D5V.83'O\RY?S!I]"MI#WIQ]D21T%KWW@2XP=,#<.4PRCEDZ#!O'W#L,'\<\.(P8QSP" MADQH/;DXR9*A0!D)R8OTMAA#?2B,Q*C7< M[K72<:TG`#$F19QYI(\07`LZF&43BP0@(CW:G%!&F0,`5.%K1U5HZD*\4;@X4S$$D'B&^-+[; M1R3^&PF*]S2%=A5L?,(/`"(L2^5$3ZX<+J:<99E/:G`#H&``@GN$$'AJQ'^D M!F]:"DTK)EZS#P`B9JSXYL6EQN*DS'CZ=<&C3QOP0[Y3/_)F5]1M\*H[LY?RK[A[*>6O>CTP7TYGC]?%W\!4$L#!!0` M```(`,ME.$=9U3$"@P$``#<#```9````>&PO=V]R:W-H965TNB=,8?3`Q>]!GMIZN1.BIP%;]]W+IZF:6 M^%(X\-T.T*)'_6$:`$N^E&S-BC;6=DO&S*X!QM*O6>FT\"K M0%*294DR9XJ+EI9%6'O598$'*T4+KYJ8@U)950T!J!+=%0K^A=NESG'A$`;P)Z//0?/7TA//YR?UQ]"M2[_E!NY1OHO*-BYL0DD%-3](N\'^"8869EYP MA]*$+]D=C$5UHE"B^%<<11O&/NXLTH%VG9`-A&PDI-,0/!J%F`_<\K+0V!/3 M<7]WZ=+!M1=QRL1E,Z[MH*E#XV5Q+//YHF!'+W2!B<1UQ&0C@CGUJQ;9I44> M+;+!XN9_@?Q28!H%\D'@]EK&B%D/F$7RQX2='4K']_#"]5ZTAFS1NO,-QU`C M6G`:R61&2>->\5A(J*V?+MQV(D0[GPT= MD9K:@[X?>DU9M6Z6JKGG+DOIA==52YX[AUV:INS^;DA-KVL7N/W$2W4\<3GA M9:DW\/950UI6T=;IR&'M/H%5`11$(7Y5Y,H^W3O2_"NE;W+P8[]V?>F!U&3' MI40I+N\D)W4ME<3*?XSH;4U)_'S?JW]3<87]UY*1G-:_JST_";>^Z^S)H;S4 M_(5>OQ.3(9"".UHS]>OL+HS3IJ>X3E-^Z&O5JNM5/XF0H=D)T!#@0!C6L1.0 M(:`;`4\2L"'@I2L$AA##I[*IRVY*76=K1J\/.I?P_@96`=U)$*#NB7$SL MA-+LU%YDZ7N&(I!Z[U+H"P8JS$9C(C@.V6K(3<03!JPNH&M;`2KZQ`*Y1D1H MPL.L2/&?R*A-]-4FTL5"IEAP7@!_%]A7"26PMN<9M->X!P@3Y"(P#B]Y;&,(E`2-KP,B(!!,!(^/(3[#O M^Q,1-7`"L5TJ5=Q+C<:*K;'BOC83L>(YM_DL8CN+*.X1HT$2:Y#$!)GX9VV2 MI?N3S.99*E7<2XW&`KXUEYH6)W,JE\$\@#@)`C1Q9G*#G#]H&P#[N8W8)4#R_Q6-G6J;;C)9^FY/)*?97>L6N:\ M4BZ:#]4C'"CE1)CV'T7-3Z+M'`8U.7!Y&\G-T(V8'G!Z[OO*H;G-_@%02P,$ M%`````@`RV4X1YW=4J?N`0``8P4``!D```!X;"]W;W)K&ULC53)DILP$/T5%1\P8O.0N#!58^Q4WDRFN4ZI<8RZ(!1N03[Z'3;RHN&%'Z M*&HL>P&DM"1&<>C[SYB1MO.RU,9>19;R0=&V@U>!Y,`8$7_60/FX\@+O$'AK MZT:9`,Y2///*ED$G6]XA`=7*>PF6V]@@+.!7"Z,\V2/C?>;RP` MA4(9!:*7/>1`J1'2B3\FS6-*0SS=']2_V=MJ]SLB(>?T=UNJ1IOU/51"10:J MWOCX':8K+(Q@P:FT3U0,4G%VH'B(D4^WMIU=1_Y3H@F M0G0DW,\03X3X?S,L)L+B(@-V=[>5VQ!%LE3P$F'8*EAHNC(A61KI<4G\) MJRGLM\C2?18E7U.\-T)GF-!BU@Z3A+!%?!\L\N!+?Z'GB?O^C M?);VI(:?1-1M)]&.*]WXMC\KSA5HL_Z3KFFC)]Y\H%`ILTU,L=T0<`?%^\-( MF^=J]A=02P,$%`````@`RV4X1]&=EK=#`@``9@<``!D```!X;"]W;W)K&ULC57;DIL@&'X5QP=8!46S&>/,YM!I+SJSLQ?M-4E( M=!;%`HG;MR\GS:'DD(L(^)WX02AZQC]%18@,OAK:BEE82=E-HTAL*M)@\<(Z MTJHW.\8;+%67[R/1<8*WAM30",9Q%C6X;L.R,&/OO"S80=*Z)>\\$(>FP?SO MG%#6ST(0#@,?];Z2>B`JBVCD;>N&M*)F;<#);A:^@>D*Q!IB$+]JTHNS=J## MKQG[U)T?VUD8ZPR$DHW4$E@]CF1!*-5*ROF/$SUY:N)Y>U#_9J:KXJ^Q(`M& M?]=;6:FT<1ALR0X?J/Q@_7?BYH"TX(918?Z#S4%(U@R4,&CPEWW6K7GV]@T" MCN8G0$>`(V'T\1,21TA.A/0N(76$]%D"<@1T%2FR56V*)RX*S/A`=UOL) M3!6<:Q&E'*AR";421I.;M2B+8YE,0!$=M=`%!AK,W&(@@K9PTN4R:V((EKF!/"*27`JD52)U`ZFCNZ4QV)@G.89>F+%)UZCB2L/>BSPZMUSK\_O.1![ M(YCA!TLT=Z`4YI/)=56CL\.E(7QOCG41;-BAE?:C'D?'J^,-ZL/I:GP.IDM[ M`9QDRJ+#>_(3\WW=BF#-I#KZS`FU8TP2%2U^41$K=>F-'4IV4C=SG=U>`[8C M63?<:N/56OX#4$L#!!0````(`,ME.$>D/HIEW@(``-\*```9````>&PO=V]R M:W-H965T,">^]J=M^Z>^%."R" MH%_O65/V]_S`6OG/EG=-*>2RVP7]H6/E1ALU=8``H$%35JV?I7KOJ MOP_JWW2Z,OR7LF:S%,S]]9S:'4`FN>=WK7V]][`5O M!A/?:\IW\ZQ:_3R9?^A@YC9`U@"-!G#:`%L#_&%`)@V(-2"W>@BM0?C)0V!R MUY4K2E%F:<=/7G\H53_!A<0[)2*5/5FN7IZ$UNST663I6X9CF@9O2NB"09IY M-$R$KB.%0>!(!#(`9Q3(=WE`VGS"06Z("$_$,"NR^B)R-4Q\&28VQ<*V6-&\ M`+D4($:`6('X,LA6,Y&IA6$@(!%!]#J7&PY%)(X^'\TY5Q@NA`@DR02W(O:4 M<4(`G4\P="88V@03ER-C^&@82"F:H')#W:$D(72"*P8N`IA2>18AY9?4&NIX/=Z>"IQK&WJX4@ M!A`C/'&]6O".Q)1,@<4`0H"ANQ7M!3N"F()S29-GS3NCK/9`U)?_T_[CW"10\=^H68Y/2U\R&?IH=RQGV6WJ]K>>^%"SAQZ--AR M+I@,&MS+DN_EM#DN:K85ZC529V'F+[,0_#",D^-,F_T#4$L#!!0````(`,ME M.$<%)82#^@$``.,%```9````>&PO=V]R:W-H965T9T\'L?5;*<<-`&+?DAZ+!S:207UI&.^Q5$-^`&+D!->& MU%,`@R`%/>X&ORS,W"LO"W:4M!O(*_?$L>\Q__M$*)NV?NC/$V_=H95Z`I0% M6'AUUY-!=&SP.&FV_F.XJ7*-,(#?'9G$6=_3WG>,O>O!SWKK!]H"H60OM0)6 MS8E4A%(MI!;^<)K_E]3$\_ZL_F*J5>YW6)"*T3]=+5ME-O"]FC3X2.4;FWX0 M5T*B!?>,"O/V]D?@^L M'##)4Q0C>-L26K6$G*7PMD"V&DIV?RCYJH/\CIUB,5`](4KC*SO%B84HCX+D MZ^X'9^=QQ`?R"_-#-PAOQZ0ZVN8$-HQ)HH2"!Y5RJV[<94!)(W47Z?CM)60' MDHWSE;K-0(``"$'```9````>&PO=V]R M:W-H965T/4-F3Z]_6+`",#*0MLWYQS[O&-=?+)GC("A5RR@\][AN!.DPCVHR#(?`+;SJM*'7MC54F/`K<=>F.` M'PF![.\283HLO-`[!][;0R-4P*]*?^3M6H(ZWM(.,+1?>*_A?#U3"`WXU:*! M7\V!\KZA]$,M?NP67J`L((RV0BE`.9Q0C3!60C+Q'ZMY2:F(U_.S^C>]6^E^ M`SFJ*?[=[D0CS08>V*$]/&+Q3H?OR&XA58);BKG^!]LC%Y2<*1X@\-.,;:?' MP3S)8TMS$R)+B$;"F,=-B"TAGDI(+"&Y$)*'A-02TB\$W^Q=5VX%!:Q*1@?` M>ZB.4SB7<*9$I#*0Y>+R36A-IM]%59ZJ>):4_DD)W6`BC5D:3![=A]0&$HX( M7QIPNH@\5X9(TQ\E>(I8&40>WX>LK4CZW&9\:S,VQ8I-L8K\N4!R*Y`8@<16 M.[TUV6E,;FIA,%$8J-_S1*DS46H39:Y$AK@TF#`*DEF1.X'&43T5N#;`*,CR M(HPG>,^S9=]_J\+MOL^]>)XM\$\29.H^7ZDV< MA=FCNHQYSC")U8G2:S\-]+I#]-\]#?U,_WUX_G%7]3W;\[??_K^ MXOSFC;K\>-$RU07L)85]7,)=?U9_#AZKXR[R-*V>K`U()R?]V\WP39)LS"^4Q?)9NO'M8&?4G^)/]\^;N9)5#_[Y67; M49/-!C#N-DL6OWCJEG!?7>69SOP89ZR=/(EU$H5+V/!2O?(C/UX$\!@0H`;: M^>'VM3IZ?MQ%`:=ML/2UADE>UG[V]5K!7M0"_PA^S<-[/X+Q-<0X7RR0W+5* M@T4`@^91X*DXR%2R4@#%Y`&WJNG3=ILFGT,@MB!Z5,\'PZ$W/IMZ_7Z?%GH^ M&)]Z@]$0O]AKD21;!VEUY&5\#[M,TK#.2R[C+``P9\XDU2'7:;#UPZ4*/@/3 MT_4I/B49X-VB!+JF'>@,Z4HK_]X/(USH!+C,B?:;5@3^F@)&(`@0S%M\DB!8 MGWB1;`*5^9\[3G"%0&G9&>^^^3>##E'HS\,HS`!^-9RPM[#U'YO6AM_3'/#3 MF:-M&:(K(`!`BSC)@M8I&\8O_&V(YX@"7P-`Q^_1C[BU^51@:R3J)ED.H_ M$/YDC[5]`U:O`CC>DH=[ZGFO/P"(IPIH.@^^46.D.2)$EL+*S[,UT-!OP1(P M,0&A&&J--YND*NEB4L34BD7*JPQXC;9U!J?>Z6#F3883\ZLLBK`8C+S32=\; M#$_-C\X^E)\ID8DD[+_9.==L-O/Z@W[+7,`W/C=(M$UHC]?+D-$)T`=Y$PG86PPKH'Z\DT> MD80@U@CS;4!16P,G"^_A"HE]5)^Z"3+0W.`1D*4QG+\%;3O0K9&:`'73)(H0 MH*&PW>:)F^>HT8IEC_6Q7:+QIVL?J7H=9"$H#/_>(2J-I`+M)U6ODWR>K?)( M68YW8QFN,BSI"*YB"6?T4UV;KD9QE@SJ#RTSM/TSB\^2AE56KW.2SYEI2O3JRZS>!_S)B!XU_!*9G%M^/3:&^[I<9> M/H+NM(7Y$<=TD-Z'@)1I`%I-7I>.P#"$-$1AJ>MQP`/@%S9P<.0\B(-56%<` M/@1+I!&S)$^K\^TV:I`^K&4D#`B@\39]Z74`#&@1%JO[&Y2!+KWN"$]S#/<# MJJ+AUJCLU0$`.N-]J!&D1W*;QPH>ZGP&L2IT%ZHI-X'6+Q4..^)QQP1>D$M9 M&L[SC'A?EJ`ZL`]WKZU7FTA$RO>!'V7K!="@!X;?HE>=Z)6OPP7=U#*,<%$2L>8FW]/.6IG#5:MTED/5L!6A MN5C[H`S"0+7R0\-\T:RJV1A`PZ#.DMRTIA@A!?[Q_*1_\MY+QE6[QD&VC\?X65)L.445C5C1FE28;AZO[BRR\;[:8 M8#M-S/=\^7-N;%^`._!^N,P0SA++`W3!"`9:M&VY&OZ_`QU5(:TB7.!<8:>- M3=2>B6NF@&+-RX/R7\W!;%L2@AHQN6OQ9@,:],8@O(O%WEP\@E"0NSZZ@PDT M8WO#[=$@C1CA@(*6H'/L99"W^P,^[@3V+GQ@6'<_TO319!L-1?[8:N M\Q1@J`GJUC>R>^W6H65@['.P*C!680Q60O9P#YJ5 MS,O:2&?*DNNA^ZS[[+O,GA;[.@#94YB!XG(7QFA"XB&VY$IN&QJ@WM4YB+QP M2T`+F`XXJPQ%+:=&!)FJ!46^^'&"XH0J/E:6#[GCO M+WU@I>DV80-)'>'=_?UO_UO>V#&P6!T(N#9%OP+7#+@1;9.D_P. M;@7P6^=S'2Y#'SVY"&&B=[--?@*ZG<(.P ME"8ZT;S(UI!G](AV`T6>ROOH[33Y"'F M#3&KQ6_BH&M7>+9K7_O+(/8]!??B=RQLEWK$Q[Y/`(!_3DA)0C0F."V#>>9X M2TI:!!P\RIGG@MV=L2_3Y=3P?`AG"Y%WY7/`.L"<58!4R(<"A#AI&]"HN==0 MKZ9ZIG=^+`:A*C09_(2APA+67JW46Z906-Y1=#K(HA'[\22W(*O#%2AL&)-L M(K6#*:1Y+;Q)?R%8S@CO:&LK>QQ='&<-!@IPTR!&<&_]E$P>FB1=DHOJ(&78$N&37$.07*4C&P9PE6'&V>]T(E[(CQH3J0Q4%6R-%^P?P.T-=!K M-@H#G#3L'*SW!;"S01]/>A/CC9HUJB/I\)X@48 M$"(11^N4-[!*DHQE9(J8BZ>>/QYV2H1R%""![8)Q#Y@6[2+9`CJS(Y\Y"$=? M<)^^H\OBA,`G<%,QJ%I:(P7BDCYS_JU[Y<7]R;&7`!F84.>+=6E69`,H+0!$ M`(F(P)`BN9+8B_TL3P/F!1O_YR1%:A;@"6_X@[9.$IKL&3I/<(SXBYX!TP@V M<%IV%!'[`^!%Z`52BPBT3"`!!*G#-]%)L]P`5)"D,K1VYH_NFNJ!)C`WBK\8 MCH^G6:&[BGPX+KOQEV!S9Z$V@G;CI[\$)<^1IQ[6(<#G`8!B'C%5IX%P=4"@@)X["/^DV3,B,5*:__^U_Z1)Z,D*% M<)<+0A7"RK2ZO0=8#`E7.VQ2Y@>B`\1W9D_NB43+J[3&D^F/-SO4R?.&@1VW MUCJY:<;X@3@(J1$F5S5,E0ET-8VM%9 M:[=U6=8)SDOZ[*TQX&SV0ZMNZ\[S&A432O]AQ:1XJN-F*QMY;92;#\1`R+]3 MG^Z([DP(S&SRG$SJXR_#".?>"?4KNA/I7NZ='Q6LD=A>'H=L&(F.JC0@ M)TFZY+MRS`CV2P`R_)HGR!2892+UH7.>6#D^C48T*PB$/&2W!#*8<(H>6*J< M>6_3;"3(=+B!*TY+)T+YE@;E&>(D/IF''"J529``@(?GNK0Y8!F$KTF:)G," M`0GT9(ZPI(N3QP'1?77T'I5Y-3PF]J2#LO\@K4JK3@.K;0I0GG\.%L3'EL'* MSZ-,I:'^I:<P1;K=\N#7AHX:%7`>C-BZRLZJ>D M3Z7`/X`GA%D"/"7,7"RCQ(,5J#8):Q_PS!)8-Z:ME8U0N@)41VEO\`E.%&P0 M%=-'HV<`UFF:@D0`2H0PW7!>"WSM?H&>*][I,D";`>2327]`.-V1@RQE!Y^P M+^LLBZT)\H@;V@"Z"BK1,#2\0+XHX*"@TUGYLPFR=0)ZT^O"!5!BE@&&U4IQ M=H\,+5"704%%(!:KHBQ;8$*7:+FZYC!Z/E&`_0#5&&<17NGJ/&L?T$[.64MD M&H)V(H^7KQ-,SD0NC[&FU;82IU7)7#.0+*P\=EB^$;_B?I12=[)YK.\'92GA M"(.&>6FT0S^K""R$7(*@0BTN2RE=7(SHV79OIUX#H)%J#+!!^YL,O-FD'B?M M^AQS[BT1">24P*SZ"/K29`]7!Z0;ET\V1&3X``.!0@XDW&IVI MT]Y8C29JXDU'M1.:7+;'T@X[965]^,$'ML-/[1\\KZ/+$NA$ZS MP=M@&3=ZR<2:UHY]BQ2\\7\)5&"W1V:?UOEF*X8_Z13-H9M7*TF&WJD)EM:^/SN(NE22:2>X2SWP;D%;V1 MC=_PKG'MO__M/T%K@@GIT56>DOQ>`CWG6I.`.>=5X49!@=%BSB]#%"5H78!` M(:0@KS^0BG9O.=?%S560,2.>W^@K:8H3E".@&(,W:3A-,?@WDEN&&>8\HH/^ MF@8?SI5W[A$0L%6?^-@EL<8DMIR_ZAD&I`A5$Q->JH]@%0#$DY3S+,HQ:Y1S MWF1X!G\<#<_.O-/)V3'][4W[(V\R.:5/`V\\''NSL_&Q^L*$#34:*ECM:#PZ M5DP+W\,!L'LC%EV)53;$32+(W[[2$([]8N>.*DO1(<0]).K3\Q`7L(C,=527]-K6G$ MW)+\R93$9[=,&BUIE\'G(%V$FI.,X0ET&-)E.6#!T3W*T"0F[$<+XWX&*"QW MGXBUL3G=7@<\;;HASH/16+Y$$A1T=C#PV'RCT72&1`2GH\445DXYI&N-F^]! M*8+%/81;2.8:R,#PQ*SAM:U()K;'!.R*7*AD00#KP]$WU`O4L[Q MK$D8-K7:15#Y\:?XB(^2QR`H&Q2<]P$@&@PIAQ]7DLQR$DT4LH%;B<1$-IZ;I@7%RH.= M+];65,:+,1CG,B5T@:C(?P"E'S#W`:@\J(0)[-9,[OOI<.K-9A,%_^N#L!B< MPH['-9N'`?:*:.ZB(RG',7&N5J61H$ZQLX6#'B3LV9EF;I-"CMIQQ-'H''2K_@)(_&D4"?` M28"$[V""N&RK&C698S9(I3(;,G$XJ\%(@`6'?5*Q$4$O]8WFOP338T&.+%*. M$U"G0&`0OX7%-NR+NP?1@A_#5)43_@%;`96!C"3TH//%@ESD=3-A;A(@`M1O M`.4U\+++C)EXQDJQ\Y3WQ]JMI#`!& M?[DD!=%4$A5@15F-T0,5H2M42X(,Q7^,<9''N4;E'T0!B'-M4P/("9>*`57, M6)(15,AS\BL\SKZARH_\$=FLS==.44#"3Z2\!))1P$$&^UMIAP\^>Q31NPC7 M%BXRLT[9+X:1+*$`X%Q%\=%PS/\'[6TJ?PZ9J=50OPB`-HTX>D;?XM_/C@MK M#R%L!%N1^DT;%$*6(Q"B;$#EGPM<60@%47@7HJ:V%VH@N,W`=CS!X'P%3:K` M6A;`*F`U'K$(E-+1'XTV\-I>9&2B0026@UZDZ%5UCJ=@%PD9;V!:<"B M*$XJ:H[5$1E$_AW(KCL,K@")IV&,:IW-P:HK2:4J+[J(QBT@RWA^HOKJ2IYS M3FF_$T!Q`,JH1]>L_GRTBF3M5HJ?Y-Z.V!8]%_?*)6)WDFN?HD,4^":R4),> MV#>S&7T%,A1N'[X:J-/^0'&5`0)\TANI\>S,PGR'Q]P!NDL#;BJL"<^C;RA! MOA`XF2(N^RU#&CWNS]7IF3_\;^;2BO2>RR**UO%( M(:Z[A'K;`P<+ZSTV2XA9S@9TP_G%N+!P;2V+8)\HTL9K[\3_/=:R"GNQI^#` M%!/":()>%U$]6EE+A,A9M+#(.+_818A9/FY.XOG:#>C7W;].6&!8YA8<(>*(=6C#8 M,\,NF0&=D#[C;A44KM1/%^M'SB6!*_Q-_*IA#,:A^"G12M+. MQR@BX2-)H+-6OU0<;AZHOW`X7`Q7"NR6`NB4/$>AR84MG7>/2>):8M?JJJ`> MV9$3?OVULE)AJ/$D0TY6A;G2^N2Z@ON]O2G-43K'7?`8`-M$`_0N\R#<% M'Z%C%F,<]L$:P_X9``:*(_5#G-3@:%?`&!,'(.:89(-6+"X5)V8N2=Q^%&>\ M>:R>QE3FT43SS;?[:1W:^])J8?.V&/CU016832?\S8X<&D-,Y$6-T<#8!A3Q.#BY1E)C)(S^ M)L=.&[[%;*JX]Y7)F`1UQ>M/9][D=-)6V7-A*GL^(?^.&MT2M;$=6DEUZ!=% M;;LVR3I)'B^DD8`M4:K:K"A"'M9)%)A8VP^]VYYZ3<7==1,.R`%6)+*NC*7$ M@Y8U$0UO0R#85W!+'$!X#T2180L(WTEV<,L(*&$!]H7QYH>8H@(4`>=,C279F-94 M:*E.A'D>N--RM#X.6)>K6D9_%>XZ5<,YRK5`H3^L8^F(<<`^3"E)7X'C;5RG\)>&9EG\E M1R+\F"^*J$E3//\?'67WRE9+!YX!TG3T7-#D"$+MQQH)-AL"\,^$)!;`G0)T M>%52P(BEZ$I2MD4HVCG%[H-89'IA%+K$E(JNZ"9?F]P*@@\I';())H2O%M\N M+IE+WE*LLWJNQM[T;.9-A^A*FGEHY0]F&`,>#CU,;AJ/3_'#P)OUX'+L3?"B''_#&/(9V=C;SP9HO]O/)EZ@[,178R!PW.,]YQ.O=,A M:A)#;PI+3J=#VLI@V(?'\>^I-QSAC)-B0807^@?1`S,;JG]5DPG\9SK%O_`_ M%PZ>%0^5<[PIELOIF,UH:>THQ,WB$ITKP1_Q^;L&>/;:E[,$@\3D_R(Q_,0@ M>FD%8Z%Z*M\B_H_ZY`Q:1'ZX0?+D"@Q&(M�ZR9V=CB%:#*AP04I%0#M99] M04!"^)/X3O-,XG?XG:R`)1^&C&20I:H\O:OT%\'X8$CB$P3R9IZG",`M_"]W MU/1SJIB[P,&7\W9$^QKT#]!+GQ'7 M8VO*,F4WUW,%4]W9J22BZF-*VX+=+2#).8;^`8U71=32GW%`CNKVU(\%Y$JQ M'!SGGL1N_ZH`D$_:D/GTUE^PYZ!T0&T+*HNO*)*#TG1CM!Q``,QI7I+EB5D] MQ6!/L@$$W!N7F3%K=W/P\/"/QB-"N5J(7W&&.6?+A(NQ4&29517WD$FK*Z`/ M*X]\+O/RR0W^C5H[P6].'_T<;O*-4!3:(+5)#-L'R8)*LL0>R.**\;+F1<3; M#;_7(1!7Y@Y+<7M4.%4#!E'B`&9OL1OE@>0RA4\+R>_J#.X*$H-@L&(,*EV> MH&/E$1-8$0H/)L=<:M\`_8D4`G$!L8B&!9$QH.Z32!(&*KP?7M\0&A!LM'4< M?7K]XP5GQ:&A29O8NM1FX6H(HJ?>8IS^3WZKT[X/?,ZA)LW_ZOQ[+C)F3DC<+M$AC4QSUE(PKQ@P3YWUU72L3CF><@Y+ M9ZQ(^?H7LSTFZ]M\BVXT.'2>9@S0^S!XX!%XE?(+;FX+-F:$Z+1@W<16;8'E M'8IVD-+ARH`$%)R30BTJTXYY65XT;(]T++LZ(#V@%V=FB=8'5Y5`(30@D.YJ(AQ MKD88@\PDU8+3]%.I#+X'R@=I3=G7['1>V]BK&*#F_D54IYRRP1T0`;^02CRU MC7)MLP$]5DFP&L[X:#-0`=(C3WI#^'4GP\71:_.F=3B=>_VQ:*M4(-T'9 M[1^*6#1$AB9%0&0&Q$"`HXB?`,VSYJ&88I5K8B'&YI\O_D=C7.KF*G?&ZE1;P8'#(Q64NR'''OUX)AV6=N*`L#,N06?*IDR MA3W)^6;V)EM,(-A:GMJV`2A465O@#?>]X?@4U&&,I*/C;0RZ[IDWGHW@,D$7 M/QVJ6Z1DT0H+ABSM2CAP!"(B\JF:P*IN"\JM()RRW0M<%<^H5<"-R$4:V(Z: M5AK!LR_0`008:-(S,,2XR(KT#(0=ST`99KQ)8C/SH&!A7%J`\W!C`H!S.(\, MX0IC6!JV0882\(8(50-,64PS87`DT^G$C>J&=C+(J72)TU#8D+=IT^:D3.'B M.].HD?FHPU,\U.@O[*`]O[VH:LC\,`&AJ"`7!3FC,AV2U.CR7KYLSEH'"=B@ MMV!.N34S+DD;G;:DD>7QRK]/4E:_1%Q2ZAX!&ED$%_"C?/=%),%'][&"]YBB M-XJ6"0RM'A32/@82@^X/^38&4S`$IS,%K*>5VLH*1%.44'``M"+#[_FXI(9+ MT+O?(F&124E3`&/H8%WN'74FS&,=1"1A_27Y"#BL9I/I)%^R@7.'<4T0,#,/ M4Z3MB%)#80?+NGH%*A45ATL*"+4F:#BT`^W*X84IEI)`^K.Z/Q<7B&Y`IT%"Q(H-,N>.H^Y-!+EJ'&X.*2*AVY$".U4 MV5:=,72?W>ZAZY*KJ=X=]CS*UB2]14G2ZA[T9X]PIW!_HLV>815FQJG>M']K M?BW1'82D)MLH]4]8)">VEQ2EG:%_+<-GO"[[&%S+SR%MP.5,8:HM M2"!N64ROT^"R?R2;,"->DS.6QZYFH.P$9,<\M@XYQ(3 M@E$8V(DC";P[#?U-?1_YZ`O_&N`7^[=<@`@"UD]*PC)"T62*E-U%W'E-;)\] MRXT^-*($87_BMS&"D7(8&KRD9KB;&E;=OMFVYF)%='P5GMU-@8>L'B3E(^@* MW"RY`\X0^*C@/&N"F8FYTSIT'5DH362(DDV,C4R[BIN1TGXH;Y-KQ8H$FM2- M7_#F5LF"=."0-5ZD0YM-&VHG"[C@WFG@DJ_#IM"9^!DH'^"T19\%MQP&*O11 M$7-80)GPV-6A*8%L0SLNZ6)@&'8UXDF8S5=@0N5:D#1$)E9)*G:88 M^7-D=\,R["(TK<)P4="SX",R1JF@L<_Y^BP$J]Q67_!'4O1>V35S,I.;+*MF,5X#:8!@^N2)8$B M\@=U#><'X)=+;FO9`,A"R65.2NQ1\(T+))VF`6)NV,01QRT(9WT@?,G<:ZVX M^2K>:SQ`VZY[E=BIXR]KG=]P#V[OX.38T5YS5)71[=NUK,EKYII<"0R:1'(W M6-C@:W0D."L+UCONKB5=W2E[IJ'QHEN,V-:[L6581["[[8DOK.UOGI0R"KB( M".O?PYB;VP-(06FI:%[+' MNVA1:"2K&V`59P#\>DSQ:?'?E;L4EI,F0J>P.VDH["X);K(G6HI*>U60A<4[ M=SH*QZ4"S*D:E])#X^G9B@IIIK/^$7G2-A_A5W\?9&8 MR77I#,ERM2NYW1MN5N[='@QM^]I;IMQW<7"&2$<#Z>[.UC(4VTP\`8,/VLC7 M"QF?=_7G4?N]J<1@G=?469;=7(/AJ3<[I:SX@7<3;"]!GTX\T:S MH3<:G:K=;=?KG8".N&GS<7,?=34XFWFG6(7L#AVN\O&3_]E)B^`2 M#OY'&M>56L>16K5?(Z,=Z^Z$+)9_SS"Z/QH=N\`ZA]=NG!>TD1=ZMS!^_5IV7^*PSO6E:3J_Q320>$50F]C37N&/6FW:J4DF-8#FWONF>[,#+(;J=\&:N8 M@GJ[15!S[TFNM2%3P"A2W-'3REQMJ[JV*1A)47!7B-+ZTM6XK#E0X_*.C\QN MI)00A/I[`1+3=K.02&*]\TOAZK.YYM8J2I)ERSK+).`,!G%V1<5%M"9XF)F0 M_4@CXLM8_*T&D=Z8BC9N`X&E+[)#K+;SQ$JU-<>5]DX/E$L6K4[H8+;*V#0! M(S>]+>JB7L-F=AYH<51R_REBM47KLNCXXNI"I%LI#0R]I]X4:0H@N5JZ3VE, ML0D<4)@D.5OR)RJV+WY93%5O\Q/^>*P5)UB)R2*CNV M:'!D;/'C2M)6&XNMK>DB)@8:?7>X4Q*.2WF=IZV=#3:Q(W&<.F_JN63BNFSQ MFSK&M'UU1A*`$Q^ MDTXFGEF!P?S1`4!/75._R9ZZ6.>>^I./KM9W/?4.[@IPY&@.XL(4S&\H94&; M\[U*$(GAPVNS_V-NA/8&_1+OL(UFBA[K(WF\Y/(_!K)-C(]'G MU'5-,6SDBF@IBYJ-GM.S87S>>-3WG``_MG63P4[))NA'7>EM@F6D()[#T.B+;OD^B> MUW8S%.HMDJ69(,7+K.\`6W7AI:#SATOFC5NMZF1!X41Q30Y!4W()A=60,6M. MF7HLA_MT/5ZFL0)ZB>-Q9[.0/.F%.HAFZ8) MVC)I:KR>':X!@&;K>MS?MW@'2VF@;;;VI(;/G><$@TZRZ:??`CSGN6VV^Q/O8+NQSNOVWB$-4'T`G,)2\A MVUL49D=#)=0U#PLI(S7-LJ(99I+?R$$E\A>O?;<.1Q:RR4L7MO[)_-3[K^PK M7M].Z7R2JUG4_B`R)M'2>7U'M1;,5@/UG,>J[[K8IR3LN/F-&#@'UX5QIQP= M^JZ^\O17891E2K%A8P%MBO;5;M_BK]SM]O!6MM@30@V&O;YINBH'J5VLK=.P M?K":J\))2"@W,>9L"*SC5)L MJ0#`?A5FUGOIOJ(+15K#JR!M9Y'B/1$F^EEO1 MP!O.3KW)&?6+',PFWAD5XAP-O4F_[YU.N8_A8#*&OX?'SFX'WJ@/_P[1+0>/ MG0ZQ,>2@/T)O'3GP1I,^?UL]RV%]*TOW5NU,P\U,I+ZX=@^PJ]G,&YZ1DW?L MG4VF>`CG#,.A-QP.O"DP+IARBH[8\;BZWQ$`>]#W^A/L\0BW,(5SC8?3FA]P MURN"CLQ?-0^^?1L7JJJE-QS]9*KT6O65VMM*/%/9M\>SK6^L.&02Y]T*MPZ7 MWGN"CK[23WFGQ.\O7?C]I0O![R]=^/VE"[^_=.&__J4+!1/'T,`-4+!X&%G6 M55Z[L%O6V'<6'"*@JLWU#WG6;=OIUFAZTMI-ZC#==H+Z@.GWZ!!VR&Z;NWKX MB\()ZK3Y.&2?#0T$#M(SW!F!LN;DEJ6V*87'9*^M@;^+L4*6BVXMWV$0[ M6\,??:(=XN=<7/FL?4V]9[3:]RTU_Z)9CI<6>*\3,P:)8*F2<3;8GHC ME/HHSP_L>FZY?7Y/> MV,5A>].Y+2X=AX^-.^_H<'KD-C47^6TZ?;[\?[Z-ZQ-OB4]USM&+WVQ(V[T] M%K$>FBGE1JKJAIHR?9T;=>[2]7V[)6H'](KU1)OGAVMO$F`#CYOJK4IONGWY MS]M4]@F:SEXT7LSC&;\/0NZ]TX[P`_=S),/\QOH]^7W+_R""IZ"X/5-+F\2- MV1=C0SG!M=P=5\)GY7:PW)F`:][==H181E_X=[E"M0D)=2"I,E2P;`HBG908 MR9)Q,^H;NG"^_&_26'"?_F<[,?)J)?V.K`O9I.C5.P1]5=Q;)P_:E@')TA3A M*$JNC*1AHYPB`?MUU?Z*&MU_^V907Y3*O1?'.VS&?Z!&LRC2'O9-`Y8(A-.. M[ROBUN]9X[]GC?_39HT?E%#2QB905,68'&(->R/$N`N#F1KTU9)#Y:E,XM8P MA+;D$-R.I)=2!:\);-EP,>UK06GG.=%:$;YFK<6VW/X]N/O_07!W-T*+BN?B M\U=#YW^:T#+;+@"-:R>#2AV]#C*0@)H.GF/6THGZX?:U.GJ.8`;N_H$#'K4D M29[NJC+=3^^1K"[!\M`-#EQS+FFL1F^U:O?V'QBR[3A)1T3!F:!K[PWKW1CY M^PX#&*@XU=2XNF[A!K>-SN].PPJ8A[$?20B[*@)[GVQ@[]*&[&`>0K+JVM]? M?7RG_HS_^>D#9:4W5*^Z<9,#H#=0'YAMOD&V69_VOJ=&?2*`6HVB^V,MSD/O MQ2Y,^<[[(#@"T/"9[H.9D:\>*3=A2U.?9T5A[0U@9'6*T]ZX_Z_=\]X$IG75 M-8GSZNC11*1+G3W9MBI`/;LW^Y18@EQFQR46SN_Z-13NX":B/\A[^P6;=S&1 MG<:)WO:S]:JW#ZBYV??9WQMI>=J\N7I(@-WF%6=Y04&'G?W0Z5NA=/A$K?!\ MRE0[(?^$23OO92<9H(_S!%727J&3NH1A7S/LN.=K!-VD3GR=>$MSL*6#M!HB M%UXM]K#70[6KN+'M'EU'ZWL,GASA6TWKAO)$/>+W:F3,QL%,+?W'UO6=T,KN M33,LK@`2;3R01R2K:IC&`]WS`:;FW^F])FT[GYJ=3QHWSC-\>DA:]V`F&O!$ M+?/L1M/=LH[Y2L,<+LM^)2Q;QAW(LK]$('A%')AX$Y$4*X*BV#<"Y8FO._Q# MY66'C20+=.=T=6U<@LOSBB!@YZ2VZOI6W!FM5_(Q,:EOI1!Y>1"I`:#MJK\& MF0F/X$:;M>=QB_+\-2^NQ!\N[=L\28&IKKOC/<=M]&(46U:-+GQN2BDL\\:T MU\1K>9MG6%1VJ;'0ND5=^$KG;N!+_X#E:A%B:PW3>8EJ6J",KY@]!,I[A84= M1=$-_WXH7E@(H"DBO6UKE61K"^^2T.:U#6V>FQX`1?#RT@8OS6L!VU9D[U%7 MH0"[")PW`5YR$-2\UJQ5JW;F*+T!S[P6[VL`W/+Z]DD.#,+[E/09I]6H_$'N M&[9+]@K?[C:FFRHUNK;3%-"LS6FCE4TVM+B66Q]R(H[5,;-AKU]W;DPF3=]. MIXUC&[_M@ETK$I!#:##B]L`MT'T;S'MJ.&.G4TQ M9I]Y!BUCI%,)O7G%+<8A%N.^6=9`K?22X`[4.9]B-YT7CG5RN;!711]'*M:Y+-`E[$ M!DQR01VKWX9((Q^21A6E?H`"NO+WMLXZJT^9D.,51KZH%?]E3*O348JVB+*) M-F/T?=&MX=:VA?!D\IU[*$/>2,^/F&H#HB."37(K&1AR8UX84=[>C=N881=8 M?T0-\XK>:YK'F,3X*:&D>FK$J"ZDF+,ZRW61QH`S\59IJNM$7GARPQW M]9M9AMM+`J;\05.V"V:_4&0-?=WG^9(:Z%U(XL=U*V>;CIL6^0!6'K[DYY6\ MB.Z&VRK1DHBZG7"[<;KC7A3=45MV(VYB7[6Q@7UO5IJU0K.E4VF'W&AY!LR"!^E6Z1`6=4`J/\##:J&@)H([,'MI#_6J M*T>G:_4GINQ4ISPPUZ:!AWR5E)J:4NOFT-3`\&5I-%\*U5*FR]=!D'T")(=E MN77&JMVFAM4M="%KT6FQH=%BUY)5M:V#QU2'5GGFHD7?:]90WK!WJ+Z?0Y*+ M=E-QO9F..T$G[^K(K6E@]FV9+1RVU)(XA(AL\X9J%'];)&JT^W9,.D.[X'D" M!-F%WP)#-Y_DZZRVFZ@H+X%81V,'F>KP5]*W>?\GG,0'4PI[4/UL,=\+K;/O M_B]02P$"%`,4````"`#+93A'%T<6;O(!``"V(```$P``````````````@`$` M````6T-O;G1E;G1?5'EP97-=+GAM;%!+`0(4`Q0````(`,ME.$=(=07NQ0`` M`"L"```+``````````````"``2,"``!?#1\7@,``&P-```0 M``````````````"``3<%``!D;V-0&UL4$L!`A0#%`````@` MRV4X1VR+8BD_`0``:0,``!$``````````````(`!PP@``&1O8U!R;W!S+V-O M&UL4$L!`A0#%`````@`RV4X1YE&PO&PO=V]R:W-H965T&UL4$L!`A0#%``` M``@`RV4X1V/__39A!```N!0``!@``````````````(`!3!H``'AL+W=O,>``!X;"]W;W)K&PO M=V]R:W-H965T&UL4$L!`A0#%`````@`RV4X1WR$U"K'`@`` MS`D``!@``````````````(`!1"8``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`RV4X1WE3?Z&D`0``L0,``!@````````````` M`(`!'S```'AL+W=O&PO=V]R:W-H965TX894VI0$``+$#```9``````````````"``;$U``!X;"]W;W)K M&UL4$L!`A0#%`````@`RV4X1XD!6%*C`0``L0,` M`!D``````````````(`!C3<``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`RV4X1]Z##X"E`0``L0,``!D````````````` M`(`!'ST``'AL+W=O&PO=V]R:W-H965T MYV&='I@$``+$#```9```` M``````````"``=9```!X;"]W;W)K&UL4$L!`A0# M%`````@`RV4X1[%>QIJE`0``L0,``!D``````````````(`!LT(``'AL+W=O M&PO=V]R:W-H965T&UL4$L!`A0#%`````@`RV4X1X!1 MIM^E`0``L0,``!D``````````````(`!1T@``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`RV4X1[HR#\RF`0``L0,``!D` M`````````````(`!WTT``'AL+W=O&PO M=V]R:W-H965T&UL4$L!`A0#%`````@`RV4X1QZK5I%3`@``@P@``!D``````````````(`! M<5,``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%``` M``@`RV4X1UXU>S.B`0``L0,``!D``````````````(`!OED``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`RV4X1V]Y&H*Q M`0``%@0``!D``````````````(`!3E\``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`RV4X1UCTQ"GN`0``8`4``!D````` M`````````(`!H64``'AL+W=O&PO=V]R M:W-H965T&UL M4$L!`A0#%`````@`RV4X1S)`FLLL`@``]08``!D``````````````(`!IFP` M`'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@` MRV4X1WAQ*LG0`@``VPL``!D``````````````(`!^7,``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`RV4X1X<-[F>#`@`` M$@@``!D``````````````(`!U'H``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`RV4X1\=:RX30`@``Z`H``!D````````` M`````(`!NH(``'AL+W=O&PO=V]R:W-H M965T:'``!X;"]W;W)K&UL4$L! M`A0#%`````@`RV4X1Z0^BF7>`@``WPH``!D``````````````(`!8(H``'AL M+W=O&PO=V]R:W-H965T-0(``"$'```9``````````````"` M`::/``!X;"]W;W)K&UL4$L!`A0#%`````@`RV4X M1Z(R-M@H,```5\8``!0``````````````(`!$I(``'AL+W-H87)E9%-T&UL4$L%!@`````^`#X`Y!```&S"```````` ` end XML 15 R46.htm IDEA: XBRL DOCUMENT v3.2.0.727
Revenue Recognition (Details Textual)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Nov. 13, 2008
USD ($)
Feb. 28, 2014
USD ($)
Jan. 31, 2014
USD ($)
Aug. 31, 2013
USD ($)
May. 31, 2015
USD ($)
Aug. 31, 2014
USD ($)
Aug. 31, 2011
USD ($)
Health Care Organization, Receivable and Revenue Disclosures [Line Items]              
Accrued Liabilities         $ 300,000    
Interest Payable, Current         $ 3,800,000    
Loss Contingency, Pending Claims, Number         179    
Service Period For Estimation Of Amounts Collectible         6 months    
Number Of Cases Filed Motions         47    
Loss Contingency, Receivable, Receipts     $ 4,200,000        
Loss Contingency Amount Of Refund In Case Of Additional Motions Granted         $ 11,300,000    
Litigation Settlement, Amount           $ 4,476,097  
Loss Contingency Pending Claims Number Negatively Affecting Recovery Of Additional Reimbursement         178    
Number Of Cases With Opportunity To Establish Criteria         80    
Percentage Of Claims With Positive Rulings         90.00%    
Reimbursement Of Usual And Customary Audited Charges Percentage 75.00%            
Minimum Billing Requirement For Reimbursement $ 40,000            
Receivables Collection Period         30 days    
Number Of Cases Awards Paid By Insurance Carriers         180    
Awards Paid By Insurance Carriers Amount         $ 11,000,000    
Number Of Cases In Which Awards Not Paid By Insurance Carriers         130    
Loss Contingency Refund Of Voluntary Award Including Prejudgment Interest         $ 4,200,000    
Accrued Income Current And Non Current   $ 300,000          
Pasadena Facility [Member]              
Health Care Organization, Receivable and Revenue Disclosures [Line Items]              
Increase In Facility Contractual Allowance       $ 149,875     $ 10,254,990
Garland Facility [Member]              
Health Care Organization, Receivable and Revenue Disclosures [Line Items]              
Additional Loss Contractual Allowance       $ 136,542     $ 779,583
XML 16 R33.htm IDEA: XBRL DOCUMENT v3.2.0.727
Industry Segments and Geographic Information (Tables)
9 Months Ended
May. 31, 2015
Segment Reporting [Abstract]  
Reconciliation of Revenue from Segments to Consolidated [Table Text Block]
Summarized financial information concerning the business segments from continuing operations is as follows:
 
 
 
Three months ended May 31,
 
Nine months ended May 31,
 
 
 
2015
 
2014
 
2015
 
2014
 
Revenues from external customers
 
 
 
 
 
 
 
 
 
 
 
 
 
Net patient service revenues
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S. Division
 
$
1,047,426
 
$
2,748,772
 
$
5,120,992
 
$
7,239,406
 
Corporate
 
 
 
 
 
 
 
 
 
Consolidated
 
$
1,047,426
 
$
2,748,772
 
$
5,120,992
 
$
7,239,406
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Income (loss) before taxes
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S. Division
 
$
(1,284,694)
 
$
186,954
 
$
(2,600,470)
 
$
(165,472)
 
Corporate
 
 
1,301,323
 
 
(486,423)
 
 
(103,194)
 
 
(1,360,423)
 
Consolidated
 
$
16,629
 
$
(299,469)
 
$
(2,703,664)
 
$
(1,525,895)
 
Reconciliation of Assets from Segment to Consolidated [Table Text Block]
 
 
May 31, 2015
 
August 31, 2014
 
Total Assets
 
 
 
 
 
 
 
U.S. Division
 
$
16,488,296
 
$
15,967,472
 
Corporate
 
 
22,221,764
 
 
31,793,055
 
Consolidated
 
$
38,710,060
 
$
47,760,527
 
XML 17 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 18 R25.htm IDEA: XBRL DOCUMENT v3.2.0.727
Recent Accounting Pronouncements
9 Months Ended
May. 31, 2015
Accounting Changes And Error Corrections [Abstract]  
New Accounting Pronouncements and Changes in Accounting Principles [Text Block]
Recent Accounting Pronouncements
 
No recent accounting pronouncements or other authoritative guidance has been issued that management considers likely to have a material impact on our consolidated financial statements.
XML 19 R50.htm IDEA: XBRL DOCUMENT v3.2.0.727
Contingencies (Details Textuals) - USD ($)
1 Months Ended 9 Months Ended
Apr. 30, 2015
Aug. 31, 2014
Sep. 30, 2013
May. 31, 2015
Commitment And Contingencies [Line Items]        
Interest Payable       $ 11,300,000
Additional Interest Payable Current And Noncurrent       $ 3,800,000
Treasury Stock, Shares, Acquired   530,616 125,000 530,616
Litigation Settlement, Expense       $ 2,047,652
Subsequent Event [Member]        
Commitment And Contingencies [Line Items]        
Treasury Stock, Shares, Acquired 427,886      
XML 20 R42.htm IDEA: XBRL DOCUMENT v3.2.0.727
Stock Based Compensation (Details Textual) - USD ($)
3 Months Ended 9 Months Ended
May. 31, 2015
May. 31, 2014
May. 31, 2015
May. 31, 2014
Aug. 31, 2014
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross     0 0  
Stock-based compensation expense associated with the Company's stock options $ 49,341 $ 49,341 $ 148,023 $ 148,023  
Total unrecognized compensation expense for outstanding stock options 33,000   $ 33,000    
Employee Service Share Based Compensation Nonvested Stock Options Compensation Cost Not Yet Recognized Period     5 months    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $ 0   $ 0   $ 0
Year 2011 Stock Incentive Plan [Member]          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]          
Common Stock, Capital Shares Reserved for Future Issuance 15,000,000   15,000,000    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 250,000   250,000    
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant 14,750,000   14,750,000    
Year 2000 Stock Incentive Plan [Member]          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]          
Common Stock, Capital Shares Reserved for Future Issuance 5,000,000   5,000,000    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 534,000   534,000    
XML 21 R37.htm IDEA: XBRL DOCUMENT v3.2.0.727
Net Income (Loss) per Common Share (Details) - USD ($)
3 Months Ended 9 Months Ended
May. 31, 2015
May. 31, 2014
May. 31, 2015
May. 31, 2014
Numerator:        
Net income (loss) $ 16,629 $ (299,469) $ (2,703,664) $ (1,525,895)
Less: Net (income) loss attributable to noncontrolling interest 32 29 (53) (4)
Net income (loss) attributable to Dynacq Healthcare, Inc. $ 16,661 $ (299,440) $ (2,703,717) $ (1,525,899)
Denominator:        
Basic and diluted average common shares outstanding 13,674,067 14,418,626 13,802,433 14,431,126
Basic and diluted income (loss) per common share: $ 0.00 $ (0.02) $ (0.20) $ (0.11)
XML 22 R52.htm IDEA: XBRL DOCUMENT v3.2.0.727
Industry Segments and Geographic Information (Details 1) - USD ($)
May. 31, 2015
Aug. 31, 2014
Segment Reporting Information [Line Items]    
Total Assets $ 38,710,060 $ 47,760,527
US Division [Member]    
Segment Reporting Information [Line Items]    
Total Assets 16,488,296 15,967,472
Corporate [Member]    
Segment Reporting Information [Line Items]    
Total Assets $ 22,221,764 $ 31,793,055
XML 23 R47.htm IDEA: XBRL DOCUMENT v3.2.0.727
Noncontrolling Interest (Details Textual)
May. 31, 2015
Noncontrolling Interest [Line Items]  
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners 1.00%
XML 24 R9.htm IDEA: XBRL DOCUMENT v3.2.0.727
Basis of Presentation
9 Months Ended
May. 31, 2015
Organization Consolidation And Presentation Of Financial Statements [Abstract]  
Basis of Presentation and Significant Accounting Policies [Text Block]
Basis of Presentation
 
The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete consolidated financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. All such adjustments are of a normal and recurring nature. The majority of the Company's expenses are "cost of revenue" items. Costs that could be classified as general and administrative by the Company would include the corporate office costs, including advertising and marketing expenses, which were approximately $1.1 million and $1.0 million for the three months ended May 31, 2015 and 2014, respectively, and approximately $3.0 million and $2.8 million for the nine months ended May 31, 2015 and 2014, respectively. These financial statements should be read in conjunction with the audited financial statements as of August 31, 2014. Operating results for the three and nine months ended May 31, 2015 are not necessarily indicative of the results that may be expected for the year ending August 31, 2015.
XML 25 R43.htm IDEA: XBRL DOCUMENT v3.2.0.727
Fair Value of Financial Instruments (Details) - Fair Value, Measurements, Recurring [Member]
May. 31, 2015
USD ($)
Quoted Prices in Active Markets for Identical Level 1 [Member]  
Assets  
Investments available-for-sale $ 0
Significant Other Observable Inputs Level 2 [Member]  
Assets  
Investments available-for-sale 12,049,876
Significant Unobservable Level 3 [Member]  
Assets  
Investments available-for-sale $ 0
XML 26 R29.htm IDEA: XBRL DOCUMENT v3.2.0.727
Stock Based Compensation (Tables)
9 Months Ended
May. 31, 2015
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]
The following table summarizes the stock option activities for the nine months ended May 31, 2015 (share amounts in thousands):
 
 
Shares
 
Weighted Average
Option Exercise
Price Per Share
 
Outstanding, August 31, 2014
 
 
995
 
$
2.18
 
Granted
 
 
 
 
 
Exercised
 
 
 
 
 
Expired or canceled
 
 
(211)
 
 
4.27
 
Outstanding, May 31, 2015
 
 
784
 
 
1.62
 
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]
The following summarizes information related to stock options outstanding as of May 31, 2015, and related weighted average price and life information:  
 
 
 
 
Options Outstanding
 
Options Exercisable
 
Exercise Prices
 
Number of 
Shares
 
Weighted Average
Remaining Contractual
Life (Years)
 
Number of Shares
 
 
 
 
(Share Amounts In Thousands)
 
$
1.10
 
 
250
 
 
6.6
 
 
188
 
$
1.86
 
 
534
 
 
6.1
 
 
401
 
Total
 
 
 
784
 
 
6.3
 
 
589
 
XML 27 R28.htm IDEA: XBRL DOCUMENT v3.2.0.727
Net Income (Loss) per Common Share (Tables)
9 Months Ended
May. 31, 2015
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
The following table presents the computation of basic and diluted income (loss) per common share attributable to the Company:
 
 
 
Three months ended May 31,
 
Nine months ended May 31,
 
 
 
2015
 
2014
 
2015
 
2014
 
Basic and diluted loss per common share:
 
 
 
 
 
 
 
 
 
 
 
 
 
Numerator:
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss)
 
$
16,629
 
$
(299,469)
 
$
(2,703,664)
 
$
(1,525,895)
 
Less: Net (income) loss attributable to noncontrolling interest
 
 
32
 
 
29
 
 
(53)
 
 
(4)
 
Net income (loss) attributable to Dynacq Healthcare, Inc.
 
$
16,661
 
$
(299,440)
 
$
(2,703,717)
 
$
(1,525,899)
 
Denominator:
 
 
 
 
 
 
 
 
 
 
 
 
 
Basic and diluted average common shares outstanding
 
 
13,674,067
 
 
14,418,626
 
 
13,802,433
 
 
14,431,126
 
Basic and diluted income (loss) per common share:
 
$
0.00
 
$
(0.02)
 
$
(0.20)
 
$
(0.11)
 
XML 28 R44.htm IDEA: XBRL DOCUMENT v3.2.0.727
Fair Value of Financial Instruments (Details Textual)
May. 31, 2015
USD ($)
Significant Other Observable Inputs Level 2 [Member]  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Trading Securities, Cost $ 4,078,646
XML 29 R30.htm IDEA: XBRL DOCUMENT v3.2.0.727
Fair Value of Financial Instruments (Tables)
9 Months Ended
May. 31, 2015
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]
The following table summarizes our financial assets and liabilities measured and reported in the Company’s statement of financial position at fair value on a recurring basis as of May 31, 2015, segregated among the appropriate levels within the fair value hierarchy:
 
 
 
Quoted prices in active
 
Significant other
 
Significant
 
 
 
markets for identical
 
observable inputs
 
unobservable
 
 
 
 
(Level 1)
 
(Level 2)
 
(Level 3)
 
Assets
 
 
 
 
 
 
 
 
 
 
Investments available-for-sale
 
$
 
$
12,049,876
 
$
 
XML 30 R31.htm IDEA: XBRL DOCUMENT v3.2.0.727
Revenue Recognition (Tables)
9 Months Ended
May. 31, 2015
Revenue Recognition [Abstract]  
Schedule Of Gross Revenues And Contractual Allowance [Table Text Block]
The following table shows gross revenues and allowances for the three and nine months ended May 31, 2015 and 2014:
 
 
 
Three months ended May 31,
 
 
Nine months ended May 31,
 
 
 
2015
 
 
2014
 
 
2015
 
 
2014
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gross billed charges
 
$
5,798,725
 
 
$
8,148,181
 
 
$
22,116,554
 
 
$
21,806,599
 
Allowances
 
 
4,751,299
 
 
 
5,399,409
 
 
 
16,995,562
 
 
 
14,567,193
 
Net revenue
 
$
1,047,426
 
 
$
2,748,772
 
 
$
5,120,992
 
 
$
7,239,406
 
Allowance percentage
 
 
82
%
 
 
66
%
 
 
77
%
 
 
67
%
XML 31 R8.htm IDEA: XBRL DOCUMENT v3.2.0.727
General
9 Months Ended
May. 31, 2015
Accounting Policies [Abstract]  
Business Description and Basis of Presentation [Text Block]
General
 
Dynacq Healthcare, Inc., a Nevada corporation (the “Company”), is a holding company that through its subsidiaries in the United States develops and manages general acute care hospitals that principally provide specialized surgeries. The Company through its United States subsidiaries owns and operates one general acute care hospital in Pasadena, Texas. The Company through its subsidiary in Hong Kong invests in debt and equity securities, including short-term investments in initial public offerings and pre-initial public offerings.
XML 32 R32.htm IDEA: XBRL DOCUMENT v3.2.0.727
Accumulated Other Comprehensive Income (Loss) (Tables)
9 Months Ended
May. 31, 2015
Equity [Abstract]  
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]
The following table summarizes the changes in accumulated other comprehensive income (loss) by component:
 
 
 
Three months ended May 31,
 
Nine months ended May 31,
 
 
 
2015
 
2014
 
2015
 
2014
 
Available-for-sale securities
 
 
 
 
 
 
 
 
 
 
 
 
 
Accumulated other comprehensive income balance, beginning of period
 
$
10,124,848
 
$
11,953,646
 
$
12,616,346
 
$
9,382,334
 
Other comprehensive income (loss):
 
 
 
 
 
 
 
 
 
 
 
 
 
Unrealized gains (losses), net of taxes of $-0-
 
 
198,467
 
 
1,194,983
 
 
(2,293,031)
 
 
3,766,295
 
Reclassification adjustments for gains included in rent and other income
 
 
(2,094,000)
 
 
 
 
(2,094,000)
 
 
 
Tax provision
 
 
 
 
 
 
 
 
 
Amount reclassified from accumulated other comprehensive income
 
 
(2,094,000)
 
 
 
 
(2,094,000)
 
 
 
Other comprehensive income (loss)
 
 
(1,895,533)
 
 
1,194,983
 
 
(4,387,031)
 
 
3,766,295
 
Accumulated other comprehensive income balance, end of period
 
$
8,229,315
 
$
13,148,629
 
$
8,229,315
 
$
13,148,629
 
XML 33 R40.htm IDEA: XBRL DOCUMENT v3.2.0.727
Stock Based Compensation (Details) - $ / shares
9 Months Ended
May. 31, 2015
May. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Shares Outstanding, Beginning balance   995,000
Shares, Granted 0 0
Shares, Exercised   0
Shares, Expired or canceled   (211,000)
Shares Outstanding, Ending balance   784,000
Weighted Average Option Exercise Price Per Share Outstanding, Beginning balance   $ 2.18
Weighted Average Option Exercise Price Per Share, Granted   0
Weighted Average Option Exercise Price Per Share, Exercised   0
Weighted Average Option Exercise Price Per Share, Expired or canceled   4.27
Weighted Average Option Exercise Price Per Share, Ending balance   $ 1.62
XML 34 R53.htm IDEA: XBRL DOCUMENT v3.2.0.727
Industry Segments and Geographic Information (Details Textual) - USD ($)
3 Months Ended 9 Months Ended
May. 31, 2015
May. 31, 2015
May. 31, 2014
Aug. 31, 2014
Segment Reporting Information [Line Items]        
Gain from marketable securities $ 2,100,000      
Balance from marketable securities 12,049,876 $ 12,049,876   $ 20,678,130
Gain (Loss) on the initial public offerings of equity securities $ 2,100,000      
HONG KONG [Member]        
Segment Reporting Information [Line Items]        
Gain (Loss) on the initial public offerings of equity securities   $ 161,864 $ 161,864  
XML 35 R2.htm IDEA: XBRL DOCUMENT v3.2.0.727
Consolidated Balance Sheets - USD ($)
May. 31, 2015
Aug. 31, 2014
Current assets:    
Cash and cash equivalents $ 17,554,608 $ 16,819,504
Accounts receivable, net of allowances of approximately $122,597,000 and $154,132,000 1,037,864 1,986,633
Accounts receivable, other 355,531 380,456
Inventories 248,638 298,662
Interest receivable 99,311 122,041
Prepaid expenses 60,258 262,944
Total current assets 19,356,211 19,870,240
Investments available-for-sale 12,049,876 20,678,130
Property and equipment, net 6,315,953 6,224,136
Income tax receivable 800,920 800,920
Other assets 187,101 187,101
Total assets 38,710,060 47,760,527
Current liabilities:    
Accounts payable 1,348,121 1,015,856
Accrued liabilities 16,246,301 18,512,986
Current portion of notes payable 0 6,734
Current portion of capital lease obligations 30,259 26,513
Total current liabilities 17,624,681 19,562,089
Non-current liabilities:    
Long-term portion of capital lease obligations 15,789 41,123
Total liabilities $ 17,640,470 $ 19,603,212
Commitments and contingencies    
Dynacq stockholders' equity:    
Preferred stock, $.01 par value; 5,000,000 shares authorized, none issued or outstanding $ 0 $ 0
Common stock, $.001 par value; 100,000,000 shares authorized, 14,418,626 shares issued and 13,460,124 shares outstanding at May 31, 2015; 14,418,626 shares issued and 13,888,010 shares outstanding at August 31, 2014 14,419 14,419
Treasury stock, 958,502 shares at May 31, 2015 and 530,616 shares at August 31, 2014, at cost (172,115) (27,061)
Additional paid-in capital 10,627,768 10,479,745
Accumulated other comprehensive income 8,229,315 12,616,346
Retained earnings 2,306,344 5,010,061
Total Dynacq stockholders' equity 21,005,731 28,093,510
Non-controlling interest 63,859 63,805
Total equity 21,069,590 28,157,315
Total liabilities and equity $ 38,710,060 $ 47,760,527
XML 36 R45.htm IDEA: XBRL DOCUMENT v3.2.0.727
Revenue Recognition (Details) - USD ($)
3 Months Ended 9 Months Ended
May. 31, 2015
May. 31, 2014
May. 31, 2015
May. 31, 2014
Accounting Policies [Line Items]        
Gross billed charges $ 5,798,725 $ 8,148,181 $ 22,116,554 $ 21,806,599
Allowances 4,751,299 5,399,409 16,995,562 14,567,193
Net revenue $ 1,047,426 $ 2,748,772 $ 5,120,992 $ 7,239,406
Allowance percentage 82.00% 66.00% 77.00% 67.00%
XML 37 R6.htm IDEA: XBRL DOCUMENT v3.2.0.727
Consolidated Statements of Comprehensive Income (Loss) [Parenthetical] - USD ($)
3 Months Ended 9 Months Ended
May. 31, 2015
May. 31, 2014
May. 31, 2015
May. 31, 2014
Net change in fair value of available-for-sale securities, net of taxes $ 0 $ 0 $ 0 $ 0
XML 38 R35.htm IDEA: XBRL DOCUMENT v3.2.0.727
Investments in Available-for-Sale and Trading Securities (Details Textual) - USD ($)
3 Months Ended 9 Months Ended
May. 31, 2015
May. 31, 2015
May. 31, 2014
Investment Securities [Line Items]      
Trading Securities Realized Gain Loss $ 2,100,000    
Available-for-sale Securities, Gross Realized Gain (Loss), Excluding Other than Temporary Impairments, Total $ 6,000,000    
HONG KONG [Member]      
Investment Securities [Line Items]      
Trading Securities Realized Gain Loss   $ 161,864 $ 161,864
XML 39 R22.htm IDEA: XBRL DOCUMENT v3.2.0.727
Noncontrolling Interest
9 Months Ended
May. 31, 2015
Noncontrolling Interest [Abstract]  
Noncontrolling Interest Disclosure [Text Block]
Noncontrolling Interest
 
The equity of minority investors (minority investors are generally physician groups and other healthcare providers that perform surgeries at the Company’s facilities) in certain subsidiaries of the Company is reported on the consolidated balance sheets as noncontrolling interest. Noncontrolling interest reported in the consolidated income statements reflect the respective interests in the income or loss of the limited partnerships or limited liability companies attributable to the minority investors (equity interest was 1% at May 31, 2015).
XML 40 R36.htm IDEA: XBRL DOCUMENT v3.2.0.727
Notes Payable (Details Textual) - USD ($)
1 Months Ended 3 Months Ended
Nov. 30, 2011
Nov. 30, 2014
Debt Instrument [Line Items]    
Secured Debt $ 116,339  
Notes Payable Secured By Equipment At Interest Rate 4.50%  
Notes Payable Repayment Period 36 months  
Repayments Of Notes Payable Secured By Equipment   $ 6,734
ZIP 41 0001144204-15-054993-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001144204-15-054993-xbrl.zip M4$L#!!0````(`#IE.$<0%P4B%<(``.UW"@`1`!P`9'EI:2TR,#$U,#4S,2YX M;6Q55`D``\\G!%;/)P16=7@+``$$)0X```0Y`0``[%UM4^.XEOZ^5?L?LGP/ MZ,UOU'3?HJ'IH:9I**!W9VIKBS*Q`.\D=L9V:')O[7]?R4E`=FQ)5NR\]*1G M:H;&LO6<1T?G2$?2T2__>!T->R\T2<,X^G``#\%!CT:#.`BCIP\'W^_.^^Y! M[Q\?__W??OF/?K_WA48T\3,:]!ZFO3,_\^\2?_!GNGB_!P_AH==C/P"O?TO' M?02@U?MO0(Z)=PSA__3^=7+Y?[W/MW>]?N_'CQ^'`?M"EG_AOW^HIY/ M?LKJ8-_Y_=/-UQXZA/-GKP_),#SF_^TQV%%Z'$S#\,/!S,L.P^C/0EG^G<,X>6(E`3[BCQ]8O8OB_&GP_G&QL'TT>_A6 M=.G3/W!>%GJ>=Y0_?2N:AE4%V4?AT>^77V\'SW3D]\,HS?QH4,`22K"7RX=I M3!!T9&_,2BQ>".@XH0/>LK7O>$=^,DCB(3UZ+[QX?1!/HBR9%LE*Z>#P*7XY MFC_D[8'[`/;?6V0P21*F;'7OS9_R%TGQQ8"&U>^P!Q7%Z>O@N;H\?Y(K2O&% M,'JA:5;]RNQ9A321'P[2ZG?R1_P56'PE#0?5+[`'5<6S<5)3GCVI>&&2]I]\ M?_SVSJ.?/N3M.7]0(?KK4*(UOW\55'F2)1)E84\/6)?M]7[AZG^75'54:FN`H(Q3<(X*"-@ MO3G)F'VE'Q?*#.#B.^_/%I\2Q`D*+V'X7GDP?T6$)%2^^-6R"6$L@UMI%8BT38JW.B#U)KZ*= M(W0V5LHJF%D\:4/E7*$ONSO>EUV3ONQVJ'*[1JB@P&XV%\S@&<'-B(,8LY<@[I!8 M"`6-A3M(+">H>8`(=J:Q?""ZB2CAYH,DGY^MG)#S\)[J9C>O(: MIFOFN3PBH$],V.RMOOF#@`%Y'0_#09C-@/>"!2D?#N:K@, MM20^;&^F=L%,;:O+*^K2WDSMH)G:-M6JW(VU-U,[8::V;`-:C2[MS=0.FJEM M52VR'TWMG)G:U@W(9#^:VG4SM66J58I;[\W3EIJG32QB[.W+;MB7]>F&NQ_' M[)"A6--9@?U`9`<-17>Z4;-"<>-'3_0JH@6E>/83FI_5/XU'8\9MSDK^V_1D MDCW'2?A/&GR/`IKDZ\A78_Z<+R*GGZ:?7VDR"%-ZG80#FG]]QU6I"S)RFU2D M?K_8H=+2NQ_Q7DLWHZ5OU.^UM&)`OK>A?SL;NHEYW]X(_NV,X";4[-P/D__T MAQ-Z$8TG6?J5OM`A$G7NK<"GZ=N/O[+&])/!\S0OOMMJI"O?4OEEPGXR37D; MG0'A8#"\O_93G[6%?^X/PB%#+"K+#1WRC%+7S&%/[Q+6T_Q\QS;K<.*3W5:8 M)C+FYJ2:L`V-K8#)V`IV=T;:KCA\CO0AI7]->$#[I;S\4WRT M^P><:@6J*;#I?5#$)(1%NCO-KYCTP>:3OO?O7%(_G23Y&DQZ0WG.US!ZJOF@ M4/8\R=MKL..&3DNXI<(2SNJ5=E,S7/A3SG"[B87LN\7?IEO\G($?C6Z!]]UB MWRUJNP7^*;M%S6KU_GCY1D;8FU\DGD3A3#/2?,VIU,RC68?].(>7%UE\;O%, MK()_K>;[WV_/:CX^OP#BF)4P__8]$_@^7S>JGSR=1P/_W^:])^.(/\YUNV:F?)%/F$W);W)LK[`V_BZ&< MX3O'?,Z#,<$]/.CQRO-R7,UZ`1V$(W^8?C@`!Q^A8UG$YG:F4>T+FE:%_)Z, M5H2,Y)!M%WH6("M"/AGD!HZ[6LI>>1C2;S0[S>\RR;3)Q7*D`#NN+0"5U;DB MOFHFB1R?Y]HVQF;X+B(>@HF3*2NBS9=Q9CDB;&',JMN8VAY5E8 M[`7UE:X(L(9*N;VW$2(0VV8`K[)GFLSTV$0MY=8?N@X$0I^MK,P440U7"KMO M@FCV7)\4N97''`*PE\R(=JTU@TVY*2>.8P,+.696&X/&Z35MX6XAH:Y3X`NX!8=DN(K_VIR8@+*7P!)BY$%:P6JS,&5<.; M8HC.A'"KB%."2B8T^!KZ#WRAG?F"QF3)C3NT$;$Q*+)57>4JV&HXD]MUZ%J0 MC^4-L'V+,VJL7G*;+MBMBEK,@-30(S?EMH-)(RRG_CC,_.%7ZJ?TZF$8/N7; ML)MKE,*\LT&\)\[I996N#+&:.:P:UEL0FT);`>'M M$$<&=!"Y*8:$0+$CEZHQ@%$30%68WF8P3H(@Y!W7'U[[87`1S;NU/BD*TPML MQ*8K0BBLID)S7#4LJ>+@Q/$<8C7'-1A,1I-\)VD^2^#'P!+ZS!.=_ZK/H]SXN@AY&%J%\6,3'.V+44.[PF`C&]J8V*W)<4,S/XQH M\-E/(F9.4^%S9_21+PSKMX`B%(\!0RX,4]55MP*VAF?YR-X"/"X!5P&;FXSG M>!C0).51IVRJSZ3<;R"&S7+$8,%R749H:JB2.P_D`@];$#1!I)E2?@P MR?B,[B[F0T0&-(F'0U:D.8=RC\.TR_8L3]J>)OC6)G5-D\G]&7(A[U)6UU(+ MXULVB%W!1EAR?[<<6575W`+2&N;E+FTY&ML4Z5V2[\Z8&@Q)+<7\Q$%0U(GE MFHRPU/`D=TG(*3@D-91?J3_,GD_]A%XE3WX4_C.?8%ZS_[(IU"U-7O@A>OI" MHPG]2M/T.HEGV;?.X^23S[S:0SGB7G.#:T$&N>>R(`*>)TSW6L"X/K&+=U@7 MQ):[2`=ACP"[4[&_^@]QPKK+_)36?%VZ<0/:BJ43URXN4U17NQ*X>IIMN=LE M-D:NN/=%#UQU8US2@.^;O)V,Q\.9(3I+)D^I,:^*:1X$CHL]E8;(074HF*1- M%/-$8F'+)>T*-I_HI/F"[JS(U9AO1&2.MWG+J!PI)L@5?("L\A:`2IB6^U&, MH>VA\GJN)M`SRB:-@S!O"U;\9,1'.+.F:4ZH8AYH`R3&0255KXY2PJ;"V[IL MMHJ,4'+*TW?.FSM16[%N#_A^$4?O@I!-:ZMO!:R$285#@*YM>Z98W^W@>1*/9@M]$_;2W%#R9!3T M,4[FT>T[_Y6R@6*6^'$2A)&?3"\R.DIUPD4:K>(JO`R;E6-;M.8=@M\\3_4* MX2J\'K20Y7K6!GEBGYCKVR<:TZW;@RF*VDD MU,N=+.E*F.:TRQUNKJD.=&KPFF"1D";WIW-]]32Q_!<-GYXS&IR\,%OZ1+]- M^-'>J\?\M.C5).-GJ_DRQB<_#0<\U!(.)ZQT8P(]T3?.C],*N"^^G?,=N"Y@ M(Q=!AU&(0Y!W0:RNQ.;U#>S M8G'0(:[C=+MLH14BUVA`Q=YSRR4(NIW$[S5H5FQNL5S7;@ZNA3"W!J^*H*:% M;-ARE+M%N21-HM@'@Q$08\IKCMYKM(OJ;*MG`Z\\$VT_>J]!M-S#0Z;\T.T\ M>J\F%`+YC-=U(.DZ>J]F$P+Y?-.U'-?M(GJO0Z#BV!1"`#BDM>B]#EER]X:Q M7QVV%'-'FW55K+>NT"A$KL.9P@M!Z%H$=1+` MUR%.<0+6(XYC=13!UR%/X2H-4XO@Y- M"G=9[#`&47P=0A1AT;(Z=A?%UR!,D76B+VXGVG@<7X-\1<**/JH+1[<=RM?A M7I5?SA;W3AL'\G58DWO47&7%O$G=!_)UZ!.=8VTDWW8($$<#6Q3)UVD82T-& M0MA0MOU0?O,C@AK++U"1,Z-/L.L`O!Q3:G1`<`7H]QP.@`CQ^U*IPU;A/Q9@B1M;IJ@DL``6`;^&C>V(H\(WEC M.\35$FYUH))&4&0>X8V`/=L(IX&MT'!.BN0D?3:CMBQQA7E-9D[#YZA2ET"/ M>.Z*R+OMU3KMHPCD0M=QO4)NWUTV);[/L="GAC&:0?X(K/^4C8V+:X5,V4+ M`$1DB(7:VX`J(U>UC\=VI-PV0EI,,M^<5T6ZG#X"R"XNW\?MCHF`ELZ'(KM-'R,%`KB`R0!T))&L1N6NT@%5<;6]? MGK>EPY7:1>XG%4U2`:%=Y+(&4*S)6K9'5"IEA+^4E]J`<\7I3XR0;>DXHCF" MMB#+R);[3KY\`Z4&TP1R*9&U`=&JHRP(>S:2=M-E&"U"EQ$N]Z>$QX1=J7:K MD?/T\W[ZG&_##VCP:?J=39LNHK>->R<,RHLA]8J$.7WB,)]F%Y=*-<&T+H:D M&12I=9#M>`Y$;4C!7AE0&N0;1OC=)E>/E_[@.8QH,A7OYS!H"<7.J\),2!-% MN^!E_&L?X31%[D_SU,EW\1F&R%T9 M?$U7X1.!=&7KHS@Z:EO`@4#9;2NPM"Z%K!D4&X?9[`^(Z=/,I="9ZRZV);_; MLHK;9[0:1^65B8>TAC]*;-V+*6L][>3B+4IXPV9YL\YX]2C>=]&\E11YA(I7 M:]15NR(\";N*=$*8]0UW-7Q?X^CICB:CF@L)#!A5;8&VW!K("BCM2R$C7I4` MW77$2^96$*/&G)V'D1\-5G00BKQ%?698"7:4IK4"2^M2R-I"E_L=7ZY=-E\&;2&W%T[/(^V\A+<:C`="")K$,7^+8L@#W8JB?Y%Q+@$7;&O M&5NN18BCPM[1[C:1E"60MHWU.QQ3[2<0JXGO)PQ>A'3^_\NU@-)B= MM1J-)YD_6QA?W$K"'&J^+^1DQ&=5!DTC^L::/?*.6]R)U`K4=`/7!NO7L8??:SW_8QJ;&M=(C41BO_;2'ZZ%']M7/K'CY?@\M79&/=2S< MA`8UP#4*+=,`^8"J4<_H0N;U[`%7I9UJ>KIZ9VR$QE9D1=8K@S/56VHB=/1$ M,?83S\CNB(W0T0#EIH)NI2X/.58^2UG.NG7/P-WGGQ9%0TPT<`B$)E4`J3@1 ML+A[A%FD[\:""]]^G^#^HG[`>8?X_13",^ M8KL>^M$EY:0W3DM0ZHT,+Y'\*1PN:":&WP?PD2?BD MCD>I[5*AU+:-NF(^^L;(PX6UWYDI@$'U$A"5XU M,2UR4@%YB95N,JJ[HA-N@,Y&,JW=1;1,,-+L^N10W`VP42FWQY[6D8HU286'-MI2>SJ?4TZR MYSCAJ\_?HX`FPB")SV'2PG=O.,S%E%3`,D5Z%./\?5\=NLR5%+WT%*U MR]656O&&COR0A^-XD#%A9$W\(=^UB!JO_"#V]X_7]A_X$KIG)18W+\Y:%%28 MY#974/6TPW*][A5T68:E9?G@?R=IMC@#$03YN7Q_R/<'741B`&6IU6_H7Y,P M#3,ZOQUE9I9OZ"!^BO*O5&R(TUA00(J4J<3#1-P0U#'^#?.EXZ`5NQ]+64;6 M3=CGT7@83^GBI6HU_Q;G!SU8S^?>B@%C(,3G_/J";W'V!\WFU2VE!)'V1OE6 M2US<_-$9X$*2_@;W#>7!DT]AOAK4/)$J4B2QM1S/==`BB;\IK"YEJU^U0HJ$ MMBY3_OP*EHW()GBMD^$P_L&#S?G*6)J?D%GE4B^DR(Y+'`LB?DE.=Y@WQHI, M'12)#;#G$;`SK##[RI<#V$#(0#_$$?)XLC2O`('=Y1KE5VF!99*=MO> M%MEE]D]CE*[(%\SL([0MBVRA<=<8V"@R"K.!#[`M$R.W6>NNTZRJ1/V>9UEV M2QUX2\R[CD(HCLP0RW:@AW>%EEH;IZ$AA=S$E3:.YZS:#AMG)+M$#0KICJOM M>V>RO\VB!H/):)+?82G+\%M_@.-]&E:=$;6P&E,F0'$U`K*AC8EPDK4#M)LE MI+0\I4C*[&&7%2%KY4/V738E'/II&CZ&@UD`]^UK?(/@R=7IQ;S"J\?W*F>W M[I@D,D>J=,Y+J6B[`[]QFF1V13N9Y7;P4Z^>9EJB?8F2,:BNI9,UKO8!K[5( M9Z0EQE<9($4NZC58@+792>-K%)`B[?6VL6/N2G4T1I%8N]E--%TYTA8HD.B# M(GUWHQMMMG]H5:<'\K&FRR9E6#S:^],,->N40I%#!D/B%DY&_32$H'OD5BG( M_[-W;4G1)"1QEB*U M).78Y]>?;H`428F2*)FR0`NI2J(+!30:'_J&1F/%.3%5T^OM]"TY+XXALPA9 M;D9J6J>!MW._3&^D0&AZ517V??!&"D2Q5Y1\%XX_Z]CK15"RW&(5V1LI,KFE MF)I">B,%YG9U#?N7[HT4@,B*LOFB<><)IG@1Q)1Y89R`WD@1/)1X\=PF'&#Q M]"1?**FRQ:I1\HMS\$8`/+W,WQ1W,I95\C]L@*O5C@[YK4_$XDID9="]Q-1# MNC565T;-E.!:F^),P:$H'S"J.+2^6]]8GI@8G194F^F*^$L(F*7U$B:&E\2\ MI6'HL)SD3:\ZT5<4[M?5>JO92&5'+^F\R+UI"\IZ%9%.2VP5A(&NS:!@6??S MTV]@ANS3[G?[\?D/?I#T-@0W`QGSB7H#WQ@/02\X\X=*5Y3PG[T!;B6-LX-: M8U_ND@8!J_H9P!-K[JK_^!;@!24!@\0`AYT^5#OEQ8=)8+O03?1,,,^/%5<" M-#0P63HI*)8POEVQC$FH@'/BPK%'MLLZVI1QA:V82K$LN[A*0]ER*Z>EU\`N M;KX(EI6,LL(E,+?`LM7E7;@_G:J^>?$0^H;G@\PT_,>A;M4O< M5$'CSI43W-QR7!=5?M:K8$UOR>,WI(H7561M-FHM]:J3/5B6%PREE<4 MPM)J3;6NKU4GL#1.EZ_,\]:`8I+GKT5<7SXH[72X>0UZ6Z7OZY7&.*-3K.5<1\WIKAD M3J\XZ*ZU.C6UT5A$MT7MXW//G&#K6&QR_2V;-G-3#O_\_>UL6^D^3N%#B^U! M.\9@@TZT@_=]&!/EO61:RQL*KU-PX5KGP,@-NL.R9O#IH=HXQ(37A4WG]?W1 M#DS#P2*?'^&3#8X"MFN\]VR_,\TN[ID3N&G?]8/W?];R>DXUF^[[@M6JOJ$# M.PBQXMB5,=J$X8V#]^=_79V>_4D^7YQ>]CZ?G=Y;8-+#GW9'[:CM=-["_L29OZ/U;-W4AQ4W@VBZWNBTLI?JK$-(V:-8Q,X5/E*C#CY2>:/X MZM,^A6\LAIBOAG_M,^UNLMT$T)Y9+)*W^OPGDQSV?EXB(2EY?.C[C8 M;K=5;1D4EW`Q)\=RC4DND-39:;0;Z7M[=;YHHFDY]QXMSMVL MJ47O/4*=N/&U1^N1O=I'JA4NR'ZH'NG/3??B,[6U8M7/.=V:MC'=<:CLG`:F M;[/*I_`P_BBX[H/.#<`X9X&V'E#_P0&XK3\%FG;P_E].>&+9]R0('QWZ[N#+ MZ*_B0WWLAP%?Z!0FZI;_?)P;\& MX0F9:>[L\N+TYOC."X>\I<./IU^ZEW\=SS1UPKZ[[?[O!>_J9&,R#HCAV`/W MW0%6O:$^(PII>@M$B4'@E(H[?/6)NM0W'$;BG7C$QMS$(Q5V_W'*3DZJ,1J? M_*(UU9/MDM^[^'?OL'MU?H%$@S!HV.X)*7=,YX^N8?Z7\%UO$U:G0KJN>:00 M`YJY-RP#%I<_]OC6"WD=#BGAHV_KNGH219:FGV@G;Q1B!_#C(;_/&G[-GB#A MT`CA']^;#(;$#@,23.X"V[(-'V,HMDNPY6\@74`R,1\E`)ER3QUO#*VY%H'1 M&`/X<,!A0PQS@J$Y]*&&7L`JWP:\D[%ONZ8]-ASG$5Y[][9%23`&^<33VJ%C M?T"QUR/2@S[/I@0FM&7IR%#J_70Y01[;C\)/7+J,*AS;5R,P+.H:,!_TP5C2 M\;2K1_S99P\8^`?^8[.*M8Q/%KT+&0%8T3=\),$T<1\X']]$20*PF\-#D`.C MZ++Y`UGMPYMDF\/O@PK,8?MCGVZ>&B!X[F$!Z_P=?L1`2Y\WR+ M^AA_B:'_T[;"X3$8^[^=$/;,H6,\>I/PN&\_4.OD@)C4<8*Q84(7['?X?FQ8 M5O1^VKX_?65-EUOZI9^\Q&[P7:*"UMFLXHANH-``63849"._*S`L"SA5$CTK== MPT5!"B.)-C8#,C3N8>%3ZJ+T&!MXM`W$##;B6^R>P9]V.(PE),AD^(:.L35C MNF)BF>T`M7W/A]^#Y+)'J?YL%SX?<26$@HJUB2K#=H/0GYB\QG_HD8_P&,%M M3/;8J1_:)L@E346HW=`!EFK`-FX/_WU$3AF-T+_SJ&!CC\3RB.N%D1P%3C@. M_H[WDR6@[WDA/`H$^S0ZT'?WN-XHD&-03H#!4`45XCX MM<+H-)+:\*Q!4'M(E$M-D'NH4+!+@_0-V\>)FJZYU/Q%P[:`,]!@,#&'F591 MJT''!K`(..$P-OBH?5`]$-?`"U^X:AL9?WL^*J>(>9&J>Q40RL_T\<8.3"\( M\1F?Y].!#,3DC2."%=@C;0[,!J?!6)@F2YL_6H'6E, MDF![3)2,L/1MA,&2>U+S>T+<(-O`3J$PM?#U$.;1!9R0+\8CJ6D*007&*$*M MIL!THKV%DX$+BTW1]CA46T1WZ1S2C]K+.01>[OH,8BLFH/FR%1H/+R&041WT^4L/'+I">+*F-2MN= M3[`:,X?WSV*9=0:P?,9J^NFC_SGCZKG]?GID0M+HY0TU84$-#4LHDJ M8H"OJ`Y0VQI1RP)P2Y((V5GU=E&B8GQBE6S'`X\8'IHK-S)"9#[%B6F]="=F MEF72?]GU`,[`;C-LYHK\M-9)D#&GN0%L@^UI,M.66='^#$[(3^@4-6>0:(*X'W`2 M0"?F].+=,],:LF=N9]`(AIB'!?]=@/-U;SAHZ20-/D5HM2LFM.X\ M,!"+2B[D&+/LV(L4[RJZW"LOK]*!X-AK#Y@_/[0'0Y!>C@V39$5A#F[0,[-_ MA.XV"_MR.SOEFX'X<,`>)QZ/&5C:7JOI[68I`TE]U77Q M2";,:U*WZ8)MG*3JIL&D<[,ARE?F)RM*42=ZU3::UU(G94972":VTLUN6DV+ MWAV"27:(9>^8%HOFBR1S65$U\)+T6,9HG=E\9)N7:5WV.@G&LD`K2`BV=PLX M=*W@#5-!8#VCRF`Z*%$UA-UQBDKNOQ,/S7L>I$7[V:11M`E_'0)&^)8$4XH& M"[M%#S-=R7Y@D0F/]N:UQJ)4@3T""/J9$6%$W:?9%ES//;RS>20K:@05.W6# M29`A#HQ^IH<]W_?N&`O8%H)W!ZN$):+'/P<%;I#7E[@;3O0W<;PP30=3U)GX MN)%9,`$NF&2C>%$3P>3N;VHR3\2B?6/BA,2W@_\EK-DVQW3>I88;/=&5"$NC78`^*/\8[`"'@CM]X&8[%ZY MSW9P?+"+P-:Q0P]L)3M,HXP@!7W/L3V^WP&_`37C8!P3B$K1RZ8`=R`9;?`. M1D1'"$7_,=[9`-0%K`GFQ*%/9_NL$V2PF_X`]$2TJV]1W'2/C@+&(5!D&C/+ MO,0L8W."VRGN=`__$0D:`5PC*+'',',!W"+0*M!1XD&.:#CTK"-R/O'C1U<$ MZ!66J3`V<$L,F9CTBMZHB8>&HGTU)`VQRI4N$OEK,PYV8RN1#9C>91D:`+MH MG/W9<+]^I,4_GS<0JR'?7I*`AJ\#+UHS?+$NS`F!N9Q+,XD!G&2GL)Q/*_K[M!R'H*UC1(,*`I#X[7\CW M4N:'$*!E%^UHH]"C^^(0^6PQ)I5W2 M36+&%GDF8C7%-_:*CU,]F$_B+ MQ,#>Y*?Y8QL7$]\;\\=/`]M(YRYNGM^?T8$I@N\-'P5IY$@Q>WN!1U)&!&+] M\$*Y.7[Y^99'P&?L.CL<)/'.<%B6,SH+DB`W]G=9 MB"`)G98:((C<3.E0%W"H$TE?=070RS63X\3L@.?\8XE"=KB*166C8'`<&P;1 MFPWV,NF4#B`E@A1LM,!S7>HPAX"Z`3?UDO1M[&5)$GG\(,APG*TD;=V=QJCC M[%=`@&?&!'H3/SH9ADBPHE$JA'L/C]%8XB=C`E(*`+G.$PCTOAU.(_M]WQO%LX\!R#M6J#*UIQ$!"+>(DH,3(!3] M0?1-M%,">`;R#*Z1TP=(HASA)+4:'9M((P^24"O?7T",(NR\`+''>$=CL;$+?PZI;]]\)Q> M=C]='5_2/K2;'1$.YWOWO/<9'U=_2R8PD@F\\P_7-^<7-X7IUUL@TX3I,\8!/2'7_W-Q\_'R^OLQ M0:4'_4^?[EU_S>OVIOOI<[K?E3'YF/\.L"(U5C\>Z.<+WJ*FCQ]2WUOQ]REN M$EXE(5X#O;\N82S\7%MVAECT#PPXF"*?31'Y<'KVQZ>;ZV]7Y\?DES[[,[>4 M3@@PH]<].[V,^X.Y#[U1].#WB-`6UG-B.Q7O#AK:;QE'>06XHCV(*HVPC`'. M8/D7GOU&M`1<0K-`K_UV@$L&0`XX;LSQHX<.=,(4[JPE[YG7EKP%]RUY`WZ< M!,E>@.0*5*S$R$88B;9KI=ZHT@CW1R2D[:4<$A=S2$M+#'V.71BMK!`2-F:# M!,K3@5*O$%`D$J3(D")CYT#9(NQR2`?J@_?TAG-5Q* MY=!*CHQLR\+X588C]9+%QNZ&MXE(V.;H?7LPK-+PU4K/O@2W!+<$=S6')\$M MP2W!+<$MP5U!!VV[,?\K/./(;RDG`;^F/*ZKNC.'J_"(JRG9GC:AXHNN$L`@]/PE/"

.Q]?3\_/NU:5>KQ9G,VW)+%[(G MSQG)'L_?8]=3A.%M(J!^+54NIZ4_B9E$#=:Z#J M2JO>5EHM7?B9E$#=:Z`V%$U7E4Y'`E4"56B@MA2]UE'JZEZK?H&]E/*PE["7L)>PE["7L)>POY% MPO[Y/#N]*=3^TUGJ1O5]=NU7+GMPR(GE35BUGMV'J4K,_"T:Q5J3+P(%NLK, M$Y9;8'*QR,4BM^'D8I&+I=S%(K<"Y6*1BT5N1XKAM`JS];C['`(1XA,B#&_9 M.DZ+GV<;_H[2NS$MX2WE4P2WOVV1L787@5/6&[W=3U"LV?A*>$I\#S)^$IX2GP_$EX2G@* M/'\5=5&$/I@F1/D,$9Q4$88GP!G:W0PK1RZ]UA2]75>:G?H;X>=-PE+PH]W; MA:K6;BJ=QB97DTB8OBR8"@/)U[K25%6EWE*E])2P%`>66K,!H-3W&I0"^QK; M/BJUXR(8(GB:.ST?*E:H1)3SH=NN^5=3X:]>DZB7J"\3]<(@_'4='*"Z7MN9 M5I<(EPC?+L(UM:9H.PQ%281+A&\9X4JMJ>Z]%!>XC,5V]X%$*&,A@G.^V_.3 MI62K[LOYR>=C5IY7UU2:>D>N%+E2GF.E",F8W&V'3D>I-SM['=^5"T,NC)S] MN!:XD,VFS&:02T,NC1G/LZ$WE':G\=*7!ONT[^&MN7P@&1)?]1B-5T#C#=+X M2GD54-_NOYJC*^GB+;;&.BGJU+X-#0!1\C;]&W@=4W9V>7%Z84A]_N7TYE/W*DMZ1_UM^H.SZ\O+TZ^W0(/I.8XQ#@#CUP#^ MCY?7WX\))H]O.]1F[<](L#8E+'"<:&:;N#=PD_H[3'](79S<;)6>M"#?"J@922^0`L`!7#&`<8*S/L>.+ M\9API*8IR1M=U1H2`_N`@=/)8!*$BV&P2=KH"X+!7I\-S],1/2\T''(:!#24 MI\$%.3!6HA]8Q?-D97I[%9I]"6X);@ENL52Z,&[(BX']7F2AY^MZF85>:-G+ M/"F9A8[BLJVT-%51FZI<+7*UR-6R?+746V!/JTI#;^WS:EF2#;B5_+5Y8F)Z MG3BO[<[S+>JSE+"H=S;*8\RN.R'LF4/'>/0FX7'??J#6R]V_H/74G]".@(6HMZ'EI,V?:$H$?AO#F MAO;?'7Q5.S]4[0?FA_0\M?&CQEXW#HAMP=089FA;/VIZ[>!]-/\QWZ:)?N,0 M$_'X]/"9(3-SJ/`/%'*+,TDR<"HE@7*:+WFD-S#O<&/:IHF"?T^"T.X_'N3" MJAIDWTY&(\.W_X]:I&^[!D#%<(CM]E&6(&(0!2;U74`;"8>P-":![=(@($&$ M'M('*#&LV.X$G_+&U&<_#8@=$`,>\!S'^QD<5Y1#8J;V;B$!ETLWF8&[K:2T MTB]#%&Z$SQ]7$HX%>BV=?MF83Z<;^I0F3!F!W!P&R7OJ6M1*WLXE[$J0[`-( MKD#%2HSL*%0I'#.DWG@Y(F&=\,$Z6?T5.[^Q,1LD4)X.E#T_X2&1($6&!(H4 M&8+L?V^0"K#["T.C*'(4_*,/,-&NX1!S$D`_U)<'Q>19&GF61H);T-F5X*[P M[$MP2W!+<%=S>!+<$MQ;F5Y!'+3MQORO:$C&1FA33(JB_KUM4N)'CMBN)E^$ M!#(1AE?1JYRW>U"R0O,GX2GA*?#\27A*>`H\?Q*>$IX"SU]%'0]AJB#D.2-" MU!82P?4487C5K]BR[2M/U7I+J>L[*RTD@2J!6JC*AM*JMY76[BH+2:!*H!8! M:D/1=%7I="10)5"%!FI+T6L=I:[NM>H7V$LISTG-OT5TQ[7:1/!1=UJT2JP@ MBRA%JYXE--/0]CHT(V$O82]A+V$O82]A+V$O8?\B82]P9<[M[C^)4)E3!-=^ MM[4&=YGY6[E:@SO-$Y9;8'*QR,4BM^'D8I&+I=S%(K<"Y6*1BT5N1XKAM`JS M];C['`(1XA,B#&_9.DZ+GV<;_H[2NS$MX2WE4`L^?A*>$I\#S5U$71>B#:4*4SQ#!215A>`*OOC!,@4+I]HTL"\Z$J@<09CW_S:GM<^U#X<2-8%GQK M]^M"U6XVK%;].4>3$$S7"Z:%@>1[QVI4JU9MMTK:DV!9'%C:C3J`TMEH4!8X MUGCMK5(K+H)1A$ASI?M#BY4J*N^>=6X<]Q"?6$^F6BOC`(?U^#`*CF MN"NSZH1P0OCK(MRNNI:]PE04(9P0_LH(M]Q&=>.U>('+6+SN/%`1RE@4(3A? M[?[)I:Q6W93]D[^/68NBNH;5<%HD*20IOT-2"LF8A=,.K995:[0V.K]+@D&" ML6`^;A="R$:#5C.0:)!HS$6>=:=N-5OU=1<-\VTWPE-STX[,D+C5-C2>`HT7 M2..6M:6%DMVM.W1-7_$16S,O>6Q0^S'F`*+IY2QC,*S[D5Z^O!W&-Q+T1N(,-;M M*!_2ML5M_"V(O)]?W[YY^X:QS_>UM*^UB'6NH7O:8?!8#!<7HONEGAT=( M356"N/Q]?-C^$V_/"W"*D<6*JSK5!MDO:=HC]_VD][D7M!!7V0,'9R7 M0*47!0$?:A"\,Y#([R=G?^\Q7+%JU&%>%]U]:Q9;3GYX$*",![(7?JF@8LEU M]5FY(`_P(]2*UV3D3_-NU)>\E*9P/2QK=G>)'``6H,0`Q@'&SAUV_."C*4=< MVYI>H,XB#&P"!O:37J+C^V'PG+6L:P2#C=ZPOLA&M*.8!RSUC39Y>J@(W7N% MX+2,F]R6&8*6:/0)W`1N`G>Q3'IA-G@N,MVTP;-`W2O`7I!B[Z1K6+5FTW): M*RM+3$@EI#X*J76KU=C%O4R%'\K-M*K+6RZYR*K25J879,MH07!)MS(YCN4X MMK7;6-E>=X(]P?ZWP]X%R+=M:J-*TD+20M+R:VFI[8(_7;7JSNXF2\OZ+U%\[,+"^06*AZ(3'TKM M!9%.E'C)^L-Z4=R.*@_(2CDZCE!2570C M?&8,Q++60=MVPW+=="?>>#4TXZ#M#""&*2!8%^2.<=:5(0>AY`&3(9`=)RB; MC,>,A_!-+)30,<.T'HNZ;)E4LMI.?8;$=Q:[Z4NOSVZ`UCAB'<&4&'+I`QU+ M?;/;F&7-`#[T@Y%A``\"LU;:@O[[AA(M/-`R/NN,F!X*3W:EQ\0_B1SB?6R8 M**_/-?P.+(L2!?*FN2]"8"Q'51>/=E@[-^*F/WYT$QH<='@`S#>L72H"&M:N M6YOM)+QB=OS]1(%V-V3$?25$R@;-1.A#;R:@=:L6`K>V4V+#,'#8#_V#/@][0A^'^7LDB,XP$/HE1JA1,B/T7%4.1'7P M`[@!*#E3-K)97IM1[$S&LWPZO_1&ZS0"S6L&B4\':3@S2"Q2#$@'!<&3N!\I M&8-3=RU8+P'G#54:*$70X`*,B-8)*)2X#PH27L][I@&4$RU!6V@6R)\"M"]H M_#Z'%CC-)& M9)X3\)30RW&?=S=,<\VPD-34JCMPF`C4&NC!H+"HF(/#"B,#OJZ.0#>@GKB1 M<=_-HN(VGB[$N^#J^U,,$?%H/7#<]ZY.CX@*UIU!I@0_,!RAP2_?0;'O' MG?-"91"`ZYTZGOABT##HBX.*>R4:W)WF0A+0WYZX_IF[:+$<6R""[Z!O"[S> M8=_!$G#F"^!^`+\!9[U$X\HZI#?N2V"O!HYG^Q$9)@%ZH>D9.P=U[HW2!?=9 MN`KCF<\!L.\3/7_Y"SU?#KR67N#R@$&"EI1%'H192N#C`^%+#T9\P(.A0EL#WYE&P'?88<=3 MT0!0!@$;]D<:7L>!E!Z\'U$S5/(:T-A#71`;Z;[[:JXPOH1`#H,[@-VX0PM? M/^W;E)`\-WB@HQQ+P$3`3<%$4$9&J,&#&H*6&BUHS_Q(F#B> MI\J'],:)B@Y`600P=D-DF4)-SKJ@9G+ORO42ASU*ADS+?X%;1]VN M\(PK^H./F&TM(!,U?,Q_BAQ+L'5$J,CZKS.E!'A)@B`;,>A0/V7+$)A!6FA% M'?@;S'>4"@%7"F0")-B+T0H!OJ(N(`T&;BIY$Y#ML'W-0`#!)T8=D5D=<D4HT81EL.WKW)64UXT!GE&/`:@,Z\^K)#[AS9>KG##OJ)Q?Z' MX^-_[+`_0'>`[GJ/)*,&&0">!B9KIL<#_RU"Y0H7A^.!_9`Z>$<*%"*T<<`5 M.%KL??8XV"PP&QCC@1[]`*1$\&*#*($Z,!(9$RZ`<<76!G'Z,YF_H"1\E0H.:9053SN:7IC*OI9XTI,L\)+S9C7 MW:K5L.>RU[H/O3"#GKT>C#[H";2F$-0#_>G.YLP.8@^6F\5W=JUF\R&:4F)T MTM'@<:5^"U(V]B/JQLO1@G6248=[/S7R$%HP*:@@R![OB\"H+,&]_IC]$TF` M(9P$3,'(FATFJ7/C9$V(RL8X&_U:C;IS9VX@LQF+0F<]"_+T/9"AU MK-*<-`01GA#H)&41*89^F#U%VP7X!5"@J>PD&EK6`*G++&+)-`DHH/^"CV6R M$$I<2Z`>4).8N$I#/`D*880)$'2KPLQ2P`U*R$$'_,DTWYW*`(J/8!`LHQ9` M$V8"L7%0BEG%7/2&&H8-4)XZ(M5.F63XV#?I86B=J%0BVHI?`WL.\"5`<]HL M!H4F`N M27AERS.R>[Z-CL8SR_OQ<9:"NT!/ZO'$M7+$@983>>K$H5Q,VN:KCH/`NJ:OBRO7J%8X'CYDO: MU>^6*,-E?5.FI.O[IMWBF"2"#9!)"<0LQ+&%G1]L_",8/LQOJHA*=L MR7I*I=22U<1]-AL(*"\'RH97S24DD,H@H)#*^*U.90$+;=<>66A[D?NY?\UE M8*:7NI':UAP319A<3Z?+GHZ5M:D^4X3N47%B*DY,X"9P$[C+UCT"-X&;P$W@ M)G"7,#I;7G7'A1'7XU9%9,5++-81/1F:33)1%S>7R(B*0JZJ&&XAJMD7I0;N M*]>[KUJV4[.:M2:AG="^]FBWK5;=M1HU.H>$T+[^:'=PHYWE$MH)[>N/]I;E M-AW+=5=VAD41P%Z0T&YYYS8L"NW.'EKD?G==^P9%]T7H'J6N*'5%X"9P$[C+ MUCT"-X&;P$W@)G`7)>PJS"GDBT*QOT(E>&!J_)BJ7&D`)K!`6"C2ND7\-BVB M])_MZO8FA^;KFX^TG*4I:FP*@,=I46:R^Z3.B]R]$J&;U'G9`5_@T.YU MI_#:_!:+Z&/%V2C4EH;EM):O>(CV!/L"?8$>X(]P9Y@3[`GV)<^NG,: MA9JXVT]/+523^3OALRZ0\Y2]LC24+(JM#FRL)$L,69CWWBL10" M-U"N^D"*(N0W'M08+LB>'R4=?/_J0;%$E?K",L_W\65-LX%-RW%:EONLHWI) M6$A8-DI8;->R:TVKX;1(6DA:2%K(M)"PD+"0:7F*M)AONU$8CSLR0^)6V]!X M"C1>((U;UI:&6*Z[=8>NZ2L^8FOF)4ML^4[#CXK#/\9X:/WTS9M%<8#V0N_5+!XE.R.*@O!6`ZRVWW!NE$01#=X:&@J`#H9#+B2 M_T)3@!;F]7G8$U@6ZY'+[;,5"ZPS,C]'H0CCNX?9E(,_O_`GEM6!5'^?&&,Q MVR/LSM_'A^T_\?:\=*D'(\V'&JS$&9B/[R=G M?^\QW#(/K3VHQ,;<0:N6H^19*4X/$"'4[Y\BF+&-NP\D.5]49:-P/?S]LQR% M8X'COJN@"`#(`GHM0E_XT\L??#2]<&V+0+(1(#F5 M(6%D55-CA6,&V8WU40E/R1O,<,C.:PSG#KLP4"H1$I[-!@+*RX'RG&-?266L M(Q)(91!02&64;KW5P=G)V<5DC)_+FAH^:F@\/#HXN]AO'Y_!K0D$%RJ`^./7 M:[.NN0Q,DKH;J6W-,5$DO$3)6`J]YK,8A>]>$=:JKMEVXQ*-/H&;P$W@+F?W M"-P$;@(W@9O`7<+H['5K-SQU-TQ']&08XGJ+E>^)*<*.J7+M,GP*`UZXUK+X MNP>?I!'MJF4[-:M9:Q+:">UKCW;;:M5=JU%K$-H)[6N/=L=JV`W+);03VM`F<)>M M>P1N`C>!F\!-X"Y*V%7H$Y[_"I7@@?Q7^*S'9:C3`$SH#Q80%.-46LQO@3KX M\)_MZO8FA^;KFX?:G,*<3TN_MII6K;%+F"?,;P[FJ88YH;YL1>][I3;Q>209X_',@H9][$@TT"$L6;=2&71GPR](/$A M&)0A4_`;X^%X]24=^ER$[E$&C$[6)'07`-UEKK]*IV(6I7LE`GPANT_JO,C= M*Q&Z29V7'?`%#NU>=PJOS6_94$58<38*-SFXIY36AJ6T5J_X"/8$>X(]P9Y@ M3[`GV!/L"?:EC^Z<1J$F[O8'41+&3$WF[X3/ND#&(T^-V>2,P$I59:F29*M8 MY4-)8I*0#9002C23T)#0D%DA"2$)(;-"9F4%$:[;*M3\Y8/58#8Y[U&N=-]: MJ-)",FB1LV%;S5;=JKLN20A)2(F[6';JFK_B(K9F7++'E.PT_*@[_ M&..A]=/+F6?&K,!AQ-L`1\H7ZDL%.)=1;!BX9U>K[SXQ<\]VP$=1$N]UY:WP M/U68)X)`#[DGPYYY#J^'W/>SZTG[:O+)GW0@_U%-/XXI_OPQT=L]SH=[EUY? M^$D@SKJY\-O,&Q_D@^]C$WN?1%JWL8VVN(V_!9'W\^O;-V_?,/9YW-P/"6B4 M\>@XC(42.CZ4V@LBG:CI(Q#5PX^W\87H?JF<5UM75?O*J=JU=E2M7[GF<[W" MI`]CRKU8^E>N6ZM\S?`U9MZ/_8L_C@&?,(3PE\E^.J1L;O"M]`N+72($V`Q< MQ\T=G!SM7^R!K/=GQ6BNJ4_S\G(/&9TH\!]!2TK*:10B1U04!'C$YIAS=S"U M!'*-'CD^/3Q"(JL[3EV"8G@V*RN,![(7?JE@N2O9'54>,)7EZ$"[+YCX)P$, M8W)ID.&9R?`:!B52FKU?\!U7@O5$*!0/@A$;]D=:>I*'K*>B9*ASI;[Z@@=Q MW\/[S<9RT`F:Q7T>8QJK"XJ<@:ST@#B@&KZ$9QC*(0]'*6.;CKW[2;,N:(5` MQG#7!ZPGY@D5<_BODXZ6ON3F<2PP/7V<25@/&:!*3-@[LPC=OS#M'VYH/TL>Z=CN$IKHRG1#827=A*>'\+G-,V7 M-J?'S61/1HKAFI5QOP(YD-CND*L8&*_[$AB-]V3?!Y)WD$XUE.X]E,L82/**:2=> MA>1OW/N)"CV\.]E05)+7PAIG%FP++48*>#4%/!N"A?&,>=/PM*G""4JZ(SR> M:&%.6AAR,)2HN(6ZEIZ8M`*/<+#"!4E.TF58L>)SG$L_2QE\YQ7+A`8DA.#`(,!)',__=/=,P,,P(MNE`B0\R*Q M2`)SZ>G[]"4XHA0`_AOVF"/3;"?$M@VEREUB*\X$B!?(`A09#KHOT`"7:FV"9$(% M?)$=3%D`]!06%"?)AZ?TO%C'`7Y-4&U5P\I?@8JQ"G"0^3CA?*6>K\D5N028 M%O$MJN@Y[:J2PD(KVVD"6E`&B\P?)9K'7_,J5K0A]+6EHRS$3&=D0C`B<`TO M25#_!EUT#=<$%OAIS:_.%-38*"9;`#@HU3DF/B</I\/G\@XA7HQCI`&E96DQB$M\*M,F%*!"6T"(G+4(R))ATDC!) M/A&/P$J$82<"0TX`M4Q3C1Y!FV2QL6Y#CN#Y<4CZDC^2X[J\(]S.G^?OKW_# MQTU/N3JPI;<&K<+MKGZ1R3?&]SF(*A/D;[R[^/CQ[/(*EHELP)L)]M:Y^,\O MGS]\O/CSC8.LDBXC3*__XK3J[B'_X4X#6\,???C&7A\5T.4SM*]?/B!RY4U` M[V3#-45KM\.7C^FL!0@&!@@ZO7\?(,D`D@,>'R]6S$2V60!%LLWB,_'/XB,P MTN(#<-2F(LE@PTBR\QO<<2KX!"J#)8)'X3)3PD#*1$$&V3 M8W06P(6F1(,PX=%@V!%*V.;^]YY0>@U"E)VG!(OJ5B9LGR?N^_[WGE#V7"98 MJZDAQ_V_\!BT)6Q+>[1/>^0U:$K8DO-LGO/,; MM"1L2=A6CGJ$7Z"(L&6!XT^\9,S$(XZ]2:G5M=_>8W#ZOF4$:EHCX$$,JN\. M3D_<0:?^%3->7/Y:.K1T^&)T>$*U.-HG[9T\R08AJJ7#O:;#3L=MMX_=?O\Q M5WGU/\H&8:HEQ/TFQ+9[T@)"/*U_=:K=MYN?]S[]+,][V]91WWM_MB!]_8*P M:U1Q_D$['T3==[NGIVZO98G:$K4EZATAZO:Q M>XJ-^(X[M4=[2]66JBU5WX^J>T#1`[=]6O].@;OO87C>FWFL%:5*[=3>FV0[ M`]C.`-ON#."V>@.WUSFN/;$T4]VQO,#R@EH":]D]C#OHG;B#P=9,'\L++"^P MO*`6O*#OMCLM]_34\@++"RPOV&]>,'`[7;SHV&L;H2;.DQ<*S\`:UIB3XHVW MYD5IA*/X63GD1M*9S!76"4(U:=T<\M=P0]QW)WH\?4R_4+Q$ZA&;8&Q+:`R[ON#3U1=-DN>M09'>?P M1WQ_O*1R2;DI7FFZO!\@]@STOJKNV['NXU>:(6$^XS54=M]S\[YJ>9-$U>\>@"WR;ZIEVY%S5FJ'6G1=C;.$&AT6G0-EP]<1,&[GFGWS MA',;)U]9(E[1(;!(R/ZM?NCQ::F!ZCB^84E4M'),LE!UEDO8.`L]=>02(G+H M]PP;ET]5P]D_Y41&[T M]HU/`W3.)2`FL9@A@P($P05RG\\0WP"XGG[+7=6^%MO8WP(J8Q?; M,8NP:2[`A.!YU]HD3(NW*P!5,^?D9ALV;FD#'X`&U5EY"1=(JK++)N`+'A2? MSD*&6)VW.K[KY#4J$AK'&6%4?MR*TGBD^XVJA_+VHUDR+K=E1>QFP`V`$R6, M3X=9@JQX!O]D2/YJF6<^L%3G'3Y\'AU>JM%^TT3P@3'GUXQC#]>(.;`[0&S/ M.1AY/%%4[8DX0D7G@-K$$FLJ>C%'BC7@3",8:IP/Q04U1_5F,U`%\/TCYRI% M,@,X_NXE\`ZUE6R=N`:KN(LYX//FCO)M7!2`PE6?YU#\X/D\Y.F\O%'AO,9) M#593_%1B.-A<>PI@'HV0-=_`)OZ(`LGZA3F>W$1^#%.S&ZSLD2O;8DLZ1Z#, MJ5GG!/MMBI0D6)2&V!@VGJ5*4N2S.K]32]ZD.@.*!."Y]/`(>$694$M? MA$!4&1N0P-AYC)QU"6:A$L%M9]IM;:!!2[V:Q%D(.A`U7W]Y]+C(.H"?1=8*?$WD"3P8%Q$M#]\.>9R;=S2M2L]:QEP2: M#XDTGAV&J*/[GB"5,Z+?A@S6)6$!#!P@<#$:81]L&.PL`,+F`O04XE*_,1"4 MV/?;!,S5Q=EO)F1 MC>H;BK_REC3W(O&#"C8=1(`/BG@$THYDHT2XR@$H%5$^`[JLQ%Z?):F'1QJ!,D#6EX^-S$%@NE);B`K\ M:'>E=)78AT@/B(*+Q6.C,4NLF11:A'Z"THT`42C*L+XA,W4,>':C)S3H+S^A M3)"Q"5OS@0G`2$`)7A;PM+`@Y5HC4V^"$Q1X')(\\EU,80A22>((Y"S:H;B/ MD*$1]:]-;J?7(UHV]0[7I!* M$)E?LF\IJ$.(FP6KN%2B&Q^0N\Y1]Q6$6U@L'LFRYM\2Z"9$`AH'$>Z6_(I/`]X"+ M*N3#=1X.YX>TWA(5DJ:]=EE3QE*EGP"U10'L!8UC("9E^>;VZ7*ZB&?``A!_ MD*VN8HL`4%KUQ(.]$=\U]Y7S?-"5?*86(P>@%Z1612_=<':+RE%"AQ84EB`8 M!H>P)YA+[Z+ZQ/+U2Z<*+:["H#]ZM\Y?68!D4Z7]7!,%A@.R*>'(Z MIP,/6`0\G\XH(0YZ*H%F0D,+ M'<$IBCO!:IA8!4""Y["%7N(^P%HK95=Z$F?CB?.[API\N^\NT=RD.`#1#U@# MVG.(5@F7N.C=HN!2&)33L/(>H9XFI+@F7H'LWG5F82:DW@E&ADNN3&3GW\B3 M#F-O5&MKGU118 M-!7REP4,4_(EWRL:&[A+7-(SXTWU2D7)ER4*F@02@$9]7@E35['^WS.ZGSK/ MZ4S+57J4=,9\QR..=I46]T1H92E3,?,$8Z00>`H;"->D.F2Z037\$?)5J$LA M6AEW%*O!1MX-Z%FPU=)>M&C2.\&#HDU+35.MY1E)K7?464IK2.E^F`72,\Y0 ML91.OYS_:)DG->,-:/;+#8X5!E+YN7')-N09QL)\B/:2F_?:9EBAT0-MH,]*KTV^)LJJ(VA=Z$]A M@>$.4Z8?S64@#5EAN#2T^D@3F>C7A;QFE<`9(Z;.]:P277,O`3P%A@D"G/F9 MZ>)8#8BC0OVXB)S_R2+F'*.?`KT5=X"PS#05]UIN^BQHRQ,6:A='A;AN/?+0 MJUD`HU/I)S`<@(K``HD<9?]0B,N00CYGS/"+1&`O*OU8IGI7H*H]1JI+L*%E&X-]N],C+K*WUS-$E'GN\G M&0DIR69@;`PW@66^"-JGQU#!(.(6PNH63V%?/FS(N59>KSH6E.$"[[3F(%]HN_DE<+^UX*``./N9(/_P,$8_ M+A#E9CFMVQL%;43<(3+5@&=:0_?H9*4K)&=+,V^.D18$3PVND'M#C(WA MTKG+A9+)3)A\+C,[U;,,6Q=\2S&;@Y$C!YDD7&WHST1\XKOJAHN]KZTYPMCSWBYX*44 M'Z1'J/J0\)4ID.IPE;%9-N+IMSZ-LJWX@0\%`BQX9B0Z_7*(Y M5&U)%WUNL%%Y4][3!FA)E2?@>!1A15Q$N>!RK"]\;_>(::534+>])5Q4AG19 M(Y]Z7UG.12MZL/-:.1L%AJ4ICB(M!WA&(&*GN<>X!(7ORK`'KC"+B]M*GCL[ M2[!IMS5P3.V+TW6%:64"8N!1\=+U*(V*7)P4604Z^:18I!#$'>G$CM6-J7DG M-@9XR5W%LUF`L_AZ-#NH^`"9#B`)Y%Y%`XEX%.6NFM*H4& ML\3(`ODZHJ`.8X`S#]-)[OPPCA(73ZBT$'9MK#AB8S`')*>4$5H5P3%BMQ3A M2!I\18(@']:23WJS@Y@`'U?0\IPB%(U[-TVI*HY)W_&K](955WCJ.,8D<,T0 MK7;?:K';TV*9IIM"V>1(9T+$/O=,PUNPY419-HES6S`>1_R_A%@^!K&R_(YN M>8J,EU(XV*4G0*9$&`&K0I(WKHVVW$Z_YYZ>5E-6I$)?,?K:Q'$VNX#>J7M2 M">;2LY,[1*[@;U`-4[JU0N9VEHW1X]K-1#$[=_DEW6S#L M'KO]7N>),%0X]ZN7A"HXG%!.9_(@I_9#H`0^XO(*`*U\F(U':!E@;*KDO16M M@:PMC&(K48&R,=@WU'A0*LDX<4E]HM!EA([_)T6M"DK+*K<658UQ/"KFM%"= ME!HB;^VF0PS^CY-YD80QEF:^BM:V4-,#_EA2#%FN\WT?R^@_+8P1 MB?Q<$FO\P1'PY4KN5![`)&-225;C>L!P%7P8ZK`=I4'G^K`G_=TL1#PMKF,F M*A%!7;XLR9$0AA))!@*I1IF\!P6)3_O;I.9R=O6NFNYC MW`D4-J:*EH1=R(!!J3`%;Y2]7KE*-8*PER1=&#'913;F.:78#%9X/[.(;JAE M#HF*V"92)L"K.R45NNOI6,I1Z;7"I#:XQ*)BSFD=DKO"'QUY.IN-0AB<+G5_ M&W$3"Y>S:Z(#,"9L`OMGT5BIS,!.@<323(HP;CJZ0C`1:!L8"HY$!4QZG'EC M5K71%.!!&"["7@?WA^CVH,MT7I@`K5.]$_5P*98BE07^:]A4P2[<4 M!YI-18FGMM&'\K;K\2 MVSG"I'J!%CUFE3TFQ-1T9B@<4DD"Z@PDI(K\OB*S`16.4BZ@2GSAB>%,+ODN M%#^7H6\Q(H_D!$DU:I_)_,3UK(T2%4W^E@??TVC&RXSL7UH/*%2:2'7*#V;< MF,DR^$&OG6*M3Y'/D&;F5E-(\ MQL](^4SC^*LZK"/G2L?EWP/]%WFO&0!\X7VK0@(-40J:"PD"'1DBX+-%`;5 M]0CD2:;EV-E.(;"BPDNE%!;T=^4^&YJ&9!HJ$5TM:Y9!?QF*J1OJ5"FEJ]WA M$^F^#.+;2,??RN3=/*^7I9,XB,-X/"^Y_TD2W%LU*^NAN:=WEA$<@454+G?- M2(]5D@LA0\E`"C8`)97;8H8/FPS9F*%TT2`-PERM(.0O5#QT[:X+J-1Q`$9> M#*FYJ#EAM6B*A,@))$$5?B=%?8L"=-']W3%[2LC]WF2RHL"_'F&-6C*U],8=:+< MZ2"]$/U0]BT!0MEM8@)#78*7G#RMDT7/#$ZVPH>^@]SP+4U8 MD+/)K\]@J=,X0K10$E3EWAGZCAIZ7QI@35["B^3VJ@O MY%3JGD`IB;=GP"AG(&]],@W1_$I3-IW1;;4!Y#1G5TY.VIM(N`AXX8:#DJ#D7DA$A*:AWP.N,\BRI3,+&+!&EK+!O/IM)[BF- M0C#_8A^8G65<=2N&YYEE"HFK&0SN!8KBH5]*+T$;6'B5C8\/#1_PBHLS])&7 MV'6@V;66ONYCZNYU6W4NC]=0'&P\$9TM579UX(ZL2ZA_$.7Z8F;MGI(->J;* M60R]D#!:3+#F`UJ,&'7CC:4&+-W-8J7=0FNQ$!8BWI;Y-_Y^0FI)I`%X1E]AI!!23YLXJ%21Q81C*[TR`F1 M)WD9DYCC4BXM^;Y!#V)+>3WI1:#$I<5WU.&AQY!!&)EE= MOEXV.M\X:GTRTA;O2X6LQ"FU$GF)&9>WH`10- MHH*4AV@`3J1>YPD5PR"#.DKBD(KX`%KQ(".'5;X769Q+QQM86MHB+8UBGZ+K M>5%7=HCE`-%)P36[EL$#VD^0,%.'-FP%+)_YS4$?9CS#"Q=Y2^)AY9D$/A5Z M>%D?DK'=6*0'582J9U.%`%=JO(DE%_AD&`A9P439`A1HJ`+5R7U1TIX2T/#' MII=HR312$5/R@R8U/+WP-5I5RD0RG;SR-8R<5NGOO!3])+,P"F.,%"L=)U': MOZT;LA9]C:HMVK6&0">5<\ADJ"\Y]2531O1F(W2S$].5<>8RR&$I\GD8^$LL MJ^HROS)NUJ0&K.\8%U4=>)='?U%8KBHH6W8IXHIYQ%$VA'F,P+)[`GQ0E98Q MM.+2-2"9O\I:1O>?\0.&9TL-O(QAE0@%J6"1UJ0(4^:YR]!>&#K+BFJ&`FY@U:I+JWM5*GRX"F_:K=:_WSKTS&'HS4$O>#/BWUCP]L#Q61B*F>?#B=-[ M^'F&0).?\_&3_*\@=^:9?R;%G[H]P@_?!W/.WWR6;MC/4I3CYJ^!XGX.8__K M3__\QS__X3@_9.)P['FS-^<1UE*!C;_G`N]3`#SYLS)%Y%OZF8U^/+ALG7YI MM;_@'>!UW.I_Z=+?_0.'!S\>?`#6S8,OW>[QP4\51O5HWN)L-+AOPRH&+&J( M?VCPX(L"HRF(WG/D6NEE)-LD MOA6Y?2M11CDG]-00+T`(Y8=H3Y2 M^ZGRCG`[?YZ_O_X-'S?[7*D#6]KTJU6T'5>_?/SEPW7I^QQ$E0GR-]Y=?/QX M=GD%RT3CP9L)]M:Y^,\OGS]\O/CSC8,>=&K*93;M6IQ6M0[+?[B32VKX8R48 M8Z^/ZOXM;_)KU,]K6?_O!_=WJ_4.G[&!7;M`KMJ!8&"`H-/[]P&2#"`YX/'Q M`CRND6T60)%LL_A,_+/X"(RT^``<"CZ!RF")X%$X8G9B MM(*Q(3O<'Y:PK(NKL<35!-$V.49G`5QH2C0($QX-AAVAA&WN?^\)I=<@1-EY M2K"H;F7"]GGBON]_[PEESV6"M9H:.?S"_RZ M)`7O$22[?WK$;M*^'BR8EN79^_?GW_Z5.*V>_#?27LG3[)!B&KI<*_I ML--QV^UCM]]_S%5>_8^R09AJ"7&_";'MGK2`$$]/=_(HFV4W/^]]>IXAN35K M^=[[>Q&F]+`PFIH=\,L#X/DXW`:ALH3#]=Q!O^UVML?@ZG7HEJAW^WSW@ZC[ M;O?TU.VU+%%;HK9$O2-$W3YV3T_[;O^X4WNTMU1MJ=I2]?VHN@<4/7#;I]W: MH_WN>QB>]V;^$Y6!IE([M?P.UUCFM/+,U4=RPOL+R@EL!:=@_C#GHG[F"P-=/'\@++"RPOJ`4O MZ+OM3LL]/;6\P/("RPOVFQ<,W$X7+SKVVD:HB?/DA<(SC.Y#M?>8[2R'W$@Z MD[G".D&H1J[DQX-M673W;EX<_;OVN[)LP+*!^K"!XZTI2Y8-6#9@V4!-V,!@ M4'N"L6S`LH&Z0&A7V<#QCK(!^C"*HU2OO[2R5Y5>/:_<5P*[`KU:6$XQ\O$L'*Q"5+KB;>T]H=GM2U"]GC M&U+EJQ!I$D=C_(@10^>1CQU\7W\$\'^'SB_L_3F-(X=@2(=6O+"`9AO8T8;[ M;LFE-:GC8;ZTYV$GR[JSS1(FF.S8RJB/=);F3=.'GE"=I`,>9M@\D2L4"7,4 M\26*"$01QTO3A`^S=$G;WB8T:GLIA)'2QG9FV[W.;&9=Z?ZN%`A;N3B2V,9E^UZ"W\J-W60)MDF-;=*R;439\R8M%A,LR["( M8EG&BRJ5-8OX7*92_KS@W$.GWH)/;]%O5[=XUSTIG%>7,O5KKB=KN?U-5ZFW MR%VGT[7(W>#3M\AMD=LB=S.W9Y';(O>S'.]S&E\Z?D[>C[>[6ZO/M,P@^Y1- M6>*E<;(UDZM>@:7-"@.L`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`"K*Z/3>]_/_O\Z_DG;$Z?8H-Z.:)\P:D,Z,HO7.<* M5ZY`N1I^]5NQXX5\'/UX\%(@63)7STY9 M.L$S^"V^93"YBW#C*<[G`80/]1SNJAGQZ_*L\&H4T[;#+""H/1)"1\Y5:>!; MGD[RHW%F"?\4(>J%C0">2*71%21+VD= M^GG3.(MPO8`!WFR6Q-_XU$M9.-\H@W<&)SVWI9P3.:-7*(!NP(U.UG9;[>[* MZ32Y1H`_#F!\.@%@1PB_W[VYTVV[#O;(I55A#U07*%3,`"D`/<+YDH3U91]( M1R!^,XP38#`_'H!85ELCZ?RFW6K]^ZU#SQR&WASXR9L1_\:"MP>.ST+LRNK# MV=-[^'GF!8'ZG(^?Y'\%N1`U_TR*/[4(_^'[3!R./6_VYACZBO$H,^B0'&Y:YPD'X;X$7SX MS$8_'ERV3K^TVE\0G-=QJ_^E2W_W#QP>P%$#T^+!EV[W]."GBG1ZM$!QZBSL MEJ-.3==Y#90RBL,POB4^2S@]`XH`AB26\9KA`SW["X4B<,QW,*87S1>]_C4% MT@NHA5+I_T@61GD+N/X_S]]?_X:/F^:,!.ER.ZY59-"I7^0]D?%]#I/*!/D; M[RX^?CR[O()E^H`@WDR`,7(!5LJ'CQ=_OG%NN.!D>YFVV>*TRL^>_W`G^].J M(AI;QEX?=7M6NV;5R^[*GA0V6[L=[D]C]I4@Z'3-SNO]!7A<3Q+&"J!(%:7X M3+I*\1&4EN(#:"\62?8"23Z!]FIQ9$M1%[4#AI4;N\,2'E+PH`2AMLDQ.HLU M5<'B:A`F/!H,%E&>CBB]!B&*Q03+,BS+V#JB[#G+>,Y0W@>`XJ53.*EA1VVB M=>L0TUV'[3U#4;$:9*]OM718@T[?(K=%;HO16Z+W!:Y+7);Y*Z+\57K M@J:?LBE+;#G3&FSO19+#:Q!IWS#N9-'3HJ=%S]IOSZ*G1<\:;\^BIT7/K9L> M-2OGN=#R;Y\-T#IL[S%,ZKY9P#M17VF+I;7!TMI@I&QA=[S?S8CJ ML#V+E"924ONXX^/MM7*V:&G1<@$M=>NV_EZC98W-C>>]Z?C(A'CCH-'Q6EH= MW\G8LVKZ:!1'5`DA#D-,6.488,A$NL\FZF.#5'?0Q_(P`-2H3.2#>&6W8]'= MHOO>H/OVC'J+[KN)[K5![=?][EX7HK/(O_G MD>?_[?S&O#"=^%13[CSRE]3>VA_#OV$]4C88XMNX'@!;#0C&6Z[CMJ442RDO M02FU!,S*F[;>]JJ=6\*PA+%UP*R^[1NT!Y8T+&E8TEAVX[C?\1E[FUOUGD7Q ME$:)^3!IV_16^+WA:]F[H]B]X6O2UZ6_2VZ%U?XZMF M=X2+E09U!ZF5?;CVV4AOF/^J3A"HT3W@PR[ZNN[QH.>VC@<6\2WB[Q/B]]Q> M^\0][AQ;Q+>(OT^(WW5/6AVWU^U:Q+>(OT^(#QR_VW;;^\WQ:VP+/N]%W*(M MN+ZEI+VMVQI[W*K/K'&!HMOUL+6.5(-D2RF64FH4]+-=JG@-9-'9Z[P42Q>6 M+I;216=[X=.6+BQ=U``RR^FBW=YKNC#MTN\IA:_X6'I'#XL@H4R_89P$+*&F M[@I`M)@WLLL\/7,8>O,X2]^,^#<6O+VS.7P^?I+_%>B_OC?_3(H_]8I_^#X3 MAV//F[VY\BR9'Z5PH_Y4PZ6IX$/G]GHQX/+UNF75OL+ML^[CEO] M+UWZNW_@\.#'@P^>G_+@2[?7.OA)'8N&T^]GGW\]AV.%LX;_E-4AS]ZY)HSY M!!CS&3'&E5^XSA5+^,@IG;(>[MW'7\X^OP'ZF)2QKS+4VRJ:K5C&,`Z#>ZSE MP/%"/HY^//@K$RD?S6EI&F@.06T!B3:P:"+"\T_O?\&E@E3KP8^SE$V'+'$`([NNXPEGYB6I$X\..$R;]N>3J! MWT;`QN`M-IV%\9PQUTDGS'D73V=>-'<2YC-^PP*"Q0@H00.CQ/1>55;\RGTE M<*VO%CB=1.=VI^^VE#6+@]*7.D)@E#N'$*/PL[F@6<)N>)R)<.YP(3)861H[ M$SX]%[H3-G'L&[MYCK_'3$4:2_`[AYEHWA"P(4 MP?ALEO`0/_9=9\@I&F0IB@I]&AYR>'E<`CV)"BGH&"?`O5@B\*P\)_1N'9%Q M0.X)O#F\J=^K'*<)V25U#1JC M*BW7<:J:T'O@;F$,SX%*A<3#(N&E/(X^L]`#=OH.F*70^A4++KTY$>M35*;V M'JE,!'M%>29T&\_IF[\!6&F&?_R?DNMMJ=9B-1/`<*!^YS+T(MI=EI-9`_?9 M](-JT%)!+75`3,YBD:LMZ['+>2V/YZ33:;VEIPCG]'?MM]^!YHM:KP"!&XUA MP*BDY0Q128YO.&E5)-;UZ/`.!YU*:_H"5801]T$1<)%EBRQ,/52ZY-4M:$MI MG,A/\":+0)FFB%Z8;(K?!.PF3NDC!^UZR$.>VH/W@IGF`D>X3/48QX41,&.G/,4]XI%84$M@65,O!3^!U]IB`Y1RY]P M=B,5'!`Z3*J3N.*'[;-B:-`VX"&1#07`TDODWAR0R-1'/1H?PCJG!GC1R)CP M\<0)83DA#3AC"9I7'CQ#`V91)C*P&]@(OH;!TTD29_`&3CQ.8%'X4C&B4M]F M*!U@[5$<'8(-$O(19T'U1_D1]3;FVSA$D*,92,O/`$<2`F5. M-4?.&;WTNS=WNFU7F1SI1%H54P]LAHTNO]-?O7;`2,!69;1F,]@#^\82GTN^ M8`3&%V>Z<>NAW7,':Y9X.^'^Q/$!RXV5+D+5\49H!H\!K6"U@,M`0<20Y"CJ M15R\CP<3LJ"B,C=)_.1+(X'?0>>SU0;JM8$&+=7@HJ^$LP2;G-<']"W^??"= MDN0P"7(ZQ1>(LF)D8I(+'@ZE!2ZY-\G(*?"[H1(ITD7&8"T<+=-[2464-/K! MU2(2F6]%0E;E1/!,F]Y'X2V70* M]/A?/+Q)!0O1Y7(C576D"_P]`LW;`7)))ZA^(R:;:.>\)CQPO"EZTX5TBL>9 M@#,6WRT&;V[J/.1-Z$>Z=BT?$)[.G^?OKW_#Q\T[7K7YI9?;K:*LD/I%!L\: MW^0!M;?51$L4_&U]A[<=A_,O0\L*"`RYG,%,=GALGW]/S%K.P0_T7I M&^8SEPDHK\4CERPI/A!&[3="/6?ZR0-`L;E,HV6BXJ+0/5VM02NUI;>M&*]Z MI9QM/[5J@\4OGZO*2I,+B)^>]AN#"CN*Z5LL\[H'"-XY:I_4'@4:FD=:&YOO M5^D3V]8YUT%AJ\/V7IQ1URA9\T%,26VZW[9GNF\4:5&VR2A;$VGZO&:Q=I=L M39Y:&WCGY.GSEHS9/G.J[YGN.$5:E&TRRM9$GCZO=?K+MQFE@\5)'M%6>QVJ MAG=5.Z-$[G27W\Z>Y\?787L[)(2?%UM[1YVMU5.N`[+61/R^X"VO&9E6>\6K MCE5%]^\6N#8%!+=ZCS8XJ7](1#/%>KW804U1^4&XVCXZ[M3^-+=3HVE30>0T MM(XA7UA,0X+JFYX5\.%^`?B838$A;3H!A$IK1'$EM4(G900RC\4;CQ,V]E*& M^;,)C[`HLUG'H_*VF<;A+:2>Y$O`?-Q_'6X:$36.C,,(<4=A?$MY9]X,I4Z3V^A!YZCMH^ECAKES!C9,CRB;&B9/BVKG^')7$.'PGYB)D3OEG.W^\H"&59>#,2B63E'YM)M$GO MT,#L1+"+B43F!CN=7=_AGF;/F"#H#!QSO`ZWV'>C2R#]7*H?S8VV7(_><5#W,`/ M826?,BP87``M'I4!J%,M&Y>@^UB`691Z*DK=*[WW,Q4P094E?^H=F+&)YZ>9 M%YI/?@0;N7CH-5;.$X^)3K#,:^^56E_&T]E%[ M:[TLZQNML3/A"[N%K)V^Q56+J\W`U>.C^O=>B46U?E&K5E9@;5&^'YW:PD%%M\MOK\XOA\?M2V^6WS? M&WSOM>J/[[NOGS^KS_DZ3N5]^^9T]-J8EPUR&=@T89LFO(TTX65DTX0T84LO MEE[J0B_'1UU++Y9>++WME.9G_IG6=)\]?K?6):Y=(\U`:FGBX# MLSYMB5[/!L*Z[>\^S^EB!>DD8?>K5F"V)_7CZ8Q%0J96LV_X-W,\(6+L5HV) MTCR=K&P.7LZ_OO6$\Z]-$\FFQNJ=NMU>NX0S903BL'W/GV#G;1X'1\Z#:T#L M(U3;O1.WU>D^`*R8XI^B>\/)HH3Y\3CB_UT%,&JN:R3U5UJ6+E;#V#BLNMV% M[JNRCH!NE%ILP<6MCEG$$B]TG?B&)A-P?`O:'.N&_O3$#/QT_ROX)\9>:?2?&G%I$_?)^) MP['GS=Z\Y\(/8Y$E[&+TSCC.S[+DPKM8I(*";']&$KGTYE,6I>*:?4M_#N%< M?_KG/_[Y#\?Y00]WY4]8D(4P6/&2.>P5(H-*NCR3O5/GU[BJ?$1LGYS"A\]L M]./!9>OT2ZO]!4GU.F[UOW3I[_Z!PP-`$6R^&GSI]CH'/U4$R:-YOW/00+G4 M0'7!]MDM='3;9W>]N5*+T'O;9WVSVZS+ MXSJXMG?,;VW[[-9R>[;/[G,BN.VS6PM!_KPVG^VS6XOM[5".V`:/M)9-UNI[ MICM.D19EFXRR-9&FML]ND^5I'=3"VML`#6-.]3W3':=(B[)-1MF:R-/GM4YM MGUV;<6G[[-8)NYLIA.M%O+M@U-H^N[40O[;/;OV$L$UPVM\$)]MGMY;;VR&Q M;OOLUB$;KSG)$4_/9GAP?@1%E9YEZ23&2/C@CP@`8TQS&7J1^'FN?>443OC9 MB\9/RI_HVOR)9N=/V)ZKMN>J[;G:P*P2VX]EIW:XIYD4MN>J10';<]7V7'T4 MLMB>JWO`*VS/U1<"F$4IVW/5,J]F8)KMN6I[KNZ:!6QM_,9OT/9JS9/90\#$VS/U5INS^*J[;EJ<77'<-7V7*V#3KNY6/W:Z[2;VZKM MN;HYO^3.Y&7L6T\^VW/5XOL^X;OMN6KQ?9_PW?9;,]52R^67FS/59OE_6PYV=4L\+,`,TAE)[WX#+:#PWCAI<># M\^B=-^-@U-"LP^I:/K._,RYXRJY8<@/S7%*#QL^RGR$^\!\OS%@E![R[)`>\ M5\D!A\\9C$!O_''U_L`)F,\!/P7"^:?>:;?7+B#VW.O?,KSNDS/?7PNO=N^D MU>EN#V#+$?DL21`M<1D_SQ>:.I[=>DF@P66=W'^)8E\B\^Y>E] M8/&%'K^(V.\,X^`S@:O:,`<^^\9%!>8G9<+],F/)%QK?Q,T.D/!1^T[DW`RP MZGDPU[?QRQ[,Z;T/YN1X!PY&9G]D9%"7E\JZMQY1.V3D^<_HD58U?:( M7IR*NG<>4:_5KLT1+5@+CYQVD6AU%JS*?9UX.,H5\[.$.M:C2;:6U7WP>$)F_'DT M@V5\9#9[_^1N'927^9$Z/+P'9\7J/3FMPT,>TJN_,T]D"0LNHL\X7`+C`G9P4:Z-^'"#N3^PE0J;5A^O M7*E0U:4KZA7&6>*,>.1%/O="QR-D4L4%.2D,CL3O M17/IOC[IM`=O!8#%2\EGA+4-B^%GL2"?F>.ES@@0V+DA[Q]^`<,J3'6&B*I+ MZR(*-D[8F,HB>M,8MP/S>[-9$L\2#E\[(=*B<&YY.E&K,Z:9:(I]TX"CE$NS MM0UM;<--7,\>=W,>Q7P'3XB/N>U%J5+(!R9?LQ.[M\1;'V]#MUB68NG;`L$)Y=VJ4 M/9K`P0[[RLSJ/:/8*$G&`]@/4/]C0NSK!PJ+#7=A0SP4++FA$"E#<4.GE$6` MO4"`+#)0H*%'7A>!_]B0SZ='=VY MM!-L$S&\SL=ZAWR21US`I_.R=27M:6_UM+O[0MD[D;H]N$,CD3?'+WBBM6*P=5R^TOTD`:=OD5NB]P6N9NY/8O<%KEW6?M\WINN$CYQZ,X.13>HWR?.U,WJ@[;>XQC=U=KM:YA5/UV_8_28NI>8VJ[X[9Z MI^[)H/ZUA2VF[C6F6IY:5?YVK;[+!I)6JADQ'^*$\7'T#EY@D3]_SX4?QCC. M4])<3NJ:YK+YC)8A_J&`Z&@H.M>)%XF0\KGH5(?Y^=8[:V+I+I\_B>(%,GBR MR)#9@`F:B M7)K*LSA2NF).L,^<*Q[%SL]Q%#CGD7_D4*D&%K@P^V^8D_._^#\_3F9QXLED M'W@2UQ7"DF\CF$]D0\$#[B4+>WBMLX@ZK;?Y-/EW[;??R7V`A<[\E!*$1@IU M\Q6R;_X$$PH=KZCYXW@)`"7RPRS`U"$$E`\SQI'*4/J,_^(R+S!P&K<53UF1 MWQ21*X-`=:43FVCRBQF3>Q1'#>;/=[/04AV?2Y;@E:8W!H;^+O3X5/S)T\DE MI7;=L,]9"(M[1+6BOEE_9):5RXZT#WYJ'9VJ0CWW6D!IR9\9GPZS1-#)78S^ M$)D7@O!Y!_@!-)C,S[(`4?C=Q$O&3!3C+V:-MMM?VEU8?>NDO/KCUIK5=W#U M@[Y:_F,74]K1[SSBTVSZ,P]QMU2D*J$!X3!+$Y2W`,NG@VB=7,`=<@1&3>6P-IV,`[F6W]3X'[LJQ2VO0B?[O/,$$5;$2 M6`SLY_EY!)CO13Y[YX$*PI)'8/)Q=PTN8'&R$PV_^Z^BM/BU3\IVH.ORG2NK M75-Y[O`85MN6/EVUY'O,O1K0Y]&?$^Y/Y!B?XG1S(._?`?+N4I#?OIZEU3-L&[ML+R^!>#RX MYRZ?M*Z%TH:^GV3,M$.D'$R!)7^*(ZE6/(2<3M9RSVYE#_>;?C5%?>`A"WZ/ MEY1SN1=BK9.YR.L'RZC&G+/,E^1FI/I4VL>[96!L=8P5=KYT3I8@Q:!U+W#> M;_H%Q`:`CV71"I:F(4FJ9>PS!V47%GJR''L'=TC-WN"X=3HPD'?EW.NXC7SB M8B2)&DM7"E""BH*6ZE2H%"-[A#0==-;38+O=7<-J'K:ZZFEH]G/IS8EZ'TIY M@^[ZM7=/*K2W?,(2^`&7$@:[.(]@%B30N5%]Y`R+*J"<6`'GEH$M[2^7GO`" M%GEZ(+.^B&)=EUZ2SLGT]DAO$3_/S5\6:XP,UE>-;;?9_UU58$]/7&0Q.^R==S1;O MW,73-KW\N)]CTVL4!-+QCON]SH,WO4*;N&14BTC:EU+\/8`5G=RAC@Y.5ZHQ M2R9>)Q&6//X)2Z2`)1S.S\A/0J:9']^P9&YRXS5FXMJ]W:$SM`Z\']0S!T%^9P:Z@C>B<\Z;.$S3SEF2X5IQ*%:Y='B-"C.)D"]5(U M*N/B.?^8N$DTC4F'%BG)ZNI M.VD,G[XRAVFL(`^T)T0V5>4YTXF7.AYQ1EGI2E+G0@4NW_10+]T0C>S[TLN. M>XABF%`ZTZ=8'D\4=28J/OE27:]BK>J*(6#`SJ8PI89GPFY8E#'<7:(+H-.M M`3XM).L1)9__+(EO>*"VOW1,3\ML.-Q;=-AH7[[0V]?2O7@T'XV&%S@2K@+[ MI*2C+-3G"3"X8LPQKAT^JPT8)?Z-"PAGR&`"&FJ4)71;$'#A9P)G.'+.Y"K@ MI+.0?"`9,(V`PQ$F#L(-.#\BRRB)I["X6)BGGXGB1"M("E_!H\M.MHGW#NM% MR:)9B.;\M?>-B<*U\QC/S,D:^Y`D>>NT4[(.U\[[]&6N<"2M*`$2-F&1`!M`(O(?$1CI(=:-_0WT+7CQ5X]':$A<1$5E MU+,$&'HT?I]AC(C48X$`5C3=Z:_104_7DIJQNV=8[O8@LJ8-T>EZ=^NN0>0> M=LKI>K_NKD*DNP9'UOB(7QPB3VU:9+"H<]`B.:S27]*2:AT_/UVO5VRPP]+* MQ6X3*BO$Q^EZ-68;4+E.*,)P;DBH,Y_LLE4W)4@%IU^Z+?J[LK][*$%M:LIB MEOA>N8#'K_7$X&&KSN(>.E&_VSIN'S]]K3*\4SV))&E:O M,S@Y>;%C>:9]KE>SVKU^J]][VE&>Z02R#W%RY86L$",/+OS??GCA_V(<%<-, MIGD>Q;QB0./9#PD!T5^\]*"8\OOQT=4P>$9H/:)-PK-":[VVUNZT\$KP>,M` MZ]8,:/=6Z.X/K4VK?C\S#/1]C)77:ZW7S]JG)[WCP?,IK?G*MPVBU69?KW5' M'$'[%,BFN\,PNML0[+76QQH<=CJGW5:WO0=`6FT;]EKKXQ*Z@^/CSFE_"S#* MF6(1W?Z$V\M>J[:-<)[A]A)AYTCS+QXY'_);B/-(I$E&@JBA]X$[<:%I-M(Q M[S-Y<3QX6Z]I)9>`%O/,GZQGLVEK"B,,.1WP+W8?(RN;C7E4N_I2O#(5,+P>RLV!$L#'$4@B0"=N9Q^B'%\"F\7/3R M%<[Q#A&>I4N_<"X?D1%6,&QZRUA^\#,O2;G/9QY=$4NP30N5$8\##UXX(O,G MKHEHV)])C7(HT6++SC:0NBMV0[6T42DG6E!?2URW.#.P!FEZ\ M1J_=OE]05AVVCI;)*OFO_&D#1]@QCO"B$`6*O*3H`-80.7]7SE>E<<)!*UQP MB4$AR94?Q8,7?,IE3NO2SG8+V/*V-$8%=^XUGD8[&;T#K""*4S7)VT(HTC:+ M9PQ9"(_X'O)J3*)-XB&FT2+KG*\0F,^"NR^*#SN'VET#M?\P*OIKY,Z/760S M%XS`>*_>5P)%>+11%*:S6[W&TW!JQK49MJU'; M:M2V&MU8D:[:[7#OFQ+:5J-[>>RVU6BS-VA;C=I6HSN%W4WMZV-;C3:!F>\X M-MA6HWN.`+;5Z.8$OFTU6I/JWK;5Z`YV*;2M1G?R6&VK47O:MM5H39H]V5:C MC6U`8AO6V89U%KDM6`#=-2ZOMKW8I2)G1/LXCRBT-@'%$@OJ/L=YF3C#DGL7G M8OX(]@T0E%_RKTV20\]M#4['0RX+S*I! ML"8YBT0F2HM[4&*CHRYY.]^YNIHW3(R]2X>8Q![%CNKT"?M$\,ARV48JFBH[ M3OGCQ0;R45?7SBY]($%0RT+:]RIN4FK@\#.>%Z#$611<)&,OXO\EH%W&(??G M3ZF'LH,=D_-54/-C:D6-+.!2UFZPO9%KL0$4%Z7&!G?W0IAXP`N)@\@J^Y)1 MXB!)0)T#J-_#DLX.RUM`4(8X7KOS::GX2EY+1?8_QC%ET0D43;ZJ?!$['^`Q MV/SA_Z/'SK#Z!7":=DNV)1YGL@FW!^T2X1RR-)[])LX"!N&W6)A2BWA=-43 M/_2$X",N2\`H0,N:,L$4H`)H0+V/\!C,=ABRZ(D^4=G?0BLP\6C$J?^60,V$ MZQZ>,.(-`\R1TCS2@AP_Z?7KQAFW5-6G*&`#)[]1G:9]U"YK^5/L#:QP<,,S MM9;/I)N-R+HM4_AY`N<8H4)DIOC2BE"J84$>,6.^;$0E58UGA%!WU;HW#J'. MTD6O&A*S9]D8"%DO MIG>D>ZT#3NON*N6#QM7>M2%5C$/S&!YBL:2`^Y(0%?'KX559HCGN!LG(IQ6K M.><,U&+9T*RRU'YC6[+<3SE<;#C!XT16W_O,--/S90WOG!F_9\)/.-5[>H1R M>;KKRF45<%:OW/8&WN5U4=@-CS,!G"(O1K%9(Q82#3N"3RD':35+!$^<6)D6.MJ0@#%4[6S8+ME=$!:PT6P-Y MUF,94)6!O?/$!%@>_O-+41+PR29QN]4PKG7?$J&TE'>ZE"+]8<"MH?3>>(9E M^$US9]9R7;P+.2@$]6)6>^-*U*FI;0+.AA+U+G&G=CE#=!G`HHSU MTA'P4@G2E$T1%9.Y=B("U@D:@O1R5--Y0I/(.C>XAT;@W[!@ MXO_B_ZB)D_/+-WE3>S\&I>O1%^-*IRSYK@TULE*HNS(N/6VPK5&887-F>?&B MF)3)R4OTLM:1V'.7X#V9,KUR_*G-M8_X@G(@5Y!10- M+(P*8PHL8$QNR\4M"-2_U.41,LW%$Z`#F"AOPX3AXYKY&0\!:P*1^"F^H79$ M3K=%\.HV69E?K9D&ED(%"W3Z//H.H_X5< M]>@D_H37B9?>'('S='=)=Y=M%@*5HV#54#'1>#EW'A6L"1"P7>:!0U2V;]FF M;RG;QVZW>UKFWI*-HAXE$<(9)?$4[[I+O5MXFND"QM1811*QHRZ"-QJ8Z?2. M^J4E_CN_+_:$/ER55.8N#1&#?S9\N[B#54>\H=@%Z-?\KYB M#^<<_89QCJ?T__M#HDL.KH;26^,9QC7=ZF/(:NY!7!I`):.N,.:`/'C(!)8' M=2Z)_E2.D3\BBL^Z(O&L(T:%V<$/.Y]Y7YG1G(_BYJIMW3SRU!I=[L1"4X^[ M(W95([XBR)>T)Q6ZB8S+#'\HAW"6;AR*M7+9`6[!(ZL".W%WZ.2%4?_+\I@O M=+XK'[VA1";Q#0_4]I>.Z6%#%%0M\R#,O/N.VGZ:>#XEK^2/YJ/1\$('[05Q M-DQ'69BW*SP"=&&.WF2G]?:SVL!GN7H*)M*_MM]BF\3XEH8:90FYM['13R8$ M19R]WB/I)#T)!-('1.F MC6?KS=\`K#3#/_Y/>9?;RNV?8[F#:$Z[RZS%8=-`[ZOK9,DL+DR5]=CEO#:D M(#U%.%?(ON](Z,>P]X1%8Q@P*KO_M"A7/69Y/CJ\0UV(I[,PGC-@12S74I:B+O^%U>;]8 M^5%^Q$MI!KH):2Q4TX!:(*)B!],7D6SY;Z45WGHR&``#`^#X."4*T,!E?R-> MGV',;8)@WZC[MMUW6ZT6_E=V-`K40H1T#4RGL#>Y74I9`TV=EI\!CDC]-J<: MZOF\T!%/IM\F;.IMV`?L=/JKURZ=S[A:#*.9Q=A*FR4^EWP!M#[0)B7NYF>* M)[%9\/;Q>SHE2Y"%6PAO(P=`UIA8I8RC&(]BGI1MB>'@PE9U1/3 M)/&3+XT$?@<+M5EMH%X;:-!2#2[Z2CA+L,EY?4#?XM\'WQ5&.7(ZQ1>(LF1( M%W%!U;=><6\SV8M$BLS=8+`6;`%Y/ZF(DD8_N%I$(O.M2,BJG`B>24X\7$R, M,LR272XM%+SEXO./3A`S%2:"B;IXJ_D-@6DX1=#5X^I#4OI)%*^0X)JQZE-! MN(%$5CXHE7O7.24IU7YIR=7O]C8MN0`06#.HI*=H++WE8;A"R.C#:*[(J%6O M8E*_32Q4C;AY45;DKFS3UX0'N=N3?&-Q)CP,7GZ^ML#U:+)[:GOL/FN1T[YM MYW?W!AO8O^LA'3/(Q=S89FWVL!]TV'\R]#R839?/Y,T]Q78DW]/S\GJA>.07 MI6^8SUQBK'/QR"4S6D`21NTW0M6D'O;3NK'<)2HN"MW3K1;:>,3QUVS'M:S< M^N!:[PVH]/_$"J];K?Y_>MIO#"KL**8_0T^+>I4PWBJ"=X[:)[5'`=O8XFF" M_%?I$]O6.==!8:O#]EZ<4=NRZ[MWICM.D19EFXRR-9&FSVL6:W?)UN2IM8%W M3IYN\$AKR9SJ>Z8[3I$699N,LC61I\]KG?[R;49UYK%TO(IHJ[T.5<.[JIU1 M(A\+@,TTFWU>,^%UI]W^KO;8W4PA7"_BW06CMG?4&=3^-'=?_+[@+:\9F59[ MQ6N;0K@+,@C3;!'SMJ]Z;O,6^($`JI%!LLE[M,%)_4,BFBG6Z\4.:HK*#\+5 M]M%QI_:GN9U^ML_2PG9A,0T)JF]Z5L"'A_:OD@D@5!$VBBNI%3HI(Y!Y+-YX MG+`QUMCC49KP2'!?E856:3SEM\TT#F\A]21?`N;C_NMPTXBXJ;%:BUBM/QRZ MJJAKM5PN[D@6GI(%LB>L2&^1]70;BER-IXY-8H930H9RSHR1+6/V0=+EVM,J MH:TG%5YI]HP)@M[`S)[I+[K"I`@JP&+XQBP*[`0*=+KK M$Z@64$!%^RPMR+Y7*/`X9WB=[S#O1I;!>F3)$^>*/#GJSK3?B-(T7O$0-_!# M6,FG#*NQ%T"+1V4`ZE3+QB7H/A9@%J6>BE+W2N_]3`5,4&7)GWI7%(\UG_P( M-G+QT&NLG"<>$YU@F=?.8=HZYM4XAE4;;:C6P+`V?N-WN.D;SMIM<%"J?W&R M&%\G:U,4XE%652J^.#?J7ESG=99V`30VS&D=)VMXRO?*K2[C:>VC=JOV]_LV M-VG_@E&6(6NG;W'5XFHS(J*0$GMJ[+]G7:S>5GU%ZGW=Q6 ME^NT)UOCO?5*+*KSC5JSL@)KC?#][M82"BR^6WQ_<7P_/FI;?+?XOC?XWFO5 M']]W7S]_5I_S=9S*^_;-Z>BU,2\;Y#*P:<(V37@;:<++R*8):<*67BR]U(5> MCH^ZEEXLO5AZN:_7Z.2T]O2RG:@-3#U=!F9]VA*] MG@V$==O??9[3Q0K22<+N5ZW`;$_JQ],9BX1,K6;?\&_F>$+$V*T:$Z5Y.EG9 M'+R=?FR:238W5.W6[O78)9\H(Q&'[GC_!SML\#HZ`V$>HMGLG M;JO3?0!8,<4_1?>&DT4)\^-QQ/^["F#47-=(ZJ^T+%VLAK%Q6'6["]U791T! MW2BUV(*+6QVSB"5>Z#KQ#4N<$;::E:ASM!I$BW)IV0>2P93^/HR3@"64.*YV M2-+OC,763%):@H_ORG?_[CG_]PG!_T$!\\GOP':Z%< MC#[PR(N`6L+S2*1)-H5WU4O8%3EEW]+/;/3CP67K]$NK_04I\#IN];]TZ>_^ M@<,#.'GLJ1I\Z;4'!S]5Y,.C6;ISL$EQLV(9PS@,'EV[!F#H_$<7E,G!Z!AP M;*IBT'3-ALJ;X/'D]7Y&^?'PXGBP\@V#MZ8D*J1``:ZHBN.DB4?,T*A0XCJW M5'_(N_%XB(1YY)P-!3:PGH']PL4$!E!OT\RRP[`7&9-B#679NQRD%$MA&[`E M;\SHMTS`*_$0&X83!U)C!5[J8146+TF0T7DIM1W7*R?N7.SV"#AU/N"0A9S= M,-45'>6@#X/,J7`+Q=U3JW!/3(C7TA_L[XS#0`@?X,"^+WL>`_ME7"X*GX3O M$^Q;'7)OR$/93-F;S9+X&RVIM)P/Q4$`O`,&1X'E8+#1.@@@KJH0N3#%#'NE M`^O"-LX3W6]9+OTVSH!2I1R`A:BJ-,!=<12")`)VYG'Z`8XN$B.$<;[".4H- M>)9X>CB7CR#;BK$G>7K+6'[P,R])N<]GLAN\!-N4>2)+)%"QZ3FU)Q>9/W%- M1(/]>6H4I9^8[]%&Q$3O)&"RD[J)>K"3;*K$KFIDO[@D"0O`%=P2`H^.TP!# MOF=8I=16#T/`@M!F@+57=(/$OC[";QP(#TY@-;E-S(Q!Z@Z6>I_-6D,RK)JL/6T3)9)?^5/VW@"#O&$5X4HD"1EQ0= M5*CM[\KY^F&&1A, MXVFT([;F4?V^5$WRMA"*M,WB&4,6RMX#R#C].$EB4,ZEU)ZO$)C/7[7NN?%A MYU"[:Z#V'U&\@-SYL8ML-HL3=;R`0JD\_RC6!TQX@T(=$:UX#>;E(T!)%+8Q M";.R%DA:Q5)&!R*-YT0DP&Y+4L^0KM,X`#'G.@$7I!`QI2R-0)*!J$LG<1"' M\9C4(%B1IH:4^9.(_YUI!0QEMKG(;!$(MMABG;R%SU!L4976*THNQEEBF"2DGORW/N*OE&4M] M';J[F/C_G&E=M=A@*7V_O;X@BS2XBCU+=;OXS(W"!E+QW0FH[/NQ7Q4*G5&, M!ZV9G=B]/=[B>!NZW;K$@]<.&%8H[TZ9M4<3N'),%6`9Q495M=S+U51LV,^B M>X_&AL(A8RINZ)FQ"+`7"&#ZY)IZY'41^(^-6KUSUW<&J&Y% MLGC.#D4WJ-\GSM3^JH.VWN,8W=7R\VN M853]=OV/TF+J7F-JN^.V>J?NR:#^Y9$MINXUIEJ>6E7^FEJBQJ9\W&,##5KJ M]8HT#V[H\'GF7X>RH3!]B24SABU%G8`-TU+J^VL_3F:40T9DXPY'+]D23QC7I[%YV+^B.?XL:#\DHV6`NFYK<&)>]P[+M&%2WO" M*B`)KJNE-CHJ$O>SG>N2G_#D@033\`0 M+,(D.7_B16-"``2/+/5BI**-9,$=RA\O-I"/NIB!UM`Z*?(L"NAC2!!5[U^S;^G/(9;+>7BUE).&54MY0F;=$/]0L'4T M8Z)8(DM#Z$>1)P4,$UZ)HU6>Q9'2%7,BB[KBP,I^!FGDG$?^D?,1F&Z* MU9\\YS=,//Q?_)\68I31B-6B8%TA+/D6JVJ(;"AXP+UD80^OM0SMM-[FT^3? MM=]^)_?!1B/FI[*^BD+=?(7LF^*R7H!`5%XT$KLJ$9\`A>6VXDBE87[&?W&9 M%Y3K#MN*IZQ(XHS(7TN@NM+9FS3Y!#HK/FT8*WY*X2H%/\<`X'.PK!4KYRDLR:\GEWV6)?_L^5_'29P!AVG* MDG="EBEF_PJ+5TF$3PJ$=V:RQ!V(,+,@PY#Y'A9IB*CF4LJ18:,.CIJ_'H6* M/('V/D7!4N+OG`IEB2R4;#LNV+;SN7C9*,8((D*-+F5'P$*P2!*FRC?J"E%2 MONGZ%7G=+KV@-"X72$2)`APP8K*Z5;4$YBMC4MQ^-OP+GJ1Z6@8D_LJ"L1)J M(+#R6F-8`8UC41E<+1=^)M#R&K(POCVJ:[DDN8KF,8XE?-J1DJZA5+E+;(64 M6R`+3]?]&_(P1$,_H9)\5"`IQ;H=`95(RBE.D@]/Z7FQC@/\FL1"Z&'EKT#% M$1!ZD/G20;"J^(`>.WH-V\R@W5`P15*0$M")U$^:/:KP!L+L9J M#X!XN"<IZ.LC`O"^B6JQ*NX9K``C^M^=69>G,J")47`51\3CC`36DOX9R* M40"KTNPQMTA(`Q=*-T]5!=R#/0N/%TN$EWHU-R,RZMU3.);X4S)G+,$9;0(B`N*O@$*H,E@BT%[-8"&%8P[B9+>$B$_D.* M5:`IT2!,>#08=H02MKG_O2>4Q[1UK07+W$5*L*AN9<+V>>*^[W_O"67/98*U MFAIRW+M89[LN2=N-V_^FL[8MAML-6A*V)&PQ?`\W:$G8DO!NG_#.;]"2L"7A M'2V`]+3RFW?Y!8H(6^SG./&2,;/%..M^D+4OT;'!K2YA4'UW<'KB#CJ/:#D_<=@_^.VGOY$DV"%$M'>XU'78Z;KM][/;[C[G*J_]1-@A3 M+2'N-R&VW9,6$.+IZ4X>9;/LYN>]3S_+\]ZV==3WWE\-N]'4[(!?'@!-K8[9 MR1&V)VA+UCA!U^]@]/>V[_>-. M[='>4K6E:DO5]Z/J'E#TP&V?=FN/]KOO87C>FWFL%:5*[=3>F[1-%M<%"L>J M7#C_]H]X@X%(]_6VV>@.WU]E:@YDZN%[KL#W+"RPOV#(O MZ+B#WHD[&&S-]+&\P/("RPMJP0OZ;KO3&H?<2#J3N<(Z0:A&KN3'@VU9=/=N7AS]N_:[ MLFS`LH'ZL('C^G?LMFS`LH&Z0&A7VC/)Q=3[QZ"M)AW1C^WW!'T',O=C1Y3+]J,CG/X([X_7E*YI-P4KS1=W@\0>P9Z7[&U&8^P M=9_LXU>:(6$^XS?8:#N;87N_33*';JO$'9S`FPO'&Z5,-D]C4:"[G,KN>V[> M5RUOD@@_P'=3;)Y*'=A$K'>'N])-`_6&L!O8FB&P-:IJOQUZ`K;(OZF6;4?. M6:D=:M%U-?\ M^OV?[\P6YWF/Q]O%04KKGC`O3"<^+ACVC4\#=,XE(":QF"&#`AR,8P&+!X3! M!7*?SQ#?`+B>?LM=U;YVXJ5P$F&(76S'+,*FN0`3@N==:Y,P+=ZN`%3-G).; M;=BXI0U\`!I49^4E7""IRBZ;@"]X4'PZ"ZG??=[J^*Z3UZA(:!QGA%'Y<2M* MXY'N-ZH>RMN/9LFXW)85L9L!-P!.E#`^'68)LN(9_),A^:MEGOG`4IUW^/!Y M='BI1OM-$\$'QIQ?,XX]7"/FP.X`L3WG8.3Q1%&U)^((%9T#:A-+K*GHQ1PI MUH`SC6"H<3X4%]00_&#Y_.0I_/R1H7S&BD<@3*G9IT3[+9/J#"@2@.?2PR/@%7$BW@)_NP4NE0`J228\];[Q:395,ANER\(@NF^N MSX(L88:P`3F"APAL"C#/1_8.7V9"+7T1`E%E;$`"8^=:;>U M@08M]6H29R'H0-3(W1MCW]J\5;PII4T)(GP2'*^SE(_3G2"8PF M2>OOC"?P'.H#R$29)!_5#1LF1.44=:!G1)[`TT& M!\9)0/?#GV$F@^)-)X=ABBCNY[@E3.B'X;,EB7A`4P M<(#`Q6B$?;!AL+,`")L+T%.(2_W&0%!BWV\3,%<79[^9D'&5MD[R-!:*0@(:*)L?*FC!ZH2!(,'LIXA%(.Y*-$N$J!Z!41/D,Z+(2 M>WV6I!X>:03*`%E?/C8R!X'I2FTA*O"CW97256(?(CT@"BX6CXW&++%F4F@1 M^@E*-P)$H2C#^H;,U#'@V8V>T*"__(0R0<8F;,T')@`C`25X6<#3PH*4:XU, MO0E.4.!Q2/+(=S&%(4@EB2.0LVB'XCY"AD;4OS:YG5[+;;7*..(/B-:)M4^]X02I!9'[)OJ6@#B%N%JSB4HEN?$#N.D?) M*?.`TFD^YH'2A;0-.AL#BO8T^H!BQ^E8815"D'VH&0,\20IFV1C5'/46AUE8 M+QS(LN7>$NLF1`(8!A+OE?Z*3`+?`RZJD`_7>3B<'])Z2U1(FO;:94T92Y5^ M`M06!;`7-(Z!F)3EF]NGR^DBG@$+0/Q!MKJ*+0)`:=43#_9&?-?<5\[S05?R MF5J,'(!>D%H5O73#V2TJ1PD=6E!8@F`8',*>8"Z]B^H3R]N,AW6%';FJX,G<$!IYPV[8FO M6C9*Z^0J`VX^90K@),WQ\-:S6$6'$WB?#CQ@$?!\.J.$)&M9B@-DAZ#'W''$ M^;CRK)PGRAWN8Q@P1-4Q?1S8+'Q ML5R75J`2[P9@\PYUO+GS7@M@VJO(_4(2$.I+DR)^!CLN$TP2/HQ365`^0+X_ MF(0T23^F#91WZ1IJ%#[F.>BI!)H)#2UT!*PQ9ZB?L`:ZV4 M7>E)G(TGSN\>*O#MOKM$+@DMA4$[#RGN$>IJ0 MXIIX!;)[UYF%F9!Z)Q@9+KDRD9U_(T\ZC+U1K:U]4G&-*]J0F@S)R-+D&U6R MVNWRW%/@.XJ-2>WYR#F/I$23PKZ@W5OT4Y#'PYNCW26D'C/U`L6+\[-1UAI# M9X4D9^WJUV_B2_J$T#><%M*4!/#24Z/IT)60[KW-?VIR>^>[(NA+H5H9=Q1K`8;>3>@9\%62WO1HDGO!`^* M-BTU3;669R2UWE%G*:TAI?MA%DC/.$/%4CK]@V2\W.%882.7+ MQ0!PGJR_X5\@N+6.GB.8]$C2,N_&-33F<+SR6!H`ZGCDQB7;D&<8"_,AVDMN MWFN;885&#[2!/BN]-OF:**N.H'6A/X4%ACM,F7XTEX$T9(7ATM#J(TUDHE\7 M\II5`F>,F#K7LTITS;T$\!08)@APYF>FBV,U((X*]>,B"8FO*1.Q@F M1HX<XN>0)5\1C4J<")TI3&DK&A?EZ2F, M4JN1[BI81.'>;/?*R*RO],W1)!UYOI]D)*0DFX&Q,=P$EODB7(_T"B\(2&BX MRPX1#IVQ_!'XNB1B%IA_HLZ@(%2,O]+W@[C]..%C,MAZ`WFH\M4Q2#B$L+F$ MDME7S)LS+U:6)2\B/[JM90ZQ];(#5V;NB_:]R#XU"`P?]0*)Y#QC$;]+T,JA MG,^A)Y4'JBAE&==>F%/+;*4T*LCG+)<&*4AD"?4A>1'7SW^3RLM&,7RP5'U_ M$A!'90@6YJ\)PZI&4^9-V^)%']@PV2`S>F&"DHR!9M"_,/#&/VX0)2;Y;1N;W#LMD[+Z+AC?L4&+?5] MEFB_)X;X%A2G+2E/*MI\B),,TI8!:##9#R@A8*M]R&O1!'W16V$7&'R%0#GFD- MW:.3E:Z0G"W-O#E&6A`\-;A"[@TQ-H9+YRX72B8S8?*YW)#(I=?0\[]6F*BI MR^'&2[R4O+U!+,.!"J4WH9Q MIZL5=KJ\D.K4HA%_7^=-I!% MQMV.]D3,*[ZK:KC8^]*>+XP]X^6"EU)\D!ZAZD/"5Z9`JL-5QF;5))F0D.OQRB>90M25=]+G!1N5->4\;H"55GH#C4805 M<1'E@LNQOO"]W2.FE4Y!W?:6<%$9TF6-?.I]93D7K>C!SFOE;!08EJ8XBK0< MX!F!B)WF'N,2%+XKPQZXPBPN;BMY[NPLP:;=UL`QM2].UQ6FE0F(@4?%2]>C M-"IR<5)D%>CDDV*10A!WI!,[5C>FYIW8&.`E=Q7/9G&29A'&]&&DCHS>D"'C M2#?X\M/NKU=06%GN%(Q,Y$"1O`=PU>,4>C,E[J8%'IRT#/HK%"R,F%1Q15HK M]M*"O'*.JV!79I%$5KXW0Y(,R"J58952??5@NVDJ`U21J$:P500-41K@+?P< MC@[I/@(F0(H#>!:10^%J%!K,$B,+Y.N(@CJ,`Y\\,X2EP\ MH=)"V+6QXHB-P1R0G%)&:%4$QXC=4H0C:?`5"8)\6$L^Z2N%@EYX`F1)A!*P*2=ZX-MIR M._V>>WI:35F1"GW%Z&L3Q]GL`GJG[DDEF$O/3NX0N8*_035,Z=8*F=M9-D:/ M:S<7-:\75><5@'T>A7HP.'7[)]UMP;![[/9[G2?"4.'0"3C$DE68WK M`<-5\&&HPW:4!IWKPY[T=[,0\;2XCIFH1`1U^;(D1T(82B09"*0:9?(6,`\S MT#LMADG1AQ&07V9CGE&(S6.']S"*ZH98Y)"IBFTB9`*_NE%3HKJ=C*4>EUPJ3 MVN`2BXHYIW5([@I_=.3I;#8*87"ZU/UMQ$TL7,ZNB0[`F+`)[)]%8Z4R`SL% M$DLS*<*XZ>@*P42@;6`H.!(5,.EQYHU9U493@`=AN`A['=P?HMN#+M-Y80*T M3O5.U,.E6'),HP7(XG?9C"Y'UT<;`CXI"=.1U[6ME7&'RBP$^Z,:1RFIB@(F MUX??EF,;S8U7(NKUHI<&_6G:5\`LW5(4(`,[0]OB'F5;"75$*NX/@_L*-:3$ M%-PBF%SGX^IA7>624F-I[K5A_*VX_4ILYPB3Z@5:])A5]I@04].9H7!()0FH M,Y"0*O+[BLP&5#A*N8`J\84GAC.YY+M0_%R&OL6(/)(3)-6H?2;S$]>S-DI4 M-/E;'GQ/HQDO,[)_:3V@4&DBU2D_F'%G#H.S&"][_H2S&R,YD!P(4E>-P^J+ M0U;(`:"$$*-.58P`;$ER8-H\B03E$H.?$6XW0+627\@P<%AC2!DTRF^KS@>U M,PYG3/*S8J=[E2-!VB_G9[J.`-%+R>-H_B,OKTBR(JYOB3JPR,1)-!`;URY7 M^-!#(7C+,/E"K)UCK4Z1SY%GY%922O,8/R/E,XWCK^JPCIPK'9=_#_1?Y+UF M`'#AAJB$0LLH:*&]!\L8D73`DR,+-&B8@`OI+_$33@'%3%9.^0]C2I"&969&J(H,C%HE;ND""RAEQ^0]`J;!RK%17H"21!)4X7=6V+,D3!_= MTQ6WKXS)"0QU"5YR\K1. M%CTS.-D*'_K*?3W2NE=*)GD.-V[P!BL@N-?EZB3"1V\ M^C[.ABFFH)^IXZ2E\Z4%UNPIO$QJH[Z04ZE[`J4DWIX!HYR!O/7)-$3S*TW9 M=$:WW8I(\R"0`)@\:6F*QH09R.G'A_G=I4=A&T$F"UHM>;'"D5SM&*20(V`I MFGA!>0P9U=&1MZ?2+@(>.F*@Y:C(?4&%"4+O=J$4%>D/41P=`D\$O2&"3?H\ M\;,I&E-H2L0RW9V%RH;+RZ#(H;3)0:'A`!X#6`">&P3VW."KN3WBY5Q(1H2D MH-X!KS/*LZ0R"1NS1)2RPK[Y;":YIS0*P?R+?6!VEG'5K1B>9Y8I)*YF,+@7 M*(J'?BF]!&U@X54V/CXT?,`K+L[01UYBUX%FUUKZNH^IN]=MU;D\7D-QL/%$ M=+94V=6!.[(NH?Y!E.N+F;5[2C;HF2IG,?1"PF@QP9H/:#%BU(TWEAJP=#>+ ME78')5]HO)*>F)PT,`P2-7>#;)0*KVN.S)>.&3`VI;L2`V$MZFV1?^?G)Z2: M0!:$9_090@8E^;")ATH=640PNM(C)T2>Y&5,8HY+N;3D^P8]B"WE]:07*8M/ MN6(UZR;7`GFAQ:3$==7CH,610QB99'7Y>MGH?..H]H@$XD7J=)U0,@PSJ*(E#*N(# M:,6#C!Q6^5YD<2X=;V!I:8NT-(I]BJ[G15W9(98#1"<%U^Q:!@]H/T'"3!W: ML!6P?.8W!WV8\0PO7.0MB8>59Q+X5.CA97U(QG9CD1Y4$:J>314"7*GQ)I9< MX)-A(&0%$V4+4*"A"E0G]T5)>TI`PQ^;7J(ETTA%3,D/FM3P],+7:%4I$\ET M\LK7,'):I;_S4O23S,(HC#%2K'2<1&G_MF[(6O0UJK9HUQH"G53.(9.AON34 METP9T9N-T,U.3%?&F+37P,H95 M(A2D@D5:DR),F>$F&EJR\KJAD*N(%5JRZM[E6I M\.'*\4N)\A3:'N*UKJK;FJG0[;73ZJ0'U`>!K7%0%H+\!BN_B$/$6BPB:?@; MI&NCN%`WYO(R`&LB?):>V,]2FN/^+\F7<@VD]W,8^U]_^N<__OD/Q_E!O_`NOPJ" M9Z^RH0#Q`B*"B8OD`ATHYQ&<%&DTXIUQ:_0+!J3#4W)TF53R+?W,1C\>7+9. MO[3:7_#6\#IN];]TZ>_^@<.#'P\^`+/GP9=>IW7P4X6U/9H;.1L-!URQC&$< M!O=VV7Z*(Q6D0&$#Y^K"KZ&,?2IYPF=.?#$E[8/,ONRE4$,3SU'=6] M457@A$&2E:MV>6F#,0F%+\R\V2V;5G3)%9414]]$'U4Q-K^BSL?G2\8'91/5 M.S+Z\H2:7('"!"CE\M7#Y7'\ZDT,TT$31^TKY%/*(D?1!H`7$SXC^:F_U_F4 MTF?G11*BH,P.L]34"I:=L#K_?&-XQ[_9<+%*A54X:C.I]KLF2Y6-"(FJY`'( M*L<5K/4RB:,8;[5I$/E"17(]0LBT&R9D'LN@85%#_.,S%;EW"K`Z9;C2^0[M M%>'V-O"),CM(*RX.:58Z).1X4K)HG536ED5MF-AY7NE4%2=4MDCNE$4>+:50 MR+]20G8LK6VCBJ:,8D2I@398B:NC[RCR\:&"L3>9>3V4SU3YU'7BX8*NF)]) M^^`S"'QTE/T*\ODC1:O.<:JYLZTY8T*"C""UGQYJ_H=*R^ M_LLWY58B=G\]\:)K-@7-P$OFYX!)/)&86P9$5P&BOX9#=U=O\_#XX*=CV9ZO MV.BSK/NI)WZ?C?;6;+1_\%.G7=GH_4[TA__O\/!#'*>?8K!YKY3G!>8X/-1[ M`G7NZYL1/!+!(Q_A@_.-O@)-#RATDJ:S-]]_?WM[>_1MF(1'<3+^OM-J=;_' MG[_'!P_4\^E\!L]K!\[!3S3X]PNCP_<_?(]#\3?X?UK%_Q]02P,$%`````@` M.F4X1QX(*_)""@``Z)4``!4`'`!D>6EI+3(P,34P-3,Q7V-A;"YX;6Q55`D` M`\\G!%;/)P16=7@+``$$)0X```0Y`0``[5U;;^.Z$7XOT/^@^CP[CO?2G@2; M'CBW;0!G8\39HD!1+&AI;+,KBSXDE<2GZ'\O*5NQ98DBY)Z'W#%Q0%ETTVB>G#0\BGP4T&ETTOC[=-G]N>+_\]8]_^/2G M9M/[#!%P(B'P!C/OFDCRQ(G_7:3R7OND?7+FJ1].SYI]F#;?G;8_>O\\_7#^ MX>R\W?Z7]Y_._7^]F_Z3U_1>7EY.`M6#3'HX\=G$:S;U83F9C*JI=G;*'_U4R;-?6OFNUW MS??MDU<1-)0-/.\39R$\PM!+%#B7LRE<-`2=3$.M>/*[,8?A12.849J8^?3C M7/ZG*R+&G2C0?]W\&M-G$D(D1RS442UE[MI522W`W6^,#4.15)UH)J-[B()'(1T4\DD MNP.U.KX?3^)04_`@Q\"OV&3*80R1H,]PIQX[@2X3CH0Z=[9CW^NK@1U1W*WM7[G2?0-0H>QNREVU57W:SES'@&B2AH:.2)>([ M&1$DB!Z9D8%NZS8.K$J\J>"3T-=1I_3KJ@=F5(%7"5$`0:J,[F?#03EYE:O' MA2;NVAJOX-!U9EP/^U0_9CC.9NS+5JT1#R9)+TUJ0K!5'[(V:2J-1>JL!(`Q!I2@JD:D;728`/&3$>6ZE%0C+FL-QTED$&G%L]E1? MH-Y$\Q'K[R2,H831PM8H*3714X@`<W%9%5\SY1PRD?V@3]3'Q:555T00D7,,]7UUK>,7Q+USA_(,L?8 M2>\('*DD'-8=8">0$3O,%1-2[QKCX2= MQ,VZJQ'%FP%$O!R[6!$1<@G^;4PJR[%*Q6I$:#D0Q%4^US#EX-.Y9:.@,]$; M<'-W+.&M5*I&M)7B0+QFF[B;RN%9]KUO'UEM@@BX.\3\QF*5O0R\^<\Q]&^^ M/:J,6KEBHI*-59L``C;=/#4EQ`8(<0J4^EA&XR]0OA)E$JD=<79(B).75&G[ M\)EK67NB+*&%8SOY;:A?:'L)$0Q+]ZB,$@@(\U0]LS.Q95GJ!GTA M(-9I;V8#:.ZL'WKST?39[P%V(@M4<2AA*)4Z6`&:2:4=%X/O_$D(8M+!#0KJ MX'9K!L19:QVWP/<4$#7=1-^R9JLVA5H_B/5M2KM03&;*`'2>"0VU56X9[Y,0 M^N#'?/[%3/#O6$C]%M_29ZH]`H%?58F?*LY2S1"(!YC?\_H-*1:#SAE@3*Y+I2':YC_79;K5NKF8)&G]4NJ*11OE[.O`I1R;QM+'5_2 M9]LY+E4ZP1!K&]!;$'S.D!$/O'7,S:N[;$W3[N/<-]V>O@UV5%&DS?>$?X?D M#;U,U!Z!A/0W"#X3&EG"T$W\*!AV@XIY.Z$_)APNU0LDT)F=2NML86L2.`H^ M3>`0ES^D;O8075,Q92+YYNYAV!$"I&B7$&D3/`I";2#MWZ4=+C359%GI$,V/ MU_%G3YPH?_2UJBFJKQ%?##8E/%?KYBA8KP;9_CG;07=[,VG^792>1_<(/J@I MP2`LWZ-W$3\*SMV@%G/]E]IPG=8"+0V3C&1;NH"QU_\;SS!:H-AA?D;J,.D* MFBZ7IMI>4;#I0&'KZDA=PP:[V!_.T/K#RCT'E<@ON!_AZ)A>P6A:74'*:X_# ME%"'3X#LHD?*[CI,`\%MI`2O%'1O/'X7]G"D=!O0&EC'421HSDO>+A78(*O+ M74AP9$SG@&KA&L1!GL,$MC4CD;[E#6=@) M`M[WN$-9"!GQILFCRC=FBZ*`[,TP1K+-(@BHK>[.^:.D3/#L>YF'>ROGCQ?L M^,JU.00]PI-_WX,&\](=(]K:RU&07PDQ MYHU0@RGT*H'8ML"HL!,$]._Q]5T(&?&W_[V%%]\RKJ#X`$'RR75_S+C4/CW' M,YE?66KDOU(O"!R@NM/G2I2J(,;\WD^!/+'%V^N>^&,:`9_ILQ/4;Z:3\FM" M7#LX*MIM8#%_I)GQ5S7T/0PK4^[:PW%P[HK6>9@_1/'VP6_1M.[8%FR^_DCU MC-]J.%V6Y":.(!ZR-.0.N':"@;@F5P7K%+B<]92WR]7P+#^&HUP,/6WEZB.> M?A;N7S@%G%42/6E6!(BG#4G1R!R>$UN&]N@Y,NB-N"YVKJS#Q:?9=NB96-,7 M\<4*Q:L+'96&32,66_/=(*#.*?(E\WI287S-=#%8G6AKQP% MXM0B53PM<5P"$)7HL\C7C4<+',0Y1UJX-K.=J+?:K"[T9+5&G%^DA:)+_[&' M4HE,??@Q0D"U$&=K7A22#^NCN;5IHPC>EOTA"*@=TIXYN7=SH^QE!K"]*^C3ISGQ M94S"3ABR%[V*GGPE(9*$JCP,]OFPWYVHJL6V/5[G4TNK.B`"$M/_#U!+`P04 M````"``Z93A'?'QW71`L``00E#@``!#D!``#M?5MSXSBRYOM&['_PUGFN M+LNV9+MC>D_(MV['N$H.VSVS$QL;#%J$)$Y3I!HD759O['_?!*D;)>)"$!!2 MKO-2%YL`\\L/!!*9B<3?_O-]&AV]$9J&2?S+I\Y/QY^.2#Q,@C`>__+I]Y>[ MSQ>?CO[S?_[W__:W__'Y\]&O)";4STAP]#H_NO$S_X7ZPS_29?NCSD^=GRZ/ MX!_'EY^?R>SSR7&G>_2_C\]^/KO\N=/Y/T?_M__U_QW=/K\?/[/W1&'\QZN?DB,0+$Y_^33)LMG/7[ZPY]]?:?130L=?3HZ/ M3[\L'_Q4/OGS>QI6GOY^NGRV\^5_?7UX'D[(U/\7E ME^*W\&@:_IP6[1^2H9\5JI+*=<1]@OWO\_*QS^Q'GSLGGT\[/[VGP4HN>";( M5J_9[*#[I?SE)U#7T='?:!*1)S(Z*F3].9O/R"^?TG`ZBQC&XF<32D:_?`KF M85@P#JAF1^&*4OY#W+5256Z,:`L/?Q&TDS-L;2 M^[C_!MW[KQ&!09;Z$8%A!S,0FZN>R3"G81:25`=*ZY<8'DS/H$Y2B#,8#69L MR@7E:@QY7C\&Q/U&LGM8)Z;D(4G31T*OD^DTB9\G,%H7RE$35Z6?O8C;:,`T MZ,Z`\"^4^&E.Y\]9,OQ#1UQA!P8$+/J%^8`$H(@9B=/-V4!-1$D7MH7L&)"R M8U_,1JRK]61`Y#L_I/_PHYP,1G=A#$M7Z$?W8&?1PC9(&XT#U;[V)G8CE3?L MTN*RP2BG9`*LAV]D/5>U6T.XG1H`\D3>2)Q#XV$RCD/=,2_OQ<1BD@#T.(,. MX+'Q?9P1L($RK75$J2<#(O>'8*CG$2-T`,8DY3#9Z%-MVN?>832B0K-K,Y]P M!NS#MGO'LE3_7@4]&+'"@QQFL?DS&1=3`=C$OY)D3/W9)!QN[/D:C9_&G>X? MB*)9T+S7_4-IN"'2ZWO_"UK+K7;S-]B$Z*>3NRCYWG:57G=CPAX-82$=`?8X M@RDRR8N9YA'>NSO7*)JE33JT:5BTM"@,F1(9@1$V9_X&/0."WWXEGD^'2PD7 M_]SL=N5:#./L2Q!.ORR>^>)'T2>` MC/P\R@P*6-.W07&3J1_&=J1==-U:V**?SU,R?274I*35?MN*.0&)Z#!_)9]7 M*C`H;&WO;46.DZQO]%M:=K@2#$9L6$Y.#]!=Y44P&Y`X(,'R54PB?9]^$7*` M%T;)L/*6B,5%$EJ+I\"2DN%/X^3M2T!"P-0Y8_]@4^'9Y^/.(O3Q'_`C;_GV MC9<")'(/JUNZ[#WR7TE4O-.3-?'.UEK:L]@O;$Y6%[EXW#NMB+NFM4^K@L/0 M6G:]&&6-YO,13:;J"ER\.%&3/T]!EF3&?L96H80&A/[R"6S>@2^AM#'7OX^2E`2_?,IH3MJ1-_+3UT(3>?IY[/LSQF#W"XFR=/F38C'> MH'+Q8V]E3EU'?@HF5>%*Z[^'=4-0VL;K="[.+?(JF!&E/*]8JW*LBJF>ZQ-7 MM&U*>5-9<6OXVGV8@;JP2!3/'%BSI*KW>K:XB.II.CUDFKP=(\TF755CTS)? M:VCUO.UY27N!;B7+&'L$1#\[L\E&G7EJ:AW;`%"O\^Y^=-X'80(FT%WDCSE* MKSS#A.X>FM;K$-2KO;??H?Y(:)B`U1O>9D!L6EU6*:G'4D_*A0M2RC&C3LO&\PR,52O+/C&[ M:.JIN=P/->4V_8F,PS2C?IQ]\Z>\V:ON40;A\M`($0#A;$"/]TG&-8"A+/8? MD/>_D[F0C:UG`47W^##IJ$?"X:.S'SZN><]SK!T#HT5"1@.,2VW M[\T^E+LP(O0:9!HG5/R95)YD"$X.C0X^#@X3+7?HJDPLTUOGT]89) M;=-3:47[=0@X>M_3#GLQ:9:YH\P)4"20IH,\8V<4F+#B=4/0D.$[N-VX,BP. M;8N-,(#]4@V(V`B3\(\6:,=(#/BK1;$2_L->UYDO<"4,+UQ2_Z!GU42JC91( MU"=QH*^EQA,?49VG'LC8C\J/DQ,#J7G*LVHN*<4\!"3L3CYUXEL);S1;';C^ M\>U'/+OVD#1TP=,A;YK?D-I*>,*>FG&$'K3U;3F\H+\4]-,4EL_^*]O0#S/! M4E!]T'-IZ&@M"C7R6XDZM*5BL7U49F3K>:_K,#(AT+6(E#H(5D(3+:*G?CKI MQP'[Z_;//'SSHR)#-[OV*9V#C5RUV'X0PY)?44JB.S$MYH\;F5 M>;#I$QD2$!N,E&\D6^`6?76"9E[78?!#ET`I("L1D/:\P:`KSHRLY4X;$2AL M#\`=>KK:4JD`S4KL1)]4=A@\AK[G(*>`N\W'O*[#@)8N0SL`[,1-VA!1'H=; M#QWY%\5MX_4?KD9*9'P:W[^RLL0)7M<][/8=1%EV>^$CL MA%@,&?:J!KW7<^CLUUZ`=A#8";*TX&)9:.0NH<]@JZ[+B[!CP7**%)I[/01[ M8_4MF"HB.V&;-C-?,B,TFS]&?GEN`G8?,^8-$)L0HF9>[Y`VSU(DXHB-"]N" M'>]\\=_)YF9#Y;.3M/1Z:#;."KRI@.%0Y\S_46PG2H1*A-4^[_70;(\5:.)# MX)#CSI-1""DU++P>F@V3LFNPD)FC;V<>B(?0?PVC8HV$:;<(FD^2"(1*V12< MS15\MZI=>#V'28):?O9&R#C,.G-#;`BO[H?G-_+.$>Q_&Q$BY;0.(2=BZ\R' ML72#+8[HJ[L$JPV\&0Y&[XY[^+,S\Z('X*1F\1N&X+$,J M9TO3OD+;USA%LON6<-)H[M]!Q^'3F%ME`J_8Q M>N<(-MMF/[T"$H<89_X3=M@@S)8U#BMU-$6?&+^5=_$Q]MDRB!PBG;E+=D'> MQ\,H#XK:@K30?Y;1\#7/F+G\DM17WE58,8'`06"!-M7Q4=$#AVN7J2PC`N9$^3'(,FIKGO8N$'@5)$KGA7+KP7`H M'A@.0^Y. MV@1!6`KSZ(?!?;S85(G\W/4MO`L$?ATMJD2`.'2Y.XVC=C7!-Y(-1B_^NSA< MT:0G[P*!`TB/7@V@'-J=.8&>6#WOF`2W/HW!VDHW,-T`$<-09'C*&WM6BY+: M)%<1&X=/9TZ@7:R--@Z>W=JD%OGB8.'PX\P7]#6,$UIL@]"P3N MNKUMYFK1<]@\<(>0=4>0=XG`7^C0#:"M,\[A=6?N(9D3K44&GG?Y,9R$2C@Y MO'90U/:IW@5T@(5^.N[,6=U*/YW3O5^*(%,@;W+;E?M'*?;3.;7ILVE3[:>@ MH4H8%\!!U?OIG%KUO6@5_"FTN*OL7;D/JN0/2(RWYH^BRO%6_8FBY#M;8>\2 M>I/DK]DHCW;K0"ADXC;I!S2"POG19'G1`(BLJE`UM`2VU(`6*@@*5_DCH46] M1^5`&Z\#P(["4]*$W";(D-4CJHI>ENSLY]DDH>%?:YM;RN9V0\"*PJ>BSV(] M(F2EA^I$OD_3O#%S92.OL<>6G83H8@YY."%!'I'!J.:5W!N;U5IZ':M53>JO;U;3WI9_L`F>'R:"8;6\ MB=H=S4UX40AI\,N:8`UIV"U2HA?2V(UGU\M]6"&-\V/$(0TUE5L(:7!6C>N$ MSA(*=L!@-`J'Y#I):VM<<9]EUQ:YO/)2>Y$0@!'&%O9CS[`*QFEY1O$^7A6/ M'"4T]2/2CX/EC5^K,I(6K)VU#.O72,T=82,@0\,UU4`\H9G#;0!BV=PT\:T; M!675C%P)#CQ6C8&$FE]),J;^;,*2DC@6C[0-J,5FKK^Z_2,AKG[;)8%EQ0AJ M05PYF#9EY:[,B"8+. M&9&GR_\P#D\W.%S\V/OM[S5DK7\)4F-('A!_%E4FMH5'EO6Q8X4]$3]BD8%? M`0\[A"7T"DK:>AV7]3;T[).&X)"E>VS;V6OQ?Z4@\S:&V_=%?G]Q#.]EXLEXWWP1[FTF&(M-VXL:D187;*_I/O5RL2[%P'8$&6 MQ9X.,?'^Q%V-:-W$^Y/.WC=\,@5*K/\-N?%L\.RZK4\ZSK=M(AKD7NH"P$%Y MJ4\Z;C=<7"U*7*:%W`?EI0:)<>R06J@<;>+];V`G9)-KGY(!'?MQ^%>QN#[" MGX5)0M_"(7DB;R3.R0-)TT>:O(5,2W<)O?*#&_(J--L,]`[:PYD!+%B*C,%& MMHDK//_L8I_RBC.56YIY3;R3$YPIP@):Q5B0[=`>_->$@K!/I"B)L9!9P%1] M`\"&(!U8K/EZMD1XD*7?U\\77TG`7#[/^6P6E8>E;V@^3N5,ZG0'>D&0+:S# MLSY:9"G]BQ)%:;96P&*W*\QQ%#4#G`B2YW18E:-"EL]_0V:4#,-B\(',_2FK M9%&.10%Y@E:`$D%.L0YW4E#XLO>K(!O8,P`(9Q9Q`SNFQ(`M.7_UN:\+M8EF MP=VG`1:*PG5-J.'"P):0_RV)DZJLB]&DL">0M@7(.`]F"YA3!&4N/Y^3Z_-$ MBKM7B_6S(@0Y"R8O8H&7[$X.-FXR?KV'48N"![&+,3-E-*XMJ/%MX*:$;A; MF@TW8=0#B>V^Y`H,54X!"H*M90N^2@#8 MKD%>EL)?UDIAI[V&+/011GDFK&LA:>F=(*TE(^!+"1*V6Y+_2<+Q!*3KOX%- M-2;?VQJ^!4Y36!F0J!+ZC=IUO% M@NW6Y7)5Z$^+&IS5A?R)S%CL*QXO\L'"E&64YE0I=:95OS"N$40/=;83^IZQ5!X+&X=8D5[V$!>'#TVD)DM6GF8#BO/O8LPS[VKD'3=/;@\]R[F M/'[OU6J2%%EF:NCQ0H6Q]JW3BG?00Q'`;$:8; MX*E"1I;Q+A??\-UO=EX(ND404VXZ%G1'E+Z&D.7P*RA,`*U<1]M-1]+N06\( MO+C[&EFJ^D!V"D`SGM)#D(5LAMD:8,A2_25+;9%@T\S5I]DC:`=!'-N`Y=$* M/[;3!&AB.#T$,?%6S)H-]/3XZ=?.HN<6([;G"*Q("^PKX<9V6J*Z,FXGS.UF MR0&X+5RJ84##;P(F7)>L->'-L*(5\5$.++$FK3*WAHJ$@0$8,/6%;QOEJE86 MAD']@%/7#+)*QC+!I=5QU3H`[%9WN\HUCM6)TB-Z$RZRVL=[I!I'+'3_G*,- MH;:<_\J\+GNV7-D_:!!!NN,^[!.#ZD)PBT?ERC0+-W14^A?M+`1/>YW.A;E+ M.=:&1>5MBM>/[;;Q3BYL1G?XJ6]"96VEC*B!^`AF\BKU]3KRTW0P*C"JWLNQ MW0;48C,?7^=>,AYWG,V4&!DR@W932*E%L_LP8+*:>]W\,HYZK==3Q<.#S!(U MP!$N"],@66A-R.?\-25_Y@#R]HV5B):["S@M`*5S#T&["5&$"UD^78VL\@MO M>&W8%0-N[W=4HD"9M0HJ9!EQYHE#-F6:9E`V<3K++ML2^VME_REGL7R>0400 M%)9]1$K$51`A2^&JN?Z[/_PS#ZDPH"]H!0/:89Y/TTV>,B!D:5T5>?_A1SE9 MBLL*9GXEV211YH_3''`[S,DQ0J00F3@5:S^>I$+**S]ETDU9Z9K-*^Z=7!JT MR%JH"M2GU(_'A<%_-5\_\NC/V8_ZWWTJ/,)IKG/OY-+=58HKZUF*(^4!48]Z MMWP'*,JFX2J^"LD0S;)0MQ$5X7'?63Z@:M6:THQ2&V%PRVO+PWY8!UGMWO6G M=Y#U\=X%F,50E ML;N8VE$:-I]@2Y2_PH-9>A\_$AHF07%EJ<6!6/,VT"J"(U.XAR)7;=C\G&S+ M5Z34!#E'V(P%H'T'Z'NXAW$B5R'SL^MZ)6I/$UF`V)X5W>HR@.(SC`6U:G=A. M?+=6P!*C\X'=2!`@`T,X&??8UM`HMD/JUFTN1S9)*[F`*@3%='!;*@84+#[) MCR"BW,$34E[D6.39)*'A7R3X'5#2C;WY8^2OYZ-"QT^,2/TP<]L7>J?NKFR3 M1W>S%\-39]41I!:C.#1"]P;4*7/THT^_38IO/(:#3;!*WR M$'>AD(,*<9\>6RW6HA7B+K0HB;<65H3> M2)18!"3V-8[Y$H#ZT>9H'=^ M]$+H]$0V^MU+"/1AN!?!1?W8BJ=;F3H6OV$^+$=KPZX$H'ZTR8\'MS;P MU(NA:KLPHR\%:9IFO8!_0Q7AB>VW M*,M;8))74JL\!_"=%Y2TQ&G]P*E!CZSHI#[X-;8X8*OB-W^JZZ9O]SK0*X[" MES5L:V8X:FL!6;G,#S*Z<$6!G`\S"RD=\AQH/`3YPC?")!(' M#F3M`,4A',/6G@9J8@EJ*C&6Y"`D]/A8CU!^.Y`>K<_>*J$RE6!+"C!6BO?T MQ*;/#I\I*=0#MO/N1BO`]BYM;AK:5^XM&%`F;1,4MO/>IFG#93>9YD]F!CF+ MR2^N8V3KPK4_"S,_*KV:3R0E](T$=PF]R]GY*%99PX^%I]T:]P7J1.M.-N4/ MTE3*882_#ZF:TNGIQSCF+O(]VE(;RG!U"Z`;H1?K)>9VW@4J19LUB&4D"0I&FS'I?%0JZ4X&:9B19S!1PB$IUX,G,DS&Y8@H2JR+ M(CF67PT*M[K/PS!8]Z-#SJ!U=K+N=CJ+DCE9BEZOXF])_$92EB[$M`GJ`55L M_IX5_?^69/\BV0+T7\)ZBM;>"2K^&,5D!4-\AA"VTQMX>%<@9?\A.RFF5YKN/,QK&:3B4K>;6WNEU.GCS"9T;G8K: MXXS0\WVF"][Y(2UD&HSNPMB/AZ$?W<=I1O/"?G%XM7H(_=

.!J M<5?9NW(?5F&@,R25"EJH'&UAH-67?C5?_?.WD%!0RV3^0-Y()$EA4>L`=(#F M8B^KDYN.6I`5WUG)N]!%81'O@I!F3S3J!S3A]BXQ'>(DU*OC1I;(YFP$X)CG M'0X%M+=EKX2^CV>POR_0=Z1W9@M:`5H$$1&-;U7"-`\ILG2X.GE/M/@\6:%$ M$#JPRF<%*;*TN#IY3[7X/%VA1.".M\IG!2FV_+6-Q6<#^QTM,C:'/+]"@]8` MV^:I`M0FN5@GV)+'ZCZ"E=A:1MA6:X!MM8*.CO$MIDC=W*J%BBTM:R\,HS6N M+5(MLZ?=)3O5KFRK"4Y]Y18T!P4@*/VC_%$VV$+5`L66&52N92OY;\*412(` M0O\U+6H$B?+19&V]TRZ"[/"]A904]6$N^<;0$-A(O'SV(_+,D!?*$7'/;00@ M$21B*W+!(5("3IR^@BDYP&%1H0/-$>BYMZ`/(T>@:].3LL\<@9[<,VI&6S], MCD#7IE/&U9Z]NUL$@(?]L'($NE;K-NCE"'1WB@;6RWU8.0+='H[M;0N5_U>. M0!?-=6E6)S<=M?Q7CD#QD;B]C$V'.".!X2[7O?&CY0ATD5P2YW`H'%2.0,N8 M<@^3DTO]6]6(*?>X[BMG.0(OU&>'.-8N&G;V2,!D[?.`#,$Q[;WM:P4Z$&8, M[,>S=9W$:1*%@5\<,(,_B[$\&+&#/I1,V*3W!J,3GBIH4'"?G',W M]5C=)^=NLQ*X6I3MY<^Y&S:L[I-S)-D!+52.UGWR2)-1F#V("XBM'P(L&(X8 M-UH8MJ5'YJT89!-".3;.-Y(-1B_^>WF&'GY.P1HD-Z3\6R%4W[YS[_0"P3:G M&>.F4"/S:HA@\4/7Z\HW2^B:XZ7)*T!_"#96IL9!\U'67%?(W"4JJFLY[P!N M!($QH05:6T?`US]AP?TF^)3';50$%45EC M@U`B=,P8?A-H$\%1CV;KE145(#L#`H`VIL=V0Z9Q7Z`1!.=%F@T*39#8CHH( MQK;>I``P,5PX8>H#+^&(3W7LQ__Z1-Y(G).-RH;NDPE_(WZ43:Y]2@9T[,?A M7XN2C$,2OK%OH1\'"['7F9Y*V8/M.O9.+]W5+%O=>;$0\#G)Z9"D]8C4[R!4 M[@U&K$T?@-`E;((VCOM85Q$_C(_YTJ8?0//:EX9<*3BB+[G[?JR.Z$NK:?=Z MCNC+G1U1O=R'Y8B^["!V1*NI'*TC^HE$+/#[Z--L_D+].(6=-2O8>#7?_(TD MET^]$]"%30>5B^E,5PG(_.&;0DH3M'8?!DPX+JUJ2H..W#3%`$'HX&"A?!0.:&[`^'L,_:3+"[SBEE1:*+I+IA^1_!Y*76 M@7=VC.";L;=;;J(%;![)I;_TT9\S)5Q+*:]O`."L9@"YIEB$&EL1&N8BOTY@ MJQ./6>&&1U(4>+^._'":2J\DDS?VSCH(F$]KE,?%)6LI@4EG=?7:8C`75_[57BC6OE/8 M@O00%)FR-#^84`VV"YD>0-AQH9YGDF5ER*P$)IHIN(T`Y?G'MMQDT,7W&1GX MZI=9<-6C,L"-))+7W'C73`X=.<_VH]82SG M%U4NY2T9!@0IGY9X5,;/X5##)Z:V$M?LY[X1-FN\D6C>'XV8]1^/6=[/&Z'S MS37CB833UYRF9%KO(;'X-J:KCVO;6]49)WU!P^&FLH'[9YA-!K-90K,2:AAEL/'VE;9V\&X;N0QKW+93!H5K#$<>+(!$ZA)'EC\&6+(\H6ISBXSM,, ME$3G_1RF%1)<3WPZ)NE:=!Z_NOTQO!_2=VY"*YQ18,[]]A4T/"LK[6/ M5`:<0YMR1K\[$J]L5P M?ES'5PN-<)@WYP;;";0PI_I@](\D@N''C#@FY_IP)B7_SH/B7(?@^**9CID& M/JX3S91Z.`/$G(]MD0%5'N:K)#_Q$XK4&C($']?SI0J?)\G(NO/V;H_ M%0D[CX2&V7PIT8/"@4=N&^],Q^ZQ`T1V6K'V>>^LX^P\HD2K]4$[`8H?Y3#A MV0F:PX0"-K:F+QZ.@SHN>':"[[A@H<5=9>_*?5#'!4%B'&=:6J@<[W%!'PQ$ MV6G`Y3.`!,UA/^7IAH,"VVD])IVTC/;&4X`"R?F\JEX%RM\4'-NY.QWUXYB5 MVO"`MLK\]M<]^!X3FD["V3K,UG M[PC[W'R:%^FYHB)PB\UDLUTDQR7!7I'$9=%TT3M%VT6]CKRS4W-.5]6W\S:+ MS3L!\6UN1VIWD&T47>-6T<#[P^PU3VWN>)2,/UV*%#:@I_PX"-)MT:G5B(;> M!O1TY\Z,>KD/:P-Z>H+#U&NA:&:8_SEQ9P9/O=`OC+Q(]?"&B#^G1^/YWY(64KXS4E05EHGJ2+ M*HI_L4C'K4]CEN:W@!H24.!]_$;*,M"IM%Z*M7>"AJT&FI3WXHU&1/V@LJPD M9/O^#S<,<2Q4AS(>T?H_!'7OY9=5R!M[G6.7!\',[=D:0T96'E[1NV'H5@H+ M;V-J19!%H\P_9_A84PRRLDT\="K(K@A,YL3&+3H&W\[4[C#IQ_S,MC^=8:LO MQ4/^>PS21VRE_RV)6/;:K\`(T^<@WE`"#5/XU4W.;O8LX:^TH3%"6[^3Z1C! MH;O]C:9FH]F4?K$5U!)]_F"Q1GZ:AJ-P6%C(:TW?`6_]P?7]@HS!:*V#-H.X M_4N9EA&<,<0ZBHTIV%R!,) M;7UN5_/5AE5A#Z_9(^C'Y5%+\_OR=GK`5B^.IXXZE&4%_WX4/H-=LNP&8@2X9_2%*"N&U`+OU5/'P6$F'=,H1KCP4@V2A3:0T'5K9;Z", M;:'/N@C*-9AUUXJ>U?NPSHET[W$8?2U4#E:X^Z.J9`\@`41W,>9'X_9 M-5/]-"59>C7_ZO\[H86U*MD6-^C%.^LYKRRC.W-IPT5V1D8@_UKZ;_Z42/=H M#7ORSJTZS-0WV8T9;#P0^/"1G51Q.AAP3.SN1P7:\R+EOG+EYGA(%CD5LI.3 MW%;>^9E-PVDO\[\4'K+#(!QYI1^TL)UWWK.:L=G@;**$C48D;H)#=L;"&HVX M9F%;?,KF6'<'$I[SUY3\F8/4MV_PQPN\3Q:'JF\!,&V>!=C+Y"J$ABT-OT98 MZ>?(;<-<7U9S.]5C4"(.E&FKH,*6>6Z>.5RSJ'$*I=.GLZCBEMS2:GNUSS., M"-)699^1$G,51-A2F9<5XQ[]>7$A\F:%\2&W,GN#UMZYW:(9:DEW6G&.QBBM MWQF]OLA0C[?FG0`P!#F3^F$J#;#8DG9?6`YF3N=%AL+SQ`<0_6%Q>U;=/54* MK9BV'!Y2-?)-RN&9N\K9WEW=M^\SL"!$"9""5H#S[%"_375XXAN<]Y,$<1\' M>9K!8"O#TRE@_94D8^K/)N%PH_B-5G520U97*=H38;>@%K=OK*1Z4$@M5FGN MG9V[VQ\,)R3(RT-B7$FOE@3)LHHU>O/.K.[EA5D=O]Z*F6KD/*ZNC=X[#8=)"Y6BS.E9>\*L\ MA?DZ35=VA.+QAKIV@-AYSIGA2:L!;F0I'`L!Y2[+S><`B=NDM0;ZYA"U"P=9 M.H4V,3AF0_,,64AMX/BJ?D]OPKN#3:SX3NFO MR]EE0&#L%1@7)OF?4!\'AXZ#S0G/UU[Q*,UZLO!74C.`P6=OQ M9EU!XD0-E$[4SH?UHEXX6_01>%&MEO0SX$6]X)O2NG!_&"^JU5)X]AT2YVIG MX_@%Z;!Z4>T6@-/SHIXK'-3B5UK#ZD4]1^(W:*'R'\V+>N'\_)OA2:L![H_A M1;5;<-"4%_6"7]AG%\['\*)>(+G0W3Q#A^=%O7!X#Y!@H#?QHE[@N]?'DA?5 M99E*9;(:8$'F15W-`PO_2CSN#S,8^4+KT'59AWHMC__)'=NQ?VMQ@&'#L7YIU[%]R-R,? MT+%_Z?Q&]=9<*3CV+[D[%:R._4NWUY%SM2CS,E]R]P18'?N72&[<;J%R_([] MM>W@1ZH;\.TV@-1YS0W#DY4B9IS._$U95?=?NVT`(8[J1A(.A#LL'BRTQ:+E:W')-&R9Y#'LM1N3I\C^,P],-#A<_]G[[>PU9ZU^"U`ANUI1\ M%E4FMH5'%@CXZM,_8)/[NGE[W++:N^"[$37SNL=X,M^U-U=RA,B"`_S;`)4J MHJ@T!]QXTN2UF55'BLW]_T)]=AO#6N"GQ34-"E^LM"U`QA-JU297$2:&O.+K M)$Z3*`S851ZKQ3T=C#@W>CSZ;&!.2,;6&R>NR%5-1!7'X\[#H'CW@5.I!['R M((ALTWH7.P-UCMP4FN5J4 M>),*N0_*@0<2X]B&ME`Y6@?>X5])UNU@,,@;+576U(#CTK%ZD\Y/)W=1\MU- MA:VV=IN[TG/:=EO'9H"IL=W6D6>C;K^>\INR.G)A.P_YIF MU!^*')_-.P/=6-W^Z%M=_(5&%R6RX"S(/PHSB:MS_1!@0)`]J:O[>B:WT2&+ MPO:#?^=I45@W?4F>"!@KPS`BH(*-&^,3GI#=-'9# M8&,Y#,N[?N*@/V5QA+(.CF`8"5H!2@2GFNSQ5S]>I`HY@#AV@^B82G/`C:!D MS[X'@KIFD,7#B]KZ5SY@9\XF,)-E3'*$LW: MMRP8#DVZ`44@V`+N>W`TUQ"V4W>@&';_"KDAY=\;JKCV9V'F1PI[#O5.0`D? M;O_9%#VV:]YVY>\/BR1-,&N&)'R31!I4FGO=4P09D$V)4J6;AQ??#7%RR6%K M4\0CU]^"[%ANBUZ]+H8:L_L;%D(UF+MRSM9H658B!1BLL$M`XD!WBA!W!9\/ M@BB^K7&A@AW;S75U*-B-F`F%1;(A\ZMV`!6!6]$>S5M`L5UCMROR(R4S/PSD M=]G)F@+@#SRQUV$57VZ'@=R-DM/:DW9-#P`?@1/0WD?,A=)0K,70JB]>I]/% MZY.5\L?)"6J,GS,.G#GKE@A>DL5MZ%_]X00^!#KOQ\$M_&0V%9]?5NL`E(C` M?+=#O@IR#NTN\_G6H]5G%6<:\Z[6`\"W6M[4"?%-H'.8=^9B4U>%D;4>E(`@ M8&N6_Z;H.4/`F4>.(_]=&/OQT)#9)^@,E(+`$#!B]DE1X3)!=L-P7/.03GSU&T.UH#=RFF.@*7K.$'#F MQF/"P\:#_<4V'V^P)6%1AN*4_K9_6C`(FG0#BD"PK6MFPS7'QR':F=.N'D$? M1B^ESLJ*`'RW+56P47U/8@2GV M`/`1[,0;EFEH`HW#K(:/C7.U6K%(^&%05D'Y%_'I74(%!,D;@>`8ML)-M%PE M2A4BAQN'B69EF^AQK]>S:6365F53U%.-,2D$@:=$&[9KZ7OGSJ^EE]/'V>3)@5DI M]K;OZ\U[YU9M%$/WSA?ZYA"U"\=*;3@'Q."H&6>>(;2EY-:9<2_P*LG4M_LP M8+.YW[,ZW_'0("OY5A7S&D;D.*&+4D0*]]7+&@-FJX<`E*=#'ATJY/&!(:L. MMP^A54/AX$;#PL.A(8+ M#Q:V$F>FB<,U=YIG4#9SNBMB]L1\8Y*IE@XT2M(&.KBL4%\\V?DJ7\2C-#PYY8Y!5''*H5GPV'B%`7 MV(IJN1T;N)8/)(-$NK)<[C-'YHF\D3@GK/+TN.QSD1B#,2/F7&>2M9L0O@%,$A2P' M9E-(Z3JT^S!@. MN5LE8R\`?3@\BN5J.MG&+\PTVH^38+-^49MS,Z:N!WW-[N,4-IJ5`W*"B8G3 MPKLX@2[E M2876-1AD'H:JF,PY*]W#\IH`/APQ#Y[J58C:AH/,V6"8+ER.!W.\H3V14QP8 M)H51*TQC73T%:!"4`M-8UG8PV'82;)IBBY=?S5=U@OO9LCS'DY]Q#?0F?7B= M3@]!>:X&U.A"-+955V!N52JP+!FF0M16$R8T@MI:;7BI1V1[^\NKR[H[2GBL MJ/?`("&XGJ8I28T!-M^B_NT+>^VKGY)"-_\?4$L#!!0````(`#IE.$<@5KRI M?%(``".?!``5`!P`9'EI:2TR,#$U,#4S,5]L86(N>&UL550)``//)P16SR<$ M5G5X"P`!!"4.```$.0$``.5]6W/D-K+F^T;L?\!Z)D[8$26[VVW/CCTS9T.W MMA6C;FDE>?OGF,P"S.%\GV=-?/OOIX?W)'S\#_^O?__M_ M^_/_.#D!/\`,%E$%U^#Q`"ZB*GHHHOB7LNX/WG[Y]LOO`/KAS7[[K[["[5\?B_3+O'CZZNLW;]Y]53?\C+;\_K5, M.JT_O:O;OOWJ_WRXOH^?X38Z2;*RBK*X[87)#/5[^]UWWWU%_HJ:ELGW)>E_ MG<=1152EY0M(6^!_G=3-3O"O3MY^??+N[9>OY?HSI`,`_ESD*;R#&T`8^+XZ M[.!?/BN3[2[%C)/?/1=P,\Q%6A1?X?Y?9?`)?RP\PG=XA+=_P"/\COWZ.GJ$ MZ6<`M_SI[DHJT'<=6JS35XA+5WS>PB+)UY?9.(;[O=US?E]%136!=[Z_2^X? M\BI*1_'-]W3)\4^+ M&%K)3K7:Y2EZM.$)S7FH)Y[:87;RT_UG_UYW`Z@?H!T!UQ/\7/?]SS_3\7M" MG1;=3Q`5<HFB'D?+M5S"MROHWQ$EQD&&__@>: M_RN(&3I/H[*\V=Q7>?S+Z6M2#N#&H(\S\)CPWT<0:0+R#2"-D/=!S3Q"Q_@3 MU/BQU/^$^>L.QIATLDEBHSE+WM[M/*7@NP^&?M-P)B.=\CL3D)GFW?F3BZ2, MT[S<%_!F(_"VS?=9]8!69F>(@U\4'L:*BG.?8R>C,(\UO;$K$F!(":")#9$` MA$8`+FK$5^T[K=&?U!UVSZ/R&2WD\/\N?]TG+U&*?&RI\'VF'9TC5"N),#6B MEF253G[@^@3A%NT^4!]Y-E_'-]A:*S%QDQ8T`H'@L'R#:(R&T,@YS[`\I/7G M-$.I]ENZ`^Q5]@++:DNX@H]DQXOXK`[W,-X7295`$T]I0\0Y9*TD[&.6ZPQP M;WKF0?J#ED!0[M3^B_9!._9S>D'M5<9X_!`5O\`*[[H%;I$!PJ**DNRAB/`M MU6E90ENOO-R0/BUB;NVI["?)J`GA*:`=;L":/B>3!!T3L$$!'?6+<.>*I3&I ML-(%`>G6IC-$^]#R9#CU2'MYL2RY#$/&05IW0!W85*+Y)$.H-/H>7H%EZO#E MW4*`EL[QBM@*SF'JOHL!O"8X+LDYZ4\EO-E6$AJ`4U&)+^S%T:/+O MELB.UL09]1JZ!TZ?4P$M],@C*&)'")=C6"^J@W@8^?6(SS?+N#64G6TG

:]MXIE&4P[48J2[4<4]RDUE1FSGI&TU0T\),4!EM M-R8X\1!$?+-YGV11%B=1>IN7B29TU*Z[O]!BM51]G#?=\,S0=`1USZ"\O\V' MDT8A&W\U#X"4/8&0-?0',MFSAQ9.RK<.DQFMN&=?BW/K!>.#;S),@+#4DYUK M^!2E]-F0Y,7%8"NG#W1$'ON?G+2H7W>IWE0L"]&9F77U=DB"`?[)D!(`2V&3 MCG>1;Z-$N'MAK'>;.$5ECSOAU(Q]7]K`&QSGX-(5#H>^-P]"^*%BRG_-=T3:?Q\*N"6`&<:X$BV^'VF=5N=141R2[.EO4;I7'2\8 M]@_D<98HE_'#K!6(*E#W!J3["I!,/7YM9K*@,?X!MET7$F@"_?_OUUZMOO_N?JS=OWA`'^?NWWWZS>OON:_P+ M_Z9G`E!AQ6&,3O>&ACS!3?4,BY:WTLKB-/V]F9Y.+BE<,>1(3\X:RZXYAF&' MHR7D#3+'%,*Q*B,TRLS+`HH>7GPA5A3FU&WF[T47Y5+Z@HO900"SD2''"0S@ M[&4(`]+79`(`7&*U@NB35:T!Z>@\<90(K4,/ M`>L:#(G`-P*0.RNX+>`N2M:7KS@XRL`").V=HU_&=Q\VK!U@#1UM,HS0;RL" MI`T#=2 M-MW].P@;,Q,V.-8VYG*VS'>PJ`ZWZ!/4Z9EV&%OJ_8ZZFX>Y4RF%./_0YBM` M.I`S@Z:+@SV2X60Z2B8B#&R%R>!B"V*NSL)<4J#?@MV@)/Y=@(FIB$L%4SMQ MN4V,\RU\B%XA?Z)ILEC0]O2P9=3)(LZ>N`<@7?C-8]O)[_YQI#Q5]!K8/M(( M9.)NT@)A[DR&G$O2P`,C0Y&T=VX>,K[[(*('YBPR*PQ+L&,]"B1,2PF4/M@- M4.(.XM=)])BD=8(_\C[Y.4_7Z%,99TLP)^'<$"RD$UX$M%U)RE:^,S!,O^#& M9&82LEYV50?_]F2+RKZ)C8.D%ZLSCY=4=?)I6?K(0ZYQ>.&35I+4S*=MIP`" M*?5P4AA(("&5]77P;70PN\*2=?`6NR!P+KW*9RU#N+FR9WY'6_I'O1HQLG`# M%5R\@N8SUF!KYZ8[S+-P(HM;U1-52)?-9NS7Z[1=7I#D M&OD&9$0BY>PU7H+!>M439;B&9?D]Z$GBWVH5F._;JQ;P+E_L[!+L66%4PIO' M-'DB^7,,9EU=1P]O=#22B*\A2`=`>@"N2PBSL+TTHF7'3,"4")BW5/P;BQGL MQ+<>YICS>6AA=5@1Q"&%X>'$PO.S-N= MS`WU\XG[03E4Q\!MA_".MXV$08U.!BPBK&,Z.;P4UJ'#EO?5E-$EJ4'?4-94 MRAM(^;(JC)O4,3)=Y]G3":*^/>[EE?X.UA*$7J8@LPG'[_2B6T^%M(R2KI]" M73<93`G>)H!\NTUH,#)^E)YG59(]P2Q6PU;9R[W35\H@N/NV-2V(S;?WZN=' MBT'R6.C%<.K0];@27+DIJ%PFI.L''%QE<;K'13-OZ;QZ6E5%\K@G`>\/.9YV M$-](48B5I_IIE5&&Y'D'\I`(;V9-B=GHQ+"=9@C`Q@#\(&C.`MUA0/-D+XP= MT>)*HT0#V#$M8TABOK_EK,BGTQGE0()R!I:&':IYJ@J&'+(H_A647)]_^]V[ M[_[$0O&"M$%[>_)M&[>(%D3[.AH*J,O.-MC:Q\/@`9X'WM325JQ*$FGG^3&P M%=L$^2OP^R_?O`6[J``ON,>?P+WE)KD%G$VV]6W[S]X^H/7_^A_BLS#[S'>_MN]?OU- M_4?.8G">O`_1`;Q[NP(8''_2TOKC'_^X>O/VC836Z?YICU;*C-PW_@U2!NVA M?:0M\K1IJQAZ#?;Y'I-J@E%Z6V4K*\R=IBO M,!-I#_>!LU+>A9C3IB7`3<%5!EACKU&S8_C':5-.DJR^2?*/>@V"A+A3$_@X M#1[?;_>D\AMY2X@KPA7P&69E\@+I4]KKO,19]&XV#]&KRBYL*?D(-+>4=2!V MNZ;`,D1V:`#VDAI3P2D@<'4V1,AS9/J,,I-0#'*S*#[+L4M34>V]W\XG?R M05R_C=3,HG?P/H/)%M,0C4-39=]PZ4@7$Y,Y,=_NUH]\QQ M[A$4#$*-U-V<&XY&BC[$<'-Z9P6X#MJ((Y.8H$SR91S"+"]@\I31)Z>Q2;"DM(=[:$EY M%T!%6X*Z:5@>2_T)!!B9Z-\;@%IL&SDK@\Z^834LD19A;;?0?)?Q!],@3_NU M7-XIOQ;F$!J M?4@2`I0WWS*8X-\,#*'R4/HNSB!BP+T10+1>:+($ZSS>XR=HY!GQ/)(\/$.` M*";(C:Y;CXK+"D0)*=-RK/+?9T<:\0`OS15G_RLYNA6O4V_N-O-D:5X:\8)>Z M%I].=U$;T&)W(*X+IQ@T0:.^JX]7+#II!AZ)B)&+N%-@\#/]4`-O,"R^4A#I M+EKS,)B#+>F$E!)C4$ZK)!D=;QG0E#WJXUIDH=!]VPXC/ZG`O#S^U;-X6>89^C&%C=Y3OJXQO MDR`KW*5F%Z+SD'=_+C"/5L0:HY\`9PU=PN2TJC:0).LVK*D'YNOG1(]P(#$[ M=!Q&^,(GS.@=)#DLLR>3-#C2+NZC<.7<"W&UM"EHV@;EQ'6?08@J-/H&_F!D MMT(VZNT=7&9K81%GP:Y_+3Z:#G]!KG1O\S3!RW"K=:W8R>,J=D`"Q9JU;AV4 M9]-_#OEB5/TM)ESRGNW+)(,EGIYOBJ`?M?:]I;[=7O\8R"8'X MK"/9Z_!=P<^T,PCD2GBZA'CAFG-=?5^QVN&P<]LZ!H0N<\@E>7%+WIC4SWK^B_^$W%"]1BG>T M^CG2LK^'^A5FO2!?^"ZA@U;J\\HEGZP_H8.0RZBXA=(GLW=PWA? MD,<_E#55I(6BD_L`"Y4$0O*#IC%H6S/H^9T*IHL1M@GI@2;$A1BB;,(>YBI[ M@72NN,KN8)1>EA6.*D36RE>2--S2C"3F=H6LTG/K&2!'V9*=#57^J,X.4.ZOX MJ80W&V2WR19;KL(6^@V=6X#`:1\Q/^%:>1O0-/$+=2-V9\7%_G^L=KL4W9,7M[!&**-F5A@?.B:PXZ.^YL/2SF%RY"Z/T`$ M0$VA#E`H04MCX7+>AB;E7E[P.5K-K?,TC8KR"_]&.`K8PH71>%3[JJIR&Q4W MQ3U>6Z[)6_];6-SC!.C*V)'SS8W((G. MUF@7T/8)Q[ZLI&%V)51Y"G9Q`FTI7%T$YN="7F_!F+ MJ3Q=BPFX9IX4;&,,[ MHDG2A+B!,0&9UDX"V+K02S)*)'*@KG'7;'56@-`C(6>,(OCY@5:]"2F88"(6A.>5 M%DD,[W`*BEF,;8;!PS/&.30ZTEC[9Q)@CP?O&#$@XZ_`XP'4+`#"`R!, M'*=ASP9B:\.?&<$^'$-3(N2T+"%),L.5/_H`(QS$O[[)[O#3DP*M'O"BH1PQ MXAR0X[EBRA>9W6#V>@V$=I$VVH-:@9:+I]8#51?JFAW&P`(0AJBDV6 M2$83M(&LIB8Q61-&SZUFU@AJL$^CHO?6ZHGHIJAU@QU(S.FF*2/@^YG5'.;1 M>6TUGVWXF(6Y.N\WU3,L!O(Q7R.I1LR[(RE[G&G'ZD(UMW(T`2$*!C-Z?XX) M?Q'X5#H)*_+)(HS<(6$CJC&(<'=R;!)S9K&<-YDK+U+4)AO7I' MN\@D0TO$)$I)N!5-O:O/^C@3?>?&,I=>^I;32?[7(4PV;#QIO*=KB(.6>E"Y M)V?%3]^8%@#/+$<7Y(#D9L.S0%R;_H!"WM/7,81"%M5A`SU<0S]T$$L]_%+' M"GZO7*^`>(BQ_OGI,X2D]?$U7^ M)D4?]R?A"OZ%A4_=%O"-T<8)-?1X5GYR+? M1HDJ0;JBCZ^:*8/\RRJE=*%$F_NU`WLA5C92>*CQ(@>4I+*+#DVV)E'"^,NG M_.4KDI6I.&"+>%?_`QO#.\X8V*__\>-?!U#/_]$9O#L<]2'P(_BKGQ MC^4;`'_=XU'O*/RW@79R02 M:-;NVT.ZX]1\`C%;MX'^W0'H1P3DZOD\*F"GB!GZ+YDLBQ?\^H*&[ES#LKPM M\I>D1"W>Y\59M+Z`CY5JFIJ%NG-@SJ,383]`J`),MEODCQ$&C'(3189I@X8X M23",R`-"W^?S$_!VI*PJGJQMKEA!N_:BT# M?J<"6>/O_=N5#D%B2A$3^+BS`/1]\@+Q[O>[79J0 M)V$7Q?ZIU%O%.'*!+/*U4ANOZADE4),B5D>(A6!S,TE?"\D6>71**EEW_U8Y M!=EF2SL;6#L,VZ=/T&)U:^#P5-6#X`=,!L7!0X1_A,FSHSB>\K>;JJ;+-)Z!:Q`VU=K]V&^19 M6.4TZQMVP[?DM;@)KFW93J7\.EV2R0$BK,1TZ'`'ZX]YEG>Y889FA,:P6=Z$Y#$W`9E85\*RRK#C,?H3HL2];%0UR6E'LQ,(LV[<]=J+7?`X4Q M,J@LV&U`F1H]8D29"73[K;$T5'/_< MWZ!H$39XAV((+]?QY_@8`2ZRQB%8NHD$[9N2SUD$Y1<`0R[=ZTS.9^QV7B.J'?;+& M2?$]R.'>,TIM>MBK:0S:G4="2$>C:VY,^4;._4Z'PP%#17_T?BNJY!&_]4GX M:=^O%PR"5Z.;-2VG\LOEZ?<)R"CQTVTC-S:'2EVZ+-'H^UY*9O$.+[]AU2X` M3ZNJ2![W%2D2D5OOAD?0(:CQNU>>#'C(76U%[0YLYQ``54.V ME1DXC;X8Z_.$:(QI#L^3ES?UX+Z]L][S^ER+FK#:68\(;N'BD$7QKX"^YXE) MB7-$41+QX':EY5@X;\9O9-B^C%93\%UAQMJ>S@U;+TL?8G4/<(N+(.,^I#9` M3)\OTFY^9U![F:@`]`":M.D9T0Z)BOZ]S3-08HH^=X7+2Q=`'*:AB?7=@Y5] MN7,8_P&3IVW2A4TS^KYGF\/B M7=_SG6YQZN#>_NL.[O#CO^SI,JN2ZG#1E%DVR2I#LZQE!X7RK MH0DH42UR-P:J55AN,T)8&DSBVT,WZK-8A@3GJ9HEE_*FCEF?=T^6#&4 M9\P.R7NIN^.5S>BIBS?QG+V`L3&VSF,8>TM;SB5;\!(>=P%@[D#,5K"/9HXSDDQAC,P:S!!L.80F@'M8HELAE$E]X=S'-V MJQ!3/"2`M>#TG#.`M;\E0"V/-WVG1]4'+!MO\U#:Q^&';WBH1;K'!X2W^"P@SR8&E"TU8(`&/5)S(XV_&0VP MX7S%L,W]AF@F-085G^M,:H(:[-I`W*+FN%Y'37%`]@YYNO<)R7FKN*>'NM/6 M4P;D`W3,1EI1!T9NY(YX4LSD>.W8YGI81$F+1!.'Y8[,36K$:M#2GH(Y'R$) M!.PN9$=3#.W\1"'[J/,4FBDCO/O7^=1P`;-\FV2!;/,F0MORI,4,U[[6$/T' MXN*K<"163R(BI?7QS`PC>5Y9S*$K[5Y/S)HQE"@#NQ/1D5`'L[CS&/5P>4DE M:H]S0PQ;7<@.U6N0F8W0G=>ZCY_A>I_"F\TI6A:1SYR\P+:$[N4KWL7!-5UH M;7=["L^;3=\[RP)+EAK(N<^:75-]:ZL'P/&T_!!\?>IZD/K\JAD&=QI8%'F, M<'&OM]Q`;YN^WG)[O;GT9LO89]^9+6F<+E/P8Z:NLC5\A>N'_*HL]PB@EZ3" M^0,:_/0U4>?D-^GN(4F_D51B^GL";]8/'Q6PGH!V70'<&2UJ4'>O_L&??&ZS M_YMC4RP'8`O,<&SN(M]&B:I6DRF!X.RND6PL,BF!H&UO61E#LK\N3FTM<`BD M[FQPXIQ]K8C_G'\(YW8\HW:$AP]SK=*O_0::AJ`JTX6Y5E4NOA$G M)02[@E1'AJ\QA"3^!PU;X!(LVZCX!5;L[T?O=;I6-;/+&3*I"4]7'@H8E?OB M0#Z;XFI$U=CMHQ09QT(R4=8.4$3J+A>QK_NDT*93TC9RSF2U#*H%S,KNHLH M5Z#NXC:)6%,<4LI^%T`B:`-KZ=N[L:EXLOF_1>D>UASA M`N4?8/6<&QN_M+M?+R"72F="I&=K02N`>P/:/2#7X%)`;Q:FP:;2U(R`Z2-V MJ8X/Q5QM<4D+J`\.[1M;J,#_MWIIZB0YL-98`R/$4O3]:/: MKS;QUVAJX>D#?@!P=N@T9(,`,DI8<4H+:BMGVCIYU&CK\=!I:*$M/]%),UF@ M/#!I5O-SZ*-T;,NX-KF5G8.X>Z\TAT8$`S-P01H/%,@=['+JT?@IH"BR1?WU=142WFP&SU6G95TJKBT8$J+C/MRV!?BKBD M";B56C@*9ZUS3+/Y;C.O=#RN_`?4L"JOLEL"U1\*=5V;148[.G<^K+,E'3H= M$209H&/BWRQ8MV?1Q:>]$FL%R`[4C\E#*>QM;A^E-3:'7@H?"9)0Z/7%OL") M7N@B@7Q=\D?&\R4+L%(=@(\AYM['C)%X21=2C\-Y$;_GZ?-IB),N!`\Q&NN" M`Y@(].-9A;S/BPU,*I*;(5M?ONZ2)C,4E7G!-8G!V$>W0C'1YY+.AAN?Y`3@ M..`7,:1*NM^<3-XT39S6CMRQYP6(\?XK#<)]N3+EN9<[EG9\/,Z1VVOVR@K5 M?O\61YN[.8-3*1H[F0#FL6DE^J#QQ%+S61S;#:KCL?,:.IH$^6) MI69>\WP8X57S]K[W>,Y#YW<+UHYW*9]P1,ZW.?WS[7\M&3D^%VRKZ46]\,"A M[V_=$4_5_XAU<$!GSU[\Q.P.>8*3",@G3SVO\G38,Y&O\#SVPM\A@'/TX_;H MCK_/&`?_7_&=%\B^X_BE;PX*[OKU%\$0S8D>6 M.ZRPJ0^.I@X%)TUZ[(;UQFL<3V#Y\FM,-^%Y>CY9%EY=CB=$"60I/U9GQ M`ZHY'*7W'--N=&@MO/^EY2RF9[9@G-'NCL)AB8)H,TXM,MHQ.2R%SI9P6,,& M&T!>;HT>^9F>^$=(J$YDT&/T#)T\[!5FY3)@H\]@%+ ML85:@)]I&R]&&ABOZSS>XR,7`K;%V766;W(8L)T,DRJT3C65AT^Y@:EPK3R8 M"L_C\/=$+0(QE2!X-3>5.=AU:RH"8$53D:#U2%?3UZ,3I$P?\+C7U-=C$JE, M7E9?AYQ?92E-+K2ZUNKR:%?8@E4ONLB6F/2Q>L3\$RR87-M$53=CV6&/W#L* M6G1GV2M`1F=F3L;_[?A*K5ZIU+CN3TO215)&L)_@6*G#JT(,BW*AK%:=U!?$*-_GR>9Z3VSSY*'V"Q_5KG:T/@T(\O M#D%RI[YZP$,/1+8VW`*.78#Y#<"=!_G-!MV]H5ZODPT$G_\=1D4(Y1_"T;%\ MQ@B!O=_0ZIS]!0>B>5J=#W'PVUB=#^K6S^J<8^4WO#HW4GCMKKG&_V56YW)K M=[(ZUYFZPV+(I!B!OIQO5]X1J\HRR M93];8\Q_C+9C(PJG#A?(5#E9:V.J2&@*V7#&@48D4R7`8P8?$3_;F%PMK3OG5`*V.S_")XH[=X_:*!L<); M$X_0EX-<]?S9AW\S6PQT M+J]-X4"V'1)4.6@'!7A4G%.*C;M2Y.QH1@=L>):("G`,+%3

X6QX."R>J9 M:2WF72E\Q3]#$)5E'B>X-`7XE%3/H'J&1+U1=OBWW[W[[D\E*,D^.5==@SD] M,'=D\\(9O%.#=^=#+[>[-#_`FKGA*>)CGKW`$M_VX]F@)+;$__T\+ZN/>?5W M6#&Q_J4LF;7@F,Z]YI+Z$])TL+$:1R=WBLV(=$6$=C&=E10>$+6IP`%6H!TS M"#?I4J.D']AG1=-HV$WB16/.180%YA07-^*^-W1DP1/.N.TXY,N7Z5B4E@!S M-*[;,W8'>C1S+[*"G(2O6T+&&%$Z)> M)]%CDJ(E+"P_P*C<%W!]@U:[\;[`U2%1`R1E4?\3J2`I=2E$9QS#^4)P3OWT MK1;3!H0XH-1)B`9'']0#@)L,-$.05OP@@(P20OY/1]IBE,BV;<4I)NHK)IBD MG;.;67_IMI"->7!$9X?FQQ\36"!%/Q^NX0OZ7NHP15,"_ER(3C(%XL\.@/M7 MTQN0[@$DM)Q!QA4G5BAQG':@E-JD!2(]&!SO344^M2&=EG3\F9^AG(;SSK`] MAI"L<3Z!5[V9=H3(7JS5!M%2H[6'LP?;OC;.CKH&SH:VL;^CI8&Y++6LU M9B+Y-I=W]N8RB#(O)QO@=Q7"'*9'9(P0,QT(,)&]%6HV3S M?0(A`:3)N8,2C9Y/"IN;!/.%G[)[$(8V()7I<6!["Q74DG"LB7"1EG.:8\]/'DB234[@F@[[N7](8R",\ MA:'XYSQ)VPUM#EG'I=R!Z0N6T8+Y-T=CD`DO/^P0YM!LN'=X]U$*[[%5$\-7 MV8NBDWM#44D@`*EN?++)BY,2-0=M>\]V82/'%0G]I'N!2)`I`$/1PDJP$$-, MN3.-AR+"[S1:1G`\K<(J).V=&X2,;^'="FW'&<"*Q+G[1X]2\WW@&*C=87Z` M*JK([NYF9A;?T4[ZQ.U"3&^\!OJ[SLOP($?,/T2M]5X!^7Z#] M`KR`]/\&.)^#N'/HSZ(1(4TN"2P8Q#ZF"Q!A;">(=/TXO28.:NK++_*-]OP+ MJB?NJ">AZODSU$-'N$EH&H,?]LEZ*'V?&XUA0>-G4FD>[0#[\_>7,2J@N>!5<*1QRV'Q[CL,5XWJ?P M9G,'7V"VA_<$("75]SG2]TWQ%&7)OT@*%EVRDE'4W)_TCY)9..UG5+#U,3J` M$6)H!9@4X&F%D&9D9NES0?K52/&=WGB,A[UPZS$5\^Z,_0ZF.*WI;514AX9FLV![81 M@4;!]%,).[>8R9KHPU2V9"*/1QA1$N-=+[8XNH$%><^#DKX5S`D1A_&H<5SL M(1^`?KXO"EQ#@@2=Q_0?JMA40P+NXU1-)1-B5FE'_DF#?\S:?2`M?6/++7V^T@R4;T[Y.!KI_,\ MJY+L"3^DO84DT_MY&B7;4EN6S:2SE>I MSC%&TO.]##*66[\R:FFPGW6.AN<"7M MG2-4QK>0.8RU:^*70KAB-65>$H(5SC6I$CU]NS"`CL-+&!SVKKO);-NXOW+A M^!.N+$C(?@#WCY-X='J9TO_:PAW*\*=VC$=MMJ].*S^8E*:W8E\\G`LT4:.# M7]UO.JJ^4S2Y#5/T\3X/J^ZP!N9B[<64GPE9)85T4@[JDDV+*]WL[/UJK,_0 MS:<,?+.A'_Q/ MFX6':FM,Z%`_$A`33MIPS&^>X5?`I+PXWFPOX M6+%GOKI@8&,*'F('3&7K`Q8WJ5,''$#=-8#]N%.1W,9(6.%0#)H8`4+'K],? MGJ/L`2*?4$3%X6J[BY(">][S`JZ3"CL"6+95C:^RRZC(T%JD9-(DL,0YE9HD M>=JPX@7']/,.?B']#;\OK]!@H!D-M,.M`!T0T!'YTNE)!NI!5Z`=%M_;\=D- M0XB;_B^D4.T\\%L`W/Y(>BHYAU$[C>+?;_?DFG_,$T_H-4MYO@FX_+8%4F)_G2QQ]4_:"#NN'QQDT8+)KW<-)U99*-K!P)L M)("'HHN=FZR3O9,.!^AX=5#\@CEOIN2DG%>!,R7Q].^3%K11TS1ZLQGHM"WQ M-B&;;9(=O0XC10/K;@#5W9QO=S52#.QU6`^6$Y_K$\*EWO&(8[H]=2:1RVVG MB>WT-YGFAN.P3"'.$`VOD6M:7Z%/F3WAYSVTK-+9X4/TS[PX3Z.RU-6WMJ'B MOL2@E8Q")3S2^X1T!VW_NBK>XP$0$H#0".8J:\1W%>K7C?VHOI^4F^8T,.H= MR&-S73:#_LMS_PBT^#9FK\\G)C&0K(-.UVN2(C]*QX%I#!&W:R1;"84#B*8_ MZ*.L3F]05TN-5=D.W"PXIDI[!]%JO<0R1:W<22WWCM+R_=QQ%&@[RY$)B/61 M%/0>/N$OCSX.3@B,D_YRH1;LC^9)02VH>4P*:B.S*BDH:PH:0H"C!,X.38,` M7JS-+'VND7Z%EV]&XOM)"FH->WE2T)&8]U#C[VQ?)ADL2\:4;N^AZ>>O?I]$ M#GFUOKI#C4CU;L*105I*8R>#4ZLRP9>TE*`>7`XMA?*@#;[KM7-O"3T^Q50K MS/$&$(LV#Z].\3R$`@&_<@A,V#/]5%XD+TF)I@Y&7_J@5-W<[3Y(SG7_8_]4 M@KIINSJ@K?V=#5NP?]^ROS#;1ELR*\6O:\Y+IO@M:>Q[QZ6!?&=O981WQX=D M3)N7:;)-,O*UM(_`-?W\'(PIY!@\$JM1Q'7P:LICA3G/"QQ:6T$-]\Y/^'3` M&CS;,T.5\Q75T.;HVB`0R:R[K_673BK94F?XO,!WN*]GX3RL\(Q0*5GX64#2 MPT[_9@>12T/OE4U^#M!T!6W?=AT:SI'`>!%7 MXV7T@/,F9XL*+KZFNQ4TLCF@D$L!G0H,4(FB8$%=WJA M!9]D7C-$GL.P=A(7H3"9NH'[$/2:,^%>E_QA!1YP846?,)=R2#AC@38^JTIJ M&(P4##J-MN]@4(BA'P"@PRQ+4?$+),4TVPC7.NI5837J;NYS):FE$!*1-$!8O!AY%O`'1?Q1W`/L(*\W); MY"_)&J[/#C^5.+YS8$%E`+LQQ)R#<93$0\]?"#)K,CAP!A,"5YEDK:T!KQL_ M/XOP1/`-,4DR!^2-O%'3W;^%CD=VWVZGPMKAMF/]SSU+F?&0X_P:69RDN)@W M]]HWG\_>EQG._99H&:V)@;/-,&B3!9J!`'8F?$8%],?`?,L++!YS@YV;>T56 M.2@:1>*7A2G6(/HM_CDFCDKFHK[W[Z.6M%=AP[>XL?K=/MZQ-Y0CMY%B]R"V MDP-2F6TKZX[+[2^_HU)E\`D_Q!^SPS00CG"/PS\B&K^;<#FV!MX9XU*T")GD MU7;H^U$98$WVI6JT.MR?/D<%/(N0G\#OFF%6#D;^\/LF20?W>U(9Y\)N%#<$ MI"7@F_J=:LW9K_+X%_!(V(^U[#O=0BNQ(VR>#8#C#O?M"_V+I-SE9<)*XY%# MU;<*_.LZ.K<#K22#'IFEET&.F>N%_?.BMPAV,\XXR;BY)I2#?#.P]0W&!FD. M'YCG!4R>,OJL+#X\%!&RY!BS5O/;9L-0F)$=&?=/S.VD%-Z8T^Z@[@\X`EPR MFI:&7T.;2=JXEA:^LLPRGS^A_LC-I"1?J']#'`->X1G]:.2Z#!&.$0LEO(#T M_]P>\#S:)2I.?$#DN_T^-(X1HY"HTFP%Y99G68TVV1['JH+\II$-4@CE.M` M:IN?U_2^P-/(@'62F80F9.1N-Q:)\IK?<,T5,F#/*Y#COL=AUAKXC[%V(^S[ M=`)U,A3$*'[#MX;9>NP\JR,5@+EKI36:?YND0#@)4$,GX-EXA-A,PK!G9C/P MZNW6!KE^C?4%9A4I'F)IF5R_(,R0E\/0YIHNX5F76AH-X[Y-2("4B;U(\.33 M.&X+N(N2]>4KOCJQF[GZ70,P$4$:(RMAO0#K%IJE:(6J^8>T19`6,XPSO=&H M0.9W4L'!,0\X5_GHA=\@A0"L2":;X5:.A:R1_D$O[XREQ.)4T6OPZSH%)$VF M)RT>0SAW8?DG1YVN-'T#,#)1'KM33&4"W\GR&$:;C!&KD6`73@IB0["9GV4, M(BW$UQL*.[(A$O!KC0$(6K_2\/FJ=+*DZFAG_^9G#];Q#S$",TA:RG2FYU1* M8J$8J%IB*T-M2!W-@,]K`@3'7P!"XP09 MTI8OC1U$;.@TJ>^C%+F@72WM\3Y+&`'POC6/1K=[,W[(3^-?]TD!/T3Q3"/K MA&I9?%B<&19EQF8#1(=VQMM_A*L,6!N:*07WEF8LFWAJSTV*X)Z]+6B-+5K2 MV.R.><8+*;`!IO-1=A]V*TT*&VR)!\-E%*6ADR3.0$5F"N?70(:IO*V9P9=V].\O;.VM[S_& M&9N?&?8ZSY[P(15[W'6-+W=O'M/DB2074!WJ6E'Q.@_K951/S;@_P`2:AXV$ M!.!HA#-AVPM[R\W<,1,PQ=W\6^((I*HF-QZS#+TWZW2TGFVBBM,]=R%61,$A*;4G"?!\I8 M-N',D^O9IBGN%A`*XLAH)A'C^M`(K),R3G.TR`OAE,@2G$)>J3'(G%`LDYQ# M1C##Q:^'/SJ3E]?U$]!,!MHW:V$J=C8 MQ_L*D6/)2Q[Z,(E,/*B=;^B:\UWA5B&`6`:.@><12F2X/4O`"[B/2$3T8QM2 MFJT'[OHNFF6LP0YF.FDO9PX3M3&X9"#;'$:4C\Y&>_3!B_.6< MG55P\=M((T-7ZP'D2IO+4H:.,^8S$X>5,^J@7;1NQ$$^;:IMF@/O*D-NKXF!>@USS4PF[KX8Q51/"0\":(-GSD0`X+D\])8J#;O"Q7TL7,,*+UT/SV(Q0IV)&@PDQ"F^6Z+N@H^[F MB+8+\"6FN:3M2\QC#ZR;'E#GRR#/HC(I;S:W""7UN1E:@]PG3UFR2>(HJ]@3 M;L3L;9XF,6+U`;Y69XBE7Q0F.HVLL=C5KL7`1:_,:T7*. M::EHFO*^"J;2Q"`>ABM'#X+!<^*88@_7UVU*4\E(X&>434:)/4_!UC0T56%%@ZW]AE`W/.NBI6E#_TA2 M:%P963ND;I=UR1$+SVCK#8L2ARU5!U7PST!C#S7(!S@>+);&&@':RN.7*T M`DI>X"WZ("59U"O-8`RU0.HBZF0>+)IX0JL.\G16@%(B>\:&%B#$Z&;Q`'YF M_P]JQS@!"F:5#"UPX+!:6Y30)QLW&W:T$Z5765D5)!A)#WG#_N[KLQG*)90J MP\?S]$G5S08T70'7EZ'8[U)[!OERB7RKH,W4"K!":39[M$X(!!TX#I(\]%4W M=QO\*>=:DO^S=PJ(&WO$B8GF.X&%1FIW>>Q19U-Z0$.=OB;J0PZQL8X?82%,62&.WN& MD$0B.:20V[G(MU&2!01]/+P` MDO,O/HBIVP+2F+FK8/"E_1;B\Q>C#Q%"@>@2;8[(/U/Z8)6NQTPN;2?0#*AT MM%Y^FSK2M(`K3R_LA?U46)C78;;"A,N\!S]J_-'$A_M67\QAB#VR",3)FM@&GCV2=1+A6ESZ,"WA1/4<9VI[?HOVCL>UB\)#%D$]L/15Z69TF* MB#X-G6%-I.?V4'2"W'WX4E(`TP(\,<"H`48.U$LA0A#4%/U<.\RM!"K3(VI` M'T<43XO%+AD]K)__^\;X^^;\]]VQ[UNR[UNP[_O4Z`)3]/TR?ZJ%=\[6YS%O M-_X*K0S(^[1]E)ZF:?XI0KHB!9%+XFC1;O(L6E_`Q\%*($L.%JRGL]+89#?( MC0::X5@)7V&A@1DS.-PE)-TV/0X%M\Y!V+,'6O,(29J$(,/Q=8U8G!1 MFT>$F#4>\XA959@U`NDXR>%7!K70-J^SB M.Q")Y]XH&`EW`*1'>!%)PJ?01"5)OH/K7%+WR!^1DZ9K/!(.:-6%*"EZ>86^0/*80OH(\4/T MS[PX3Z.R_!AM]5$GUI3I!;&F7RA.4PI0A=L,!HE&W\;0=?I%&5_!QZ3^VV!S]_>`PUR+ M*=>XJE':W').K_(4:A>NZ[0Z=P<7?%33)F4SN566]G`.&CGO?=S@EIVLA$%= M`VN^01\^1A_`%X(,7(ZL@V?\*-R.`)^`'(]:_6KLA.!\VO=6LM=0RM9>0"/R M+(2-Q\]PO:>5?W$9GI,*UU,B..*?#GI_'F7P)88@I/P,OO"C.7D8:NP9/9)S MAAY,@CE=D*M;C1&?9PE=3HP.#>1=/,-%>0S0`\TJM+V^[D.H(>1_]][E1W5P MKNWA&4:J8W/!]01Q9&[X#=00\GY@3O+:0G(YKD!-IY7[IW$='H55#?TK6HJ>X'4>9>5-=@>C]++$1T87L(R+A"0!P8_P<"+) M?`>+ZJ!9QXPEZ!Q+HR47'P%%*:!=5_3])4E(2OL$LSJ:]J'[R)WC*X>03-_@ M/,"D?0J.)XO]VG^&D2>;:$ MDT<5\!EF9?("Z=T#3H"O$&#]SSU]Y_015C>;A^A5985+C.;>;!?1V4!P23T* M>X_7&0>P&Z_/\5!?K(#:+;0CKDA%##2WH5$79D=.=3A!N=]LUWUFGBD;"!IXE5,*M* MGVH=](2?IUBM`51>G#/!N,4Q7N(1J.;T](6HE=7L0JS2C MFPE271;_\/N3-R?A>L/9[-;4!\YLM/X]'^;]#L8XV)44(")AW(T[?X^^Q.G- M^17S^#>;5L@IKF^.08/Q?;-H<(3SZX_)+?9H53D\+'F<2HII(EMNAP[?[2VB M54%E44.Q))JBWA"M!=,]KCZ(IA):>"FKM\]TF1BN0YS/G$T]XMRV'(9+E*]U MQWL\#AJV/\EX& MER,+CAF4KYBJ/^=KG\4O3'RM?11*52Q]FI4/WC#'49IBY92 M)+NZ->;]+R+E2>*[.>)=7+,NR$LPB\XE]3UB,:JJG]`OGR"YD0W&IX6C\N.\ MGEW<%9BNK!SY@0!"XO$KGSJLXU\AL:A[F;?$#? M=8%/"V1\3Y`N;=HFM]&!O'K\%!5K6N2UO-E72*H,WS)>9561(.N.2>%)!;87 M'#.0&L/SZ,^T$C'@AL.[$+X=&Q*0,>N2Q27ZH1UW!9J1:<%4_S:X."K-"AG/ M#LD)*0X17]N$S(%H;L1I%=%0:-(T275HU-5MRD,S:<0",G4OD@Z[T\_@0>>R MAWQ'+)=1`E8OHCE+6VEA7IWTE=:VY:V8I;9@JJ2][R*6TK*H0@'+GVG3`-:0 M2M5KZE;ZK8!ZG53)$RTO!:LJ)7/?Y2N>$54K.F4OYP!2R]"'4=L:M,U7@'7P MCR6#+])'E/'GL,55">,OG_*7K]8PP9#Z!O^`D?0-AR3TJW]K#Y$[(5,$^S-YD.UQ6I+HL9E^E$IHN'6Y-XKC9XDG[;7QNFW[?,G M7HNROP/)^4<93^'4;%>_2;P]%I>%@KG$->&2:^R-7S] M*QPJI*UHZP$,(K\2-+"&@+0$J&D(>)!H6P2$4M5+(8)>`7-3F'KE*6_N%!<* MKH5S4-JTL\P(8PVJ4SV/$#.]+^LVWB7$:?5XG#(,U` MW2X$;S&H9-%7*#2\%`@>B@C?LMT?MH^YH'PF0Z^-TP_?YT]X=4/_#F@#O]]Z M4)?\5U8H_D'M7_H)5O5!0=O2Q:E!+(EM"D%Z`=%O1"_V2 MO[,/P4>8?*.!Y87Q!W)WZ7&V+Y,,EB67@?(T6Y]%95+B+)2PK.]&3:J(C"'F M_(IDE,1]K-9$`$>%Q)(2.C25:4LIL-(DX[]Y_[9EZ@>?%!12[/("S;\WFTT2 MP_.\E!=M'V[K.NQCD%\Q:(`U`[0=(`W]!C]8,IY3QF/L$,.H@X MK/8%J_.H?+[%#Y37<'UV^*G$1?"NLA=8XB"+T[A*7L@S*X4OMB'BOC*8C81" MO3!8`=P;U-W!V0%@`N`J`PT)T-)8*B0JKZ+T>FE)8RPI>;V8-*)%&M%<3B;V M8!4JIXU$ZH3)@R_6QM+)GQTN?]TG.Q+.5%UE%420J.XDYS#V--Q.-I;RJ2OR MU04"D)4U),`IKBA!B8`[Z4&.FQEJ%FEW3-J22?MX`+"1-JJ0]3%I\23A>UH; M@]_.=#<>O#-9W1WAEC8F1"%W\V)7*O-J&F/;M`"\5:3.6HC:-HY*`I MB$.R`PFBI+!7PFD"RANZ:`ND-C,9Z&THN+4!*]G$-T]U9[2W`?HYQJ>1S"5H MO@&9=GKQ;47VB.T8U5BX3K`Q_+*WC3@_T(0?-YL[N-EG:.F(EI-H'W>Z7B?X M&T?IAYR\5/D!7_5"Z5PSD:A;2YRJ`2$4&-'CGB@<`$NB@BR5TL2;*TP5_Z:E M"QAAP"C[M-E%5!)S*HFH2I!-%U0E"<['4Y+\15&KDBU3R1.E[-NZ9[&5CL'/ M:"A^H_LIYXI#%%6G(&+[&PD,0_MI>_^G!OJO81+8/_0I)LPJ]9/ZJ^Q]%"IFG^"5?AD$T?IKW=SA/&,O4!5'?$?K_N"KB^H.GLT^>/%@\M M6NCU1`FJ9Y*_@DK;^OA-+73,"1W5)+'O7RSL4=QS[ M&`A/L+=VBJAG%%-;,^GIULZ,9!%>9+2+AF;]%91YC9*J9UJM17'BXCPQV(1P M@V'[^O2+Y]06FA]/-!L:XY1V,\Q=8'/CEW!U,MH_[HH2J(XRE1O.ZR9I/9]K=%QL* MT+$`'0RTHX%F.%"/U]N8=88,:%NVL!+Y_=J.*3&F2LRH$K-6B5&CQ*)68GWB/E.N4@@+-QL\$ZS_(^D>K[9[?*BVF=HQ?*0XUQ#CVE2 M/I\7206+)))>+MB2<7SA8"VE<'A/$8\<`Z$!,!'`40$/.6CH@)J0U\N)N61& M=AP3F3]AF:,,+15:L:L0L1&-"G?8)H;.(E M\."W>9E@'W&W1Q2>I-%9AIW=&I^I1'WXM?V(V=&9A]A=W1>PSC[-;*QTYZU) ME?LXQ@&0+$GF?<7%K)&U_C;)R.LJ(O./,,+%EKS'@UD!M6-:(U`ZZ1*1FS=O M-C^5>$^0K<_W995OH^)PND0CTS(@A,2U_<(:J=IC=..F8T$Z:39,H;)"XXY0+O6-(4DC[(Z ML$S9Q?6-*],G?PQ?!L.)UTZ,SD%WP4D5MU*%$2EG8"*] MN=+0/N8ZQB$I9OG<-@KR\X4WT%C4F\W?\A1Y"'RV@QFY(H7#49/;`OYSOW["`*E? M.AE&,HPA[#5H890FM/$)+"8PXQ=3/"GU[@=GL1Q5',-5XIJR"X[C8XV?%N/@6R^5UFJT_ MYJP$EWP-K._H>`5L((FP2J1]ZLIX=48V?!>"^M7_]KKZ'2$5GD0.V*!><+D9 M'!R(*QX_0_`8I62*+9\AK,":)J4`^6/*(LCK13$[LH'K%3ZEJ:(DP]2JG.:N M0*2B"D0%HH-XWR.DX>D;9.CG`J[('Y!-8^[6I#(S%\;(#;4"><$5'@8X1`94 MR19^":XJYBW1FF$-=_@JL20W,Q'[7*$X!V/CZ2[=[2QG2OA!5$9KF$5UU+*T MWH>RM>,``QG/0D0!:]A&X:N+?3B*(+!FOXZG]PUF-5BZ=_X&2)D`VQ^B`JEJ M;89:26.WH)5QW/_HK%U8D%V(>6?`5<*E@UL#K"R=%/TJV^3%EGR/:U61-FT7 M+ZG1)=Q+LZ-S[4.I[&7X+8:RI.L_Q`2G]X!?&.V+`TF#J(2&JK5;MR?E6[IR]1DN)[2(3),F)9!4@VJ!\*M+O$Q663?\'U M#VCQCG>;EZ]L,TD*+S\\1]D#W.+,;L7A:KN+DH(D*AB`V\+C.7\MO)3>A*UE M/KBG,WHP):$EQM-_*0#,LX,9=@0><;,W_N^5% MT=A_\KP@%)'NJ"Z1??^"_HW^A7[`=7.)#P``*G[`P`5`!P`9'EI:2TR,#$U,#4S,5]P&UL550)``//)P16SR<$ M5G5X"P`!!"4.```$.0$``.U]67/CQK+F^T3,?^CQ/+=;E$0MCN.Y06VVXJA; M#$D^=TY,3"`@LDC!A@"Z`*A%WYC_/ED`%Y"L%2BP$I!?O'2CBO5]F;5E9F7^ MXS_>7\-/;X0F01S]_$/OQX,?/I%H%(^#:/KS#[\]W7P^^^'3?_RO__[?_O$_ M/G_^]`N)"/53,O[T//]TY:?^$_5'?R3+]I]Z/_9^//\$_W%P_OF1S#X?'O3Z MG_[/P?%/Q^<_]7K_]]-_#;[^OT_7CT^?/G_Z_OW[CV/H(!X$.&/YY$_^I.)X`O[ZR_R'K[``&L.L5"C4&\TJX\M M_/"%GP3)_61(20+X#"CA-K0PH`J1C#(: MI`'1''&%;BV`^1:G)!GZ<_9;>N/<;&&)SRB-J1%3JP86!O!;0NXGUTD:P(*B M.X;M-C9$0=);V.=>R5V<)$-"+^/7USAZ?/&IKF1D'5@8X!,E?I+1^6,:C_[0 M&])6$QN+0APE<1B,V9Y_X8=LXWQ\(41[71`WMS"X'":LS&0,W,](E!@LH:*V M%H9UXP?T7WZ8@!!%@#OSP%DX=--]4-9E3=F)CH#$EP32ZS"B%(]\R'J!TANG=F=VEI84R`#-T=Z*MIK8.7^Q M@^YH%&=YUT,:1_"?(V(P555]6-FTQQG,_?DCF>:=P@'E%Q)/J3]["4;&YWO] MWFPLTK!"Y`?5#8I@4V`R7/Y;<\W6ZZK);6\(NWL$,R.%46C>7W3[:O9,\\0. MD)H\:W33V.YM,DYY#\WOY"9CU>RJD6W39)SBUOO;JTS&:]CE'M=B$Q2F?39C M"KDB*=R#DR?RGF:ZJYM&-RZ,`%6@U/X1RP:"*AAD[9O=8!:_5GN'6?5C>1M_ M!.4L3F3WD_L9LV*#JE:XQHKZV0N[9KJ@WYUM&MR":YFIC#O=W]W%2+%-^]P[#".=JMBU;5/B9O]5+(L[/>SQUFBD/\:= M[A^(YIG%O-?]0S&\3%;K>_]+;DV3IODO-&U4KG0,->FP21GYRT^[K7>XYD9WJ`L^\F"NA(Q^G,9O7\8D^`*C/V;_ MP6`NQ;%OQ>&.7?.X=;0RW+,P!W1RZ3T?+SN$_=R2Y&8JV^.++ M+)^CGTMT"@3]"M M0H#L$U#<8XPRVY""6&XE"'Q1]1&+:@`(Q@S%3>A/!;+:^(8A[;=/6#P,?&F= M();6$O>0T""&<]_X"K8.Q0S;^)8A/VF?]&18^%(\;8$4;X($KN#_)CZ]@3]1 M;75;7S/T&`^FFI+DH^'+\JPULBST4U^:I>\9`TZ/HS;DN8N'+]%SQ!(M;M,/ M9!JP2W24?O-?14LL[U.&^[Q]X7\Q"/ZG!'0:Y\P%7`$\G1APS&;EC=!2.@E M`)G&5#XI-[YDL`_;)T4Q$H$`,5MJED&7\]?G.!2(;N,;!M6MK;R2T'@8!.+" M;(=9;`=%I"$S%.;AALE]EK)7]PRA?$^4-&2DM-!FHPU,(.TZIAS@Z,NVVZ\9 M=^#RD;Z1Y\^.47[77RMQ#ZH;,6F:O?(48S3MCV)W>\+7%P_=05$9LWPFYOZG'2TWA8!K>TZD?!7_EO[\.2R@D M4!Y;*>AT';&@,6.M]._U3\Z=S>U=.<'0I8$G6K.\1K=>_]3IE;,!V0H6AMHD MM7F%V$D78R,^9[M354R.Z'NOYVQ&7L$]-XR3C)+[R<[P7ID^Z$Q`@UZ\0[<6 M'J4<^+/'%&&;YXH@DY&##94_$HV=4M[0.ZP9^&8;T5J[=&:;=A_>H5,K@($P M^)/.#&B;IYQY*BX'L[$TR"ORG,=`@E32^7I4&C-3OQ/OL.]JEFZ(8S',KS[] M@Z1,+#L#!A4E-/6#:"&F09(0TTG=U$]ZATXC#RJ*G;\>-,I1FY>/C0QY#E:& M\N]KK`&\S[VSK8/A/@_!H$IFLU70`D`X=7FI"1:<;F5PVCPQRHD;'>V8[.?G M:W(UMTA!*^^HYW)/W!J5[KXF:N8=.74MZO(MWHRDP-H\;[:2C=HPEFQVJ3*5 M\+_VCH[-U5\X'G]:_@V9,LL;>$=N0W,5?&WYX]10VJRXLHRT#C:`:Y]&9+?W71F MQ\:'WO&1JSFQ09G.A.`W\-R^P9'0RI\#$A26)L`;H<]Q0NZ<6+Z%N;H=S(F5 M>Z_D\AO&2:#P-)DT]XZ=.9Y6PQ.]!.=_Z+D-$#8FES^+.)@LS9Z4T(VYTW2P MVQV9^F$1WR5X[,WYRG,;&"R1PM9963!T2^^X]RVK`H7PT?;V)Y[[P%\>^;LB MVAFTI/BH8BV-+>^]_I.C482.=K+9WNNC\,B*!6H2C,'#9NEM.`:%6,1$)JR^"4"&[>L;21>:\R)D?BE[8$T%-ZOJHJ@`<[2,W0,*K'R M]@%&'6\G?.;U422Z,I7O#@1;+]%QB+'(\KQ66O5L%K;Q3E#8HLP%+,-CZ\&Z M^V/ZD)*9'XROWUE*?0TY<[_W3E"8JDQE+,9BZP&[>_EN<*)[_?).4)A$C#?= M'0RVWK&G<>J';N6X#'>^B>DCW"K6$9PL0[]:O!K-O1,4%A3]R[8N)EO/XS'L MS4,:SPA-Y\/0CY8!PC-F;Y(?N63-O)-V&5F46&P]D'>_>A=1.D_^.RE?*74F MO**E=X+(O*(AX% M6\!3'L.\$T278FVS=SYJ@:R,+5SN3UQW@?\!2-A*O6!AU$0#=)*^]C2N+MX M.Z1OZMYLX)VBL)HH!">W;W,0"23=0ML8@*09C':'(+FH^6T\'(Z,JM*6@!(( MO(7&LO*+0+6H.5][IR@,9Y6$+((C$&\+`\4N_5G`3I7$3\C]]!8! M[Q2%*<;NE,]!"83:0LL<>ZX87LM=Z(FCSA[PS;$:?JJK6`"^")TG&1D*, MVEE)TTIIB3!H30,BU]6M#28$>M)"$^-P.=XKE!.=K[PR%Q4DA,%$@!Q^. M0+PM-"B6JCDH7\5L?>J=H;`J51(L%XM`JBVT(VZD=U#)=?=C[^2@O:(5P1%( M5]]*>%Y(-R)3EE?"K=]G/`X*($,_&-]&BTNSS.O#;^&=H;`85A*T#))`V"T, ML!N,1MEK%C*5R^./8.4"""\D2H(WLLZ1]8VD]Y,G_UWN^#/IR3M#85JLIAH5 MH`I4IH7FQ0?"LN62\3+158F-*S()1H'LB*]N[)VA"-NKI!B:Z`2ZT$+SXBY+ M1M<[[PR%,;F2K`5H!+)MH97Q:Q#%-+_B%M=6B62W/_7.4!B1]W9=Y^(7:,*' M-34V;F+TSE%8L1T:B2JS)DB>8VYX=+YJJ0R[-:*5O?.NF*ZUD`ITPMS(N*43 M^TO4F`.[\!,R9B=T.)X[J_E7+@Q5'LL#R0^'EW&2)GFVV&MJ.0J3L9)R_IQ30VOUC(HI":91 M$5!0(+DH.94#EL3F'6Z1TXJRZ[;:TTVUXT6@,X%$$Y.B+0,^@*0;9Y MDFFZ,=M4Z:5WX*P:+(<]]J)0JU2SHBG`0N$LYY$M#(#20-3FR;,9=>]@BD@B MW8WJ2!KU`W([J2Q?5I0N$C8PWQB- M(_C/$7%F[UN/Y?+%!^Z9'*XIC6$'!BI'^8LTG8H!!MUXO9ZSFK#?R'<1^TP! MB['?1N5O`E#'6:AG-[31/="#XH&!N4CY<]P>)VV>^;?1.`.NYH]DNH3^"XFG MU)^]!*/;:!+35V=FRL68'LB,N>JCJ<[S&$$3$%2%@K?-P##;B35:`S@<,<12 M\@4!&KKPVCS)'H-I%$R"D;^QQ\9AP`X4RW^[W667HS#:4[<;@:1.K1DQ+[(D MB$B2ET>@4S\*_LJED?_F7&G/U&OMG?10Q*NH*.78-DT`VI\[+E[!!3$=$OCG M&$ZKH9\D^8S*!37^'?8PMHQF&E)/;26*C-B2,7' MK[>D7D>,VGN]0Q1.DFHZ8@#14DE(IVO)5Y_^0?*(SW4^^`*LS*@O;`3$M'`7 MT<5EJ6ADO95`<$9@)7:*!>PV>B!^>)VP]+1L3RQGJM,\,E3J##A"=BO6/D'4 MP&NI`J7316!5GDE_)Q`U`5)0./.J+0!R5!TJ2OE;0NXGH.7!*]-SB9PW/P0> M4`3659,N#TN'ZDJNPW#+@;KW.398R6XC9M@.W@@K!*+>XROTYIV"=PUND97[]$X/ M6GR[J`G;5LE,I^O,;ABBOMHHV\+D0Q'X4DT]-.'9JJ7I5`TN0D?.8LU7XWMB]C8=(/F',&041B=]>@574`XJ M2PY+6VE!$C+Z<1J_?1F3@(GUF/T'D^9Q29KP1]X=F?IAOIG,!^\!S\+$^0H0 MHS`O\>2P9346#=Z2LW#?XBI@7,6O?L!S%V]_`EB=WN2%].]*:7?8EMQV&!+M M;!<@U%DQ5Q\#&RBN2^K9IL)@R2_G7J*#,(R_L^/&34ROXNPYG63ALG;I'+)6?H^*5*`17V?(W6P!>*&"XS)=`&9LN'ADH3#/9Z22L@")<-S53R M?$"VW&4():[6A0BAEO;U=U@PH0A%V4U/>.XALN9@P MW."72YGSM]<];N'P+@0AD:VS2_G&FM M5\75>@024)C&Y$(2V-'K0&[UZV-NBF]WDQ)KHN]>_\#]!.<'9.6#95*PH:^T?!T&AL/8X5&9+'%H*^\"8XM[=[MA$HOM>WUWRFY4N MKD8X2!*2)QHJE5CYFE^)R/@>U'^440K',W8J2RIL7[J)GUT-T&MIGX\<5;GB6T9<+4(@^)9_62Q#]R`\BZY?XK+#V_TGH16[12H MP.$$E8J*/VGKHNZ"96:;@^)07Z*@OC+I=@FDHK@BV5`E,\QMMGKDU[O[R;#4 MZ16KQQ[F*8TS-\_[RNDK-Q[PPK94'FG)4K-RN.J81JST#[)OXJ+%$8CH%:!F M2Q@HBDN31=:E]RLY#Q_K(>&)TZAU(\%LR52$YJ.\+#QU>NI']72KO#1O"R M4)1!>E<#[R2/!I5M`*_3FVZ="::'#<&;0H$L+V,*)SS8'^XGDV!$:?[HJ8$.&*3P+&?AW.?1HA5+I;;:/`&AU"FO).8)GY(BMQ0+.QQG936 M_4FU-.0K\IRRPB.YT6D]1HWCJ'XGH!$5_';*5+GK'Y(>-84-8%@HKGZF1'*F ME@)C%VP&JT/UVL+GAX)#I;(-T.+T];R.T`0V7SDD^Y=Z9S;3,D#A"539!FC! M]3Z>+S>!L.6H\*2P7]XG\A?\=,YD?;3\'R;FHY*8%W_L_?I/CCS7?PD04=S_ M%3+8%-SV\-N1[\SMS5]3D/QU5A->AU+(;]]3UM`7<1Z;^*_?1V'&*,J]RT\O?O1$ M7MEECLYO7V=^0(OZFF(%:N3W6(4?IR&P];2N24XLY<=P\P*K5+7#_5V97*WINX7&TGW9L?EJQ!XC,)Q2@]7J*X".(II-*AF1@6H+A=N+LL#243Y0 M+D9\,6K"4.*(M=N'7'R,=F_)EJ0WFJHR?U$KI$B8>KWP'A`X1\PE:TQ1/N% MSE#D9%D8"-J>E.6PRLM6P?S120LBFCDZ;6&P*'8W.9F<.:,/[D.%6Q[VW?O" M]46S)5<1G@\2<'G8=[I[">G?E=+NL/$&7"JT4>DEU6T//+B/Y:L\]5=7&ZAQUJ(R]!MD26HHS8KV%4-D]<([" M,;8OO=1EI*Z!Z+S0P@BN`^GB6W?E8DOV(HDZ;7P'+*`P:]C1"PXT2X4TQF02 M%-F#?LF",4O[@_04GL=)F66?J]@C\(O"06#AU%6+@>Y4Z/A/$DQ?&&6PJ?I3 M\BU[?29TD8>RE,M^BQV)9E7K$&A%X9VHI15\1:M#2'?J@BB(K;Y4>8=NW_@V MJ#E:R+M35&3S/+`^!5RPN&%R_0Y\`;H@8G'`S`H#M&PQHNN=LOQ+($/TUDTM MVU4CO-@J@%(F=?-`MC__;#G+T#KYR?UD396;5\Y,;*OQ:$^`G1;>8<]=WN&- M^LJR@++-0LR'/427&0&C_-G&`_*Q_+$]%)<)GAPTG*^]#^1\[>%SOO8TG*\] M',Y7RPNDS"LK_AC8P/',6#G;5!@ZXUS]E?AA^G+)[H&EW&M#^&?^QHZ^L3(. M1=;,.Y(D0QJ_!0E\<1/#L2N/19:I@(7>@6^L9;5S3>#KC37@EKRS[A4MST#$ MTJV\LY(B6@9"41/O\!"%W]5,)>1H.N-0A1^/*,QFLS#(2Q=PU:),]/TC5U"QN&M("OK!DPA.*97A6-4..RY%/$$+IP16#,HV"9VW?P MRL(XBCD@$;VD%3"$XEU?%N:]`82N!TX@^98^BBB0JN_@6U]ZAT M?6L;HO#;?/$24J2Z1PL;`E$H[&^&AS(-3`+AFYO@G)_/U,'+1=!,\=V3_TZ2 MW?B9!AZP5/Y5$!`*@YZ9TC5.B$!CS4U^2#06*%C,R`L2D4F@UK:=%D`,"D-? M%4T1@!%(N97FO2&-`9?"%+#^"`AHH05@>_R"0!SS@'SGTW3C/4O-]X[&?0&9 M;30,5(,IT!E],R"BDVC%AV!'*(P(-:1=0!!(LH5FOP:?2>#(DFHF:RU0`ND; M&_PP;-YHGF/A2+EJIBUUL`J4J)7V1JOYVHY0V!OK+1N;:`2B;E>1DV(+'+RR M.CQ;9YY5:>U%,+31P^!:_<)40A$(4.5F6`NR0*5JAQ!BRCSIL#2%U07M],C5 MG%U7@AV`.HW9]A.\E:JA%(5/R+@P9;W.LF7![6TPRB=25G\(*$,QJ^4BY<_M M)IA`]D:K3O0(PW`+Z\0[&3_%MTF2P9B*FIQ/\..*0ALZS8$Q'&%##>B!*#9% MEQ5DC\>:TR-E:0^]#H`U%)9*?0E7TY`RVLZ\7JLY[>XTWKS9^@E@'H=9;&]K MEEWF.O,^KR8MQ8VB.84M^@?.4=S0[>I0(WI:)JRAMWW[N[`]4>+#373^F,:C M/^I^=05#&>]&&[\EC3'OZP-#,Y]14T);9L30!-. M%VK]K6PWEZ&?)/>3@AOY3438!FAQ:L?6E)O@[BI'U84R@&5DREO"[L=`!`K+ MA$)2?/&*X'2A]M]C]IR0/S-@Y/J-I7I0&Q,$+8`2I_:#>A-8AJD3%0!W`2IG ML;`-*^B,(N99*C9M26^`.V&:%Q+3DO($)98'` MC05+9D21?`WXSMS7YC!=A-6`W-8$M#,I-P#FE]QD,/HS"Z@T*$32"JAT7R1+ M*C;^S%1"LI2Z`4-\QP;6?_EA1I90V7OGKR1]X9;_-&D.G+E-^69##:38&DOH ML#\34`[RPD\8N%<6U)[WZ[!0Y#H^XGY2'M(B&4_^&C^?F\]LT,-%74\-;WZ] MCD'@Y^Y]_LL`QDUI#2CUHVF11_9BOOYF@6'PW:?"0I;6?\,[Q'$"MR%N53R` M%:J0A0(TG*X5RCUW:Q47T;\KI=UA=\97KM1KD5KK M>,GK=PYLXP@.;W(AL$U79YSBE0DIPEZ24B!^$:#?A*Z*?@MD@<-A8$FK+.NL MG#9+1LP9H4',JB?0M-6*_`M\F":WT3#'\PN5/[QKX-=`*CAB*U$KLY"XSF3] MS13A^"JCK"YG,<-R(UC^EPLJKM\)'06)U#1HWAFPB2(LLV$UK,A+ATJ> MUIV)-S&=D"#-7\_D*1F#54'9@LP&ET_E;X.T<+Q\1[V8:M+8H0JK;3_NXHAD M1JW4`MHL.0B*X^YUU!DUWGIEO=SOAC0828W4^QD!R`Y%.'1K5%Y-IJT,V*VY M^`FM1=PK15/SP=XHO*,#%&X=QW/"-J&VTHBWXFRO(F_)C_-I8300$"0.GQ;N MF5&!4UN9V%LQ.>K>FAP=J6J-"\2,(Z$4ZH.6!8IMY;/OPDQJSS7DZ`"'CQ3U M[#`BTU9%`-Z%'$G,7N_OH+UU%-?101]KT-XBOCA+7V(:_$7&OX$*T)(38!CZ M$9RI-I3X@H)K_]=`'CBL\7M?/QHGM>,!A5H,[?*C M?GYL_]>\HQYB\[H%5;.NV7(F&TK-8Z-^'QOJ?42$;Y\Y7P$FQ"9F"^+:VI%% M#"`(MY-)]>E[K"'5U5>`";'ULT&I;C%@*;RM8[O07>5W&'5_$*2"(R:XC0JI5"XCNG]LKY(R8NQ M\&OL:PJ(1P!RPV&X:_=L4!%L*S0.C6_VV1)QNX1M.?@>"#MKPE^SFIW,K)_Y MX1.AKX>JN>-^A"!ZQ%'5C<\M+`+H?OA=S45K\3?LP.QH7]H=`8@.AT&X&_N2 MB.#FHN^01$HX+$:$-E[BL$*V[8^8Y.CH$(7ISH:XJT5!&%+5A:SB!29U&N*- M[P`^CB`^N_+D*PT'>1D"(A&`"9X(VSX3'BENDZ=+ M]>#@H)H>B-L!9,26[4;U0$5*!_.JUZB5<'2(PRZUC^.*E`.WJ=@QUE8X09*R M3R8U;4&7,74AB7O]1SI-/'A:6[5.W"8%W>^Z8HDN2Z$";JLS%37`V0Y\Z<^" MU`\+<^4#B)^^D?%-3&\R]K:1Y<7R(^F[.^.^0$B(+<7F"L%7MXJT6'+(MW/5 M0Y-_\>@(<=RO+0UMC#A;OO-6*W')@=-X>K"=WP(Y(`Y-QJ+``MILN9_;J;Y+ M!^3"?_GF!R$C"+:K?+XWH<6*GP2IX#BEXE1F+?9LN8W=NGK&OV=)FM\"GN+! M>!P4<(9^,+Z-RH>LG4"6![AG!DF0DDP4C4FQ9#V043Z.\E[R@D,Q[U/!/ M@Y1P7.,;U?']L-BEM"K7K[,PGI,E;+YXOL71&TE8>!63!%`+-);_GCF3JZM`B_,([V7WP7J MV^&PJZ2Y>Z10H+TM\^O4O'>4XF-OHY0&41*,5`>0QG[3Z_4P!VXZ/UYK\B=0 M[#J>J?T%9-[X``_!R$<84GR-2]P2L;W<-H=9925HH`/8,FER_\%Y0P2 M53BEM=\`HE!XG=7"Y$]YRT1\K.Q01RCV!,LBW#KVB'!_E$10QTZ='$+Z=Z6T M.^S.)()::?C%?/6?OP:$`H!\`:"H=`HQ.Z"B6=2;:T0KI@ M,3^Y[<)71AH9]0,7&T1:M_#N4BM15DAU,UDM7\TM]O),V!,ERF3)5T#2XI7*BV8M@0:4>- M]?A.XS6%U=\!(73??MH@<[;"U=RK;\$)QX6AX<52MO6.^BCBU!O0`$$`F1XC M78H`*P=T/OHA>62LY<3*-$?8"`A"80C6E*1`#13PFHN1PN:3=Y@MJ1'7?/^H MS>>,/;KF^[B,:D)A-NZ:[XMC(K$[;"NZYONX;&AV1*CAFN\+[6G=<\WWG=K" MA/2K7/-]H\V"O9QV6X:F)"5Z'D;]=\/==\'Y?)2T/B5ESS?:'YJR.N M^9KNV!-<)@-]H59PQYX(C0%M=LVWRQ)Z@L+>L-_=S1YSG0DF>*(^>SRQ-M6P MIT(2+>1^#YS@BC>S)VB^1DE8L)^':'_&K0=8I:.,E-[O.GQC,AB-X@RN,=%T M&(?!*-`R8XD;>:>]8_-))GA0N?LS(AN3[',8$@J;@8JTK>NE$E$7\E<_@A3R MT\]EZ"?)_21_6:E*$REJXYT>.KU+JD7&7^84@+J0KKJ,3'G3V_T8B$!QG5-( MBB]>$1R429]WU5=V:%8U`:UOU8S4PX,R2_.OQ`_3ETN@XYY._2CX*^=X"/\$ M?A;/VA<'CSQ9V4400J=3H52K]@<4.9VJ>B+DB+T>8$LVET;R4A@@*Y6D&H1A M_)VE9H3C.W-P,4)O8GKACZ_(-A"7TIIFIUH=&Q^ECIWSLZ M.W-F;5AE6E^([S'.0"\3OG+K5V[3[@W`HXB,MBA)@4FC*C%+9T+SW8M#%M:5)D<^C2=/U$_2F"A8AG,+N;E MOU%8F/4[`?90N.0L3>&J!'0F6*D,3VFGWOT8V$"1^L%4?FHM*.-#$%\DN`@. M_<0?D\B_\4?,'3V7%ZCC?^WU>FA'XWU!,7] MF*%#\6;>0$XR(%VH^,7?;N"23((WMN?`]6*Q/Y6>3,@<3'8Z!GF@T!3+N[0- M4KI0SVLP&M&,E(.0+C/*Y%$$'HV*_Y&'LVATX!T?H-@7;(B=KU`F/'2A5-=M M!&<0DJ1#?\Z(NU0J"K\!$(+B#4-SBB'#W8EZ5W=QDC"[=1!-63**(MO!28-HK%W6]-'9!*Y_"7>7Q\_L^`DB_+R7PG<"M=%P183)Z]AQRU75;]3K]<[01%4V]!J9(.< M3A3LN0.$TYS31Y*F8>[$+=B0K4O"1D#-:=+P:6C6,6!"HP;YLMJ(0_M6:MEP"=55`W9(!1^'A:DC\ MV@P(1+\OPZG>*8-S"_]&V,+V1L+Y8#)AEZ]HRF+8W@B=EW?#!Q*\/F.'I5]C!'?YEM0H:P*UW)=95N<&_9]!^G(_F\4TS2)87I_BZR0%.H/DY9(& M*:&!KW6O5G?#*.GH-:D&'8)@K'V9:T6.^U5\,.#)IP(#-(R3@$V$ARR4/572 M:LS@HW`"-J0-)B0(=,"Q$79C/;N?_):P;3<:7V9)&K_Z=#[(8.4CX\L7GTY) MH@[:K]H?(ZFC_AP;O`B4Q[&1]FL0!:_9Z^)17EXP?9%@/*9:AQGM#A@-7;:; MF!(AT`?'[YC7-*S<#'$D+Z,M:<*@H@C<;VQ)4$$72-FQ577C"%04DQ_ZP?AB M?AL!4^#;ZSY=@]%)@^A:G=98&S;X8.5TVC];@1*`PCHVE.XY&YAVZ MG_PK#D'5V6&8@;N-1F'&K#1#2G[/QE-V^EF&1&D:Q\P[9K1UV=1JBR"!7CFV MQ"Y"*6'\\2O9B*(41QGJ-62PNVP?U25`(/MN[>:;R1%+8!6E!X/HTG MI`)19VH;;..\_Q[!F%Z"V=KY=C'?//H5GQAH@W:?P"T*[Z="^'H:8XC:_AOL M_5TIUWFWR]6P[B?%0)C;>7=X&M=- MPYZ\H],*6>DM@U;F$]OX$(:,(GBI$M/\RT\-*Y4E.=P^_NQ\`&BC`=]6Q38>C,171(XTF0 MYJ/XK,\)82S*8OA`K.D]\(G!">_/`CIF^V,+=F=NPC)#!FQ^$;!V]B>FC'Y)U:;#!^/8KYCF")FEG^)9`# MBB`4L[VV$1(L94)SKXQ`16EAKZ=NQGT!E[CL75H*51%F[9QIYX7.1.RE*!D_ M.3^S2296M34)>,)E*ZN[OA2`;*4_VUXL]N=F&(Q&V6N6I^.1[=<.*]I>_YDQ MHYGZQKGYH7=\>&X^?03AGXR5."H<,#*:I/5LC3KQCH]07'YYI&Z9+2MB^U"N M@N,C]P7'*LA([4;(@7T0-\+QD=MB7R+Z%6Z$?-B=<2/<1I.8%IDG+^:7L&]- M8Y9'@Q6V6Q@K5.5`-'L`WIQ>TNW,V4J@.^.AR"E[>O&C)P(\4I_.;U]G?D#S MFL\`HS#LDV11]^TO]D[AVJ<12ZZP("D@"7.5OY'"^)4HRX@T]IL@&Q1W="-5 MDIB&FN,(;T43W?DL\Y%6ZPB8<5^[N_X1I`;VSGA4)$9Z]2U)W=CK';C-"5A' MR/SU1ANT)6\&!N^NYLW>D@NN@5]C(D'A)M'6'H'R-4:-);_)+'?Q/*8^3=V? MUGC!B!K,7!`XE)`F`A8L_CH3F],CG/V5=7^L6?++8%B:1:3]%@'PD!UW?XU# MYKSZ!8ZT3!3W48D_&B3P5U?PO]&T8&Y%9`7UKOV;3#PH7#W[4T6SJ6"+85N5 M>3#/`$8+7/I"/TF"23`J5&@EI1N0^>#^\G8AR/O)FK\Z4Z#^CS()H?!O89T# MUBBVY7'#/@G$`FLB%&[!+XJ'8IA56(=!6U6/L&MHI>E<,X"NUF\R^:!X0H!9 MPVTP;*LRE'M+6YMBEX%[%,\K,&MW!4)MU9]RK\Q=,`CB>!'B6L6;X]96A:S" MI'@=C9UJ/.`FP721:&XT?Z)^E(1;V]K%?&4/TS`25NR1L=N>`"`MPU\])FQ5 MW,)\2.8QY.>IN`?1F,]78T;LQL;"Y-F>,)E:)NVF.;15?FQW3F`-)W:8&;-R M5/%QA:CBO9[?5'E)3+KQCOLH#EP\(=0Z&I7068I#=II?;/6LX9)=WN%JGL:C M/Q1AD,(V0`N*G/CFHN2KA`*HI>!EI_(O(U,&*.Y^#$2@>/>LD!1?O"(XEB*> MGK+8=^HLU9?*EC1%4#[*(\6^ M4R^@D/Y=*>T.NS./%&]8+B-R![OZ^!:XCZ8!*Z"3)"1-+N9?_=]CFM]:%#=T M@UZ\XQ.GAIJJL[4RU"X:4W[,D[Q6'6,Y:ZL?*(T7>AK$!Q M95CG-(D7,3NJ]\_"5M[IL=O=H^8RHH1FZ0T@1JDK%PEI.^_T!$4`LU*"1H(O M8[-?#,"!G3][3LB?&2"\?H-_/,'OJ:S\_!9`B=,W&W4GNA26I6=QV"2MG.#" M-EZO=X@B\E4J-FU);X"R]"P,D["5M9VXWS,^4`2`JB2F)><-3+9>/E44LK%9 M3>:/T6W*H*-(V&!L@#$#:"V%GO-+_S(GY-"?,VXV:MV.A%6"#5I[IVX3P!A* M5G12T\1IZQV-W4D_&(^#8DC5Q&W>";"!(L"NDM2KPK7UA,3IMO[$HOPR.L]# M$QY?@.5D,/HS"^C:&\99""2M&,68C^UZ*X`:H*TW%TZE?P4G_V M$HQ*F=,<)M1=#.V!S%AJ]&BJ4Y]/T,0[/G%7B&_T0L99\1!QH6?ZFL MUF?>&X!'D?="+AS!;:LJW(_E`L=A$ZTL+`W/N-@RVCW/^`FZ*H`Y_2K/^$DG MJP!>9`F<%Y)DM5%J1JOSV@%'.,R;=B:J`>;.9.I=0%/;N,O?`0XI+]2>:\,&D.C.%X5&1Y4]:&;JNJ MG7-E^97X8?IR"6S?TZD?!7_E:(?P3R#BD="W8$0>R!N),G('F]^0QL62>1/3 M"W_,\L++=,E"[\`WBK=*^KK!URUK5'0H5^KZ70U+0%48'#/@]GY&:$[/(D5@ M\=V3_TZ2Z_>4^H`9%G`ZSTDWKG?7X*^"A%"\9JJKK(U3U%R^4[3FX%[K[<&G M%9XM=<8>C".!IEPX%NW!DFR7V&V'%>W!./)'5A:6ACU8G+^Q>_9@M_D2A?2K M[,'BK(1_VX.7)C<<>0(M350#S!_='NPVRYZ!H+3LP>),>5VR!Y_A,!/M4F]B M#SX3&GS^M@>O.,)DI!$+V@!-=^S!RQ5K<7N'6\,H!4UGV486A.ENR/(>@#<< MUH^&MF8=])TQ#"^0<3#K[MO"IL`4CN`J$\%*-W4%5$LF6S1*T:QKZ:Q+%W%S MZ+9,H^ZUI7BF+]&'X@.`C2/20UM$?!&7T33U\@FM==MANE^K-N[SW@>V<9]C MNJT)A&/1QGTNO-=UU<9]CN.65E58&C;N<^'-K7LV[G.W+T9%]*MLW.?":U*; M;=SKS=$/=:_3VVV`&QP7(SL35!-OU^S:992Z=^7=-L`-C@A1G$9QXF<"/EO_#9'U4DO7BC[U?_\D1ZOHO`2>F>`&1(#:EMSU\2S9O M#)%F>S%CIN30%/X>M48$:TO#/883*-@`L?A*!V,J$:N_^C+3RE^!S&!**15I%VM;&JT34J0K`5M_1G+C-U:(6G6)O M%H/J0M7?:F]D3I"DY5#+2.IL**/I0JG?V^B-)'E>58VJ'KL?`Q%.#SM5IZH( M21?J>VUBNP1]G\9TD=1#XRV-JC$0A<)"(1*ACL#%N+I0G\MNX,_)J5,;8^W- MF`^H"Q6Y[`;UG"!Y)R>7FW1S%J'J0@VN!S^:JO;GU3<`V^EIJ^JDW0+0A8I: M.23EMEOZRNL=]%!LL%O"D$AL8^!=J(QUGP__-AJ3=S)^BF^3)",TN?XS"]*Y MQCE9ISECJY4;JP$XQP6T]J,+RBU7KP.@[!B%W=A`OM449`.OK==H3E7D:TS3 MJ3\E=[$?)?<1"R6Y3M@YYHHD(QKDZ!CR^\F0QC-"A0[A>ATR2EMI.*L%UW'! MKH8UB-6/7H+66FT,>P(2<3RMJZ4#AFHEI<)Q#3!M5XK,XZUJPJ"VRFZG":B! M"EX((O7\Y.4FC+^[J=JT#NU:C<,L]FZGF=?O'3DWC9D&VO5PI(]1TJHPAI70 M?*RHNAZ.UXL<.6PM=*+!?Y2H.L>78A']NU+:'?;?477+.",2L@TC3]T/9Y*+^6\)&=]&G.10&IN[>6?`)HX'B`(Y\[6B*DYD;XBK:PT@ MGP2IXLG0^B-`CR)0JZK<^%JPC:\SZ38'X]^SPB6>/,4/9!1'HR`D0-[Z-=!3 M;&_5:.+GO/XA"N.%78UKCBE+CE`,S^:O"(QY%!22CL:#5_8.L(CGD"BAI!4P MA,(!WIST^=JFI,22%Q:#TO#>B!N\CM5I#IRA,!7L6XWTN:GK(#XO]"F":UJZ M^-;91>D%9''A`V_LZ02)$M7ZPV\`O*!XQ[EOG9&QT5P9IOVKR?K-S%60S.(D M8*CN)T56SIY$7>0-@2@4]^Q]JXT.*[7]RHA6F9N8DF`:7>;9*D;S)^K#3!DQ M:$LFUJ^T),IDT@V0B.+"OF_5,N>HMOL9D:(!J0`N(5>D^'>)QDM_%J1^J''/ MT^\$".R@O<`4ORU_LWN#PB[RA<<6#H(C$KPI7&XZS;W^$8ID5:9"UE45$>+: MCFW4J\PN:KB(YB^2UW-0E;"]1J]>'T<=W_TIE90(@:[IVZ]1Z]JRV"M0P&HJ MC4DTKKH\R;N"B8LBGK,IK=)!+U`E?6,Y5[TV+MD`7"O-RT^?;#;B">+E6VH^Y MD&D&"`+_.0ASTX2I@FPU!])0V)(;U!$N8H&:&(?!8E`3?3N6E>`NK^_VM5$S MYCM3_`(%,@_,C4&W,:I/D3G#4HR@I#.@$\5]V4J,H!*G0&U::/6%73?WS]S$ M%%@8$3).;H#4QY>8ID^$OJXSKTBC"/5[\7J]/F:_@5+V@CA#8P8$.M1*H_`2 M_5,\&/V9!91\]8']B-#Y(!JSM\,S]M<:"B3O``2`XKK4C.KH8!1$F MK`?EFR#RHY&E@[*D,Z`3Q?''RD%9B5.@-BVLVO1`9HM]^G[R+4Z)AFE/U,3K M]S%?O95"Y:N('*U`$5II[GUB5JF,SA_3>/3'O_PP(XN#VWCHT_S_OY+T)99% M\^EV`7<%MT]JF]$50_B"I[FMM`:7I\E='$W9Y7!A&[UCQL[[YS"8YM*5Y@K4 M[P7F'PK+3'.KC18!`AUJ94BQ/I56CBY`(.9K=T4-,L4O4*`6FHH9;%;C"_[% MKHEO<'ED_K>\\L>V[T6B0";=`(4HKN!FIUYSA`(E,3<,(U62`[&:T0NJV/C'-,%%IQ M'3E^1IG-9F'.DQ\N\UJ5"KKJY!O3ZP'(0V&),],+(W`"S=AK?@I!#L/\L.0' MXZ).V+^)3V]B*A&NNA%`QF$*,Y'0II!U00KDVL(:]LO`<098&K6T_LSKG[A/ M;*LA)%$TTC82@3!;F5.A%*')`,*E2!Z*MO4Q$.(^$VD-T?+Q"`1LG`4?@X"7 M"]JW.!K!?ZX=/-&8<]6]"I)1&"<9U2G17;=K(!O%\PGS M_"!DIGZ8=LP3O4XA'-D550)``//)P16SR<$5G5X"P`!!"4.```$.0$` M`.U=W7/;-A)_[TS_!YR><@^RK#AN:T_2R&,[_9A.IP.1D(0K"2H` M:%N]N?_]%B`ID2(!?DA)V3F\V!2!7>SN#UA@ER#Q^H?G,$"/A`L:L;/!^.!P M@`CS(I^R^=G@X\/U\+L!^N'[K[]Z_8_A$+TEC'`LB8^F*W2%)7[@V/M#9/1H M?#`^.$%P<7@RO"?+X1SR\(C,RY@Q#2C[HU#[>G2K&HLAG.,E^O*,RRFNFI:H`TW M/!P/UZ8[]:*82;XJZBB(=S"/'D=IH2([VB*+.8?.9Z)+2Q7AJR*A3V@U#114 M5"?/WJ*ZOBJIT(>R1R)D-4E25J$-P]03U32Z2)&,BR2">M4$4%!1'0"0JR41 ME=#HD@I=A%QR0R-04M&*3Y:<>&K4&_O7R0ASCT`25AE"+<.JMZ>J)4@+P'PB]QHQ%X%C`(>G?ZLYR2=DL M2G_"#=6_3Y7`#T".U,7'NQN38]"*745>K/S+.?/?,$GEZ@88\E`W,T`4;&.M ML6XZ:]PG,\JH%G)\.`:'F)'G+X$52GBA'+/7HVT.7W^US3X6Q)^P[_4UP">` MFZ95/B.E3ZO8:3>-M*7T<.#%@;'1E&Q40"+'L@-$EQ$344!]U54O<*#`B+W8#V2HI/G@U)&*.'DD&F)S"T&ERX71%(0J@:F8ET[9D?- M,4._%AC_YC"LQW!M6C&9399J20AR5`PS0ST[=J]LV&TXHFB&-CP=:NU0NXQ" M,,&",$$?R0TL^$/R+A(U$)J(['@>-\>ST`!*6D`O5!O_=`#O!>`:A]N:@QWZ M;_8"O?/0.W8%+!;70?14-[K7U>R@?ML"5&")-$^'635F248E'8G9#[O]OU,1 M`A5>$(F8$Y1E90)GXFH37V!!H7O?YM1-S%U58#?]R;;I-0O5T_-,'!#50-P1 M+\!"T!EX\0T*I;M6",:'VQ!LTSOK&V8'\,7GS%?_WGR*Z2,.E)=.IX3J,CL2 MXVTDM+?'S$\N?A[XL4< M5"(I6NW)[$"^W`8RUP"B#*V;&$(;PWMH1*.<-H,V[3B&.'9VC;70T+5HFQ,[DYJ'%9,0+@R:[83?XJZKAD)(Z;^Z,@D]D;(6D( MR__4XEOW[$8_WC8Z4*MUU9K>6=[@6XC,Q>:$0QP=1NQ^`1%SZFHL%>R8?%/R M/$1N1>9+PE'"$&F.#J5JE!XXP6#$U;V,O#\27(JW[$A\NXU$1HPTM;-ZM=6U M<2!$([[*+A$FF$T==)3M&I1A=L4.:GYI0UAQ1CJ6#RP!7Q`F=L\MTYP6L^)D(?%H6H2FI`+O=XU M/^EL6MD.62E$S[%%FJ][LMD>R$OH]-#A8398!_'%6W902F%\@=@9W9BC5UO8 M/+U)$ZQURR,&EQ[)K<]JZMAA*07Z"3>T88>*_!Q2I@R7'\,"=G5/YMI.Y\Q_ M2Z(YQ\L%]4J;$QO7MJ-72@ED?%'&6*>&-ZS=OL4&82HL?/7CJ\*@B@*J'%7V M/XU:&U6U8UA*)N28%H9AR@Z]R*[<5-4^"?>@LO2B-A675K,C5TH_U"?DT(N$ MLX.N58XHCYJUAAVP4B["E"]R,.V6.,KCU:RJ%;BCK'8D=PU+*HU7\[-#=4Z20A[99QM+JVO9@>QE$^IW/N(7J1,4PCU4Q/6QOI9/3M@I31-DV`_9>W0ZXQ> M<;0UKF['LE/BQHW(#GNKJE"T5;#C5LK?%/==.8QVR[(5'*:]BA6G5Z5TC3G/ MYCSD#DB-&T`UKL&JE+"IQ0J-'5I=T"HXP48U[JE#NQ0>7&4Z<=L]7)K@8U[="5LRC5NVD=?'M^5ECPD2UI[)"6 MDBDMGQ8ZE[I/@`L#MANI'>Y2#J8;W&YE!$V!5PDD M-SAW?99?<+]MB>Q8EA(X[9[F._>[5X3'G2"N2=(=5WP2I`/&+G&W+Y2W'OIW MHK4CON,>'3?+[F&O?V7>M@6!'>%2EJAVW___,:CJC_IH_QV9(?TU_%/UH?&S M@:#A4GW$)[FWX&1V-E"'"@RSTP-^!Z4/GL,@JZ):L'R77W>*;3NE#6%JM\TH$WZ`1GM4#!!IJU@1Q'ZJ%>!I6[6`A`3]U0@&0%N-ML;, M?O5*QEO^&_SP*_^-?GT+U(JX1*SRQ`_381;)82'OHN33?Q82]6N8T0W5K>'X MY?!H?/`L_(WUVPBQT;&=$!E=!R&JCPIIV'Q&H-H];MJB]:P/0\.ZT4K"$0FD MR.X,-ZQ:Z6\Y=\,F4`59>CWJ,E$;"Y`G7OX8; M-IW$*1VGTD24-9&^VK6;E(]::2+#ABJY'&X8=))B^_R6)C)D-.IBY_:WCW9I M)$!&I*\ZB%`^)D9/-HS,5?*NF><*."]0*?=UHMSF^)N=Q6CH/',BR+TT;S\L MIZE(>2YO-DPZ2&@],JE)3\EHU$4'GV$_U*>10;:I=L6I^CRB=I)$[$-G8>PG M.76?>34OLT]-#U'3`ME/-#J?"G5T&_379%FJ#R`[A7OJ29TDH8JJ!@BGM=Y`I5\N`CT9Q,339)CQ$YE M=K]*FQD.Q&=3QRB?L8^5WFSMF4Y6"0U:7<2",B)4]G'"YYC1/[40.GNTZIN" M384UZ+IY[^F&W1$<`/BZ+S,__SY./U7O*+O!$NKD2S\.8`!`FT*D'4=Q4T_T ME#(Q#LZ#('I2@;9^<[-O!ME-A5J[5+QG^9!\^/L+.V)?GBZ`DGOQE-R83&"6 MUC3LRP3O8&BI!L1?/]?8I:L=W9LW%GL'F47(%FKU"*H:\8QSJ5[HZ7T?R48/ M"'T($UM8A1'$:IBO]N1:DKK3Y-S`LX''B4]EF^G5*+1!S3>8,T!$O7.FWP93 M_=H#%E;2VI0M?`J6G^6Z`:Q:N>Z`EWO.J5=3I.# MP0R6]XR\)^&4\*TEBQ^%F+(O'`=N"623^^$IZI?<.8$,910T-.$]B'2D[PZ M9Q#83Y;JGLA7N(R$A##D%R+3V/-/XM]J!8N.)%/T"X<*GU])DXM-&DQJ74<\ MS38`L\GL/%3/BJ"%("">I"6G^Q?9JJW(!LT_Q*K;Z=,HB;BF`?'?1]JB124I MDV0.JZDOJZ-%.(,ZJA_`6C0Y`;GN.UE]FCQ;"KZC^CU:XW40V:Q\2&6:FBYL M>.XCVG91#2J>^[Y.%ZIW%Y,7:=)\4G*.@]19)I8\3I9["-&2'1QR[Q%:2SV, MJ>LK^D@%\$GW3/9FFC=*9NJZ6"QN,?6O8M4KU2(!/'I_XI4:\4R=M;1_LG?C MT"BB0:5_$1S(Q24L2PII;?BK\RIZ1DX3G#K9>4'U:V^BS]F2[CKM;J2J#+". M[X7&!7K9!?:OR%1^40OZ9/J9#-A&W\]C75@OJJ`#S]?C4/G(97+W"R_O]JA* M8Q?4HY6/5;C6:YP>*=9(2*."?!F!`&0RFP'\*I;K\]BO%M<4:^4>`.HD//$O M5NK!"QV M(_5YUF^CA<$0*BK;C.Y5DG28S.[(+&;^#5-!^V2V6>FGH?M;#MV2^#T>TSOJ M97P\Z*FL.$2TU]BC`96KJCFMQV9IJD!MZ)K9]V^D>Q/AFXV26\+4QWHO`TQ# MD>2W/JB=MO21!*OSV4SEZ]A<)2X?"5_E^]D=H>$TYH*474N7[-S.$\3G4JQ) MHO(G*A>3I=K+&3/HB`^1VF4S#:A87'(0DU/RC4*,+EH^QD%$(?N`\AOY"_,L%YG,B]A?& M[#P.N@MNL,1[RF@8AVF/^>OM1(:YKT;53)PJK/6>HF MTC>!^H;]M*#>(N$'J^V_"^B-Y6ZV]DE6T)/9CU$`IE.N43&&=640^_I<2_+O MV)\G6V>SME-BQPLL$\8SH*+ MWCS+,0EFT.,MYF`ZOW=J&.1JLG&N1ZE%DUQ*C=>CY#TMK='_`%!+`0(>`Q0` M```(`#IE.$<0%P4B%<(``.UW"@`1`!@```````$```"D@0````!D>6EI+3(P M,34P-3,Q+GAM;%54!0`#SR<$5G5X"P`!!"4.```$.0$``%!+`0(>`Q0````( M`#IE.$<>""OR0@H``.B5```5`!@```````$```"D@6#"``!D>6EI+3(P,34P M-3,Q7V-A;"YX;6Q55`4``\\G!%9U>`L``00E#@``!#D!``!02P$"'@,4```` M"``Z93A'?'QW71&UL550%``//)P16=7@+``$$)0X```0Y`0``4$L!`AX#%``` M``@`.F4X1R!6O*E\4@``(Y\$`!4`&````````0```*2!5_\``&1Y:6DM,C`Q M-3`U,S%?;&%B+GAM;%54!0`#SR<$5G5X"P`!!"4.```$.0$``%!+`0(>`Q0` M```(`#IE.$<'EH'5>#P``*G[`P`5`!@```````$```"D@2)2`0!D>6EI+3(P M,34P-3,Q7W!R92YX;6Q55`4``\\G!%9U>`L``00E#@``!#D!``!02P$"'@,4 M````"``Z93A'[ZGY<8X.``!IHP``$0`8```````!````I('IC@$`9'EI:2TR M,#$U,#4S,2YX`L``00E#@``!#D!``!02P4&``````8` ,!@`:`@``PIT!```` ` end XML 42 R24.htm IDEA: XBRL DOCUMENT v3.2.0.727
Contingencies
9 Months Ended
May. 31, 2015
Commitments And Contingencies Disclosure [Abstract]  
Commitments And Contingencies Disclosure [Text Block]
Contingencies
 
Due to the uncertainties associated with the stop-loss fee dispute cases, the Company has accrued an amount of $11.3 million, and an additional amount of $3.8 million in interest payable, as accrued liabilities. For a detailed discussion of this, see Revenue Recognition Policy under Notes to Consolidated Financial Statements.
 
The Company maintains various insurance policies that cover its Pasadena facility including occurrence medical malpractice coverage. In addition, all physicians granted privileges at the Pasadena facility are required to maintain medical malpractice insurance coverage. The Company also maintains general liability and property insurance coverage, including flood coverage. The Company does not currently maintain workers’ compensation coverage in Texas. In regard to the Employee Health Insurance Plan, until April 2014, the Company was self-insured with specific and aggregate re-insurance with stop-loss levels appropriate for the Company’s group size. Effective May 1, 2014, the Company has taken coverage for its employees under a fully insured health plan.
 
We do not carry director and officer liability insurance. As permitted under Nevada law and pursuant to our governing documents and indemnification agreements with certain of our officers and directors, we indemnify our directors and officers against monetary damages, including advancing expenses, to the fullest extent permitted by Nevada law.
 
Ping S. Chu, James G. Gerace (both former members of our Board of Directors), and Eric G. Carter (former legal counsel) along with eleven other claimants instigated a series of lawsuits making claims against Ella Y.T.C. Chan (in her individual capacity and in her capacity as Independent Executrix of the Estate of Chiu M. Chan, Deceased, our former Chief Executive Officer and director), Eric K. Chan (our current Chief Executive Officer and director), and Dynacq Healthcare, Inc. All claims were settled in mediations and as part of the settlements Dynacq repurchased 530,616 shares of Dynacq common stock in August 2014, and 427,886 shares of Dynacq stock subsequently in April 2015. These buybacks represent all stock held by each of the claimants. Additionally, as part of this settlement, Dynacq settled claims made by Eric G. Carter for payment of attorney fees, and claims by a company controlled by Mr. Carter, for breach of contract. The Company recognized $2,047,652 of expense associated with these settlements during the fiscal year ended August 31, 2014. This amount is reported as other operating expenses in the consolidated statements of operations. A portion of the settlements were attributed to the repurchase of the Company’s common stock.
 
The Company is routinely involved in litigation and administrative proceedings that are incidental to its business. Specifically, all judicial review of unsatisfactory determinations of reimbursement amounts due us for our Texas facilities’ fees must be made in the district courts of Travis County, Texas in what can often be a lengthy procedure.

XML 43 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 44 R7.htm IDEA: XBRL DOCUMENT v3.2.0.727
Consolidated Statements of Cash Flows - USD ($)
9 Months Ended
May. 31, 2015
May. 31, 2014
Cash flows from operating activities    
Net loss $ (2,703,664) $ (1,525,895)
Adjustments to reconcile net loss to net cash from operating activities:    
Depreciation and amortization 260,223 280,632
Gain on sale of investments available-for-sale and trading securities (2,094,000) (161,864)
Stock based compensation 148,023 148,023
Gain on sale of assets (2,750) 0
Foreign currency exchange (gains) losses 335,223 (60,485)
Changes in operating assets and liabilities:    
Accounts receivable 948,769 (752,967)
Accounts receivable, other 24,925 0
Interest receivable 22,730 (50,513)
Inventories 50,024 (11,677)
Prepaid expenses 202,686 34,464
Income tax receivable 0 569,430
Accounts payable 332,265 (29,916)
Accrued liabilities (2,239,623) 4,240,480
Net cash from operating activities (4,715,169) 2,679,712
Cash flows from investing activities    
Sales proceeds of investments available-for-sale and trading securities 6,000,000 1,233,286
Purchase of equipment (352,040) (231,280)
Sales proceeds of equipment 2,750 0
Net cash from investing activities 5,650,710 1,002,006
Cash flows from financing activities    
Principal payments on notes payable (6,734) (30,028)
Purchase of treasury stock (172,115) 0
Payments on capital lease (21,588) (108,776)
Net cash from financing activities (200,437) (138,804)
Net change in cash and cash equivalents 735,104 3,542,914
Cash at beginning of period 16,819,504 13,585,447
Cash at end of period 17,554,608 17,128,361
Cash paid during the period for:    
Interest 2,527 21,564
Income taxes 0 0
Non cash investing and financing activities:    
Unrealized change in fair value of available-for-sale securities $ (4,387,031) $ 3,766,295
XML 45 R3.htm IDEA: XBRL DOCUMENT v3.2.0.727
Consolidated Balance Sheets [Parenthetical] - USD ($)
May. 31, 2015
Aug. 31, 2014
Allowance For Doubtful Accounts Receivable Current (in dollars) $ 122,597,000 $ 154,132,000
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock, shares authorized 5,000,000 5,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized 100,000,000 100,000,000
Common stock, shares issued 14,418,626 14,418,626
Common Stock, shares outstanding 13,460,124 13,888,010
Treasury Stock, Shares 958,502 530,616
XML 46 R17.htm IDEA: XBRL DOCUMENT v3.2.0.727
Treasury Stock
9 Months Ended
May. 31, 2015
Equity [Abstract]  
Treasury Stock [Text Block]
Treasury Stock
 
In September 2013, as part of a settlement agreement with a former employee, the Company received 125,000 shares of common stock of the Company previously issued to him. These shares were accounted for as treasury shares with zero cost, and were retired in the second quarter of fiscal year 2014.
 
In August 2014 and April 2015, binding settlement agreements were reached with some of the shareholders in a law suit whereby the Company received 530,616, shares and 427,886 shares, respectively, of stock owned by the shareholders. Based on an independent appraisal, the value of these shares repurchased as treasury stock were $27,061 and $145,054, respectively.
XML 47 R1.htm IDEA: XBRL DOCUMENT v3.2.0.727
Document And Entity Information - shares
9 Months Ended
May. 31, 2015
Aug. 31, 2015
Document Information [Line Items]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date May 31, 2015  
Document Fiscal Year Focus 2015  
Document Fiscal Period Focus Q3  
Entity Registrant Name DYNACQ HEALTHCARE INC  
Entity Central Index Key 0000890908  
Current Fiscal Year End Date --08-31  
Entity Filer Category Smaller Reporting Company  
Trading Symbol DYII  
Entity Common Stock, Shares Outstanding   13,460,124
XML 48 R18.htm IDEA: XBRL DOCUMENT v3.2.0.727
Stock Based Compensation
9 Months Ended
May. 31, 2015
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
Stock Based Compensation 
 
Year 2011 Stock Incentive Plan
 
The purpose of the Year 2011 Stock Incentive Plan (“2011 Plan”) is to strengthen the Company by providing an incentive to its employees, officers, consultants and directors and to encourage them to devote their abilities and industry to the success of the Company’s business enterprise. It is intended that this purpose be achieved by extending to employees, officers, consultants and directors of the Company and its subsidiaries an added long-term incentive for high levels of performance and unusual efforts through the grant of incentive stock options, non-qualified stock options, stock appreciation rights, dividend equivalent rights, performance awards and restricted stock. The Company has reserved 15,000,000 shares of common stock for issuance under the 2011 Plan. As of May 31, 2015, there remain 250,000 shares to be issued upon exercise of outstanding options, and 14,750,000 shares which can be issued under the 2011 Plan after giving effect to shares issued and canceled.
 
2000 Incentive Plan
 
The Company's 2000 Incentive Plan ("2000 Plan") provides for options and other stock-based awards that may be granted to eligible employees, officers, consultants and non-employee directors of the Company or its subsidiaries. The Company had reserved 5,000,000 shares of common stock for future issuance under the 2000 Plan. The 2000 Plan does not have a fixed termination date, provided that no incentive stock option can be granted subsequent to August 29, 2011. As of May 31, 2015, there remain 534,000 shares to be issued upon exercise of outstanding options, and no new stock options awards will be issued under the 2000 Plan.
 
The following table summarizes the stock option activities for the nine months ended May 31, 2015 (share amounts in thousands):
 
 
Shares
 
Weighted Average
Option Exercise
Price Per Share
 
Outstanding, August 31, 2014
 
 
995
 
$
2.18
 
Granted
 
 
 
 
 
Exercised
 
 
 
 
 
Expired or canceled
 
 
(211)
 
 
4.27
 
Outstanding, May 31, 2015
 
 
784
 
 
1.62
 
 
For the nine months ended May 31, 2015 and 2014, there were no stock options exercised. The aggregate intrinsic value of the stock options outstanding as of May 31, 2015 and 2014 is $-0-, since the market price is lower than the exercise price.
 
The following summarizes information related to stock options outstanding as of May 31, 2015, and related weighted average price and life information:  
 
 
 
 
Options Outstanding
 
Options Exercisable
 
Exercise Prices
 
Number of 
Shares
 
Weighted Average
Remaining Contractual
Life (Years)
 
Number of Shares
 
 
 
 
(Share Amounts In Thousands)
 
$
1.10
 
 
250
 
 
6.6
 
 
188
 
$
1.86
 
 
534
 
 
6.1
 
 
401
 
Total
 
 
 
784
 
 
6.3
 
 
589
 
 
For the three months ended May 31, 2015 and 2014, stock-based compensation expense associated with the Company’s stock options was $49,341 in each period. For the nine months ended May 31, 2015 and 2014, stock-based compensation expense associated with the Company’s stock options was $148,023 in each period. The total unrecognized compensation expense for outstanding stock options as of May 31, 2015 was $33,000, and will be recognized, in general, over five months.
XML 49 R4.htm IDEA: XBRL DOCUMENT v3.2.0.727
Consolidated Statements of Operations - USD ($)
3 Months Ended 9 Months Ended
May. 31, 2015
May. 31, 2014
May. 31, 2015
May. 31, 2014
Net patient service revenue $ 1,047,426 $ 2,748,772 $ 5,120,992 $ 7,239,406
Costs and expenses:        
Compensation and benefits 1,584,218 1,588,618 4,865,531 4,632,833
Medical services and supplies 252,614 532,021 1,107,839 1,453,584
Other operating expenses 1,296,099 1,158,181 3,834,285 3,316,921
Depreciation and amortization 87,143 85,788 260,223 280,632
Total costs and expenses 3,220,074 3,364,608 10,067,878 9,683,970
Operating loss (2,172,648) (615,836) (4,946,886) (2,444,564)
Other income (expense):        
Rent and other income 2,118,542 194,775 1,950,393 611,884
Interest income 178,921 226,705 607,980 653,320
Interest expense (108,186) (105,113) (315,151) (346,535)
Total other income, net 2,189,277 316,367 2,243,222 918,669
Income (loss) before income taxes 16,629 (299,469) (2,703,664) (1,525,895)
Provision (benefit) for income taxes 0 0 0 0
Net income (loss) 16,629 (299,469) (2,703,664) (1,525,895)
Less: Net (income) loss attributable to noncontrolling interest 32 29 (53) (4)
Net income (loss) attributable to Dynacq Healthcare, Inc. $ 16,661 $ (299,440) $ (2,703,717) $ (1,525,899)
Basic and diluted income (loss) per common share $ 0.00 $ (0.02) $ (0.20) $ (0.11)
Basic and diluted average common shares outstanding 13,674,067 14,418,626 13,802,433 14,431,126
XML 50 R12.htm IDEA: XBRL DOCUMENT v3.2.0.727
Investments in Available-for-Sale and Trading Securities
9 Months Ended
May. 31, 2015
Investments Debt And Equity Securities [Abstract]  
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]
Investments in Available-for-Sale and Trading Securities
 
The Company’s investments in debt instruments (corporate and municipal bonds) are recorded at fair value based on quoted market prices that are traded in less active markets or priced using a quoted market price for similar investments or are priced using non-binding market consensus prices that can be corroborated by observable market data (Level 2). These investments are classified as available-for-sale securities. These investments are subject to default risk. Unrealized gains in the fair value are reported in accumulated other comprehensive income, net of related income tax effect. The Company regularly monitors its investment portfolio for any decline in fair value that is other than temporary and records any such impairment as an impairment loss. The determination of the gain or loss on the sale of any security is made using the specific identification method. During the three months ended May 31, 2015, one particular security was called with sales proceeds of $6 million, on which the Company had a gain of approximately $2.1 million.
 
The Company also invested in initial public offerings of equity securities on the Hong Kong Stock Exchange. These investments are classified as trading securities, and were carried at fair value. These investments were subject to fluctuations in the market price. During the nine months ended May 31, 2014, the Company had a net gain of $161,864 in these securities. During the first quarter of fiscal year 2014, the Company sold all of its trading securities and has not held any such securities since November 30, 2013.
XML 51 R11.htm IDEA: XBRL DOCUMENT v3.2.0.727
Cash and Cash Equivalents
9 Months Ended
May. 31, 2015
Cash And Cash Equivalents [Abstract]  
Cash and Cash Equivalents Disclosure [Text Block]
Cash and Cash Equivalents
 
The Company considers all highly liquid instruments with maturities of three months or less on the date of purchase to be cash equivalents. Cash equivalents are carried at cost, which approximates fair value.
XML 52 R23.htm IDEA: XBRL DOCUMENT v3.2.0.727
Accumulated Other Comprehensive Income (Loss)
9 Months Ended
May. 31, 2014
Equity [Abstract]  
Comprehensive Income Note [Text Block]
Accumulated Other Comprehensive Income (Loss)
 
The following table summarizes the changes in accumulated other comprehensive income (loss) by component:
 
 
 
Three months ended May 31,
 
Nine months ended May 31,
 
 
 
2015
 
2014
 
2015
 
2014
 
Available-for-sale securities
 
 
 
 
 
 
 
 
 
 
 
 
 
Accumulated other comprehensive income balance, beginning of period
 
$
10,124,848
 
$
11,953,646
 
$
12,616,346
 
$
9,382,334
 
Other comprehensive income (loss):
 
 
 
 
 
 
 
 
 
 
 
 
 
Unrealized gains (losses), net of taxes of $-0-
 
 
198,467
 
 
1,194,983
 
 
(2,293,031)
 
 
3,766,295
 
Reclassification adjustments for gains included in rent and other income
 
 
(2,094,000)
 
 
 
 
(2,094,000)
 
 
 
Tax provision
 
 
 
 
 
 
 
 
 
Amount reclassified from accumulated other comprehensive income
 
 
(2,094,000)
 
 
 
 
(2,094,000)
 
 
 
Other comprehensive income (loss)
 
 
(1,895,533)
 
 
1,194,983
 
 
(4,387,031)
 
 
3,766,295
 
Accumulated other comprehensive income balance, end of period
 
$
8,229,315
 
$
13,148,629
 
$
8,229,315
 
$
13,148,629
 
XML 53 R19.htm IDEA: XBRL DOCUMENT v3.2.0.727
Fair Value of Financial Instruments
9 Months Ended
May. 31, 2015
Fair Value Disclosures [Abstract]  
Fair Value Disclosures [Text Block]
Fair Value of Financial Instruments
 
The fair value of financial instruments is estimated based on market trading information, where available. Absent published market values for an instrument or other assets, management uses observable market data to arrive at its estimates of fair value. Management believes that the carrying amount of cash and cash equivalents, accounts receivable and accrued liabilities approximate fair value. Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. A three-level fair value hierarchy prioritizes the inputs used to measure fair value. The three levels of inputs used to measure fair value are as follows:
 
Level 1  Quoted prices in active markets for identical assets or liabilities.
 
Level 2  Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted price for identical or similar assets and liabilities in markets that are not active; or other input that are observable or can be corroborated by observable market data.
 
Level 3  Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. This includes certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.
 
The following table summarizes our financial assets and liabilities measured and reported in the Company’s statement of financial position at fair value on a recurring basis as of May 31, 2015, segregated among the appropriate levels within the fair value hierarchy:
 
 
 
Quoted prices in active
 
Significant other
 
Significant
 
 
 
markets for identical
 
observable inputs
 
unobservable
 
 
 
 
(Level 1)
 
(Level 2)
 
(Level 3)
 
Assets
 
 
 
 
 
 
 
 
 
 
Investments available-for-sale
 
$
 
$
12,049,876
 
$
 
 
The Company’s investments in Level 2 are in perpetual debt instruments (corporate and municipal bonds) traded on the European markets, at a cost of $4,078,646, are recorded at fair value based on quoted market prices that are traded in less active markets or priced using a quoted market price for similar investments or are priced using non-binding market consensus prices that can be corroborated by observable market data (Level 2), and there has been no change in valuation techniques for these investments (Level 2).
XML 54 R15.htm IDEA: XBRL DOCUMENT v3.2.0.727
Use of Estimates
9 Months Ended
May. 31, 2015
Use Of Estimates [Abstract]  
Usage Of Estimates [Text Block]
Use of Estimates
 
The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The most significant of the Company’s estimates is the determination of revenue to recognize for the services the Company provides and the determination of allowances, which includes the contractual allowance and the provision for doubtful accounts. See “Revenue Recognition” below for further discussion. Actual results could differ materially from those estimates used in the preparation of these financial statements.
XML 55 R13.htm IDEA: XBRL DOCUMENT v3.2.0.727
Notes payable
9 Months Ended
May. 31, 2015
Notes Payable [Abstract]  
Debt Disclosure [Text Block]
Notes Payable
 
In November 2011, the Company borrowed $116,339 as notes payable from a financial institution at an interest rate of 4.5%, which was to be repaid in 36 monthly installments, and was secured by specific equipment purchased at our Pasadena facility. The Company paid down the balance of $6,734 of notes payable during the three months ended November 30, 2014.
XML 56 R14.htm IDEA: XBRL DOCUMENT v3.2.0.727
Inventories
9 Months Ended
May. 31, 2015
Inventory Disclosure [Abstract]  
Inventory Disclosure [Text Block]
Inventories
 
Inventories, consisting primarily of medical supplies, are stated at the lower of cost or market, with cost determined by use of the average cost method.
XML 57 R16.htm IDEA: XBRL DOCUMENT v3.2.0.727
Net Income (Loss) per Common Share
9 Months Ended
May. 31, 2015
Earnings Per Share [Abstract]  
Earnings Per Share [Text Block]
Net Income (Loss) per Common Share
 
The following table presents the computation of basic and diluted income (loss) per common share attributable to the Company:
 
 
 
Three months ended May 31,
 
Nine months ended May 31,
 
 
 
2015
 
2014
 
2015
 
2014
 
Basic and diluted loss per common share:
 
 
 
 
 
 
 
 
 
 
 
 
 
Numerator:
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss)
 
$
16,629
 
$
(299,469)
 
$
(2,703,664)
 
$
(1,525,895)
 
Less: Net (income) loss attributable to noncontrolling interest
 
 
32
 
 
29
 
 
(53)
 
 
(4)
 
Net income (loss) attributable to Dynacq Healthcare, Inc.
 
$
16,661
 
$
(299,440)
 
$
(2,703,717)
 
$
(1,525,899)
 
Denominator:
 
 
 
 
 
 
 
 
 
 
 
 
 
Basic and diluted average common shares outstanding
 
 
13,674,067
 
 
14,418,626
 
 
13,802,433
 
 
14,431,126
 
Basic and diluted income (loss) per common share:
 
$
0.00
 
$
(0.02)
 
$
(0.20)
 
$
(0.11)
 
 
Basic net income (loss) per share is computed by dividing net income (loss) available to common shareholders by the weighted average number of common shares outstanding for the reporting period. Diluted net income (loss) per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. For the calculation of diluted net income (loss) per share, the basic weighted average number of shares is increased by the dilutive effect of stock options determined using the treasury stock method. However, if it is anti-dilutive, the dilutive effect of the stock options is not included in the calculation of diluted net income (loss) per share. Stock options with exercise prices exceeding current market prices that were excluded from the computation of net income (loss) per share amounted to approximately 784,000 shares and 1,013,000 shares for the nine months ended May 31, 2015 and 2014, respectively.
XML 58 R34.htm IDEA: XBRL DOCUMENT v3.2.0.727
Basis of Presentation (Details Textual) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
May. 31, 2015
May. 31, 2014
May. 31, 2015
May. 31, 2014
Basis Of Presentation [Line Items]        
Corporate Office Costs $ 1.1 $ 1.0 $ 3.0 $ 2.8
XML 59 R51.htm IDEA: XBRL DOCUMENT v3.2.0.727
Industry Segments and Geographic Information (Details) - USD ($)
3 Months Ended 9 Months Ended
May. 31, 2015
May. 31, 2014
May. 31, 2015
May. 31, 2014
Segment Reporting Information [Line Items]        
Net patient service revenues $ 1,047,426 $ 2,748,772 $ 5,120,992 $ 7,239,406
Income (loss) before taxes and discontinued operations 16,629 (299,469) (2,703,664) (1,525,895)
US Division [Member]        
Segment Reporting Information [Line Items]        
Net patient service revenues 1,047,426 2,748,772 5,120,992 7,239,406
Income (loss) before taxes and discontinued operations (1,284,694) 186,954 (2,600,470) (165,472)
Corporate [Member]        
Segment Reporting Information [Line Items]        
Net patient service revenues 0 0 0 0
Income (loss) before taxes and discontinued operations $ 1,301,323 $ (486,423) $ (103,194) $ (1,360,423)
XML 60 R21.htm IDEA: XBRL DOCUMENT v3.2.0.727
Revenue Recognition
9 Months Ended
May. 31, 2015
Revenue Recognition [Abstract]  
Revenue Recognition [Text Block]
Revenue Recognition
 
Background
 
The Company's revenue recognition policy is significant because net patient service revenue is a primary component of its results of operations. Revenue is recognized as services are delivered. The determination of the amount of revenue to be recognized in connection with the Company's services is subject to significant judgments and estimates, which are discussed below. 
 
Revenue Recognition Policy
 
The Company has established billing rates for its medical services which it bills as services are delivered. Gross billings are then reduced by the Company’s estimate of allowances, which includes the contractual allowance and the provision for doubtful accounts, to arrive at net patient service revenues. Net patient service revenues may not represent amounts ultimately collected. The Company adjusts current period revenue for differences in estimated revenue recorded in prior periods and actual cash collections.
 
The following table shows gross revenues and allowances for the three and nine months ended May 31, 2015 and 2014:
 
 
 
Three months ended May 31,
 
 
Nine months ended May 31,
 
 
 
2015
 
 
2014
 
 
2015
 
 
2014
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gross billed charges
 
$
5,798,725
 
 
$
8,148,181
 
 
$
22,116,554
 
 
$
21,806,599
 
Allowances
 
 
4,751,299
 
 
 
5,399,409
 
 
 
16,995,562
 
 
 
14,567,193
 
Net revenue
 
$
1,047,426
 
 
$
2,748,772
 
 
$
5,120,992
 
 
$
7,239,406
 
Allowance percentage
 
 
82
%
 
 
66
%
 
 
77
%
 
 
67
%
 
Contractual Allowance
 
The Company computes its contractual allowance based on the estimated collections on its gross billed charges. The Company computes its estimate by taking into account collections received, up to 30 days after the end of the period, for the services performed and also estimating amounts collectible for the services performed within the last six months. A significant amount of our net revenue results from Texas workers' compensation claims, which are governed by the rules and regulations of the Texas Department of Workers’ Compensation (“TDWC”) and the workers’ compensation healthcare networks. If our hospital chooses to participate in a network, the amount of revenue that will be generated from workers’ compensation claims will be governed by the network contract.
 
For claims arising prior to the implementation of workers’ compensation networks and out of network claims, inpatient and outpatient surgical services are either reimbursed pursuant to the Acute Care In-Patient Hospital Fee Guideline or at a "fair and reasonable" rate for services in which the fee guideline is not applicable. Starting March 1, 2008, the Texas Workers’ Compensation 2008 Acute Care Hospital Outpatient and Inpatient Facility Fee Guidelines (the “Guidelines”) became effective. Under these Guidelines, the reimbursement amounts are determined by applying the most recently adopted and effective Medicare reimbursement formula and factors; however, if the maximum allowable reimbursement for the procedure performed cannot be calculated using these Guidelines, then reimbursement is determined on a fair and reasonable basis.
 
Should we disagree with the amount of reimbursement provided by a third-party payer, we are required to pursue the medical dispute resolution (“MDR”) process at the TDWC to request proper reimbursement for services. From January 2007 to November 2008, the Company had been successful in its pursuit of collections regarding the stop-loss cases pending before the State Office of Administrative Hearings (“SOAH”), receiving positive rulings in over 90% of its claims presented for administrative determination. A 2007 district court decision upholding our interpretation of the statute as applied to the stop-loss claims was appealed by certain insurance carriers, and on November 13, 2008 the Third Court of Appeals determined that in order for a hospital to be reimbursed at 75% of its usual and customary audited charges for an inpatient admission, the hospital must not only bill at least $40,000, but also show that the admission involved unusually costly and unusually extensive services. Procedurally, the decision means that each case where a carrier raised an issue regarding whether the services provided were unusually costly or unusually extensive would be remanded to either SOAH or MDR for a case-by-case determination of whether the services provided meet these standards. As a result of the Third Court of Appeals opinion, any stop-loss cases pending at SOAH have been remanded to the TDWC since these cases have not been reviewed or decided by the two-prong standard decided by the Third Court of Appeals. The SOAH Administrative Law judges determined that the most appropriate location for these cases is the TDWC.
 
A petition asking the Texas Supreme Court to review the Third Court of Appeals decision has been denied. Therefore, the Company is bound by the Third Court of Appeals decision. The Texas Supreme Court’s decision delayed final adjudication in these pending stop-loss cases. The uncertain outcome in these cases will depend on a very lengthy process. We anticipate further, lengthy litigation at the Travis County District Courts and the Texas Courts of Appeals. Because of this lengthy process and the uncertainty of recovery in these cases, collection of a material amount of funds in these pending stop-loss cases cannot be anticipated.
 
Through May 2015, insurance carriers have voluntarily paid the awards in the decisions and orders issued by SOAH, plus interest, in approximately 180 cases, involving approximately $11 million in claims. In most of these cases, when the payments were made, the carriers requested refunds of the payments made in the event that the SOAH decisions and orders were reversed on appeal (which they were). Our request that the TDWC Commissioner enforce the awards which were not voluntarily paid by the carriers was refused in approximately 130 cases. As a result of the reversal of the SOAH decisions and orders, Texas Mutual Insurance Company and other carriers filed petitions in Travis County district court seeking a refund in cases in which the awards were voluntarily paid. The district court found in favor of Texas Mutual and the Company was ordered to refund approximately $4.2 million, including prejudgment interest, pending remand for a case-by-case determination of whether the services provided were unusually costly and unusually extensive. The Company did not object to the reversal and remand of the SOAH decisions and orders, but did object to the judgments ordering refunds and those judgments were appealed to the Third Court of Appeals. As part of the appeals, the Company deposited the amounts that were ordered to be refunded as cash deposits into the registry of the court in order to stay execution of the judgments ordering refunds. On June 6, 2013, the judgments ordering refunds were reversed by the Court of Appeals. The Court of Appeals held that if Texas Mutual wants a refund, it must pursue the refund demand administratively through the TDWC rather than through the district courts. Texas Mutual filed a motion for rehearing with the Court of Appeals which ultimately was denied. The Company filed motions in all 47 cases with the district court asking that the district clerk be ordered to release the deposited funds to the Company, and in January 2014, the Company received the deposits and accrued interest totaling $4.2 million. In addition, Texas Mutual filed three additional petitions in district court for cases that were left out of the original 47. The court granted Texas Mutual’s petitions and ordered the Company to refund approximately $300,000, including prejudgment interest to Texas Mutual. These judgments were granted before the Court of Appeals reversed the district court’s original judgments. These three cases were appealed to the Court of Appeals and the funds ordered refunded were deposited with the district clerk. As with the other 47 cases, the Court of Appeals reversed the district court’s final judgments in these three cases and the Company filed motions with the district court asking that the district clerk be ordered to release the deposited funds to the Company, and in February 2014, the Company received the deposits and accrued interest totaling approximately $300,000. The total refund received by the Company in fiscal year 2014 for the 50 stop-loss cases discussed above was $4,476,097.
 
During the time that the carriers’ petitions seeking refunds were pending, because of the uncertainty of the results at that time, as of May 31, 2015, the Company has accrued the total potential refund amount of $11.3 million, and an additional amount of $3.8 million in interest payable, as accrued liabilities. This includes the deposit amounts refunded back to the Company in January and February 2014. We do not anticipate that any other carriers will pursue refund demands through district court but instead will pursue them administratively through TDWC. The cases in which the SOAH decisions and orders were reversed have been or are being remanded to TDWC for determinations of whether the services provided were unusually costly and unusually extensive. The carriers contend that the voluntary payments made pursuant to the Decisions and Orders were premature payments by the carriers and may be ordered to be refunded. The Company disagrees with this contention. After the reversal of the judgments it obtained from the district court ordering refunds, on December 4, 2013, Texas Mutual made a formal request to the Commissioner of Workers’ Compensation that he administratively order the Company to make refunds to Texas Mutual (in the same amount that was sought in the district court). The Company responded to this request on December 11, 2013, asking that it be denied. The matter is pending at this time. As to the matters remanded to TDWC and SOAH, once the Company is given the opportunity to present its evidence regarding whether the services provided were unusually costly and unusually extensive, the Company anticipates that it will prevail in many of the underlying stop-loss fee disputes and that payments refunded to the carriers will be recaptured. In March 2014, a settlement conference with one self-insured entity successfully resolved the stop-loss cases in which that entity was involved. Although the Company is willing to participate in settlement negotiations, we anticipate that few, if any, other carriers are interested in doing so at this time. It is anticipated that hearings at SOAH on the pending stop-loss cases will begin in November 2015.
 
Due to the uncertainties associated with these stop-loss fee dispute cases, the Company recognized increases in the contractual allowance at our Pasadena facility of $10,254,990 during fiscal year 2011 and $149,875 during the fiscal quarter ended August 31, 2013, (and an additional contractual allowance amount of $779,583 during fiscal year 2011 and $136,542 during the fiscal quarter ended August 31, 2013, at our Garland facility, which was classified as discontinued operations). The Company has also recognized interest expense related to these refunds starting from fiscal year 2011.
 
Some claims regarding payment for ambulatory surgical center and hospital outpatient services remain pending at the TDWC and/or SOAH. It is expected that these remaining claims will be adjudicated at SOAH and possibly in the Texas district and appellate courts. The basis for reimbursement for these services made the subject of these pending cases is the same as it was for the other ASC and outpatient cases that have been either tried or settled: the determination of “fair and reasonable” charges. In 2007, the Company received unfavorable rulings from SOAH in all of its appeals of unfavorable decisions related to services provided in 2001 and 2002. The 179 cases, which were appealed to the Travis County district courts, challenged the constitutionality of the relevant statutory language. The Company received an unfavorable ruling in its lead case in March 2009, which ruling was appealed to and was upheld by the Third Court of Appeals on August 26, 2010. The Texas Supreme Court denied a petition asking for review of the Third Court of Appeals decision. The unfavorable interpretation by the Texas Courts of Appeal in the Company’s lead case negatively affects the recovery of additional reimbursement, not only in the lead case, but in the remaining 178 pending cases. Consequently, the Company is bound by the Third Court of Appeals’ ruling that interprets the applicable statute and fee guideline to require that the amount that will be paid to a provider must not only be at a “fair and reasonable rate” but also must “ensure the quality of medical care” and “achieve effective cost control” and be the same or less than that charged to others with an equivalent standard of living. This ruling has impacted cases in which a fee guideline was not applicable, specifically all pending cases involving ambulatory surgical services provided from 2001 through 2004 as well as all pending cases involving hospital outpatient services provided prior to March 1, 2008, when the Guidelines took effect. Since the Third Court of Appeals’ unfavorable ruling, collection, if any, in these cases depends on the Company’s ability to establish the criteria in this ruling. The Company was given the opportunity to establish the criteria in approximately 80 cases, which were set for hearing on the merits from March through May 2012 and was unsuccessful. In 2014, hearings were held in 23 of the Company’s hospital outpatient cases at SOAH. Decisions and Orders were handed down by SOAH adopting the methodology for determining “fair and reasonable” reimbursement that was put forth by the Company and ordered additional reimbursement in each of the 23 cases plus interest be paid to the Company. The carrier has appealed these decisions to Travis County district court and the cases have been consolidated. In April 2015 a large group of outpatient cases with various carriers were tried at SOAH. The Company and the carriers have presented their evidence and the parties’ closing arguments were filed in June 2015.
 
Due to the uncertainties regarding the accounts receivable in the MDR process, the 2008 and 2010 Third Court of Appeals’ opinions and our legal counsel’s advice that settlements with insurance carriers in stop-loss cases have virtually stopped, the Company had fully reserved all accounts receivable related to the MDR process as of August 31, 2008. The Company has had settlement negotiations with insurance carriers for ambulatory surgical center and hospital outpatient cases. Some of these negotiations have been successful. Any monies collected for these MDR accounts receivable is recorded as current period’s net patient service revenues.
 
Provision for Doubtful Accounts
 
Although outcomes vary, our policy is to attempt to collect amounts due from patients, including co-payments and deductibles due from patients with insurance, at the time of service while complying with all federal and state laws and regulations. In non-emergency circumstances or for elective procedures and services, it is our policy to verify insurance prior to a patient being treated; however, there are various exceptions that can occur.
 
The Company computes its allowances based on the estimated collections on its gross billed charges. The Company computes its estimate of allowance, which is a combination of contractual allowance and provision for doubtful accounts, by taking into account collections received, up to 30 days after the end of the period, for the services performed and also estimating amounts collectible for the services performed within the last six months.
 
Accounts receivable represent net receivables for services provided by the Company. At each balance sheet date management reviews the accounts receivable for collectibility and provides full allowance reserves for any accounts receivable deemed uncollectible.
 
The allowances stated as a percentage of gross receivables at the balance sheet dates is larger than the allowance percentage used to reduce gross billed charges due to the application of partial cash collections to the outstanding gross receivable balances, without any adjustment being made to the allowances. The allowance amounts netted against gross receivables are not adjusted until such time as the final collections on an individual receivable are recognized.
 
The focal point of our business is providing patient care services, including complex orthopedic and bariatric procedures. The Company pursues optimal reimbursement from third-party payers for these services. In some instances, we do not have contractual arrangements with third-party payers which provide for “prompt payment” which may result in additional time to collect the expected reimbursement.
 
The collection process may also be extended due to our efforts to obtain all optimal reimbursement available to the Company. Specifically, for medical services provided to injured workers, the Company may initially receive reimbursement that may not be within the fee guidelines or regulatory guidelines mandating reimbursement. The Company reviews and pursues those particular claims that are determined to warrant additional reimbursement pursuant to the fee or regulatory guidelines. The Company's pursuit of additional reimbursement amounts that it believes are due under fee or regulatory guidelines may be accomplished through established dispute resolution procedures with applicable regulatory authorities.
XML 61 R26.htm IDEA: XBRL DOCUMENT v3.2.0.727
Industry Segments and Geographic Information
9 Months Ended
May. 31, 2015
Segment Reporting [Abstract]  
Segment Reporting Disclosure [Text Block]
Industry Segments and Geographic Information
 
The Industry Segment “U.S. Division” comprises of the Company’s Pasadena facility. The Company at the present time has the U.S. Division and the Corporate Division.
 
Certain previously reported financial information has been reclassified to conform to the current period’s presentation.
 
Corporate Division
 
The Company formed Sino Bond to hold and manage investments in Hong Kong. Sino Bond invests in debt instruments (corporate and municipal) and equity securities in Europe and Asia, including initial public offerings and pre-initial public offerings. The Company invests in various marketable securities. During the three months ended May 31, 2015, one particular security was called on which the Company had a gain of approximately $2.1 million. As of May 31, 2015, the balance of these securities is valued at approximately $12.0 million. During the nine months ended May 31, 2014, the Company also traded in initial public offerings of equity securities on the Hong Kong Stock Exchange and had a net gain of $161,864 in these securities. During the first quarter of fiscal year 2014, the Company sold all of its trading securities and has not held any such securities since November 30, 2013.
 
The Corporate Division includes interest and other income related to its investments in securities, corporate personnel compensation expenses, and general and administrative expenses. Such expenses and income are not allocated to our operating division, as they relate to our general corporate activities.
 
We generally evaluate performance based on profit or loss from operations before income taxes and non-recurring charges and other criteria. The accounting policies of the reportable segments are the same as those described in the summary of significant accounting policies. There are no transfers between segments.
 
Summarized financial information concerning the business segments from continuing operations is as follows:
 
 
 
Three months ended May 31,
 
Nine months ended May 31,
 
 
 
2015
 
2014
 
2015
 
2014
 
Revenues from external customers
 
 
 
 
 
 
 
 
 
 
 
 
 
Net patient service revenues
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S. Division
 
$
1,047,426
 
$
2,748,772
 
$
5,120,992
 
$
7,239,406
 
Corporate
 
 
 
 
 
 
 
 
 
Consolidated
 
$
1,047,426
 
$
2,748,772
 
$
5,120,992
 
$
7,239,406
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Income (loss) before taxes
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S. Division
 
$
(1,284,694)
 
$
186,954
 
$
(2,600,470)
 
$
(165,472)
 
Corporate
 
 
1,301,323
 
 
(486,423)
 
 
(103,194)
 
 
(1,360,423)
 
Consolidated
 
$
16,629
 
$
(299,469)
 
$
(2,703,664)
 
$
(1,525,895)
 
 
 
 
 
May 31, 2015
 
August 31, 2014
 
Total Assets
 
 
 
 
 
 
 
U.S. Division
 
$
16,488,296
 
$
15,967,472
 
Corporate
 
 
22,221,764
 
 
31,793,055
 
Consolidated
 
$
38,710,060
 
$
47,760,527
 
XML 62 R49.htm IDEA: XBRL DOCUMENT v3.2.0.727
Accumulated Other Comprehensive Income (Loss) (Details Textual) - USD ($)
3 Months Ended 9 Months Ended
May. 31, 2015
May. 31, 2014
May. 31, 2015
May. 31, 2014
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Net change in fair value of available-for-sale securities, net of taxes $ 0 $ 0 $ 0 $ 0
XML 63 R41.htm IDEA: XBRL DOCUMENT v3.2.0.727
Stock Based Compensation (Details 1) - May. 31, 2015 - $ / shares
shares in Thousands
Total
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]  
Options Outstanding, Number of Shares 784
Options Outstanding, Weighted Average Remaining Contractual Life (Years) 6 years 3 months 18 days
Options Exercisable, Number of Shares 589
Range One [Member]  
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]  
Range of Exercise Prices, Lower Range Limit $ 1.10
Options Outstanding, Number of Shares 250
Options Outstanding, Weighted Average Remaining Contractual Life (Years) 6 years 7 months 6 days
Options Exercisable, Number of Shares 188
Range Two [Member]  
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]  
Range of Exercise Prices, Lower Range Limit $ 1.86
Options Outstanding, Number of Shares 534
Options Outstanding, Weighted Average Remaining Contractual Life (Years) 6 years 1 month 6 days
Options Exercisable, Number of Shares 401
XML 64 R5.htm IDEA: XBRL DOCUMENT v3.2.0.727
Consolidated Statements of Comprehensive Income (Loss) - USD ($)
3 Months Ended 9 Months Ended
May. 31, 2015
May. 31, 2014
May. 31, 2015
May. 31, 2014
Net income (loss) $ 16,629 $ (299,469) $ (2,703,664) $ (1,525,895)
Other comprehensive income (loss):        
Net change in fair value of available-for-sale securities, net of taxes of $-0- (1,895,533) 1,194,983 (4,387,031) 3,766,295
Other comprehensive income (loss) (1,895,533) 1,194,983 (4,387,031) 3,766,295
Comprehensive income (loss) (1,878,904) 895,514 (7,090,695) 2,240,400
Less comprehensive (income) loss attributable to noncontrolling interest 32 29 (53) (4)
Comprehensive income (loss) attributable to Dynacq Healthcare, Inc. $ (1,878,872) $ 895,543 $ (7,090,748) $ 2,240,396
XML 65 R10.htm IDEA: XBRL DOCUMENT v3.2.0.727
Reclassification
9 Months Ended
May. 31, 2015
Reclassification [Abstract]  
Disclosure of Reclassification Amount [Text Block]
Reclassification
 
Certain previously reported financial information has been reclassified to conform to the current period’s presentation. The impact of such reclassification was not significant to the prior period’s overall presentation.
XML 66 R27.htm IDEA: XBRL DOCUMENT v3.2.0.727
Significant Accounting Policies (Policies)
9 Months Ended
May. 31, 2015
Accounting Policies [Abstract]  
Business And Organization [Policy Text Block]
Basis of Presentation
 
The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete consolidated financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. All such adjustments are of a normal and recurring nature. The majority of the Company's expenses are "cost of revenue" items. Costs that could be classified as general and administrative by the Company would include the corporate office costs, including advertising and marketing expenses, which were approximately $1.1 million and $1.0 million for the three months ended May 31, 2015 and 2014, respectively, and approximately $3.0 million and $2.8 million for the nine months ended May 31, 2015 and 2014, respectively. These financial statements should be read in conjunction with the audited financial statements as of August 31, 2014. Operating results for the three and nine months ended May 31, 2015 are not necessarily indicative of the results that may be expected for the year ending August 31, 2015.
Reclassification, Policy [Policy Text Block]
Reclassification
 
Certain previously reported financial information has been reclassified to conform to the current period’s presentation. The impact of such reclassification was not significant to the prior period’s overall presentation.
Cash and Cash Equivalents, Policy [Policy Text Block]
Cash and Cash Equivalents
 
The Company considers all highly liquid instruments with maturities of three months or less on the date of purchase to be cash equivalents. Cash equivalents are carried at cost, which approximates fair value.
Marketable Securities, Policy [Policy Text Block]
Investments in Available-for-Sale and Trading Securities
 
The Company’s investments in debt instruments (corporate and municipal bonds) are recorded at fair value based on quoted market prices that are traded in less active markets or priced using a quoted market price for similar investments or are priced using non-binding market consensus prices that can be corroborated by observable market data (Level 2). These investments are classified as available-for-sale securities. These investments are subject to default risk. Unrealized gains in the fair value are reported in accumulated other comprehensive income, net of related income tax effect. The Company regularly monitors its investment portfolio for any decline in fair value that is other than temporary and records any such impairment as an impairment loss. The determination of the gain or loss on the sale of any security is made using the specific identification method. During the three months ended May 31, 2015, one particular security was called with sales proceeds of $6 million, on which the Company had a gain of approximately $2.1 million.
 
The Company also invested in initial public offerings of equity securities on the Hong Kong Stock Exchange. These investments are classified as trading securities, and were carried at fair value. These investments were subject to fluctuations in the market price. During the nine months ended May 31, 2014, the Company had a net gain of $161,864 in these securities. During the first quarter of fiscal year 2014, the Company sold all of its trading securities and has not held any such securities since November 30, 2013.
Investment In Real Estates And Notes Payable [Policy Text Block]
Notes Payable
 
In November 2011, the Company borrowed $116,339 as notes payable from a financial institution at an interest rate of 4.5%, which was to be repaid in 36 monthly installments, and was secured by specific equipment purchased at our Pasadena facility. The Company paid down the balance of $6,734 of notes payable during the three months ended November 30, 2014.
Inventory, Policy [Policy Text Block]
Inventories
 
Inventories, consisting primarily of medical supplies, are stated at the lower of cost or market, with cost determined by use of the average cost method.
Use of Estimates, Policy [Policy Text Block]
Use of Estimates
 
The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The most significant of the Company’s estimates is the determination of revenue to recognize for the services the Company provides and the determination of allowances, which includes the contractual allowance and the provision for doubtful accounts. See “Revenue Recognition” below for further discussion. Actual results could differ materially from those estimates used in the preparation of these financial statements.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]
Stock Based Compensation 
 
Year 2011 Stock Incentive Plan
 
The purpose of the Year 2011 Stock Incentive Plan (“2011 Plan”) is to strengthen the Company by providing an incentive to its employees, officers, consultants and directors and to encourage them to devote their abilities and industry to the success of the Company’s business enterprise. It is intended that this purpose be achieved by extending to employees, officers, consultants and directors of the Company and its subsidiaries an added long-term incentive for high levels of performance and unusual efforts through the grant of incentive stock options, non-qualified stock options, stock appreciation rights, dividend equivalent rights, performance awards and restricted stock. The Company has reserved 15,000,000 shares of common stock for issuance under the 2011 Plan. As of May 31, 2015, there remain 250,000 shares to be issued upon exercise of outstanding options, and 14,750,000 shares which can be issued under the 2011 Plan after giving effect to shares issued and canceled.
 
2000 Incentive Plan
 
The Company's 2000 Incentive Plan ("2000 Plan") provides for options and other stock-based awards that may be granted to eligible employees, officers, consultants and non-employee directors of the Company or its subsidiaries. The Company had reserved 5,000,000 shares of common stock for future issuance under the 2000 Plan. The 2000 Plan does not have a fixed termination date, provided that no incentive stock option can be granted subsequent to August 29, 2011. As of May 31, 2015, there remain 534,000 shares to be issued upon exercise of outstanding options, and no new stock options awards will be issued under the 2000 Plan.
 
The following table summarizes the stock option activities for the nine months ended May 31, 2015 (share amounts in thousands):
 
 
Shares
 
Weighted Average
Option Exercise
Price Per Share
 
Outstanding, August 31, 2014
 
 
995
 
$
2.18
 
Granted
 
 
 
 
 
Exercised
 
 
 
 
 
Expired or canceled
 
 
(211)
 
 
4.27
 
Outstanding, May 31, 2015
 
 
784
 
 
1.62
 
 
For the nine months ended May 31, 2015 and 2014, there were no stock options exercised. The aggregate intrinsic value of the stock options outstanding as of May 31, 2015 and 2014 is $-0-, since the market price is lower than the exercise price.
 
The following summarizes information related to stock options outstanding as of May 31, 2015, and related weighted average price and life information:  
 
 
 
 
Options Outstanding
 
Options Exercisable
 
Exercise Prices
 
Number of 
Shares
 
Weighted Average
Remaining Contractual
Life (Years)
 
Number of Shares
 
 
 
 
(Share Amounts In Thousands)
 
$
1.10
 
 
250
 
 
6.6
 
 
188
 
$
1.86
 
 
534
 
 
6.1
 
 
401
 
Total
 
 
 
784
 
 
6.3
 
 
589
 
 
For the three months ended May 31, 2015 and 2014, stock-based compensation expense associated with the Company’s stock options was $49,341 in each period. For the nine months ended May 31, 2015 and 2014, stock-based compensation expense associated with the Company’s stock options was $148,023 in each period. The total unrecognized compensation expense for outstanding stock options as of May 31, 2015 was $33,000, and will be recognized, in general, over five months.
Fair Value of Financial Instruments, Policy [Policy Text Block]
Fair Value of Financial Instruments
 
The fair value of financial instruments is estimated based on market trading information, where available. Absent published market values for an instrument or other assets, management uses observable market data to arrive at its estimates of fair value. Management believes that the carrying amount of cash and cash equivalents, accounts receivable and accrued liabilities approximate fair value. Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. A three-level fair value hierarchy prioritizes the inputs used to measure fair value. The three levels of inputs used to measure fair value are as follows:
 
Level 1  Quoted prices in active markets for identical assets or liabilities.
 
Level 2  Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted price for identical or similar assets and liabilities in markets that are not active; or other input that are observable or can be corroborated by observable market data.
 
Level 3  Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. This includes certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.
 
The following table summarizes our financial assets and liabilities measured and reported in the Company’s statement of financial position at fair value on a recurring basis as of May 31, 2015, segregated among the appropriate levels within the fair value hierarchy:
 
 
 
Quoted prices in active
 
Significant other
 
Significant
 
 
 
markets for identical
 
observable inputs
 
unobservable
 
 
 
 
(Level 1)
 
(Level 2)
 
(Level 3)
 
Assets
 
 
 
 
 
 
 
 
 
 
Investments available-for-sale
 
$
 
$
12,049,876
 
$
 
 
The Company’s investments in Level 2 are in perpetual debt instruments (corporate and municipal bonds) traded on the European markets, at a cost of $4,078,646, are recorded at fair value based on quoted market prices that are traded in less active markets or priced using a quoted market price for similar investments or are priced using non-binding market consensus prices that can be corroborated by observable market data (Level 2), and there has been no change in valuation techniques for these investments (Level 2).
Foreign Currency Transactions and Translations Policy [Policy Text Block]
Foreign Currency Translation
 
The functional currency of the Company as a whole is the U.S. Dollar. The Company has designated the U.S. Dollar as the functional currency for Sino Bond Inc. Limited, a Hong Kong corporation and wholly owned subsidiary of the Company (“Sino Bond”). The effects of foreign currency exchange adjustments are included as a component of Rent and Other Income in the Consolidated Statements of Operations.
Revenue Recognition, Policy [Policy Text Block]
Revenue Recognition
 
Background
 
The Company's revenue recognition policy is significant because net patient service revenue is a primary component of its results of operations. Revenue is recognized as services are delivered. The determination of the amount of revenue to be recognized in connection with the Company's services is subject to significant judgments and estimates, which are discussed below. 
 
Revenue Recognition Policy
 
The Company has established billing rates for its medical services which it bills as services are delivered. Gross billings are then reduced by the Company’s estimate of allowances, which includes the contractual allowance and the provision for doubtful accounts, to arrive at net patient service revenues. Net patient service revenues may not represent amounts ultimately collected. The Company adjusts current period revenue for differences in estimated revenue recorded in prior periods and actual cash collections.
 
The following table shows gross revenues and allowances for the three and nine months ended May 31, 2015 and 2014:
 
 
 
Three months ended May 31,
 
 
Nine months ended May 31,
 
 
 
2015
 
 
2014
 
 
2015
 
 
2014
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gross billed charges
 
$
5,798,725
 
 
$
8,148,181
 
 
$
22,116,554
 
 
$
21,806,599
 
Allowances
 
 
4,751,299
 
 
 
5,399,409
 
 
 
16,995,562
 
 
 
14,567,193
 
Net revenue
 
$
1,047,426
 
 
$
2,748,772
 
 
$
5,120,992
 
 
$
7,239,406
 
Allowance percentage
 
 
82
%
 
 
66
%
 
 
77
%
 
 
67
%
 
Contractual Allowance
 
The Company computes its contractual allowance based on the estimated collections on its gross billed charges. The Company computes its estimate by taking into account collections received, up to 30 days after the end of the period, for the services performed and also estimating amounts collectible for the services performed within the last six months. A significant amount of our net revenue results from Texas workers' compensation claims, which are governed by the rules and regulations of the Texas Department of Workers’ Compensation (“TDWC”) and the workers’ compensation healthcare networks. If our hospital chooses to participate in a network, the amount of revenue that will be generated from workers’ compensation claims will be governed by the network contract.
 
For claims arising prior to the implementation of workers’ compensation networks and out of network claims, inpatient and outpatient surgical services are either reimbursed pursuant to the Acute Care In-Patient Hospital Fee Guideline or at a "fair and reasonable" rate for services in which the fee guideline is not applicable. Starting March 1, 2008, the Texas Workers’ Compensation 2008 Acute Care Hospital Outpatient and Inpatient Facility Fee Guidelines (the “Guidelines”) became effective. Under these Guidelines, the reimbursement amounts are determined by applying the most recently adopted and effective Medicare reimbursement formula and factors; however, if the maximum allowable reimbursement for the procedure performed cannot be calculated using these Guidelines, then reimbursement is determined on a fair and reasonable basis.
 
Should we disagree with the amount of reimbursement provided by a third-party payer, we are required to pursue the medical dispute resolution (“MDR”) process at the TDWC to request proper reimbursement for services. From January 2007 to November 2008, the Company had been successful in its pursuit of collections regarding the stop-loss cases pending before the State Office of Administrative Hearings (“SOAH”), receiving positive rulings in over 90% of its claims presented for administrative determination. A 2007 district court decision upholding our interpretation of the statute as applied to the stop-loss claims was appealed by certain insurance carriers, and on November 13, 2008 the Third Court of Appeals determined that in order for a hospital to be reimbursed at 75% of its usual and customary audited charges for an inpatient admission, the hospital must not only bill at least $40,000, but also show that the admission involved unusually costly and unusually extensive services. Procedurally, the decision means that each case where a carrier raised an issue regarding whether the services provided were unusually costly or unusually extensive would be remanded to either SOAH or MDR for a case-by-case determination of whether the services provided meet these standards. As a result of the Third Court of Appeals opinion, any stop-loss cases pending at SOAH have been remanded to the TDWC since these cases have not been reviewed or decided by the two-prong standard decided by the Third Court of Appeals. The SOAH Administrative Law judges determined that the most appropriate location for these cases is the TDWC.
 
A petition asking the Texas Supreme Court to review the Third Court of Appeals decision has been denied. Therefore, the Company is bound by the Third Court of Appeals decision. The Texas Supreme Court’s decision delayed final adjudication in these pending stop-loss cases. The uncertain outcome in these cases will depend on a very lengthy process. We anticipate further, lengthy litigation at the Travis County District Courts and the Texas Courts of Appeals. Because of this lengthy process and the uncertainty of recovery in these cases, collection of a material amount of funds in these pending stop-loss cases cannot be anticipated.
 
Through May 2015, insurance carriers have voluntarily paid the awards in the decisions and orders issued by SOAH, plus interest, in approximately 180 cases, involving approximately $11 million in claims. In most of these cases, when the payments were made, the carriers requested refunds of the payments made in the event that the SOAH decisions and orders were reversed on appeal (which they were). Our request that the TDWC Commissioner enforce the awards which were not voluntarily paid by the carriers was refused in approximately 130 cases. As a result of the reversal of the SOAH decisions and orders, Texas Mutual Insurance Company and other carriers filed petitions in Travis County district court seeking a refund in cases in which the awards were voluntarily paid. The district court found in favor of Texas Mutual and the Company was ordered to refund approximately $4.2 million, including prejudgment interest, pending remand for a case-by-case determination of whether the services provided were unusually costly and unusually extensive. The Company did not object to the reversal and remand of the SOAH decisions and orders, but did object to the judgments ordering refunds and those judgments were appealed to the Third Court of Appeals. As part of the appeals, the Company deposited the amounts that were ordered to be refunded as cash deposits into the registry of the court in order to stay execution of the judgments ordering refunds. On June 6, 2013, the judgments ordering refunds were reversed by the Court of Appeals. The Court of Appeals held that if Texas Mutual wants a refund, it must pursue the refund demand administratively through the TDWC rather than through the district courts. Texas Mutual filed a motion for rehearing with the Court of Appeals which ultimately was denied. The Company filed motions in all 47 cases with the district court asking that the district clerk be ordered to release the deposited funds to the Company, and in January 2014, the Company received the deposits and accrued interest totaling $4.2 million. In addition, Texas Mutual filed three additional petitions in district court for cases that were left out of the original 47. The court granted Texas Mutual’s petitions and ordered the Company to refund approximately $300,000, including prejudgment interest to Texas Mutual. These judgments were granted before the Court of Appeals reversed the district court’s original judgments. These three cases were appealed to the Court of Appeals and the funds ordered refunded were deposited with the district clerk. As with the other 47 cases, the Court of Appeals reversed the district court’s final judgments in these three cases and the Company filed motions with the district court asking that the district clerk be ordered to release the deposited funds to the Company, and in February 2014, the Company received the deposits and accrued interest totaling approximately $300,000. The total refund received by the Company in fiscal year 2014 for the 50 stop-loss cases discussed above was $4,476,097.
 
During the time that the carriers’ petitions seeking refunds were pending, because of the uncertainty of the results at that time, as of May 31, 2015, the Company has accrued the total potential refund amount of $11.3 million, and an additional amount of $3.8 million in interest payable, as accrued liabilities. This includes the deposit amounts refunded back to the Company in January and February 2014. We do not anticipate that any other carriers will pursue refund demands through district court but instead will pursue them administratively through TDWC. The cases in which the SOAH decisions and orders were reversed have been or are being remanded to TDWC for determinations of whether the services provided were unusually costly and unusually extensive. The carriers contend that the voluntary payments made pursuant to the Decisions and Orders were premature payments by the carriers and may be ordered to be refunded. The Company disagrees with this contention. After the reversal of the judgments it obtained from the district court ordering refunds, on December 4, 2013, Texas Mutual made a formal request to the Commissioner of Workers’ Compensation that he administratively order the Company to make refunds to Texas Mutual (in the same amount that was sought in the district court). The Company responded to this request on December 11, 2013, asking that it be denied. The matter is pending at this time. As to the matters remanded to TDWC and SOAH, once the Company is given the opportunity to present its evidence regarding whether the services provided were unusually costly and unusually extensive, the Company anticipates that it will prevail in many of the underlying stop-loss fee disputes and that payments refunded to the carriers will be recaptured. In March 2014, a settlement conference with one self-insured entity successfully resolved the stop-loss cases in which that entity was involved. Although the Company is willing to participate in settlement negotiations, we anticipate that few, if any, other carriers are interested in doing so at this time. It is anticipated that hearings at SOAH on the pending stop-loss cases will begin in November 2015.
 
Due to the uncertainties associated with these stop-loss fee dispute cases, the Company recognized increases in the contractual allowance at our Pasadena facility of $10,254,990 during fiscal year 2011 and $149,875 during the fiscal quarter ended August 31, 2013, (and an additional contractual allowance amount of $779,583 during fiscal year 2011 and $136,542 during the fiscal quarter ended August 31, 2013, at our Garland facility, which was classified as discontinued operations). The Company has also recognized interest expense related to these refunds starting from fiscal year 2011.
 
Some claims regarding payment for ambulatory surgical center and hospital outpatient services remain pending at the TDWC and/or SOAH. It is expected that these remaining claims will be adjudicated at SOAH and possibly in the Texas district and appellate courts. The basis for reimbursement for these services made the subject of these pending cases is the same as it was for the other ASC and outpatient cases that have been either tried or settled: the determination of “fair and reasonable” charges. In 2007, the Company received unfavorable rulings from SOAH in all of its appeals of unfavorable decisions related to services provided in 2001 and 2002. The 179 cases, which were appealed to the Travis County district courts, challenged the constitutionality of the relevant statutory language. The Company received an unfavorable ruling in its lead case in March 2009, which ruling was appealed to and was upheld by the Third Court of Appeals on August 26, 2010. The Texas Supreme Court denied a petition asking for review of the Third Court of Appeals decision. The unfavorable interpretation by the Texas Courts of Appeal in the Company’s lead case negatively affects the recovery of additional reimbursement, not only in the lead case, but in the remaining 178 pending cases. Consequently, the Company is bound by the Third Court of Appeals’ ruling that interprets the applicable statute and fee guideline to require that the amount that will be paid to a provider must not only be at a “fair and reasonable rate” but also must “ensure the quality of medical care” and “achieve effective cost control” and be the same or less than that charged to others with an equivalent standard of living. This ruling has impacted cases in which a fee guideline was not applicable, specifically all pending cases involving ambulatory surgical services provided from 2001 through 2004 as well as all pending cases involving hospital outpatient services provided prior to March 1, 2008, when the Guidelines took effect. Since the Third Court of Appeals’ unfavorable ruling, collection, if any, in these cases depends on the Company’s ability to establish the criteria in this ruling. The Company was given the opportunity to establish the criteria in approximately 80 cases, which were set for hearing on the merits from March through May 2012 and was unsuccessful. In 2014, hearings were held in 23 of the Company’s hospital outpatient cases at SOAH. Decisions and Orders were handed down by SOAH adopting the methodology for determining “fair and reasonable” reimbursement that was put forth by the Company and ordered additional reimbursement in each of the 23 cases plus interest be paid to the Company. The carrier has appealed these decisions to Travis County district court and the cases have been consolidated. In April 2015 a large group of outpatient cases with various carriers were tried at SOAH. The Company and the carriers have presented their evidence and the parties’ closing arguments were filed in June 2015.
 
Due to the uncertainties regarding the accounts receivable in the MDR process, the 2008 and 2010 Third Court of Appeals’ opinions and our legal counsel’s advice that settlements with insurance carriers in stop-loss cases have virtually stopped, the Company had fully reserved all accounts receivable related to the MDR process as of August 31, 2008. The Company has had settlement negotiations with insurance carriers for ambulatory surgical center and hospital outpatient cases. Some of these negotiations have been successful. Any monies collected for these MDR accounts receivable is recorded as current period’s net patient service revenues.
 
Provision for Doubtful Accounts
 
Although outcomes vary, our policy is to attempt to collect amounts due from patients, including co-payments and deductibles due from patients with insurance, at the time of service while complying with all federal and state laws and regulations. In non-emergency circumstances or for elective procedures and services, it is our policy to verify insurance prior to a patient being treated; however, there are various exceptions that can occur.
 
The Company computes its allowances based on the estimated collections on its gross billed charges. The Company computes its estimate of allowance, which is a combination of contractual allowance and provision for doubtful accounts, by taking into account collections received, up to 30 days after the end of the period, for the services performed and also estimating amounts collectible for the services performed within the last six months.
 
Accounts receivable represent net receivables for services provided by the Company. At each balance sheet date management reviews the accounts receivable for collectibility and provides full allowance reserves for any accounts receivable deemed uncollectible.
 
The allowances stated as a percentage of gross receivables at the balance sheet dates is larger than the allowance percentage used to reduce gross billed charges due to the application of partial cash collections to the outstanding gross receivable balances, without any adjustment being made to the allowances. The allowance amounts netted against gross receivables are not adjusted until such time as the final collections on an individual receivable are recognized.
 
The focal point of our business is providing patient care services, including complex orthopedic and bariatric procedures. The Company pursues optimal reimbursement from third-party payers for these services. In some instances, we do not have contractual arrangements with third-party payers which provide for “prompt payment” which may result in additional time to collect the expected reimbursement.
 
The collection process may also be extended due to our efforts to obtain all optimal reimbursement available to the Company. Specifically, for medical services provided to injured workers, the Company may initially receive reimbursement that may not be within the fee guidelines or regulatory guidelines mandating reimbursement. The Company reviews and pursues those particular claims that are determined to warrant additional reimbursement pursuant to the fee or regulatory guidelines. The Company's pursuit of additional reimbursement amounts that it believes are due under fee or regulatory guidelines may be accomplished through established dispute resolution procedures with applicable regulatory authorities.
Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]
Noncontrolling Interest
 
The equity of minority investors (minority investors are generally physician groups and other healthcare providers that perform surgeries at the Company’s facilities) in certain subsidiaries of the Company is reported on the consolidated balance sheets as noncontrolling interest. Noncontrolling interest reported in the consolidated income statements reflect the respective interests in the income or loss of the limited partnerships or limited liability companies attributable to the minority investors (equity interest was 1% at May 31, 2015).
New Accounting Pronouncements, Policy [Policy Text Block]
Recent Accounting Pronouncements
 
No recent accounting pronouncements or other authoritative guidance has been issued that management considers likely to have a material impact on our consolidated financial statements.
XML 67 FilingSummary.xml IDEA: XBRL DOCUMENT 3.2.0.727 html 50 206 1 false 14 0 false 4 false false R1.htm 101 - Document - Document And Entity Information Sheet http://www.dynacq.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 102 - Statement - Consolidated Balance Sheets Sheet http://www.dynacq.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 103 - Statement - Consolidated Balance Sheets [Parenthetical] Sheet http://www.dynacq.com/role/ConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets [Parenthetical] Statements 3 false false R4.htm 104 - Statement - Consolidated Statements of Operations Sheet http://www.dynacq.com/role/ConsolidatedStatementsOfOperations Consolidated Statements of Operations Statements 4 false false R5.htm 105 - Statement - Consolidated Statements of Comprehensive Income (Loss) Sheet http://www.dynacq.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss Consolidated Statements of Comprehensive Income (Loss) Statements 5 false false R6.htm 106 - Statement - Consolidated Statements of Comprehensive Income (Loss) [Parenthetical] Sheet http://www.dynacq.com/role/ConsolidatedStatementsOfComprehensiveIncomeLossParenthetical Consolidated Statements of Comprehensive Income (Loss) [Parenthetical] Statements 6 false false R7.htm 107 - Statement - Consolidated Statements of Cash Flows Sheet http://www.dynacq.com/role/ConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows Statements 7 false false R8.htm 108 - Disclosure - General Sheet http://www.dynacq.com/role/General General Notes 8 false false R9.htm 109 - Disclosure - Basis of Presentation Sheet http://www.dynacq.com/role/BasisOfPresentation Basis of Presentation Notes 9 false false R10.htm 110 - Disclosure - Reclassification Sheet http://www.dynacq.com/role/Reclassification Reclassification Notes 10 false false R11.htm 111 - Disclosure - Cash and Cash Equivalents Sheet http://www.dynacq.com/role/CashAndCashEquivalents Cash and Cash Equivalents Notes 11 false false R12.htm 112 - Disclosure - Investments in Available-for-Sale and Trading Securities Sheet http://www.dynacq.com/role/InvestmentsInAvailableforsaleAndTradingSecurities Investments in Available-for-Sale and Trading Securities Notes 12 false false R13.htm 113 - Disclosure - Notes payable Notes http://www.dynacq.com/role/NotesPayable Notes payable Notes 13 false false R14.htm 114 - Disclosure - Inventories Sheet http://www.dynacq.com/role/Inventories Inventories Notes 14 false false R15.htm 115 - Disclosure - Use of Estimates Sheet http://www.dynacq.com/role/UseOfEstimates Use of Estimates Notes 15 false false R16.htm 116 - Disclosure - Net Income (Loss) per Common Share Sheet http://www.dynacq.com/role/NetIncomeLossPerCommonShare Net Income (Loss) per Common Share Notes 16 false false R17.htm 117 - Disclosure - Treasury Stock Sheet http://www.dynacq.com/role/TreasuryStock Treasury Stock Notes 17 false false R18.htm 118 - Disclosure - Stock Based Compensation Sheet http://www.dynacq.com/role/StockBasedCompensation Stock Based Compensation Notes 18 false false R19.htm 119 - Disclosure - Fair Value of Financial Instruments Sheet http://www.dynacq.com/role/FairValueOfFinancialInstruments Fair Value of Financial Instruments Notes 19 false false R20.htm 120 - Disclosure - Foreign Currency Translation Sheet http://www.dynacq.com/role/ForeignCurrencyTranslation Foreign Currency Translation Notes 20 false false R21.htm 121 - Disclosure - Revenue Recognition Sheet http://www.dynacq.com/role/RevenueRecognition Revenue Recognition Notes 21 false false R22.htm 122 - Disclosure - Noncontrolling Interest Sheet http://www.dynacq.com/role/NoncontrollingInterest Noncontrolling Interest Notes 22 false false R23.htm 123 - Disclosure - Accumulated Other Comprehensive Income (Loss) Sheet http://www.dynacq.com/role/AccumulatedOtherComprehensiveIncomeLoss Accumulated Other Comprehensive Income (Loss) Notes 23 false false R24.htm 124 - Disclosure - Contingencies Sheet http://www.dynacq.com/role/Contingencies Contingencies Notes 24 false false R25.htm 125 - Disclosure - Recent Accounting Pronouncements Sheet http://www.dynacq.com/role/RecentAccountingPronouncements Recent Accounting Pronouncements Notes 25 false false R26.htm 126 - Disclosure - Industry Segments and Geographic Information Sheet http://www.dynacq.com/role/IndustrySegmentsAndGeographicInformation Industry Segments and Geographic Information Notes 26 false false R27.htm 127 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.dynacq.com/role/SignificantAccountingPoliciesPolicies Significant Accounting Policies (Policies) Policies http://www.dynacq.com/role/RecentAccountingPronouncements 27 false false R28.htm 128 - Disclosure - Net Income (Loss) per Common Share (Tables) Sheet http://www.dynacq.com/role/NetIncomeLossPerCommonShareTables Net Income (Loss) per Common Share (Tables) Tables http://www.dynacq.com/role/NetIncomeLossPerCommonShare 28 false false R29.htm 129 - Disclosure - Stock Based Compensation (Tables) Sheet http://www.dynacq.com/role/StockBasedCompensationTables Stock Based Compensation (Tables) Tables http://www.dynacq.com/role/StockBasedCompensation 29 false false R30.htm 130 - Disclosure - Fair Value of Financial Instruments (Tables) Sheet http://www.dynacq.com/role/FairValueOfFinancialInstrumentsTables Fair Value of Financial Instruments (Tables) Tables http://www.dynacq.com/role/FairValueOfFinancialInstruments 30 false false R31.htm 131 - Disclosure - Revenue Recognition (Tables) Sheet http://www.dynacq.com/role/RevenueRecognitionTables Revenue Recognition (Tables) Tables http://www.dynacq.com/role/RevenueRecognition 31 false false R32.htm 132 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Tables) Sheet http://www.dynacq.com/role/AccumulatedOtherComprehensiveIncomeLossTables Accumulated Other Comprehensive Income (Loss) (Tables) Tables http://www.dynacq.com/role/AccumulatedOtherComprehensiveIncomeLoss 32 false false R33.htm 133 - Disclosure - Industry Segments and Geographic Information (Tables) Sheet http://www.dynacq.com/role/IndustrySegmentsAndGeographicInformationTables Industry Segments and Geographic Information (Tables) Tables http://www.dynacq.com/role/IndustrySegmentsAndGeographicInformation 33 false false R34.htm 134 - Disclosure - Basis of Presentation (Details Textual) Sheet http://www.dynacq.com/role/BasisOfPresentationDetailsTextual Basis of Presentation (Details Textual) Details http://www.dynacq.com/role/BasisOfPresentation 34 false false R35.htm 135 - Disclosure - Investments in Available-for-Sale and Trading Securities (Details Textual) Sheet http://www.dynacq.com/role/InvestmentsInAvailableforsaleAndTradingSecuritiesDetailsTextual Investments in Available-for-Sale and Trading Securities (Details Textual) Details http://www.dynacq.com/role/InvestmentsInAvailableforsaleAndTradingSecurities 35 false false R36.htm 136 - Disclosure - Notes Payable (Details Textual) Notes http://www.dynacq.com/role/NotesPayableDetailsTextual Notes Payable (Details Textual) Details 36 false false R37.htm 137 - Disclosure - Net Income (Loss) per Common Share (Details) Sheet http://www.dynacq.com/role/NetIncomeLossPerCommonShareDetails Net Income (Loss) per Common Share (Details) Details http://www.dynacq.com/role/NetIncomeLossPerCommonShareTables 37 false false R38.htm 138 - Disclosure - Net Income (Loss) per Common Share (Details Textual) Sheet http://www.dynacq.com/role/NetIncomeLossPerCommonShareDetailsTextual Net Income (Loss) per Common Share (Details Textual) Details http://www.dynacq.com/role/NetIncomeLossPerCommonShareTables 38 false false R39.htm 139 - Disclosure - Treasury Stock (Details Textual) Sheet http://www.dynacq.com/role/TreasuryStockDetailsTextual Treasury Stock (Details Textual) Details http://www.dynacq.com/role/TreasuryStock 39 false false R40.htm 140 - Disclosure - Stock Based Compensation (Details) Sheet http://www.dynacq.com/role/StockBasedCompensationDetails Stock Based Compensation (Details) Details http://www.dynacq.com/role/StockBasedCompensationTables 40 false false R41.htm 141 - Disclosure - Stock Based Compensation (Details 1) Sheet http://www.dynacq.com/role/StockBasedCompensationDetails1 Stock Based Compensation (Details 1) Details http://www.dynacq.com/role/StockBasedCompensationTables 41 false false R42.htm 142 - Disclosure - Stock Based Compensation (Details Textual) Sheet http://www.dynacq.com/role/StockBasedCompensationDetailsTextual Stock Based Compensation (Details Textual) Details http://www.dynacq.com/role/StockBasedCompensationTables 42 false false R43.htm 143 - Disclosure - Fair Value of Financial Instruments (Details) Sheet http://www.dynacq.com/role/FairValueOfFinancialInstrumentsDetails Fair Value of Financial Instruments (Details) Details http://www.dynacq.com/role/FairValueOfFinancialInstrumentsTables 43 false false R44.htm 144 - Disclosure - Fair Value of Financial Instruments (Details Textual) Sheet http://www.dynacq.com/role/FairValueOfFinancialInstrumentsDetailsTextual Fair Value of Financial Instruments (Details Textual) Details http://www.dynacq.com/role/FairValueOfFinancialInstrumentsTables 44 false false R45.htm 145 - Disclosure - Revenue Recognition (Details) Sheet http://www.dynacq.com/role/RevenueRecognitionDetails Revenue Recognition (Details) Details http://www.dynacq.com/role/RevenueRecognitionTables 45 false false R46.htm 146 - Disclosure - Revenue Recognition (Details Textual) Sheet http://www.dynacq.com/role/RevenueRecognitionDetailsTextual Revenue Recognition (Details Textual) Details http://www.dynacq.com/role/RevenueRecognitionTables 46 false false R47.htm 147 - Disclosure - Noncontrolling Interest (Details Textual) Sheet http://www.dynacq.com/role/NoncontrollingInterestDetailsTextual Noncontrolling Interest (Details Textual) Details http://www.dynacq.com/role/NoncontrollingInterest 47 false false R48.htm 148 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Details) Sheet http://www.dynacq.com/role/AccumulatedOtherComprehensiveIncomeLossDetails Accumulated Other Comprehensive Income (Loss) (Details) Details http://www.dynacq.com/role/AccumulatedOtherComprehensiveIncomeLossTables 48 false false R49.htm 149 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Details Textual) Sheet http://www.dynacq.com/role/AccumulatedOtherComprehensiveIncomeLossDetailsTextual Accumulated Other Comprehensive Income (Loss) (Details Textual) Details http://www.dynacq.com/role/AccumulatedOtherComprehensiveIncomeLossTables 49 false false R50.htm 150 - Disclosure - Contingencies (Details Textuals) Sheet http://www.dynacq.com/role/ContingenciesDetailsTextuals Contingencies (Details Textuals) Details http://www.dynacq.com/role/Contingencies 50 false false R51.htm 151 - Disclosure - Industry Segments and Geographic Information (Details) Sheet http://www.dynacq.com/role/IndustrySegmentsAndGeographicInformationDetails Industry Segments and Geographic Information (Details) Details http://www.dynacq.com/role/IndustrySegmentsAndGeographicInformationTables 51 false false R52.htm 152 - Disclosure - Industry Segments and Geographic Information (Details 1) Sheet http://www.dynacq.com/role/IndustrySegmentsAndGeographicInformationDetails1 Industry Segments and Geographic Information (Details 1) Details http://www.dynacq.com/role/IndustrySegmentsAndGeographicInformationTables 52 false false R53.htm 153 - Disclosure - Industry Segments and Geographic Information (Details Textual) Sheet http://www.dynacq.com/role/IndustrySegmentsAndGeographicInformationDetailsTextual Industry Segments and Geographic Information (Details Textual) Details http://www.dynacq.com/role/IndustrySegmentsAndGeographicInformationTables 53 false false All Reports Book All Reports In ''Consolidated Balance Sheets'', column(s) 3, 4 are contained in other reports, so were removed by flow through suppression. In ''Consolidated Statements of Cash Flows'', column(s) 1, 2 are contained in other reports, so were removed by flow through suppression. dyii-20150531.xml dyii-20150531_cal.xml dyii-20150531_def.xml dyii-20150531_lab.xml dyii-20150531_pre.xml dyii-20150531.xsd true true XML 68 R38.htm IDEA: XBRL DOCUMENT v3.2.0.727
Net Income (Loss) per Common Share (Details Textual) - shares
9 Months Ended
May. 31, 2015
May. 31, 2014
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Stock options with exercise prices exceeding current market prices 784,000 1,013,000
XML 69 R20.htm IDEA: XBRL DOCUMENT v3.2.0.727
Foreign Currency Translation
9 Months Ended
May. 31, 2015
Foreign Currency [Abstract]  
Foreign Currency Disclosure [Text Block]
Foreign Currency Translation
 
The functional currency of the Company as a whole is the U.S. Dollar. The Company has designated the U.S. Dollar as the functional currency for Sino Bond Inc. Limited, a Hong Kong corporation and wholly owned subsidiary of the Company (“Sino Bond”). The effects of foreign currency exchange adjustments are included as a component of Rent and Other Income in the Consolidated Statements of Operations.